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The	   enteric	   nervous	   system	   (ENS)	   arises	  mainly	   from	   cells	   exiting	   the	   vagal	   neural	   crest,	  
entering	  the	  bowel	  and	  migrating	  caudally.	  	  A	  failure	  in	  this	  migratory	  process	  is	  thought	  to	  
result	  in	  the	  clinical	  entity	  Hirschsprung’s	  disease	  (HSCR),	  which	  is	  typically	  characterised	  by	  
the	   absence	   of	   enteric	   ganglia	   in	   the	   colon	   and	   rectum	   (aganglionosis).	   	   Untreated	  HSCR	  
may	  present	  with	  life-­‐threatening	  bowel	  obstruction	  in	  the	  first	  few	  days	  of	  life.	  	  However,	  
despite	   recent	   surgical	   advances	   children	   and	   adults	   still	   suffer	   significant	   life-­‐long	   post-­‐
operative	  morbidity.	  
ENS	  progenitor	  cells	   (ENSPC)	  have	  been	  shown	   to	  persist	   in	   the	  postnatal	  bowel,	   thereby	  
stimulating	   research	   into	   the	   potential	   of	   manipulating	   or	   transplanting	   these	   cells	   to	  
improve	  long-­‐term	  outcomes.	  	  Early	  results	  have	  been	  promising,	  ENSPC	  have	  been	  isolated	  
from	  children	  with	  HSCR	  and	  clonally	  expanded	  in	  cultured	  neurospheres,	  after	  which	  they	  
have	   been	   transplanted	   into	   aganglionic	   embryonic	   mouse	   gut	   ex-­‐vivo	   and	   shown	   to	  
restore	   a	   normal	   pattern	   of	   contractility.	   	   However,	   questions	   still	   remain	   about	   the	  
functional	   potential	   and	   the	   safety	   implications	   of	   transplanting	   these	   cells	   back	   into	  
humans.	   	  Therefore,	  this	  thesis	   is	  aimed	  at	   improving	  our	  understanding	  of	  the	  properties	  
of	  these	  cells	  and	  the	  mechanisms	  controlling	  their	  behaviour	  when	  they	  are	  brought	  into	  
culture	  and	  after	  subsequent	  transplantation.	  
The	   first	   part	   of	   this	   thesis	   focuses	   on	   the	   proliferation	   of	   ENSPC	   within	   the	   in-­‐vitro	  
environment	   of	   cultured	  mouse	   and	   human	   neurospheres.	   	   The	  main	   findings	  were	   that	  
cells	   undergoing	   proliferation	   are	   predominantly	   found	   at	   the	   neurosphere	   periphery	  
rather	   than	   being	   evenly	   distributed	   throughout	   the	   neurosphere.	   	   Subsequently,	   post-­‐
mitotic	   peripheral	   cells	   were	   found	   to	   be	   distributed	   throughout	   the	   neurosphere.	  
Furthermore,	   using	   embryonic	   and	   postnatal	  mouse	   tissue	   it	  was	   demonstrated	   that	   the	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proportion	   of	   cells	   undergoing	   of	   proliferation	   decreased	  with	   increasing	  maturity	   of	   the	  
source	  tissue.	  
The	  second	  part	  of	  the	  thesis	  identifies	  the	  requirement	  for	  Notch	  signalling	  pathway	  in	  the	  
self-­‐renewal	  of	  undifferentiated	  human	  ENSPC.	  	  Inhibition	  of	  the	  Notch	  signalling	  pathway	  
with	   both	   chemical	   inhibitors	   and	   siRNA	   knockdown	   resulted	   in	   decreased	   ENSPC	  
proliferation	   together	   with	   increased	   neuronal	   differentiation.	   	   Manipulation	   of	   this	  
pathway	  may	  therefore	  improve	  both	  the	  effectiveness	  and	  safety	  of	  any	  future	  cell-­‐based	  
therapy.	  
The	   next	   section	   of	   the	   thesis	   describes	   the	   development	   of	   an	   ex-­‐vivo	   human	   colonic	  
smooth	  muscle	  model	   to	   investigate	   the	  behaviour	  of	  ENSPC	   in	  an	  environment	  closer	   to	  
that	   of	   the	   human	   colon.	   	   The	   chapter	   describes	   the	   development	   and	   maintenance	   of	  
human	   colonic	   smooth	  muscle	   cells	   in	   long-­‐term	   culture	   and	   demonstrates	   contractility,	  
thus	   providing	   a	   model	   in	   which	   ENSPC	   behaviour	   can	   be	   investigated	   in	   a	   more	  
physiologically	  relevant	  environment.	  
During	   the	   routine	  culture	  of	  human	  aganglionic	   smooth	  muscle	  preliminary	  observations	  
were	   made	   consistent	   with	   the	   presence	   of	   cells	   that	   could	   give	   rise	   to	   neurospheres,	  
despite	   the	   absence	   of	   an	   ENS	   in	   this	   region	   of	   the	   bowel.	   	   The	   final	   part	   of	   this	   thesis	  
confirms	   the	   presence	   of	   ENSPC	   within	   the	   aganglionic	   bowel	   and	   characterises	   their	  
behaviour.	   	  These	  progenitors	  are	  demonstrated	   to	  differentiate	   into	  mature	  ENS	  specific	  
neuronal	  phenotypes,	   and	   importantly	  have	   the	   capability	   to	   restore	  a	  normal	  pattern	  of	  
contractility	  in	  the	  embryonic	  aganglionic	  gut	  model.	  
Taken	   together	   the	   work	   in	   this	   thesis	   furthers	   our	   understanding	   of	   the	   control	   and	  
behaviour	  of	  human	  ENSPC.	  	  Furthermore,	  demonstration	  of	  the	  existence	  of	  ENSPC	  in	  the	  
bowel	  of	  children	  with	  HSCR	  raises	  important	  questions	  regarding	  both	  the	  aetiology	  HSCR	  
and	  the	  potential	  to	  utilise	  the	  cells	  in	  future	  autologous	  cell-­‐based	  therapies.	  	  
|	  Contents	  
v	  	  
Table	  of	  Contents	  
Acknowledgements	  .............................................................................	  i	  
Abstract	  .............................................................................................	  iii	  
Table	  of	  Contents	  ...............................................................................	  v	  
Abbreviations	  ....................................................................................	  xi	  
Chapter	  1:	  Introduction	  ......................................................................	  1	  
1.1.	   The	  Enteric	  Nervous	  System	  .............................................................................	  2	  
1.1.1.	   Function	  of	  the	  enteric	  nervous	  system	  ........................................................	  3	  
1.1.2.	   Origin	  &	  development	  of	  the	  Enteric	  Nervous	  System	  ..................................	  5	  
1.1.3.	   The	  sacral	  neural	  crest	  contribution	  ..............................................................	  7	  
1.1.4.	   Control	  of	  the	  developing	  ENS	  .......................................................................	  8	  
1.1.4.1.	   Glial	  cell	  line-­‐derived	  neurotrophic	  factor	  (GDNF)/	  RET	  .......................................	  8	  
1.1.4.2.	   Endothelin-­‐3	  (ET3)	  /	  Endothelin	  type-­‐B	  receptor	  (EDNRB)	  ...................................	  9	  
1.2.	   Intestinal	  Smooth	  muscle	  ...............................................................................	  11	  
1.2.1.	   Origin	  and	  development	  ..............................................................................	  11	  
1.2.2.	   The	  development	  of	  gut	  motility	  .................................................................	  11	  
1.2.3.	   Intrinsic	  (myogenic)	  contraction	  ..................................................................	  12	  
1.3.	   Interstitial	  Cells	  of	  Cajal	  ..................................................................................	  13	  
1.3.1.	   Origin	  ...........................................................................................................	  13	  
1.3.2.	   Function	  .......................................................................................................	  14	  
1.4.	   Notch	  signalling	  ..............................................................................................	  15	  
1.1.5.1.	   The	  canonical	  Notch	  signalling	  pathway	  .............................................................	  15	  
1.1.4.2.	   Role	  of	  Notch	  in	  the	  central	  nervous	  system	  ......................................................	  16	  
1.1.4.3.	   The	  role	  of	  Notch	  in	  the	  enteric	  nervous	  system	  ...............................................	  17	  
1.5.	   Hirschsprung’s	  disease	  and	  other	  Neuropathies	  of	  the	  Gut	  .............................	  19	  
1.5.1.	   Overview	  ......................................................................................................	  19	  
1.5.3.	   Hirschsprung’s	  disease	  .................................................................................	  20	  
1.5.3.1.	   Epidemiology	  and	  aetiology	  of	  HSCR	  ..................................................................	  21	  
1.5.3.2.	   HSCR	  Genetics	  .....................................................................................................	  23	  
1.5.3.3.	   Current	  surgical	  management	  ............................................................................	  24	  
1.5.3.4.	   Long-­‐term	  Outcomes	  ..........................................................................................	  24	  
1.6.	   Development	  of	  potential	  cell	  based	  therapies	  for	  HSCR	  ................................	  26	  
1.6.1.	   Sources	  of	  stem/progenitor	  cells	  .................................................................	  26	  
1.6.1.2.	   The	  central	  nervous	  system	  ................................................................................	  26	  
1.6.1.2.	   Human	  embryonic	  stem	  cells	  .............................................................................	  27	  
1.6.1.3.	   The	  enteric	  nervous	  system	  ................................................................................	  28	  
1.6.2.	   Potential	  role	  of	  antenatal	  intervention	  ......................................................	  29	  
|	  Contents	  
vi	  	  
1.6.3.	   Enteric	  nervous	  system	  progenitor	  cells	  ......................................................	  30	  
1.6.3.1.	   Isolation	  of	  ENSPC	  ...............................................................................................	  30	  
1.6.3.2.	   In-­‐vitro	  culture	  of	  ENSPC	  ....................................................................................	  31	  
1.6.3.3.	   Origin	  of	  ENSPC	  ...................................................................................................	  31	  
1.6.4.	   Postnatal	  ENSPC-­‐based	  therapies	  ................................................................	  33	  
1.6.5.	   Outstanding	  questions	  .................................................................................	  34	  
1.6.5.1.	   Is	  transplantation	  of	  autologous	  ENSPC	  safe?	  ....................................................	  34	  
1.6.5.2.	   Will	  transplanted	  ENSPC	  survive	  in	  human	  post-­‐natal	  aganglionic	  bowel?	  .......	  34	  
1.6.5.3.	   Which	  cell	  type	  will	  provide	  the	  best	  functional	  response?	  ...............................	  36	  
1.6.5.4.	   What	  is	  the	  most	  effective	  route	  to	  deliver	  cells?	  ..............................................	  37	  
1.7	   Aims	  of	  the	  thesis	  ...........................................................................................	  38	  
Chapter	  2:	  Materials	  and	  Methods	  ...................................................	  39	  
2.1.	   Standard	  sample	  isolation	  techniques	  ............................................................	  39	  
2.1.1.	   Embryonic	  mouse	  ........................................................................................	  39	  
2.1.2.	   Adult	  and	  neonatal	  mouse	  ...........................................................................	  40	  
2.1.3.	   Postnatal	  human	  ..........................................................................................	  40	  
2.2.	   Standard	  buffers	  and	  tissue	  culture	  media	  ......................................................	  43	  
2.2.1.	   Standard	  neurosphere	  medium	  (SN	  Medium)	  .............................................	  43	  
2.2.2.	   Fetal	  Bovine	  Medium	  (FB	  Medium)	  .............................................................	  43	  
2.2.3.	   Horse	  Serum	  Medium	  (HS	  Medium)	  ............................................................	  43	  
2.2.4.	   Tissue	  Culture	  Medium	  (TC	  Medium)	  ..........................................................	  44	  
2.2.5.	   Immunofluorescence	  Blocking	  Buffer	  (IBB)	  .................................................	  44	  
2.3.	   Cell	  Culture	  Techniques	  ..................................................................................	  45	  
2.3.1.	   Generation	  of	  neurospheres	  from	  primary	  cultures	  ...................................	  45	  
2.3.1.1.	   Embryonic	  mouse	  ...............................................................................................	  45	  
2.3.1.2.	   Neonatal	  mouse	  .................................................................................................	  46	  
2.3.1.3.	   Ganglionic-­‐derived	  human	  neurospheres	  ..........................................................	  46	  
2.3.1.4.	   Aganglionic-­‐derived	  human	  neurospheres	  .........................................................	  47	  
2.3.2.	   Colonic	  smooth	  muscle	  cultures	  ..................................................................	  48	  
2.3.2.1.	   Mouse	  colonic	  smooth	  muscle	  ...........................................................................	  48	  
2.3.2.2.	   Human	  colonic	  smooth	  muscle	  ...........................................................................	  48	  
2.3.3.	   HEK293T	  cell	  culture	  ................................................................................................	  48	  
2.4.	   Notch	  Inhibition	  .............................................................................................	  49	  
2.4.1.	   Gamma	  secretase	  inhibition	  ........................................................................	  49	  
2.4.2.	   siRNA	  inhibition	  of	  RBP-­‐Jκ	  ............................................................................	  49	  
2.5.	   Transplantation	  Assays	  ...................................................................................	  49	  
2.5.1.	   Bowel	  explant	  culture	  ..................................................................................	  50	  
2.5.2.	   Assessment	  of	  bowel	  contractility	  ...............................................................	  51	  
2.6.	   Lentiviral	  transfection	  .....................................................................................	  52	  
2.6.1.	   Plasmid	  cloning	  ............................................................................................	  52	  
2.6.2.	   HEK293T	  transfection	  ..................................................................................	  52	  
2.6.3.	   Viral	  transductions	  .......................................................................................	  53	  
2.7.	   Immunohistochemistry	  ...................................................................................	  54	  
2.7.1.	   Tissue	  section	  preparation	  ...........................................................................	  54	  
|	  Contents	  
vii	  	  
2.7.1.1.	   Full	  thickness	  colonic	  frozen	  sections	  .................................................................	  54	  
2.7.1.2.	   Neurosphere	  frozen	  sections	  ..............................................................................	  54	  
2.7.1.3.	   Paraffin	  sections	  .................................................................................................	  55	  
2.7.2.	   Dissociated	  neurosphere	  preparations	  ........................................................	  56	  
2.7.2.1.	   Chamber	  slide	  preparation	  .................................................................................	  56	  
2.7.2.2.	   Cell	  centrifugation	  for	  single	  cell	  analysis	  ...........................................................	  56	  
2.7.3.	   Staining	  protocols	  ........................................................................................	  57	  
2.7.3.1.	   Haematoxylin	  and	  eosin	  (H&E)	  ...........................................................................	  57	  
2.7.3.2.	   Standard	  immunofluorescence	  ..........................................................................	  57	  
2.7.3.3.	   Assessment	  of	  proliferation	  ................................................................................	  58	  
2.7.4.	   Primary	  antibodies	  .......................................................................................	  59	  
2.7.5.	   Secondary	  antibodies	  ..................................................................................	  59	  
2.8.	   Molecular	  biology	  ...........................................................................................	  60	  
2.8.1.	   RNA	  extraction	  .............................................................................................	  60	  
2.8.1.1.	   Neurospheres	  .....................................................................................................	  60	  
2.8.1.2.	   Colonic	  tissue	  ......................................................................................................	  60	  
2.8.2.	   cDNA	  synthesis	  ............................................................................................	  61	  
2.8.3.	   qRT-­‐PCR	  reaction	  .........................................................................................	  61	  
2.8.4.	   Primers	  .........................................................................................................	  62	  
2.9.	   Image	  acquisition	  and	  analysis	  .......................................................................	  63	  
2.9.1.	   Microscopy	  ..................................................................................................	  63	  
2.9.2.	   Image	  analysis	  software	  ...............................................................................	  63	  
2.10.	   Smooth	  Muscle	  Physiology	  .............................................................................	  64	  
2.11.	   Statistical	  Analysis	  ..........................................................................................	  65	  
Chapter	  3:	  Cell	  Proliferation	  within	  Mouse	  and	  Human	  Neurospheres
	  .........................................................................................................	  66	  
3.1.	   Introduction	  ...................................................................................................	  66	  
3.1.1.	   Background	  ..................................................................................................	  66	  
3.1.2.	   Attribution	  of	  work	  in	  this	  chapter	  ..............................................................	  67	  
3.1.3.	   Aims	  .............................................................................................................	  67	  
3.2.	   Results	  ............................................................................................................	  68	  
3.2.1.	   Neurosphere	  formation	  is	  influenced	  by	  cell	  density	  ..................................	  68	  
3.2.2.	   Expression	  and	  localisation	  of	  typical	  ENS	  markers	  .....................................	  69	  
3.2.3.	   Localisation	  of	  proliferation	  in	  embryonic	  mouse	  neurospheres	  is	  
predominantly	  peripheral	  .............................................................................................	  71	  
3.2.4.	   Following	  proliferation	  cells	  are	  predominantly	  located	  in	  the	  central	  zone	  
of	  both	  mouse	  and	  human	  neurospheres	  .....................................................................	  73	  
3.2.5.	   Rate	  of	  proliferation	  in	  neurospheres	  is	  determined	  by	  cell	  age	  ................	  76	  
3.3.	   Discussion	  ......................................................................................................	  77	  
3.3.1.	   Rate	  of	  neurosphere	  formation	  is	  influenced	  by	  cell	  density	  ......................	  77	  
3.3.2.	   Expression	  and	  localisation	  of	  typical	  ENS	  markers	  is	  similar	  between	  
neurospheres	  derived	  from	  mouse	  and	  human	  sources	  ..............................................	  78	  
3.3.3.	   Proliferation	  occurs	  predominantly	  at	  the	  periphery	  of	  neurospheres	  .......	  79	  
3.3.4.	   Rate	  of	  proliferation	  in	  neurospheres	  is	  determined	  by	  the	  developmental	  
maturity	  of	  the	  cells	  ......................................................................................................	  81	  
|	  Contents	  
viii	  	  
3.4.	   Conclusion	  ......................................................................................................	  83	  
Chapter	  4:	  The	  Role	  of	  Notch	  Signalling	  in	  Human	  ENS	  Derived	  Cells	   84	  
4.1.	   Introduction	  ...................................................................................................	  84	  
4.1.1.	   Background	  ..................................................................................................	  84	  
4.1.2.	   Attribution	  of	  work	  in	  this	  chapter	  ..............................................................	  85	  
4.1.3.	   Aims	  .............................................................................................................	  85	  
4.2.	   Results	  ............................................................................................................	  86	  
4.2.1.	   Key	  components	  of	  the	  Notch	  signalling	  pathway	  are	  present	  in	  both	  
human	  post-­‐natal	  bowel	  and	  neurospheres.	  ................................................................	  86	  
4.2.2.	   Inhibition	  of	  the	  Notch	  signalling	  pathway	  inhibits	  cell	  proliferation	  and	  
promotes	  neuronal	  differentiation	  ...............................................................................	  89	  
4.2.3.	   DAPT	  administration	  does	  not	  appear	  to	  reduce	  the	  proportion	  of	  
proliferating	  cells	  by	  induction	  of	  apoptosis	  .................................................................	  91	  
4.2.4.	   Dissociation	  of	  mature	  human	  neurospheres	  increases	  cell	  proliferation	  and	  
neuronal	  differentiation.	  ...............................................................................................	  92	  
4.2.5.	   Selective	  siRNA	  knockdown	  of	  the	  canonical	  Notch	  pathway	  confirms	  the	  
involvement	  Notch	  in	  regulating	  cell	  proliferation	  and	  neuronal	  differentiation.	  .......	  93	  
4.2.6	   Rate	  of	  neuronal	  differentiation	  is	  increased	  following	  Notch	  inhibition	  in	  cells	  
dissociated	  from	  neurospheres.	  ...................................................................................	  97	  
4.2.7.	   Notch	  signalling	  is	  disrupted	  by	  dissociation	  of	  neurospheres	  ..................	  100	  
4.3.	   Discussion	  ....................................................................................................	  104	  
4.3.1.	   Notch	  ligands	  and	  receptors	  are	  present	  the	  human	  post-­‐natal	  ENS	  ........	  104	  
4.3.2.	   Notch	  inhibition	  reduces	  proliferation	  in	  human	  ENS	  progenitor	  cells	  .....	  105	  
4.3.3.	   Notch	  inhibition	  increases	  the	  neuronal	  differentiation	  human	  ENS	  neural	  
progenitor	  cells.	  ..........................................................................................................	  107	  
4.3.4.	   Notch	  signalling	  is	  disrupted	  by	  dissociation	  of	  neurospheres	  ..................	  108	  
4.4.	   Conclusions	  ..................................................................................................	  110	  
Chapter	  5:	  Development	  of	  a	  mature	  human	  colonic	  smooth	  muscle	  
model	  .............................................................................................	  111	  
5.1.	   Introduction	  .................................................................................................	  111	  
5.1.1.	   Background	  ................................................................................................	  111	  
5.1.2.	   Attribution	  of	  work	  contained	  within	  this	  chapter	  ....................................	  112	  
5.1.3.	   Aims	  ...........................................................................................................	  112	  
5.2.	   Results	  ..........................................................................................................	  113	  
5.2.1.	   Development	  of	  a	  fibrin	  based	  human	  colonic	  smooth	  muscle	  model	  .....	  113	  
5.2.2.	   Confirmation	  that	  fibrin-­‐based	  HCSMMs	  contain	  smooth	  muscle	  ............	  115	  
5.2.3.	   Transplanted	  ENSPC	  survive	  and	  migrate	  within	  fibrin-­‐based	  HCSMMs	  ...	  117	  
5.2.4.	   Decellularised	  colonic	  HCSMM	  contains	  physiologically	  active	  smooth	  
muscle	   122	  
5.2.5.	   Cultured	  smooth	  muscle	  from	  aganglionic	  human	  bowel	  contains	  cells	  with	  
a	  neuronal	  phenotype	  .................................................................................................	  124	  
5.3.	   Discussion	  ....................................................................................................	  126	  
|	  Contents	  
ix	  	  
5.3.1	   Development	  of	  a	  fibrin	  based	  HCSMM	  .........................................................	  126	  
5.3.2.	   Development	  of	  a	  decellularised	  mouse	  colon	  based	  HCSMM	  .................	  128	  
5.3.3.	   Cultured	  smooth	  muscle	  contains	  cells	  with	  a	  neuronal	  phenotype	  .........	  130	  
5.4.	   Conclusions	  ..................................................................................................	  131	  
Chapter	  6:	  Neurospheres	  from	  Aganglionic	  Hirschsprung	  Bowel	  .....	  132	  
6.1.	   Introduction	  .................................................................................................	  132	  
6.1.1.	   Background	  ................................................................................................	  132	  
6.1.2.	   Aims	  ...........................................................................................................	  133	  
6.2.	   Results	  ..........................................................................................................	  134	  
6.2.1.	   Cells	  from	  human	  aganglionic	  colonic	  biopsies	  have	  the	  potential	  to	  form	  
neurospheres	  in-­‐vitro.	  .................................................................................................	  134	  
6.2.2.	   HSCR	  aganglionic-­‐derived	  neurospheres	  possess	  increasing	  proportions	  of	  
cells	  expressing	  neural	  crest	  markers	  .........................................................................	  137	  
6.2.3.	   HSCR	  aganglionic-­‐derived	  neurospheres	  possess	  increasing	  proportions	  of	  
the	  immature	  glial	  marker	  GFAP	  over	  time.	  ...............................................................	  140	  
6.2.4.	   HSCR	  aganglionic-­‐derived	  neurospheres	  possess	  increasing	  proportions	  of	  
cells	  expressing	  neuronal	  markers	  over	  time	  ..............................................................	  140	  
6.2.5.	   HSCR	  aganglionic-­‐derived	  neurospheres	  contain	  cells	  capable	  of	  
differentiating	  into	  mature	  neuronal	  phenotypes	  ......................................................	  143	  
6.2.6.	   Cell	  proliferation	  does	  not	  differ	  between	  HSCR	  aganglionic-­‐	  or	  ganglionic-­‐
derived	  neurospheres	  .................................................................................................	  144	  
6.2.7.	   Transplanted	  HSCR	  aganglionic-­‐derived	  neurospheres	  give	  rise	  to	  cells	  
expressing	  immature	  neuronal	  markers	  .....................................................................	  144	  
6.2.8.	   Transplanted	  HSCR	  aganglionic-­‐derived	  neurospheres	  can	  restore	  a	  normal	  
pattern	  of	  contraction	  to	  an	  embryonic,	  aganglionic	  mouse	  model	  ...........................	  146	  
6.3.	   Discussion	  ....................................................................................................	  148	  
6.4.1.	   Aganglionic	  HSCR	  bowel	  contains	  neuronal	  progenitors	  ...........................	  148	  
6.4.2.	   Cells	  from	  human	  aganglionic-­‐	  and	  ganglionic-­‐derived	  neurospheres	  
differentiate	  to	  express	  neuronal	  markers	  characteristic	  of	  the	  ENS	  .........................	  149	  
6.4.3.	   ENSPC	  derived	  from	  aganglionic	  bowel	  can	  generate	  functional	  neurons	  150	  
6.4.4.	   Progenitors	  in	  the	  aganglionic	  colon	  may	  arise	  from	  extrinsic	  nerve	  fibres
	   151	  
6.4.	   Conclusions	  ..................................................................................................	  153	  
Chapter	  7:	  Final	  conclusions	  ...........................................................	  154	  
7.1.	  	  Embryonic	  ENSPC	  behaviour	  is	  not	  comparable	  to	  that	  of	  similar	  cells	  derived	  from	  
the	  postnatal	  gut	  ......................................................................................................	  155	  
7.2.	  	  Notch	  signalling	  is	  involved	  in	  the	  regulation	  of	  both	  proliferation	  and	  
differentiation	  of	  ENSPC	  ...........................................................................................	  155	  
7.3.	  	  Transplanted	  ENSPC	  behaviour	  can	  be	  investigated	  in	  a	  post-­‐natal	  human	  
aganglionic	  colonic	  smooth	  muscle	  model	  ................................................................	  156	  
7.4.	  	  ENSPC	  can	  be	  isolated	  from	  HSCR	  aganglionic	  bowel	  .........................................	  157	  
7.5.	  	  Final	  conclusion	  .................................................................................................	  158	  
|	  Contents	  
x	  	  
7.6.	  	  Future	  work	  ......................................................................................................	  159	  
7.6.1.	  	  Role	  of	  Notch	  signalling	  post-­‐transplantation	  ..................................................	  159	  
7.6.2.	  	  Development	  of	  the	  human	  colonic	  smooth	  muscle	  model	  ............................	  159	  
7.6.3.	  	  The	  optimum	  method	  of	  ENSPC	  transplantation	  .............................................	  160	  
7.6.4.	  	  Origin	  of	  ENSPC	  in	  the	  aganglionic	  bowel	  ........................................................	  160	  
7.6.5.	  	  Stimulating	  ENSPC	  differentiation	  in	  aganglionic	  bowel	  ..................................	  161	  
7.7.	  	  Publications	  arising	  from	  this	  thesis	  ..................................................................	  162	  
References:	  ....................................................................................	  163	  









Abbreviations	  used	  within	  this	  thesis:	  
ANOVA	  	   Analysis	  of	  variance	  
cGRP	   	   Calcitonin	  gene	  related	  peptide	  
ChAT	   	   Choline	  acetyl	  transferase	  
CIPO	   	   Chronic	  intestinal	  pseudo-­‐obstruction	  
CNS	   	   Central	  nervous	  system	  
DAPT	   	   N-­‐[N-­‐(3,5-­‐Difluorophenacetyl)-­‐L-­‐alanyl]-­‐S-­‐phenylglycine	  t-­‐butyl	  ester	  
DMEM	   	   Dulbecco’s	  modified	  Eagle	  medium	  
DMSO	   	   Dimethyl	  sulfoxide	  
DPC	   	   Days	  post	  coitum	  
EDNRB	   	   Endothelin	  receptor	  type-­‐B	  
EdU	   	   5-­‐ethynyl-­‐2’-­‐deoxyuridine	  
EGF	   	   Epidermal	  growth	  factor	  
eM	   	   Embryonic	  mouse	  
ENS	   	   Enteric	  nervous	  system	  
ENSPC	   	   Enteric	  nervous	  system	  stem	  cell	  
Et3	   	   Endothelin	  3	  
FBM	   	   Fetal	  bovine	  media	  
FGF	   	   Fibroblast	  growth	  factor	  
FITC	   	   Fluorescein	  isothiocyanate	  
GDNF	   	   Glial	  cell-­‐line	  derived	  neurotrophic	  factor	  
GFAP	   	   Glial	  fibrillary	  acidic	  protein	  
GFP	   	   Green	  fluorescent	  protein	  
GRP	   	   Gastrin	  related	  peptide	  
HCSMM	   Human	  colonic	  smooth	  muscle	  model	  
H&E	   	   Haematoxylin	  and	  eosin	  
HES	   	   Hairy	  expresser	  of	  split	  
HESC	   	   Human	  embryonic	  stem	  cells	  
Hey	   	   Hairy	  expressor	  of	  split	  with	  YRPW	  motif	  
5-­‐HT	   	   5-­‐hydroxytryptamine	  
HSM	   	   Horse	  serum	  media	  
|	  Abbreviations	  
xii	  	  
HSCR	   	   Hirschsprung’s	  disease	  
IBB	   	   Immunofluorescence	  blocking	  Buffer	  
ICC	   	   Interstitial	  cells	  of	  Cajal	  
LB	   	   Lysogeny	  broth	  
NCC	   	   Neural	  crest	  cell	  
NICD	   	   Notch	  intracellular	  domain	  
nM	   	   Neonatal	  mouse	  
NO	   	   Nitric	  oxide	  
nNOS	   	   Neuronal	  nitric	  oxide	  synthase	  
NPY	   	   Neuropeptide	  Y	  
PACP	   	   Pituitary	  adenyl-­‐cyclase	  activating	  peptide	  
PBS	   	   Phosphate	  buffered	  saline	  
PCR	   	   Polymerase	  chain	  reaction	  
PGP9.5	   	   Protein	  gene	  product	  9.5	  
RBP-­‐Jκ	   	   Recombination	  signal	  binding	  protein	  for	  immunoglobulin	  κ-­‐J	  
RET	   	   Rearranged	  during	  transfection	  
RT-­‐PCR	   	   Reverse	  transcriptase	  polymerase	  chain	  reaction	  
S100B	   	   S100	  Calcium	  binding	  protein	  B	  
SDC	   	   Sodium	  deoxycholate	  
SFFV	   	   Spleen	  focus	  forming	  vector	  
siRNA	   	   silencing	  ribonucleic	  acid	  
SMA	   	   Smooth	  muscle	  actin	  
SNM	   	   Standard	  neurospheres	  media	  
TCM	   	   Tissue	  Culture	  Media	  
TK	   	   tachykinin	  
Tuj	   	   Neuron-­‐specific	  class	  III	  ß-­‐tubulin	  
VIP	   	   Vasoinhibitory	  peptide	  
	  
	  
Chapter	  1	  |	  Introduction	  
	   Page	  |	  1	  
Chapter	  1:	  Introduction	  
	  
Hirschsprung’s	  disease	  (HSCR)	  is	  the	  commonest	  congenital	  neuropathy	  affecting	  the	  bowel	  
and	   is	   caused	   by	   a	   failure	   of	   the	   enteric	   nervous	   system	   (ENS)	   to	   develop	   normally	   and	  
colonise	  the	  distal	  bowel.	  	  The	  outcomes	  for	  HSCR	  have	  improved	  with	  advent	  of	  surgery	  to	  
remove	  the	  affected	  bowel,	  however	  despite	  this	  both	  children	  and	  adults	  still	  experience	  
significant	   life-­‐long	  morbidity	  as	  a	   result	  of	   the	  disease.	   	  There	  has	  been	  growing	   interest	  
over	  the	  last	  10-­‐15	  years	  regarding	  the	  possibility	  of	  using	  ENS	  progenitors	  as	  a	  cell-­‐based	  
therapy	   to	   improve	   the	   current	   poor	   long-­‐term	   outcomes.	   	   This	   chapter	   introduces	   the	  
normal	   and	   abnormal	   development	   of	   the	   bowel	   and	   its	   nervous	   supply,	   it	   covers	   the	  
known	  enteric	  neuropathies,	  specifically	  HSCR,	  summarises	  the	  current	  progress	  towards	  a	  
clinical	  therapy	  and	  highlights	  the	  outstanding	  issues.	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1.1.	   The	  Enteric	  Nervous	  System	  	  
The	  ENS	  is	  distributed	  throughout	  the	  length	  of	  the	  gastrointestinal	  tract	  providing	  intrinsic	  
regulation	  of	  multiple	  processes	   including:	  muscle	  contraction,	  absorptions	  and	  immunity.	  	  
It	  is	  network	  of	  neurons	  and	  glia	  with	  interconnecting	  ganglia	  organized	  into	  two	  plexi:	  the	  
myenteric	   (Auerbach’s)	   situated	  between	   the	   inner	   circular	   smooth	  muscle	   layer	   and	   the	  
outer	  longitudinal	  muscle,	  and	  the	  submucosal	  plexus	  which	  lies	  between	  the	  inner	  smooth	  
muscle	  and	  muscularis	  mucosa	  (Fig	  1.1).	  	  Unlike	  the	  innervation	  of	  most	  organs,	  the	  ENS	  is	  
capable	  of	  reflex	  activity	  independent	  of	  the	  brain	  and	  spinal	  cord.	  	  This	  is	  made	  possible	  by	  
the	   presence	   of	   complete	   neuronal	   circuits,	   sensory	   neurons,	   afferent	   neurons,	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Figure	  1.1.	  	  Organisation	  of	  the	  ENS	  
Figure	  1.1	  Organisation	  of	  the	  ENS.	  	  The	  myenteric	  plexus	  lies	  between	  the	  longitudinal	  and	  circular	  
layers	   of	   muscle.	   	   The	   inner	   submucosal	   plexus	   lies	   below	   the	   circular	   muscle	   and	   above	   the	  
muscularis	  mucosa.	  	  Adapted	  from	  (Furness	  2005).	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1.1.1.	   Function	  of	  the	  enteric	  nervous	  system	  
Comprising	   some	   400-­‐600	   million	   neurons	   the	   ENS	   (Furness	   2012)	   is	   involved	   in	   the	  
regulation	  of	  a	  number	  of	  individual	  functions	  within	  the	  human	  gut,	  the	  primary	  one	  being	  
to	  co-­‐ordinate	  the	  widespread	  contraction	  seen	  within	  the	  bowel.	  	  This	  is	  achieved	  through	  
the	   generation	   of	   two	   main	   types	   of	   propulsive	   wave	   (segmentation	   and	   peristaltic)	  
promoting	  both	  the	  passage	  and	  mixing	  of	   intestinal	  contents	  as	  they	  progress	  proximally	  
through	   the	   bowel.	   	   Other	   roles	   include	   the	   co-­‐ordination	   of	   gastric	   acid	   secretion	   and	  
absorption	  of	  nutrients,	  the	  regulation	  of	  blood	  flow	  within	  the	  bowel	  and	  local	  modulation	  
of	  both	  the	  immune	  and	  endocrine	  systems	  (Furness	  2005).	  
	  
Given	  the	  wide	  range	  of	  functions	  it	  is	  of	  no	  surprise	  that	  the	  ENS	  is	  composed	  of	  more	  than	  
10	   types	  neuron	  and	  greater	   than	  15	  neurotransmitters	   (Table	  1.2).	   	   Including	   those	   that	  
are	   unique	   to	   the	   ENS	   and	   others	   that	   integrate	   with	   both	   CNS	   and	   sympathetic	   /	  
parasympathetic	  pathways.	   	  Our	  understanding	  of	  both	   the	  neurons	  and	   their	   associated	  
transmitters	  is	  increasing	  but	  it	  remains	  to	  be	  seen	  whether	  the	  intricate	  arrangements	  and	  
delicate	   balance	   between	   neuronal	   and	   hormonal	   control	   can	   be	   replicated	   with	   novel	  
therapeutic	  modalities	  such	  as	  ENS	  progenitor	  transplantation.	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Table	  1.1.	  	  Common	  Neurotransmitters	  in	  the	  gut	  
Neuronal	  Type	   Primary	  
Transmitter	  
Associated	   Neurochemical	  
markers	  
References	  
Enteric	   excitatory	  
muscle	  motor	  neuron	  
ACh	   TK,	  encephalin,	  cRET	   (Brookes,	   et	   al.	   1991,	   Holzer,	  
et	  al.	  1997,	  Grider	  2003)	  
Enteric	  inhibitory	  muscle	  
motor	  neuron	  
NO	   VIP,	   TP,	   PACAP,	   carbon	  
monoxide,	  opioids	  
(Fahrenkrug,	   et	   al.	   1978,	  
Costa,	   et	   al.	   1992,	   K.	   M.	  




ACh	   TK,	  ATP,	  cRET,	  encephalin	   (Brookes,	  et	  al.	  1991)	  
ChAT,	   nNOS	   descending	  
interneuron	  
ATP,	  Ach	   NO,	  VIP	   (Young,	   et	   al.	   1995,	   Brookes	  
2001)	  
ChAT,	   5-­‐HT	   descending	  
interneuron	  
ACh	   5-­‐HT,	  ATP	   (Furness,	   et	   al.	   1982,	   Monro,	  
et	   al.	   2002,	   Gwynne,	   et	   al.	  
2007)	  
ChAT,	   Somatostatin	  
descending	  interneuron	  
ACh	   Somatostatin	   (Portbury,	   et	   al.	   1995,	  
Gwynne,	  et	  al	  2007)	  
Intrinsic	  sensory	  neuron	  
	  
ACh,	  CGRP,	  TK	   Calbindin,	  cRET	   (Portbury,	   et	   al	   1995,	   Grider	  
2003,	  Johnson,	  et	  al.	  2004)	  
Interneurons	   supplying	  
secretomotor	  neurons	  




VIP	   PACAP,	  NPY	   (Cassuto,	   et	   al.	   1981,	   Banks,	  
et	  al.	  2005)	  
Cholinergic	  
secretomotor	  neuron	  
ACh	   cRET	   (Keast,	   et	   al.	   1985,	   Young,	   et	  
al	  1995)	  
Motor	  neuron	   to	  gastrin	  
cells	  
GRP,	  ACh	   NPY	   (Holst,	  et	  al.	  1987,	  Weigert,	  et	  
al.	  1997)	  
Motor	   neurons	   to	  
parietal	  cells	  
Ach	   VIP	   (Nilsson,	  et	  al.	  1972,	  Feldman,	  
et	  al.	  1979)	  
Sympathetic	   neurons:	  
motility	  inhibiting	  
Noradrenaline	   NPY	   (Finkleman	   1930,	   Macrae,	   et	  
al.	  1986)	  




-­‐	   (Dresel,	   et	   al.	   1966,	   Costa,	   et	  
al.	  1984)	  




NPY	   (Dresel,	   et	   al	   1966,	   Furness	  
1971,	  Furness,	  et	  al.	  1983)	  
Intestinofugal	   neurons	  
to	  sympathetic	  ganglia	  
ACh	   VIP	   (Crowcroft,	   et	   al.	   1971,	  
Dalsgaard,	   et	   al.	   1983,	   Love,	  
et	  al.	  1987)	  
Table	   1.1	   Common	   neurotransmitters	   in	   the	   gut.	   	   Abbreviations:	   	   Ach:	   Acetylcholine,	   ,	   ATP:	   adenosine	  
triphosphate;	  CGRP:	  Calcitonin	  gene	  related	  peptide;	  GRP:	  Gastrin	  releasing	  peptide;	  NPY:	  Neuropeptide-­‐Y;	  nNO:	  
Neuronal	   nitric	   oxide	   PACAP:	   pituitary	   adenylyl-­‐cyclase	   activating	   peptide;	   TK:	   Tachykinin;	   5-­‐HT:	   5-­‐
hydroxytrypamine;	   VIP:	   Vasoinhibitory	   peptide.	   	   	   Adapted	   from	   Furness	   JB.	   The	   enteric	   nervous	   system	   and	  
neurogastroenterology.	  Nat	  Rev	  Gastroenterol.Hepatol	  2012.	  9:286-­‐294	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1.1.2.	   Origin	  &	  development	  of	  the	  Enteric	  Nervous	  System	  
The	  cells	  of	  the	  ENS	  originate	  from	  the	  neural	  crest	  in	  the	  developing	  embryo.	  	  	  Neural	  crest	  
cells	   (NCC)	   are	   a	   migratory,	   multi-­‐potent	   population	   of	   cells	   located	   at	   the	   apex	   of	   the	  
neural	  tube,	  formed	  from	  the	  elevation	  and	  fusion	  of	  the	  two	  folds	  of	  the	  neural	  plate.	  	  NCC	  
undergo	  an	  epithelial	  to	  mesenchymal	  transition	  and	  then	  delaminate	  to	  migrate	  from	  the	  
neuroectoderm	   into	   the	   underlying	   mesenchyme.	   	   Following	   delamination,	   NCC	   migrate	  
along	  a	  number	  of	  stereotypical	  pathways	  to	  form	  a	  wide	  range	  of	  tissues,	  including	  ganglia	  
of	  the	  cranial	  nerves	  (V,	  VII,	  IX	  &	  X),	  the	  pia	  and	  arachnoid	  meninges,	  the	  adrenal	  medulla	  
and	  the	  enteric	  nervous	  system	  (Sadler	  1995).	  
	  
Localisation	  of	  the	  origin	  of	  the	  specific	  NCCs	  responsible	  for	  the	  development	  of	  the	  ENS	  
was	  initially	  determined	  using	  neural	  crest	  ablation	  studies	  (Yntema,	  et	  al.	  1954,	  Peters-­‐van	  
der	   Sanden,	   et	   al.	   1993,	   Burns,	   et	   al.	   2001).	   	   In	   these	   studies	   selective	   ablations	   were	  
performed	   at	   different	   levels	   of	   the	   neural	   crest	   of	   chick	   embryos	   and	   the	   effect	   on	   the	  
formation	   of	   the	   ENS	   observed.	   	   These	   experiments	   were	   later	   supported	   by	   quail-­‐chick	  
chimaera	   studies	   performed	   by	   Le	   Douarin	   and	   colleagues.	   	   Le	   Douarin	   and	   Teillet	  
engrafted	  sections	  of	  quail	  neural	  tube	  into	  the	  neural	  tube	  of	  a	  chick	  embryo	  at	  different	  
somite	  levels	  and	  were	  able	  to	  track	  the	  migrating	  NCC,	  identifying	  those	  cells	  giving	  rise	  to	  
the	  ENS.	   	  They	  demonstrated	   that	   the	  cells	   responsible	   for	   the	  development	  of	   the	  avian	  
ENS	   were	   limited	   to	   the	   vagal	   neural	   crest	   adjacent	   to	   somites	   1-­‐7,	   along	   with	   small	  
contributions	   from	   the	   thoracic	   and	   sacral	   region	   caudal	   to	   somite	  28	   in	   the	   lumbosacral	  
neural	  crest	  (Le	  Douarin,	  et	  al.	  1973,	  1974,	  Burns,	  et	  al.	  1998,	  Burns,	  et	  al	  2001).	  
	  
Study	   of	   NCC	   migration	   in	   the	   human	   fetus	   is	   limited	   by	   access	   to	   the	   developing	   gut.	  	  
However	  studies	  using	  serial	  sections	  of	  aborted	  embryos	  and	  fetuses’	  have	  attempted	  to	  
provide	   some	   answers.	   	   After	   delamination	   from	   the	   neural	   crest,	   cells	   migrate	   dorso-­‐
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ventrally	   along	   the	   course	   of	   the	   vagus	   nerve	   towards	   the	   primordial	   gut.	   	   They	   then	  
congregate	  in	  the	  caudal	  branchial	  arches	  prior	  to	  moving	  into	  the	  anterior	  foregut	  at	  about	  
4	  weeks	  gestation,	  colonising	  the	  distal	  hindgut	  by	  week	  7.5	  (Fu,	  et	  al.	  2004,	  Wallace,	  et	  al.	  
2005).	  	  Initially,	  NCCs	  are	  located	  in	  the	  dorsal	  aspect	  of	  the	  gut	  and	  then	  migrate	  inwards	  
and	  encircle	  the	  gut.	  	  	  As	  the	  colonisation	  continues,	  the	  ganglia	  group	  together	  forming	  the	  
outer	   myenteric	   plexus	   starting	   in	   the	   oesophagus	   by	   week	   7	   and	   continuing	   in	   a	  
craniocaudal	   direction	   to	   reach	   the	   distal	   hindgut	   by	   week	   10.	   	   The	   submucosal	   plexus	  
develops	   following	   a	   further,	   centripetal,	   migration	   of	   NCCs	   from	   the	   myenteric	   plexus,	  
again	   following	   the	   same	   craniocaudal	   pattern,	   commencing	   in	   the	   foregut	   at	   week	   8	  
gestation,	   but	   not	   reaching	   the	   distal	   hindgut	   until	   week	   14	   (Burns	   2005,	  Wallace,	   et	   al	  
2005,	   Fu,	   et	  al.	   2010).	   	   This	  apparent	   slowing	  of	  migration	   is	  due	   to	  a	   lengthening	  of	   the	  
bowel	  rather	  than	  a	  decrease	  in	  velocity	  (Landman,	  et	  al.	  2007).	  
	  
The	  migration	  of	  NCCs	   through	  the	  developing	  bowel	   takes	  place	   in	   the	   form	  of	  a	   rapidly	  
proliferating	  wave-­‐front	  of	  NCCs	  at	  the	  head	  of	  a	  chain	  of	  cells	  left	  behind,	  which	  provides	  a	  
scaffold	   to	   be	   populated	   by	   subsequent	   migrating	   and	   proliferating	   cells	   (Young,	   et	   al.	  
2004).	   	  There	  are	   two	  main	   factors	   involved	   in	   this	  process:	   the	  rapid	  cell	  proliferation	  at	  
the	   migrating	   wave-­‐front	   and	   chemotactic	   ‘pull’,	   e.g.	   GDNF	   and	   EDN3	   produced	   by	   the	  
developing	   mesoderm	   (considered	   in	   1.1.4.).	   	   Landman	   et	   al,	   (2007)	   using	   a	   chick-­‐quail	  
chimaera	   gut	   explant	   coupled	   with	   mathematical	   modelling,	   suggested	   that	   rapid	  
proliferation	   at	   the	   migrating	   wave-­‐front	   is	   the	   predominant	   force	   responsible	   for	  
colonisation,	   with	   NCCs	   preferentially	   colonising	   ‘empty’	   aganglionic	   bowel	   ahead	   of	   the	  
wave-­‐front	  (Simpson,	  et	  al.	  2006,	  Landman,	  et	  al	  2007,	  Simpson,	  et	  al.	  2007).	  	  They	  suggest	  
that	   it	   is	   the	   discordance	   between	   the	   rate	   of	   proliferation	   relative	   to	   the	   rate	   of	   bowel	  
growth	  that	  is	  responsible	  for	  the	  migration	  of	  NCCs	  along	  of	  the	  entire	  length	  of	  the	  bowel,	  
and	   that	   any	   failure	   to	   colonise	   the	   entire	   length	   may	   either	   be	   due	   to	   rapid	   bowel	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elongation,	  or	  inadequate	  proliferative	  properties	  of	  the	  NCCs	  in	  the	  wave-­‐front.	  	  They	  have	  
also	   shown	   a	   difference	   in	   the	   propensity	   to	   proliferate	   depending	   on	   the	   origin	   of	   the	  
migrating	  NCCs	  in	  the	  neural	  crest	  (Zhang,	  et	  al.	  2010)	  which	  suggests	  that	  both	  differences	  	  
between	   NCCs	   and	   the	   local	   environmental	   factors	   within	   the	   gut	   determine	   ENS	  
development.	  
Moreover,	   proliferation	   may	   not	   just	   be	   a	   driver	   for	   distal	   migration,	   but	   may	   also	   be	  
responsible	   for	   the	   development	   of	   the	   myenteric	   and	   submucosal	   plexi.	   	   Zhang	   et	   al,	  
(2010)	  have	  proposed	  a	  mechanism	  of	  hierarchical	  preference,	  suggesting	  that	  once	  the	  gut	  
ahead	  is	  colonised,	  NCCs	  continue	  to	  proliferate	  and	  populate	  the	  existing	  plexus	  layer	  until	  
the	   layer	   reaches	   its	   maximal	   cell	   density,	   after	   which	   proliferating	   cells	   will	   be	   driven	  
inwards	  to	  populate	  the	  submucosal	  plexus	  (Zhang,	  et	  al	  2010).	  
	  
More	   recently,	  an	  elegant	   study	  by	  Nishiyama	  and	  colleagues	  provided	  evidence	   that	   the	  
migration	  of	  mouse	  NCCs	  from	  the	  mid-­‐gut	  to	  the	  hindgut	  also	  occurs	  via	  a	  transmesenteric	  
route	   (Nishiyama,	   et	  al.	   2012).	  Between	  10-­‐5-­‐11.5	  days	  post-­‐coitum	   (DPC)	   the	  distal	  mid-­‐
gut	   and	  proximal	   hindgut	   lie	   in	   close	   proximity	   in	   a	   hairpin	   configuration.	   	  Using	   live	   cell	  
imaging	   of	   individual	   cells	   it	  was	   shown	   that	  NCCs	   in	   the	   distal	  mid-­‐gut	  migrate	   out	   and	  
across	   the	   mesentery	   entering	   the	   hindgut	   at	   12.5DPC.	   	   These	   cells	   were	   found	   to	  
contribute	  to	  a	  significant	  proportion	  of	  NCCs	  populating	  the	  hindgut.	  
	  
1.1.3.	   The	  sacral	  neural	  crest	  contribution	  	  
A	  relatively	  small	  population	  of	  neural	  crest-­‐derived	  progenitor	  cells	  in	  the	  gut	  migrate	  from	  
the	  sacral	  neural	  crest	  and	  have	  been	  shown	  to	  differentiate	   into	  neurons	  and	  glia	   in	   the	  
distal	   hindgut.	   	   The	   evolutionary	   and	   functional	   impact	   of	   this	   population	   is	   uncertain:	  
studies	   in	   chicks	   have	   found	   that	   only	   17%	   of	   neurons	   in	   the	   myenteric	   plexus	   of	   the	  
colorectum	  are	  derived	  from	  the	  sacral	  neural	  crest	  (Burns,	  et	  al	  1998).	  Moreover,	  although	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cells	  arising	  from	  the	  sacral	  neural	  crest	  may	  enter	  the	  hindgut	  in	  the	  absence	  of	  migration	  
from	   the	   vagal	   neural	   crest,	   this	   contribution	   is	   not	   enough	   to	   preserve	   function	   (i.e.	  
prevent	   a	  HSCR	   phenotype)	   (Burns,	   et	   al.	   2000).	   	   It	   has	   been	   proposed	   that	   this	  may	   be	  
either	  because	  the	  number	  of	  cells	  is	  simply	  not	  great	  enough,	  or	  that	  the	  development	  of	  a	  
functional	  enteric	  plexus	  may	  be	  dependant	  on	  an	  interaction	  with	  the	  vagal	  NCCs	  (Burns,	  
et	  al	  1998,	  Burns,	  et	  al	  2000).	  
	  
	  
1.1.4.	   Control	  of	  the	  developing	  ENS	  
In	  keeping	  with	  the	  complex	  process	  of	  NCC	  migration	  described	  above,	  a	  growing	  number	  
of	  molecular	   signalling	  mechanisms	  have	  been	   shown	   to	  be	   involved	   in	   the	   regulation	  of	  
the	  migration,	  proliferation,	  and	  differentiation	  of	  enteric	  NCCs.	  
	  
1.1.4.1.	  Glial	  cell	  line-­‐derived	  neurotrophic	  factor	  (GDNF)/	  RET	  
The	   GDNF/RET	   signalling	   pathway	   is	   the	   most	   well	   studied	   pathway	   involved	   in	   the	  
development	  of	  the	  ENS	  with	  a	  key	  role	  in	  development	  of	  neurons	  within	  the	  ENS.	  	  GDNF	  
is	   expressed	   by	   the	   developing	   gut	   mesenchyme,	   whereas	   its	   transmembrane	   tyrosine	  
kinase	   receptor	   RET	   (Abbreviation	   for	   ‘rearranged	   during	   transcription’)	   is	   found	   on	   the	  
migrating	   NCCs	   themselves	   (Young,	   et	   al.	   2001,	   Young,	   et	   al	   2004).	   	   GDNF	   signalling	   has	  
been	   shown	   to	   be	   necessary	   for	   enteric	   NCC	   differentiation,	   migration,	   survival	   and	  
proliferation	   in	   the	   gut	   (Sanchez,	   et	   al.	   1996,	   Peters,	   et	   al.	   1998).	   In	   murine	   models	   a	  
homozygous	   RET	   knockout	   results	   in	   complete	   intestinal	   aganglionosis	   distal	   to	   the	  
oesophagus	  (Schuchardt,	  et	  al.	  1995).	  	  In	  humans,	  mutations	  in	  RET	  have	  been	  implicated	  in	  
50%	   of	   familial	   cases	   of	   HSCR	   and	   up	   to	   35%	   of	   non-­‐familial	   cases	   (Attie,	   et	   al.	   1995,	  
Svensson,	  et	  al.	  1998).	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1.1.4.2.	  Endothelin-­‐3	  (ET3)	  /	  Endothelin	  type-­‐B	  receptor	  (EDNRB)	  
Similarly	   to	   the	   GDNF/RET	   pathway,	   mesenchymal	   ET3	   acts	   on	   migrating	   NCCs	   via	   the	  
membrane	  receptor	  EDNRB,	  promoting	  both	  their	  proliferation	  and	  migration	  but	  inhibiting	  
differentiation	   (Leibl,	   et	  al.	  1999,	  Barlow,	   et	  al.	  2003).	  Studies	  have	  shown	   that	   the	   time-­‐
dependent	   mesenchymal	   expression	   of	   ET3	   is	   necessary	   for	   normal	   migration,	   and	  
mutations	   in	   ET3	  have	  been	   identified	   in	  both	   isolated	  and	   syndromic	   cases	  of	  HSCR,	   for	  
example	   Shah-­‐Waardenburg	   syndrome	   (Bidaud,	   et	   al.	   1997).	   	   In	   mouse	  models	   ET3	   and	  
EDNRB	  knockouts	  produces	  a	  phenotype	  very	  similar	  to	  that	  usually	  seen	  in	  human	  HSCR	  as	  
aganglionosis	  is	  largely	  restricted	  to	  the	  distal	  colon,	  in	  marked	  contrast	  to	  the	  widespread	  
aganglionosis	   that	  results	   from	  a	  disruption	  of	   the	  GDNF/RET	  signalling	  pathway	  (Hosoda,	  
et	  al.	  1994).	  
	  
As	  our	  understanding	  of	  the	  control	  and	  coordination	  of	  ENS	  development	  has	  deepened,	  
there	  has	  been	  a	  corresponding	  growth	  in	  the	  number	  of	  downstream	  transcription	  factors	  
and	   signalling	   pathways	   implicated	   (Table	   1.1),	   such	   as	   the	   transcription	   factor	   Phox2b	  
(Garcia-­‐Barcelo,	  et	  al.	  2003),	  the	  Notch	  signalling	  pathway	  (Okamura,	  et	  al.	  2008,	  Ngan,	  et	  
al.	   2011),	   and	   Sonic	  Hedgehog	   (Ramalho-­‐Santos,	   et	   al.	   2000,	  Ngan,	   et	   al	   2011).	   	  What	   is	  
emerging	   is	   a	   complex	   relationship,	   with	   components	   effecting	   both	   synergistic	   and	  
antagonistic	  roles	  at	  different	  developmental	  stages.	   It	   is	  this	  deepening	  understanding	  of	  
how	   failures	   of	   normal	   development	   or	   signalling	   pathways	  may	   result	   in	   HSCR	   and	   the	  
identification	   of	   “progenitor”	   cells	   that	   remain	   under	   the	   control	   of	   these	   transcription	  
factors	  that	  has	  driven	  current	  research	  to	  develop	  new	  therapies	  aimed	  at	  improving	  ENS	  
function	  within	  the	  bowel.	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Table	   1.2.	   Signalling	   pathways,	   transcription	   factors	   and	   genes	   involved	   in	   NCC	  
development	  within	  the	  ENS	  
Table.	   1.2.	   Abbreviations:	   DCC	   –	   detected	   in	   colorectal	   cancer	   Table	   adapted	   from	  
Obermayr,	  F	  et	  al.	  Nat	  Rev	  Gastroenterol.Hepatol	  2013.	  10:43-­‐57	  
	   	  
	   Role	  in	  the	  developing	  ENS	   References	  
GDNF/RET	   • Promotes	  survival	  and	  proliferation	  
• Promotes	  differentiate	  &	  migration	  
(Ivanchuk,	  et	  al.	  1996,	  Sanchez,	  et	  al	  
1996,	  Peters,	  et	  al	  1998)	  
ET3/EDNRB	   • Promotes	  proliferation	  &	  migration	  
• Inhibits	  differentiation	  
(Bidaud,	  et	  al	  1997,	  Leibl,	  et	  al	  1999,	  
Barlow,	  et	  al	  2003)	  
Sonic	  
Hedgehog	  
• Promotes	  proliferation	  
• Promotes	  concentric	  patterning	  




• Promotes	  survival	  
	  
(Ramalho-­‐Santos,	  et	  al	  2000)	  
Notch	   • Promotes	  proliferation	  
• Promotes	  glial	  development	  
(Okamura,	   et	   al	   2008,	   Ngan,	   et	   al	  
2011)	  
Sox	  10	   • Progenitor	  maintenance	   (Southard-­‐Smith,	   et	   al.	   1998,	   Kapur	  
1999,	  Lang,	  et	  al.	  2000)	  
Sox	  8	   • Acts	  with	  Sox	  10	  
• Progenitor	  maintenance	  
(Maka,	  et	  al.	  2005)	  
Foxd3	   • Regulates	  Sox10	  
• Progenitor	  maintenance	  
(Teng,	  et	  al.	  2008)	  
Phox2b	   • Promotes	  ENSPC	  survival	  
• Regulates	  RET	  expression	  
(Young,	   et	   al.	   1998,	   Pattyn,	   et	   al.	  
1999,	  Corpening,	  et	  al.	  2008)	  
Hand2	   • Promotes	  neuronal	  differentiation	  
	  
(D'Autreaux,	  et	  al.	  2007)	  
Netrin	   • Required	  for	  centripetal	  migration	  
	  
(Jiang,	  et	  al.	  2003)	  
ASCL1	  (Mash1)	   • Promotes	  neuronal	  survival	  
• 	  Promotes	  mature	  differentiation	  
(Blaugrund,	  et	  al.	  1996)	  
Pax3	   • Regulates	   RET	   expression	   (with	  
Sox10)	  
(Lang,	  et	  al	  2000)	  
Zeb2	   • Specification	  of	  vagal	  NCCs	  
	  
(Garavelli,	  et	  al.	  2003,	  Van	  de	  Putte,	  
et	  al.	  2003,	  Stanchina,	  et	  al.	  2010)	  
TCF4	   • Interacts	   with	   Wnt-­‐ß-­‐catenin	  
pathway	  
(Zweier,	  et	  al.	  2007)	  
Hoxb5	   • Induces	  RET	  expression	  
• Promotes	  migration	  
(Lui,	  et	  al.	  2008,	  Carter,	  et	  al.	  2012)	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1.2.	   Intestinal	  Smooth	  muscle	  
The	  human	  gut	  is	  composed	  of	  two	  layers	  of	  smooth	  muscle,	  inner	  circular	  layer	  and	  outer	  
longitudinal,	  however	  this	  configuration	  is	  altered	  in	  the	  colon	  where	  the	  outer	  longitudinal	  
muscle	  is	  concentrated	  in	  three	  thin	  distinct	  bands	  (taeniae	  coli).	  	  Intestinal	  smooth	  muscle	  
cells	  are	  smaller	  than	  the	  more	  common	  skeletal	  striated	  muscle.	  	  They	  contract	  at	  a	  slower	  
rate	   to	   skeletal	  muscle,	   using	   the	   protein	   calmodulin	   rather	   than	   troponin	   (as	   in	   skeletal	  
muscle)	   to	   regulate	   the	   influx	   of	   calcium	   to	   activate	   actin-­‐myosin	   cross	   bridge	   cycling	  
(Prosser	   1974,	   Marston,	   et	   al.	   1998).	   	   Furthermore,	   due	   to	   tight	   cell	   junctions	   and	  
numerous	   cell	   membrane	   connections	   the	   whole	   intestinal	   muscle	   tube	   functions	   as	   a	  
whole	  unit	  with	  spontaneous	  propagation	  of	  contractions	  distally	  (Kenton	  M.	  Sanders	  2008).	  
	  
1.2.1.	   Origin	  and	  development	  
As	  is	  seen	  in	  the	  migration	  of	  NCC	  in	  the	  developing	  bowel,	  myoblasts	  colonise	  the	  bowel	  in	  
a	  rostrocaudal	  direction,	  reaching	  the	  oesophagus	  by	  embryonic	  week	  8	  and	  the	  hindgut	  by	  
week	  11.	   	   It	  takes	  a	  further	  three	  weeks	  for	  the	  distinct	  circular	  and	  longitudinal	   layers	  to	  
develop	  through	  the	  gut	  (Fu,	  et	  al	  2004,	  Wallace,	  et	  al	  2005).	  
	  
1.2.2.	   The	  development	  of	  gut	  motility	  
The	   process	   of	   propulsion	   of	   material	   through	   the	   intestine	   is	   complex,	   requiring	  
interaction	   between	   three	   separate	   components:	   the	   enteric	   nervous	   system	   (ENS),	   the	  
interstitial	   cells	   of	   Cajal	   (ICC)	   and	   the	   smooth	   muscle	   of	   the	   intestine.	   	   The	   study	   of	   its	  
development	  within	  humans	  is	  limited.	  	  Three	  main	  types	  of	  propulsive	  waves	  are	  present	  
within	   the	   gastrointestinal	   tract;	   segmentation	   waves,	   peristaltic	   waves	   and	   migrating	  
motor	  complexes.	   	  Although,	   in	  the	  adult,	  the	  ENS	  is	  thought	  to	  be	  largely	  responsible	  for	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these	  waves	  (Hasler	  1999)	  both	  the	  ICC	  and	  intestinal	  smooth	  muscle	  are	  thought	  to	  exert	  
their	  own	  influence	  on	  motility	  (K.	  M.	  Sanders	  2006,	  Young	  2008).	  
	  
During	   fetal	   development	   each	   individual	   component,	   required	   for	   intestinal	   motility,	   is	  
present	   by	   the	   14th	   week	   of	   gestation.	   	   At	   this	   stage	   there	   are	   no	   functional	   propulsive	  
waves	   but	   by	   the	   mid	   to	   late	   third	   trimester	   studies	   have	   observed	   fetal	   swallowing	   of	  
amniotic	   fluid	   and	   the	   subsequent	   propulsion	   of	   the	   amniotic	   distally	   through	   the	   bowel	  
(McLain	   1963).	   Human	   studies	   on	   the	   later	   stages	   of	   development	   intestinal	  motility	   are	  
largely	   limited	   to	   detailed	   observation	   utilising	   antenatal	   ultrasound.	   	   Initial	   studies	  
observed	  fetal	  swallowing	  of	  amniotic	   fluid	  and	  the	  subsequent	  propulsion	  of	   fluid	  within	  
the	  bowel	   in	  the	   late	  third	  trimester	  (McLain	  1963).	   	  Gastric	  emptying	  has	  been	  shown	  to	  
start	  at	  24	  weeks	  of	  gestation,	  although	  not	  exhibiting	  a	  mature	  pattern	  of	  contraction	  until	  
nearer	   term	  (Sase,	  et	  al.	  2005).	   	  Waves	  of	  contraction	  are	  not	   seen	   in	   the	  small	   intestine	  
until	  5	  weeks	  later	  when	  small,	  infrequent	  coordinated	  waves	  may	  be	  observed	  (Goldstein,	  
et	  al.	  1987).	  	  	  There	  is	  little	  reported	  in	  the	  literature	  regarding	  colonic	  motility	  but	  studies	  
looking	  at	   the	  human	  fetal	   internal	  anal	  sphincter	  have	  reported	  rhythmic	  contractions	   in	  
the	  third	  trimester	  (Bourdelat,	  et	  al.	  2001).	  
	  
1.2.3.	   Intrinsic	  (myogenic)	  contraction	  
Intestinal	  smooth	  muscle	  retains	  the	  ability	  to	  continue	  to	  generate	  a	  rhythmic	  slow	  wave	  
contraction	   in	   the	   absence	   of	   higher	   (CNS)	   control.	   	   These	   slow	   wave	   contractions	   are	  
propagated	   cell-­‐to-­‐cell	   through	   calcium	   dependent	   voltage	   gated	   channels	   (at	   about	   -­‐
35mV).	   	  Although	   these	  waves	  are	   typically	  described	  as	  myogenic	   contractions,	   they	  are	  
not	  initiated	  from	  smooth	  muscle	  cells,	  but	  rather	  has	  been	  shown	  that	  interstitial	  cells	  of	  
Cajal	   (ICCs)	   provide	   the	   stimulus	   -­‐	   acting	   as	   the	   ‘pacemaker	   of	   the	   intestine’(Kenton	  M.	  
Sanders	  2008)(See	  1.3.).	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1.3.	   Interstitial	  Cells	  of	  Cajal	  
ICCs	   were	   first	   described	   in	   late	   19th	   Century	   as	   cells	   situated	   between	   and	   distinct	   to	  
smooth	  muscle	   cells	   and	   neurons	   within	   the	   gut	   (Ramon	   y	   Cajal	   1911).	   	   However,	   their	  
function	  was	  not	  determined	  until	   studies	   in	   the	  1980’s	  confirmed	   their	   responsibility	   for	  
the	  ‘pacemaker’	  activity	  of	  the	  gut	  (Bauer,	  et	  al.	  1985,	  Hara,	  et	  al.	  1986,	  Smith,	  et	  al.	  1987).	  	  
	  
1.3.1.	   Origin	  
ICCs	  have	  a	  common	  mesodermal	  origin	  with	  smooth	  muscle	  cells	  (Young,	  et	  al.	  1996).	  	  The	  
immature	  ICC	  expresses	  common	  smooth	  muscle	  markers,	  such	  as	  smooth	  muscle	  actin	  but	  
can	   be	   distinguished	   histologically	   by	   the	   marked	   sparsity	   of	   contractile	   filaments	   and	  
absence	  of	  desmin	  (K.	  M.	  Sanders,	  et	  al.	  1999,	  Young	  1999).	  	  Mature	  ICCs	  can	  be	  identified	  
within	  the	  gut	  by	  their	  expression	  of	  the	  tyrosine	  kinase	  receptor	  (c-­‐Kit)	  (Maeda,	  et	  al.	  1992,	  
S.	  M.	  Ward,	   et	   al.	   1994).	   	   Human	   studies	   into	   the	   development	   of	   ICCs	   are	   limited,	   but	  
studies	  suggest	  that	  they	  develop	  in	  parallel	  with	  myoblasts,	  colonising	  the	  bowel	  between	  
week	   8	   and	   11	   gestation	   in	   a	   rostrocaudal	   direction.	   	   C-­‐kit	   immunoreactivity	   is	   first	  
detected	  in	  the	  outer	  muscle	  layers	  at	  week	  9,	  and	  is	  almost	  fully	  developed	  by	  term	  (Kenny,	  
et	   al.	   1999,	   Wallace,	   et	   al	   2005).	   	   In	   the	   mature	   bowel	   ICCs	   are	   predominantly	   located	  
around	   the	   myenteric	   plexus	   but	   may	   also	   be	   seen	   throughout	   both	   the	   circular	   and	  
longitudinal	  muscle	   layers	   (S.	  M.	  Ward,	  et	  al.	  2000).	   	  The	  density	  of	   ICCs	   is	  also	  known	  to	  
vary	   according	   to	   location	  within	   the	   bowel,	  with	   a	  marked	   reduction	   in	   c-­‐kit	   expression	  
seen	  in	  the	  colon	  compared	  to	  the	  small	  bowel	  (Mostafa,	  et	  al.	  2010).	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1.3.2.	   Function	  
In	   conjunction	   with	   both	   the	   ENS	   and	   intestinal	   smooth	   muscle	   ICCs	   are	   essential	   for	  
coordinated	  peristalsis	  within	  the	  gut.	   	  Unlike	  their	  cardiac	  counterparts	  intestinal	  smooth	  
muscle	  do	  not	  typically	  generate	  spontaneous	  electrical	  rhythmicity,	  rather	  it	  is	  now	  widely	  
accepted	  that	  this	  is	  the	  main	  role	  of	  the	  ICC.	  	  Furthermore,	  they	  also	  play	  a	  role	  in	  signal	  
transduction	   for	   both	   neural	   and	  mechanical	   stretch	   receptors	   inputs	   (S.	  M.	  Ward,	   et	   al	  
1994,	  Huizinga,	  et	  al.	  1995).	  
	  
The	  evidence	  supporting	  the	  pacemaker	  role	  of	  the	  ICC	  is	  strong:	  	  ICCs	  have	  been	  shown	  to	  
possess	  spontaneous	  rhythmic	  electrical	  activity	  (S.	  M.	  Ward,	  et	  al	  1994,	  Zhu,	  et	  al.	  2009).	  	  
The	   slow	   waves	   transmitted	   throughout	   both	   ICCs	   and	   intestinal	   smooth	   muscle	   are	  
coordinated	  with	  the	  wave	  of	  contraction	  in	  ICCs	  slightly	  preceding	  that	  seen	  in	  the	  smooth	  
muscle.	   Furthermore,	   studies	   have	   demonstrated	   electrical	   coupling	   between	   ICCs	   and	  
smooth	  muscle	  cells	  (Dickens,	  et	  al.	  1999,	  Kito,	  et	  al.	  2003),	  although	  this	  has	  been	  harder	  
to	   show	  on	  an	  ultrastructural	   level.	   	   It	   is	   important	   to	  note	   that	   the	   rhythmic	   slow	  wave	  
contraction	  seen	  within	  the	  gut	  is	  essentially	  normal	  in	  the	  absence	  of	  NCC	  colonisation	  of	  
the	  bowel	  (S.	  M.	  Ward,	  et	  al.	  1999).	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1.4.	   Notch	  signalling	  
Notch	   is	  a	   transmembrane	  protein	   responsible	   for	   regulating	  a	  number	  of	  developmental	  
processes	  to	  control	  cell	  fate.	  	  It	  was	  first	  suggested	  to	  have	  a	  role	  in	  development	  the	  early	  
1900’s	  where	  a	  homozygous	  mutation	  in	  the	  Notch	  gene	  was	  found	  to	  result	  in	  a	  ‘notch’	  in	  
the	   wing	   of	   Drosophila	   (Mohr	   1919).	   	   However,	   it	   wasn’t	   until	   the	   1930’s	   that	   its	   full	  
significance	   in	   development	   was	   appreciated	   following	   experiments	   by	   Poulson	   which	  
demonstrated	   that	   complete	   loss	   of	  Notch	   resulted	   in	   a	   lethal	   switch	   in	   the	   fate	   of	   cells	  
from	  an	   epidermal	   phenotype	   to	   neural	   tissue	   (Poulson	   1937).	   	   In	   vertebrates,	   there	   are	  
currently	  four	  known	  Notch	  transmembrane	  receptors	  (Notch	  1-­‐4)	  and	  five	  corresponding	  
transmembrane	   ligands	   (Delta-­‐like	  1,	  3	  and	  4	  and	   Jagged	  1-­‐2)	  which	  have	  been	  shown	  to	  
have	  broad	  expression	  patterns	  throughout	  development	  (Lindsell,	  et	  al.	  1996).	  	  Notch	  has	  
been	   identified	   in	   most	   species	   with	   a	   high	   degree	   of	   conservation	   from	   Caenorhabitis	  
elegans	   to	  humans	   (Ellisen,	  et	  al.	  1991)	  and	   this	   is	  one	   factor	   that	  has	  driven	   research	   to	  
identify	  its	  roles	  in	  development	  (e.g.	  cell	  differentiation,	  cell	  survival	  and	  apoptosis)	  which	  
are	   increasingly	   being	   understood	   as	   highly	   context	   and	   cell-­‐type	   dependent	   (Kadesch	  
2004).	  	  
	  
1.1.5.1.	  The	  canonical	  Notch	  signalling	  pathway	  
The	   classical	   description	   of	   the	  mammalian	   canonical	   Notch	   pathway	   (Figure	   1.2)	   is	   that	  
activation	  occurs	  via	  contact	  with	  a	  Notch	  ligand	  (Delta/Jagged)	  expressed	  on	  adjacent	  cell	  
membranes,	   which	   initiates	   a	   cascade	   of	   proteolytic	   cleavages	   of	   the	   Notch	   receptor	  
resulting	  in	  the	  intracellular	  release	  of	  the	  notch	  intracellular	  domain	  (NICD)	  (Blaumueller,	  
et	   al.	   1997,	  Mumm,	   et	   al.	   2000).	   	   This	   then	   crosses	   into	   the	  nucleus	  where	   it	   binds	  with	  
recombination	   binding	   protein-­‐JK	   (RBP-­‐JK)	   (Jarriault,	   et	   al.	   1995)	   changing	   its	   action	   from	  
repressor	   to	   promoter	   of	   target	   genes	   transcription	   (e.g.	   the	   transcriptional	   repressor	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families	  hairy	  enhancer	  of	  split	  [Hes]	  and	  hairy	  related	  transcription	  factor	  [HRT/Hey])	   (Lai	  
2002,	  Kadesch	  2004).	  
Although	   the	  canonical	  pathway	  has	  become	   increasingly	  well	  defined	   in	   recent	  years,	   so	  
has	   the	   awareness	   of	   the	   complexity	   of	   the	  multiple	   interactions	  with	   pathways	   such	   as	  
Sonic	  Hedgehog,	  tyrosine	  kinase	  receptors,	  Janus	  kinase-­‐	  signal	  transducer	  and	  activator	  of	  
transcription	  (JAK-­‐STAT)	  and	  Wingless	  (Wnt)	  (Hurlbut,	  et	  al.	  2007).	  	  Furthermore,	  it	  has	  also	  
been	   demonstrated	   that	   Notch	   signalling	   can	   be	   activated	   in	   a	   NICD	   independent,	   non-­‐
canonical	   manner	   (Heitzler	   2010).	   	   Thus,	   the	   complexity	   of	   Notch	   signalling	   is	   highly	  
dependent	  on	  both	  context	  and	  the	  cell	  type	  involved.	  
	  
1.1.4.2.	  Role	  of	  Notch	  in	  the	  central	  nervous	  system	  
There	  has	  been	  increasing	  interest	  in	  role	  of	  Notch	  since	  early	  studies	  reported	  that	  Notch	  
is	  implicated	  in	  the	  regulation	  of	  both	  neuronal	  and	  glial	  differentiation,	  together	  with	  the	  
maintenance	   of	   the	   neural	   progenitor	   pool	   (Gaiano,	   et	   al.	   2000,	   Morrison,	   et	   al.	   2000).	  	  
Within	  the	  CNS	  it	  is	  thought	  that	  Notch	  is	  required	  for	  the	  maintenance	  of	  radial	  glia,	  which	  
themselves	   function	   as	   neuronal	   and	   glial	   progenitors	   (Noctor,	   et	   al.	   2001).	   	   During	  
embryonic	  development,	   it	  has	  been	   shown	   that	  disruption	  of	   the	  key	   component	  of	   the	  
canonical	   pathway	   RBPJ-­‐κ	   results	   in	   a	   significant	   reduction	   in	   numbers	   of	   radial	   glia	   and	  
corresponding	  increase	  in	  premature	  neurogenesis	  (Imayoshi,	  et	  al.	  2010).	  	  Furthermore,	  if	  
RBP-­‐Jκ	   is	   knocked	   out	   in	   postnatal	   mouse	   models,	   it	   again	   leads	   to	   an	   increase	   of	  
neurogenesis	   in	   the	   subventricular	   zone	  with	   corresponding	   loss	  of	   the	  neural	  progenitor	  
pool	   (Gao,	  et	  al.	  2009,	   Imayoshi,	  et	  al	  2010).	   	  These	  results	  provide	  strong	  evidence	  for	  a	  
crucial	  role	  for	  Notch	  signalling	  in	  both	  embryonic	  neural	  development	  and	  the	  post-­‐natal	  
maintenance	  of	  neural	  progenitors	  within	  the	  CNS.	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Figure	  1.2.	  	  The	  Notch	  ligand	  delta	  is	  transported	  to	  the	  plasma	  membrane	  where	  it	  binds	  with	  the	  
receptor	  and	  promotes	   the	  gamma-­‐secretase	  mediated	  cleavage	  of	   the	  notch	   intracellular	  domain	  
(NICD).	  	  This	  is	  then	  transported	  into	  the	  nucleus	  where	  it	  binds	  with	  RBP-­‐JK,	  thereby	  promoting	  the	  
transcriptions	  of	  target	  genes,	  such	  as	  Hairy	  Expresser	  of	  Split	  (HES).	  
	  
1.1.4.3.	  The	  role	  of	  Notch	  in	  the	  enteric	  nervous	  system	  
Compared	  to	  the	  comprehensive	  studies	  of	  Notch	  and	   its	  role	   in	  the	  CNS	  there	  have	  only	  
been	  a	   limited	  number	  of	   studies	  specifically	   looking	  at	   its	   role	   in	   the	  ENS,	  and	   these	  are	  
largely	  restricted	  to	  embryonic	  mouse	  models.	  	  Notch	  receptors	  and	  corresponding	  ligands	  
have	  been	  shown	  to	  be	  present	  in	  the	  embryonic	  and	  post-­‐natal	  enteric	  nervous	  system	  in	  
both	  mice	  and	  rats	  (Sander,	  et	  al.	  2004,	  Okamura,	  et	  al	  2008).	  	  One	  study,	  the	  Pofut1	  gene	  
(involved	   in	   the	   posttranslational	   modification	   of	   the	   Notch	   receptor)	   was	   specifically	  
deleted	   in	  NCCs	   using	   a	  Wnt1-­‐Cre	   promoter	   (Okamura,	   et	   al	   2008).	   	   Deletion	  of	   Pofut-­‐1,	  
thereby	  inactivating	  the	  Notch	  signalling	  pathway	  resulted	  in	  premature	  neurogenesis	  and	  
a	   loss	   of	   ENS	   progenitors.	   	  More	   recently,	   this	   evidence	   has	   been	   strengthened	  using	   an	  
alternative	  deletion	  of	  PTCH1	  (a	  Sonic	  Hedgehog	  receptor),	  which	  was	  reported	  to	  generate	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the	  same	  effects	  in	  a	  Notch	  dependent	  manner	  (Ngan,	  et	  al	  2011).	  Given	  the	  similarities	  in	  
the	  expression	  of	  markers	  between	  the	  CNS	  and	  ENS,	  and	  the	  preliminary	  data	  supporting	  
its	   involvement	  in	  mouse	  ENS	  models	   it	  can	  be	  hypothesised	  that	  Notch	  is	   involved	  in	  the	  
regulation	  of	  proliferation	  and	  neuronal	  differentiation	  in	  the	  post-­‐natal	  human	  ENS.	  
	  
Chapter	  1	  |	  Introduction	  
	   Page	  |	  19	  
	  	  
1.5.	   Hirschsprung’s	  disease	  and	  other	  Neuropathies	  of	  the	  Gut	  
1.5.1.	   Overview	  
Neuropathies	   encompass	   a	  wide	   range	   of	   conditions	   that	   are	   caused	   by	   a	   defect	   in	   cells	  
arising	  from	  a	  neuronal	  lineage.	  	  Within	  the	  intestine	  these	  include	  diseases	  that	  affect	  the	  
control	   systems	   of	   the	   gut,	   i.e.	   enteric	   neuropathies	   including	   HSCR,	   or	   the	   interfacing	  
systems,	   i.e.	   anomalies	   in	   the	   ICC	   network	   which	   are	   implicated	   in	   conditions	   such	   as	  
gastroparesis	  (Forster,	  et	  al.	  2005).	  Enteric	  neuropathies	  may	  be	  either	  a	  primary	  defect	  in	  
the	  neuronal	  cell	  line	  (summarised	  in	  table	  1.3)	  or	  secondary	  to	  a	  systemic	  disease	  such	  as	  
Crohn’s	  disease,	  multiple	  endocrine	  neoplasia	  syndrome	  2B	  or	  neurofibromatosis	  (Ferrante,	  
et	  al.	  2006,	  Hanemann,	  et	  al.	  2007,	  Moline,	  et	  al.	  2011).	  	  HSCR	  is	  the	  most	  common	  primary	  
congenital	  enteric	  neuropathy	  and	  perhaps	  the	  most	  well	  studied.	  
	  












HSCR	   Distal	   aganglionosis	   of	  
variable	  length	  in	  100%	  
1	  in	  5000	   (Goldberg	  1984)	  
Idiopathic	  achalasia	   Progressive	   neuropathy,	  
particularly	   nitrergic	  
motor	  neurons	  
1	  in	  10	  000	   (Goldblum,	   et	   al.	   1994,	  
Goldblum,	   et	   al.	   1996,	  
Gockel,	  et	  al.	  2008)	  
Idiopathic	  
gastroparesis	  
Neuropathy	   identified	   in	  
70%	  with	   associated	   ICC	  
depletion	  in	  47%	  
1	  in	  4000	   (Grover,	  et	  al.	  2011)	  




myopathies.	   	   25%	   have	  
associated	  neuropathy	  
1	  in	  10	  000	   (Schuffler,	   et	   al.	   1977,	  
Heneyke,	  et	  al.	  1999)	  
Acquired	   chronic	  
intestinal	   pseudo-­‐
obstruction	  (aCIPO)	  
Neuropathy	   identified	   in	  
60%	  of	  cases	  	  
<1	  in	  2000	   (Knowles,	   et	   al.	   2004,	  
Lindberg,	  et	  al.	  2009)	  
Table	  1.3.	  	  Summary	  of	  primary	  enteric	  neuropathies,	  estimated	  prevalence	  of	  positive	  histological	  
findings	  and	   lifetime	  prevalence.	   	  Adapted	  from	  Knowles	  et	  al.	  New	  perspectives	   in	  the	  diagnosis	  
and	  management	  of	  enteric	  neuropathies.	  	  Nat	  Rev	  Gastroenterol	  Hepatol	  2013	  10(4):206-­‐218	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1.5.3.	   Hirschsprung’s	  disease	  
HSCR	  is	  the	  commonest	  congenital	  disorder	  of	  gut	  motility.	   	  Characterised	  by	  the	  absence	  
of	  enteric	  ganglia,	  it	  typically	  affects	  the	  distal	  colon	  (rectosigmoid	  disease)	  in	  80%	  of	  cases.	  	  
However,	  the	  disease	  is	  variable	  in	  its	  manifestation	  and	  may	  involve	  longer	  segments	  such	  
as	   total	  colonic	  HSCR	  (10%	  of	  cases)	  or	  even	  total	   intestinal	  HSCR	   in	  approximately	  1%	  of	  
children	   (Moore,	  et	  al.	  2009,	  Ruttenstock,	  et	  al.	  2009).	   	  The	  majority	  of	   infants	  born	  with	  
HSCR	   will	   present	   within	   the	   first	   few	   days	   of	   life,	   usually	   with	   a	   delayed	   passage	   of	  
meconium	   (>48hrs).	   	   Untreated,	   the	   tonic	   contraction	   of	   the	   affected	   bowel	  may	   quickly	  
progress	  to	  a	  potentially	  life	  threatening	  bowel	  obstruction	  requiring	  urgent	  intervention.	  
	  
The	   clinical	   entity	  was	   first	   described	   in	   the	   late	   19th	   Century	   by	   the	  Danish	   physician	  Dr	  
Harold	   Hirschsprung	   following	   the	   death	   of	   two	   young	   children	   patients	   (Hirschsprung	  
1887).	   	   However,	   although	   correctly	   surmising	   that	   the	   disease	   was	   due	   to	   a	   congenital	  
defect	  in	  the	  development	  of	  the	  bowel	  resulting	  in	  obstruction	  he	  initial	  thought	  that	  the	  
underlying	   pathology	   problem	   originated	   in	   the	   dilated	   segment	   of	   bowel.	   	   This	  
unfortunately	  directed	  early	  surgical	  efforts	  towards	  resecting	  the	  normally	  innervated	  and	  
dilated	  proximal	  bowel	  and	  leaving	  the	  effected	  distal	  colon	  behind.	  
	  
It	   wasn’t	   until	   the	   1940’s	   that	   the	   clinical	   presentation	   of	   HSCR	   was	   attributed	   to	   an	  
absence	  of	  ganglia	  in	  the	  distal	  colon	  (Tiffin,	  et	  al.	  1940,	  Whitehouse,	  et	  al.	  1948).	  	  Shortly	  
after	  this	  Orvar	  Swenson	  and	  Alexander	  Bill	  reported	  their	  initial	  results	  following	  resection	  
of	   the	   contracted	   distal	   bowel	   and	   ‘pull-­‐through’	   of	   the	   proximal	   bowel	   (Swenson,	   et	   al.	  
1948),	  which	  as	  a	  concept	  still	  underpins	  the	  modern	  treatment	  of	  HSCR	  today.	  	  From	  the	  
1950’s	   onwards	   mortality	   associated	   with	   HSCR	   has	   dropped	   dramatically,	   with	   current	  
overall	  survival	  rates	  in	  England	  reported	  at	  over	  90%	  (Best,	  et	  al.	  2012).	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1.5.3.1.	  Epidemiology	  and	  aetiology	  of	  HSCR	  
HSCR	  has	  an	  overall	  worldwide	  reported	  incidence	  of	  1	  in	  5000	  live	  births	  (Goldberg	  1984),	  
however	   most	   large	   scale	   epidemiological	   studies	   have	   been	   limited	   to	   Caucasian	  
populations.	   	   There	   is	   evidence	   to	   suggest	   that	   there	   is	   significant	   variation	   within	  
interracial	  groupings	   from	  15:100	  000	   live	  births	   in	  European	  populations	  up	  to	  28	   in	  100	  
000	  in	  Asian	  groups,	  which	  is	  consistent	  with	  the	  prevalence	  of	  known	  genetic	  mutations	  in	  
the	   respective	   populations	   (Emison,	   et	   al.	   2005,	   Emison,	   et	   al.	   2010).	   	   In	   addition	   to	   the	  
racial	   variation	   HSCR	   is	   also	   associated	   with	   a	   significant	   male:female	   preponderance	  
(4:1)(Emison,	  et	  al	  2005).	  	  Associated	  congenital	  anomalies	  can	  be	  found	  in	  between	  4	  and	  
35%	  of	  cases	  (summarized	  in	  table	  1.4).	  
Table	  1.4	  Congenital	  anomalies	  found	  in	  association	  with	  HSCR	  
	  
Associated	  Neural	  Crest	  Anomalies	  
Sensorineural	  
Deafness	  
• Congenital	  central	  hypoventilation	  syndrome	  
• Isolated	  sensoriuneural	  deafness	  
• Type	  IV	  (Shah)	  Waardenburg	  Syndrome	  
Cardiovascular	   • DiGeorge	  Syndrome	  
Cleft	  Palate	   • Goldberg	  Sphrintzen	  Syndrome	  
• DiGeorge	  Syndrome	  
Systemic	  anomalies	   • Multiple	  endocrine	  neoplasia	  type	  IIA	  and	  IIB	  
• Neurofibromatosis	  Type	  I	  
• Smith-­‐Lemli	  Opitz	  syndrome	  
Other	  Anomalies	  
• Trisomy	  21	   • Small	  Bowel	  Atresia	   • Duodenal	  Atresia	  
• Microcephaly	   • Mental	  retardation	   • Undescended	  testes	  
• Inguinal	  hernias	   • Imperforate	  anus	   • Colonic	  atresia	  
Table	   1.4.	   	  Additional	   congenital	   anomalies	   found	   in	  association	  with	  Hirschsprung’s	   disease.	  	  
Adapted	  from	  (Kenny,	  et	  al.	  2010)	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Although	   all	   cases	   of	   HSCR	   arise	   from	   a	   failure	   of	   the	   ENS	   to	  migrate	   and	   populate	   the	  
entire	  bowel	  during	  development	   the	  precise	  underlying	  aetiology	  of	  HSCR	  remains	   to	  be	  
fully	   elucidated.	   	   It	   is	   widely	   accepted	   that	   HSCR	   has	   a	   multi-­‐genic	   disorder	   with	   the	  
majority	   of	   cases	   arising	   from	   sporadic	  mutations	   (Emison,	   et	   al	   2005).	   	   However,	  more	  
recent	   evidence	   suggests	   that	   environmental	   factors	  may	   also	  play	   a	   contributory	   role	   in	  
the	  development	  of	  this	  disease	  (N.	  L.	  Ward,	  et	  al.	  2012,	  Lake,	  et	  al.	  2013).	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1.5.3.2.	  HSCR	  Genetics	  
The	   majority	   (70-­‐80%)	   of	   cases	   are	   thought	   to	   be	   sporadic,	   but	   familial	   forms	   do	   exist,	  
albeit	  with	   variable	   penetrance	   accounting	   for	   approximately	   20%	   of	   cases	   (Amiel,	   et	   al.	  
2008).	   	  Mutations	   in	  genes	   involved	  in	  any	  one	  of	  the	  pathways	  previously	  described	  (see	  
1.1.4)	  may	  result	  in	  HSCR.	  	  However,	  individuals	  may	  possess	  significant	  mutations	  in	  these	  
key	  genes	  and	  yet	  not	  display	  any	  phenotypic	  features	  of	  the	  disease,	  which	  may	  indicate	  a	  
significant	  role	  for	  environmental	  factors	  in	  the	  development	  of	  HSCR	  (Kenny,	  et	  al	  2010).	  
	  
The	  most	  studied	  gene	  in	  relation	  to	  susceptibility	  to	  HSCR	  is	  RET,	  mutations	  in	  RET	  can	  be	  
found	   in	  more	   than	   50%	   of	   familial	   cases	   of	   HSCR	   and	   15-­‐20%	   of	   sporadic	   (Amiel,	   et	   al	  
2008).	   	   Furthermore,	   linkage	   studies	   looking	   at	   previously	   un-­‐investigated	   non-­‐coding	  
regions	   of	   the	   RET	   gene	   suggest	   that	   a	   mutation	   in	   RET	   (coding	   or	   non-­‐coding)	   may	   be	  
necessary	  for	  the	  development	  of	  the	  HSCR	  phenotype	  in	  almost	  all	  cases.	  	  However	  these	  
studies	  also	  confirmed	  that	  RET	  mutations	  are	  not	  sufficient	  alone,	  in	  all	  cases,	  to	  result	  in	  
the	  disease	  (Emison,	  et	  al	  2010).	  
	  
In	   a	   family	   with	   one	   affected	   child	   the	   risk	   of	   a	   subsequent	   sibling	   being	   affected	   lies	  
between	   1	   and	   33%	   depending	   on	   the	   length	   of	   aganglionic	   bowel	   and	   the	   sex	   of	   the	  
children.	  	  The	  highest	  recurrence	  risk	  for	  siblings	  is	  33%	  for	  male	  children	  with	  a	  sister	  with	  
long	  segment	  disease,	  falling	  to	  just	  1	  %	  for	  females	  with	  an	  older	  affected	  brother	  (Amiel,	  
et	  al	  2008).	   	  The	  underlying	  reason	  for	  this	  variable,	  sex	  dependent	  penetrance	   is	  not	  yet	  
fully	   understood.	   	   Genetic	   screening	   studies	   in	   mice	   have	   identified	   a	   number	   of	   genes	  
expressed	  in	  the	  developing	  ENS	  that	  are	  linked	  to	  the	  X-­‐gene	  but	  no	  human	  studies	  have	  
identified	  a	  locus	  on	  the	  X-­‐gene	  (Heanue,	  et	  al.	  2007).	  	  Alternative	  hypotheses	  suggest	  that	  
differential	  epigenetic	  regulation	  at	  the	  RET	  locus	  may	  account	  for	  these	  changes	  (Amiel,	  et	  
al	  2008).	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1.5.3.3.	  Current	  surgical	  management	  
The	  distal	  bowel	  obstruction,	  due	  to	  the	  tonic	  contraction	  of	  aganglionic	  bowel	  can	  usually	  
be	  resolved	  with	  rectal	  washouts	  and	  dilatations	  in	  newly	  diagnosed	  infants.	  	  This	  allows	  a	  
definitive	  single-­‐stage	  procedure	  to	  be	  performed	  electively	   in	  the	  first	  few	  months	  of	   life	  
(Keckler,	  et	  al.	  2009).	  	  If	  adequate	  decompression	  of	  the	  bowel	  is	  not	  achievable	  with	  these	  
simple	  measures	  a	  levelling	  stoma	  is	  required	  in	  the	  early	  neonatal	  period.	  
	  
There	  are	  a	  number	  of	   surgical	   techniques	   currently	   in	  widespread	  use,	  however	   they	  all	  
share	   the	   key	   aim	   of	   resecting	   the	   majority	   of	   the	   aganglionic	   bowel	   and	   pulling	   down	  
‘normal’	  ganglionic	  to	  a	   low	  anastomosis	  above	  the	  anal	  sphincters.	   	  Approaches	  included	  
both	  single	  and	  multi-­‐staged	  procedures	  and	  both	  laparoscopic	  and	  open	  approaches.	  	  The	  
two	  most	  popular	  techniques	  in	  widespread	  use	  are	  the	  Duhamel	  and	  modified	  Soave	  pull-­‐
throughs,	   however,	   there	   is	   a	   paucity	   of	   evidence	   to	   promote	   a	   single	   technique	   as	   the	  
operation	  of	  choice	  (Baillie,	  et	  al.	  1999,	  Conway,	  et	  al.	  2007,	  Craigie,	  et	  al.	  2007).	  
	  
1.5.3.4.	  Long-­‐term	  Outcomes	  
Over	  recent	  decades,	  the	  surgical	  management	  of	  HSCR	  has	  continued	  to	  evolve;	  however,	  
despite	  adoption	  of	  minimally	   invasive	  approaches	  and	  refinements	   in	  surgical	   technique,	  
HSCR	   is	  still	  associated	  with	  significant	   long-­‐term	  morbidities.	  A	  number	  of	  cohort	  studies	  
report	  significant	  rates	  of	  refractory	  constipation	  and	  fecal	  incontinence	  affecting	  between	  
10%	   and	   30%	   of	   patients,	   resulting	   in	   significant	   social	   morbidity	   (Ludman,	   et	   al.	   1995,	  
Baillie,	  et	  al	  1999,	  Minford,	  et	  al.	  2004,	  Mills,	  et	  al.	  2008).	   	  Furthermore,	  one	  recent	   long-­‐
term	   Finnish	   study	   has	   also	   suggested	   that	   rates	   of	   certain	   morbidities	   such	   as	   fecal	  
incontinence	  may	  actually	  increase	  with	  time	  (Jarvi,	  et	  al.	  2010).	  	  It	  is	  the	  results	  of	  studies	  
such	  as	  these,	  coupled	  with	  our	  growing	  understanding	  of	  the	  development	  of	  the	  enteric	  
nervous	   system	   (ENS),	   that	   have	   provided	   the	   stimulus	   to	   investigate	   the	   possibility	   of	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developing	  alternative	  or	  adjunctive	   therapies	   to	  surgery	   in	  an	  effort	   to	  alleviate	  some	  of	  
the	  ongoing	  morbidity	  experienced	  by	  children	  and	  adults	  with	  HSCR.	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1.6.	   Development	  of	  potential	  cell	  based	  therapies	  for	  HSCR	  
Advances,	  particularly	  over	  the	   last	  15	  years,	   in	  our	  understanding	  of	  the	  development	  of	  
the	   ENS	   and	   in	   translational	   stem	   cell	   research	   has	   prompted	   growing	   interest	   into	   the	  
potential	  of	  using	  cell-­‐based	  therapies	  to	  ‘replace’	  the	  missing	  components	  of	  the	  ENS	  with	  
the	  goal	  of	  improving	  the	  quality	  of	  life	  of	  patients	  with	  enteric	  neuropathies	  such	  as	  HSCR.	  	  
	  
1.6.1.	   Sources	  of	  stem/progenitor	  cells	  
Following	  the	  discovery	  that	  neurogenesis	  is	  a	  continuous	  process	  in	  the	  adult	  human	  brain	  
and	  not	  just	  restricted	  to	  early	  development	  (Eriksson,	  et	  al.	  1998)	  there	  has	  been	  interest	  
in	  the	  potential	  of	  using	  neural	  progenitor	  cells	  to	  restore	  defects	  in	  ENS	  colonisation.	  	  This	  
has	  driven	  the	  efforts	  of	  several	  research	  groups	  towards	  the	  development	  of	  both	  de	  novo	  
and	   adjunctive	   cell-­‐based	   therapies	   for	   HSCR.	   	   The	   underlying	   hypothesis	   for	   these	  
therapies	   is	   that	   progenitor	   cells	   exist	   in	   the	   post-­‐natal	   gut,	   and	   that	   they	   retain	   the	  
potential	   to	   differentiate	   into	   both	   enteric	   glia	   and	   neurons.	   	   Furthermore,	   these	  
progenitors	   can	   be	   isolated	   and	   expanded	   in-­‐vitro	   to	   generate	   sufficient	   numbers	   for	  
transplantation	  with	   the	   goal	   of	   restoring	   a	   normal	   pattern	   of	   bowel	   contractility	   and/or	  
improving	  function.	  	  Consequently,	  a	  number	  of	  potential	  sources	  have	  been	  investigated,	  
including	  the	  central	  nervous	  system	  (CNS),	  embryonic	  stem	  cells	  (ESC)	  and	  the	  ENS	  itself.	  
	  
1.6.1.2.	  The	  central	  nervous	  system	  
The	  potential	  for	  using	  progenitors	  derived	  from	  the	  CNS	  was	  demonstrated	  in	  early	  studies,	  
transplanting	   CNS	   derived	   progenitor	   cells	   into	   the	   pylorus	   of	   a	   well-­‐established	   mouse	  
model	   of	   gastroparesis	   (a	   neuronal	   nitric	   oxide	   synthase	   (nNOS)	   neuron	   null	   mouse).	  	  	  
Within	   one	  week	   of	   transplantation	   new	   functional	   nNOS	   neurons	  were	   seen	  within	   the	  
muscle	  wall	   and	   this	  was	  associated	  with	  a	   significant	   improvement	   in	  both	   relaxation	  of	  
Chapter	  1	  |	  Introduction	  
	   Page	  |	  27	  
the	  pylorus	  and	  gastric	  emptying	   (Micci,	  et	  al.	  2005).	   	  This	  study	  provided	  the	   first	  strong	  
evidence	   to	   support	   the	  use	  of	  CNS-­‐derived	   transplanted	  progenitors	   in	   the	   treatment	  of	  
gastrointestinal	   motility	   disorders.	   	   More	   recent	   studies	   have	   looked	   specifically	   at	  
functional	   outcomes	   in	   an	   in-­‐vivo	   rat	  model	   of	  HSCR.	   	   In	   this	   study	  Dong	   and	   colleagues	  
report	  that	  new	  nNOS	  and	  choline	  acetyltransferase	  (ChAT)	  positive	  neurons	  could	  be	  seen	  
following	   transplantation	  of	   rat	   fetal	  CNS-­‐derived	  progenitors	   into	   the	  aganglionic	   rectum	  
of	   a	   rat,	   and	   more	   importantly	   that	   this	   transplantation	   could	   restore	   the	   rectoanal	  
inhibitory	   reflex	   (Dong,	  et	  al.	  2008).	   	  However,	   there	  are	  both	  practical	  and	  ethical	   issues	  
regarding	  the	  isolation	  and	  transplantation	  of	  fetal	  human	  CNS	  progenitors	  that	  would	  pose	  
significant	  barriers	  to	  development	  of	  a	  clinical	  application.	  
	  
1.6.1.2.	  Human	  embryonic	  stem	  cells	  
Studies	   have	   also	   demonstrated	   the	   ability	   to	   direct	   the	   differentiation	   of	   human	   ESC	  
(HESC)	   and	   progenitor	   cells	   isolated	   from	   amniotic	   fluid	   towards	   a	   neuronal	   lineage,	  
including	  the	  neuronal	  phenotypes	  found	  within	  the	  ENS	  (Hotta,	  et	  al.	  2009,	  Kamiya,	  et	  al.	  
2011,	  Bottai,	   et	   al.	   2012).	   	   Progenitors	  derived	   from	  HESC	  and	   induced	   to	  express	  neural	  
crest	  markers	   have	   been	   transplanted	   into	   embryonic	  mouse	   gut	   explants	   and	   shown	   to	  
have	   the	   capability	   to	   migrate	   and	   differentiate	   into	   cells	   expressing	   markers	   of	   both	  
neuronal	  and	  glial	  phenotypes	  (Hotta,	  et	  al	  2009).	  	  However,	  the	  translation	  from	  promising	  
animal	   study	   to	   human	   trial	   has	   been	   hampered	   by	   similar	   issues	   to	   those	   limiting	   the	  
clinical	  application	  of	  CNS-­‐derived	  stem	  cells.	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1.6.1.3.	  The	  enteric	  nervous	  system	  
Despite	  the	  clear	  ability	  of	  progenitors	   from	  a	  variety	  of	   lineages	  to	  migrate,	  differentiate	  
and	   even	   show	   functional	   improvement	   post-­‐transplantation	   the	   mainstay	   of	   current	  
research	  is	  focused	  around	  the	  use	  of	  ENS-­‐derived	  progenitor	  cells	  (ENSPC).	  	  This	  source	  of	  
progenitors	   has	   the	   key	   advantage	   of	   providing	   the	   ability	   to	   perform	   autologous	  
transplantations,	  thus	  alleviating	  the	  necessity	  of	  immunosuppression	  and	  avoiding	  some	  of	  
the	  technical	  and	  ethical	  concerns	  associated	  with	  some	  of	  the	  alternative	  sources.	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1.6.2.	   Potential	  role	  of	  antenatal	  intervention	  
The	  prospect	  of	  antenatal	  intervention	  with	  the	  aim	  of	  correcting	  the	  failure	  to	  colonise	  the	  
distal	  bowel	  in	  HSCR	  is	  attractive.	  	  Studies	  have	  reported	  that	  in	  an	  experimental	  model	  of	  
aganglionosis,	  created	  by	  ablating	  of	  the	  vagal	  NCCs	  before	  they	  have	  migrated,	  a	  ‘rescue’	  
may	   be	   achieved	   following	   transplantation	   of	   a	   small	   number	   of	   NCCs	   into	   the	   existing	  
migratory	   pathways	   (Druckenbrod,	   et	   al	   2005).	   The	   potential	   of	   antenatal	   intervention,	  
either	  with	  transplantation	  or	  by	  manipulation	  of	  the	  known	  migratory	  signalling	  pathways	  
is	  certainly	  attractive	  however	  research	  into	  the	  development	  of	  antenatal	  therapies	  is	  not	  
a	  major	  active	  field	  of	  research	  primarily	  due	  to	  the	  inherent	  difficulties	  of	  diagnosing	  HSCR	  
in	  the	  antenatal	  period.	  	  Although	  there	  are	  known	  genetic	  mutations,	  in	  particularly	  in	  the	  
Ret-­‐GDNF	   and	   ET-­‐3-­‐EDNRB	   genes,	   the	   genetic	   picture	   is	   far	   from	   simple	   with	   an	   ever-­‐
growing	  number	  of	  associated	  single	  or	  multiple	  mutations	  being	   identified.	   	  Furthermore	  
there	   is	   wide	   variability	   in	   the	   penetrance	   of	   these	   known	  mutations,	   such	   that	   even	   in	  
individuals	  with	  mutations	   known	   to	   be	   strongly	   associated	  with	  HSCR	  we	   are	   unable	   to	  
accurately	  predict	  whether	   they	  will	  develop	  a	  HSCR	  phenotype.	   	  This	  might	   suggest	   that	  
other	   factors,	   such	   as	   environmental	   insults	   during	   gestation	   are	   also	   involved	   in	   the	  
development	  of	  HSCR.	   	  However,	   it	   also	  makes	  a	  widespread	  genetic	  antenatal	   screening	  
programme	  non-­‐viable	  at	  this	  current	  time.	  
The	   alternative	   antenatal	   diagnostic	  modality	   is	   the	   use	   of	   ultrasonography	  however	   this	  
has	   yet	   to	   be	   shown	   to	   be	   of	  much	   value.	   	   Not	   least	   because	   colonic	   dilatation	   is	   rarely	  
observed	  before	  25	  weeks	  (Belin,	  et	  al.	  1995)	  making	  it	  highly	  improbable	  that	  features	  of	  
bowel	   obstruction	   will	   be	   visible	   at	   the	   time	   of	   routine	   antenatal	   scans.	   	   Furthermore,	  
abdominal	  distension	  due	  to	  bowel	  dilatation	  is	  a	  postnatal	  phenomenon,	  appearing	  after	  
the	   first	   few	   days	   of	   life.	   	   	   Therefore,	   largely	   due	   to	   the	   lack	   of	   a	   reliable	   method	   of	  
diagnosing	   these	   children	   in	   the	   antenatal	   period	   the	   prospects	   for	   fetal	   intervention	  
remain	  minimal.	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1.6.3.	   Enteric	  nervous	  system	  progenitor	  cells	  
1.6.3.1.	  Isolation	  of	  ENSPC	  	  
The	  ability	  to	  isolate	  ENSPC	  was	  initially	  reported	  using	  fetal	  bowel	  from	  mice	  and	  rats.	  	  It	  
was	  found	  that	  a	  subpopulation	  of	  cells	  isolated	  from	  dissociated	  gut	  tissue	  expressing	  the	  
neural	  crest	  markers	  such	  as	  P75	  could	  be	  maintained	  in	  culture,	  forming	  conglomerations	  
of	  cells	  termed	  neurospheres.	   	  The	  subsequent	  demonstration	  that	  cells	  could	  be	  isolated	  
from	  mature	  post-­‐natal	  gut,	  and	  that	  these	  cells	  maintain	  the	  potential	  to	  differentiate	  into	  
enteric	  neurons	  and	  glia	  prompted	  further	  study	  into	  a	  potential	  therapeutic	  role	  for	  these	  
cells	  (Natarajan,	  et	  al.	  1999,	  Sidebotham,	  et	  al.	  2002).(Kruger,	  et	  al.	  2002)	  
Importantly,	   with	   regard	   to	   obtaining	   a	   practical	   source	   for	   future	   therapies	   it	   has	   since	  
been	   shown	   that	   ENSPC	   can	   be	   isolated	   from	   human	   postnatal	   bowel	   including	   patients	  
with	   HSCR	   (Rauch,	   et	   al.	   2006,	   Almond,	   et	   al.	   2007,	   Lindley,	   et	   al.	   2008,	  Metzger,	   et	   al.	  
2009).	   	  Cells	  can	  be	  isolated	  either	  from	  full	  thickness	  colonic	  wall	  biopsies	  (Almond,	  et	  al	  
2007,	  Lindley,	  et	  al	  2008)	  or	  as	  described	  by	  Metzger	  et	  al,	   from	  endoscopic	  gut	  mucosal	  
biopsies	   (Metzger,	   et	   al	   2009).	   	   	   Significantly,	   human	   cells,	   including	   those	   isolated	   from	  
patients	   with	   HSCR	   have	   been	   transplanted	   into	   both	   embryonic	   aganglionic	  mouse	   and	  
human	  postnatal	  colon	  and	  have	  been	  shown	  to	  migrate,	  differentiate	  (Lindley,	  et	  al	  2008,	  
Metzger,	   et	   al	   2009).	   	   Furthermore,	   Lindley	   et	   al,	   demonstrated	   that	   human	   cells	   from	  
patients	   with	   HSCR	   maintain	   the	   ability	   to	   restore	   a	   normal	   pattern	   of	   contractility	   to	  
embryonic	  aganglionic	  bowel	  (Lindley,	  et	  al	  2008).	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1.6.3.2.	  In-­‐vitro	  culture	  of	  ENSPC	  
Neural	  progenitors	  both	  from	  the	  CNS	  and	  the	  ENS	  are	  typically	  maintained	  in	  culture	  in	  the	  
form	  of	  neurospheres.	  	  However,	  despite	  the	  widespread	  use	  of	  neurosphere	  assays	  in	  CNS	  
neural	  progenitor	  research	  our	  knowledge	  of	  the	  precise	  composition	  and	  behaviour	  of	  ENS	  
neurospheres	   is	   limited.	   	   Studies	   have	   shown	   that	   ENS-­‐derived	   neurospheres	   contain	   a	  
mixed	  population,	  comprising	  of	  both	  progenitors	  and	  more	  differentiated	  cell	   types	  such	  
as	   neurons	   and	   glia	   (Kruger,	   et	   al	   2002,	   Almond,	   et	   al	   2007).	   	   Later	   studies	   have	  
demonstrated	  that	  ENSPC	  cultured	  as	  neurospheres	  are	  capable	  of	  clonal	  expansion	  itself	  a	  
key	  property	  for	  a	  stem	  cell	  population	  (Lindley,	  et	  al.	  2009),	  but	  more	  importantly,	  when	  
transplanted	  onto	  embryonic	  aganglionic	  gut	  explants	  ENSPCs	  proliferate	  and	  differentiate	  
into	   cells	   expressing	   neural	   and	   glial	   markers	   (Natarajan,	   et	   al	   1999,	   Bixby,	   et	   al.	   2002,	  
Sidebotham,	  et	  al.	  2002,	  Bondurand,	  et	  al.	  2003,	  Lindley,	  et	  al	  2008)	  	   	  However,	  how	  cells	  
behave	   whilst	   in	   this	   artificial	   environment	   particularly	   in	   terms	   of	   proliferation	   and	  
differentiation,	  and	  the	  control	  of	  these	  processes	  remains	  largely	  unknown.	  
	  
	  
1.6.3.3.	  Origin	  of	  ENSPC	  	  
Despite	  the	  significant	  progress	   in	  the	   isolation	  and	  characterisation	  of	  ENSPC	   in-­‐vitro	  the	  
identity	  and	  localisation	  of	  neural	  progenitors	  in-­‐vivo	  is	  yet	  to	  be	  determined.	  	  The	  common	  
assumption	  is	  that	  ENSPC	  present	   in	  the	  post-­‐natal	  bowel	  are	  derived	  from	  the	  vagal	  NCC	  
colonising	  the	  bowel	  during	  development.	  	  Current	  evidence,	  supported	  by	  the	  expression	  
of	  glial	  markers	  (GFAP,	  Sox10,	  S100)	  and	  lineage	  tracing	  studies,	  is	  stacking	  up	  behind	  a	  glial	  
lineage	  for	  these	  cells	  (Joseph,	  et	  al.	  2011,	  Laranjeira,	  et	  al.	  2011),	  however	  the	  absence	  of	  
a	  definitive	  marker	  for	  ENSPC	  has	  hampered	  their	  identification	  in-­‐vivo.	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With	  regard	  to	   localisation,	  early	  studies	  have	  suggest	   that	  progenitors	  are	   located	   in	   the	  
region	  of	  the	  myenteric	  plexus,	  within	  the	  enteric	  ganglia	  themselves	  (Kruger,	  et	  al	  2002),	  
which	  explains	  their	  absence	  in	  the	  distal	  aganglionic	  bowel	  in	  HSCR.	  	  Not	  all	  studies	  agree	  
with	  this,	  a	  more	  recent	  pulse-­‐chase	  DNA	  labelling	  study	  from	  the	  Gershon	  group	  suggested	  
that	  a	  small	  pool	  of	  progenitors	  exist	  in	  an	  extra-­‐ganglionic	  location	  giving	  rise	  to	  cells	  that	  
subsequently	  migrate	   into	   the	  myenteric	  and	   submucosal	   ganglia	  of	   the	  postnatal	   gut	   in-­‐
vivo	  (Liu,	  et	  al.	  2009).	  	  However,	  the	  current	  inability	  to	  reliably	  identify	  ENSPC	  in-­‐vivo	  has	  
prevented	  any	  definitive	  conclusions	  being	  drawn.	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1.6.4.	   Postnatal	  ENSPC-­‐based	  therapies	  
Studies	   confirming	   the	   ability	   of	   human	   postnatal	   ENSPC	   to	   restore	   a	   normal	   pattern	   of	  
contraction	   to	   an	   aganglionic	   model	   have	   provided	   significant	   stimulus	   in	   the	   search	   to	  
develop	   cell-­‐based	   therapies	   as	   a	   treatment	   modality	   for	   HSCR	   (Lindley,	   et	   al	   2008).	  	  
However	   transplantation	   into	   a	   small	   section	   of	   embryonic	   bowel	   in-­‐vitro	   is	   an	   entirely	  
different	  proposition	  to	  transplanting	  these	  ENSPC	  into	  mature	  postnatal	  human	  gut	  in-­‐vivo.	  	  	  
The	   ENS	   is	   a	   complex	   and	   extensive	   division	   of	   the	   nervous	   system	   and	   even	   in	   HSCR	  
limited	   to	   the	   sigmoid	   colon	   both	   the	   population	   of	   transplanted	   ENSPC	   that	   would	   be	  
required	  to	  restore	  the	  ENS	  and	  the	  distances	  required	  for	  them	  to	  migrate	  would	  be	  vast.	  	  	  
This	   has	   prompted	   some	   groups	   to	   target	   the	   development	   of	   adjunctive	   therapies	   to	  
surgery	  rather	  than	  aiming	  to	  transplant	  ENSPC	  into	  large	  lengths	  of	  aganglionic	  colon.	  	  The	  
underlying	   premise	   being	   that	   surgery	   always	   leaves	   behind	   a	   small	   cuff	   of	   aganglionic	  
tissue	  around	  the	  internal	  anal	  sphincter	  and	  that	  conceivable	  that	  it	  this	  residual	  cuff	  that	  
is	  responsible	  for	  at	  least	  some	  of	  the	  long-­‐term	  morbidity	  seen.	  	  It	  is	  hoped	  that	  the	  more	  
practically	   achievable	   target	   of	   transplantation	   of	   ENSPC	   into	   this	   defined	   region	   may	  
improve	  current	  outcomes	  (Almond,	  et	  al	  2007,	  Lindley,	  et	  al	  2008).	  
	  
Although	   the	  majority	   of	   studies	   looking	   at	   the	   potential	   role	   for	   ENSPC	   based	   therapies	  
have	  been	  based	   in	   ex-­‐vivo	  models,	   a	   recent	   study	  has	   reported	   the	   ability	   to	   transplant	  
post-­‐natal	   ENPSC	   into	   mice.	   	   They	   have	   shown	   that	   ENSPC	   can	  migrate	   extensively	   into	  
postnatal	  mouse	  bowel,	  survive,	  proliferate,	  and	  integrate	  with	  the	  host’s	  nervous	  system.	  	  
Most	   importantly,	   these	   transplanted	   cells	   can	   differentiate	   into	   electrophysiologically	  
active	   neurons	   (Hotta,	   et	   al.	   2013).	   	   Although	   encouraging,	   it	   still	   remains	   to	   be	   seen	  
whether	   transplanted	   cells	   can	   actually	   achieve	   ‘restoration	   of	   function’	   and	   questions	  
remain	  regarding	  the	  ability	  to	  translate	  the	  findings	  of	  these	  studies	  to	  humans.	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1.6.5.	   Outstanding	  questions	  
1.6.5.1.	  Is	  transplantation	  of	  autologous	  ENSPC	  safe?	  
Since	  the	  main	  aim	  of	  any	  new	  HSCR	  therapy	  is	  to	  alleviate	  morbidity	  rather	  than	  mortality	  
it	   is	   unsurprising	   that	   ensuring	   the	   safety	   of	   any	   future	   cell-­‐based	   therapy	   is	   of	   primary	  
importance.	   	  Given	   the	   dramatic	   change	   in	   behaviour	   seen	  when	   these	   cells	   are	   isolated	  
from	  the	  human	  colon	  where	  they	  move	  from	  what	  appears	  to	  be	  an	  essentially	  quiescent	  
state	   to	   that	   of	   rapid	  proliferation	   in-­‐vitro	   it	   is	   important	   to	   understand	   the	  mechanisms	  
that	  regulate	  this	  change.	  	  The	  key	  question	  being,	  what	  will	  happen	  to	  this	  behaviour	  when	  
they	   are	   transplanted	  back	   into	   the	   environment	   of	   a	   human	   colon,	  will	   they	   come	  back	  
under	   the	   control	  of	   the	   local	   regulatory	  mechanisms	  or	  will	   they	   continue	   to	  proliferate	  
and	   develop	  malignant	   potential?	   	   Detailed	   long-­‐term	   studies	   are	   required	   to	   determine	  
the	  how	  ENSPC	  behaviour	  alters	  post-­‐transplantation,	  specifically	  there	  is	  a	  need	  to	  assess	  
the	  genomic	  stability	  of	  these	  cells	  to	  establish	  what	  tumour	  potential	  they	  may	  pose.	  
	  
1.6.5.2.	  Will	  transplanted	  ENSPC	  survive	  in	  human	  post-­‐natal	  aganglionic	  bowel?	  
Since	   NCC	   colonisation	   of	   the	   gut	   involves	   a	   complex	   relationship	   between	   both	   the	  
migrating	   NCC	   and	   the	   developing	   gut,	   it	   is	   possible	   part	   of	   the	   underlying	   cause	   of	   the	  
failure	  to	  colonise	  the	  distal	  bowel	  may	  continue	  to	  make	  aganglionic	  inhospitable	  to	  ENSPC	  
transplantation.	   	   	   	   It	   has	   been	   reported	   that	   the	   ability	   of	   ENPSC	   becomes	  more	   limited	  
simply	  by	  the	  maturation	  of	  the	  bowel	  (Druckenbrod,	  et	  al.	  2009)	  so	  it	  is	  quite	  possible	  that	  
a	  post-­‐natal	  aganglionic	  environment	  may	  make	   it	   impossible	   for	  cells	   to	  migrate	   further,	  
differentiate	  or	  even	  survive.	  	  However,	  recent	  work	  presented	  by	  two	  groups:	  Hotta	  et	  al,	  
and	  Cooper	  et	  al,	  provides	  at	   least	   some	  hope	   that	   these	  obstacles	  may	  be	  overcome,	   in	  
preliminary	  studies	  transplanting	  ENPSC	  into	  postnatal	  mice	  both	  groups	  have	  shown	  that	  
the	   transplanted	   cells	   continue	   to	  migrate	  differentiate	   and	  even	   integrate	  with	   the	  host	  
Chapter	  1	  |	  Introduction	  
	   Page	  |	  35	  
ENS	   (Cooper,	  et	  al.	  2012,	  Hotta,	  et	  al	  2013).	   	  Even	  though	  these	  early	   results	  continue	  to	  
provide	  support	  for	  the	  feasibility	  of	  future	  cell-­‐based	  therapies	   it	  still	  one	  step	  further	  to	  
transplant	  ENSPC	  into	  an	  aganglionic	  environment.	  	  As	  other	  groups	  have	  suggested	  it	  may	  
require	  manipulation	  with	  the	  addition	  of	  missing	  neurotrophic	  factors	  such	  as	  GDNF	  or	  ET3	  
to	   either	   the	   recipient’s	   bowel	   or	   the	   pre-­‐transplanted	   ENSPC	   themselves	   for	   integration	  
with	  the	  bowel	  to	  be	  successful	  (Bondurand,	  et	  al.	  2006,	  Schafer,	  et	  al.	  2009).	  
	  
The	  possibility	  of	  manipulating	  aganglionic	  bowel	  to	  optimise	  the	  environment	  for	  receiving	  
transplanted	   ENSPC	   also	   raises	   the	   question	   as	   to	   whether	   manipulation	   of	   the	  
environment	  may	  allow	  inward	  migration	  of	  neurons	  and	  glia	  arising	  from	  progenitor	  cells	  
in	   neighbouring	   ganglionic	   regions	   in-­‐vivo	   (Laranjeira,	   et	   al	   2011).	   	   The	   potential	   for	  
neurogenesis	  following	  injury	  to	  the	  bowel	  has	  been	  demonstrated	  in	  studies	  in	  both	  mice	  
and	  guinea	  pigs	  (Matsuyoshi,	  et	  al.	  2010,	  Laranjeira,	  et	  al	  2011).	  	  However,	  it	  has	  not	  been	  
universally	   possible	   to	   replicate	   their	   success	   with	   the	   Morrison	   group	   unable	   to	  
demonstrate	  any	  neurogenesis	  in-­‐vivo	  (Joseph,	  et	  al	  2011).	  	  Although	  this	  area	  of	  research	  
merits	  further	  study	  any	  therapy	  that	  involves	  the	  manipulation	  of	  proliferation	  of	  cells	  in-­‐
vivo	   has	   additional	   potential	   for	   ‘off-­‐target’	   effects,	   including	   the	   proliferation	   of	  
unexpected	  cell	  types	  and	  their	  consequences.	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1.6.5.3.	  Which	  cell	  type	  will	  provide	  the	  best	  functional	  response?	  
The	  neurosphere	  is	  a	  conglomeration	  of	  progenitors,	  glia,	  neurons	  and	  smooth	  muscle	  and	  
as	  yet	  we	  are	  still	  unable	  to	  find	  a	  specific	  marker	  to	  identify	  the	  progenitor	  cells	  within	  this	  
melee.	  	  	  Recent	  studies	  have	  suggested	  that	  neural	  progenitors	  may	  arise	  from	  cells	  with	  a	  
glial	   lineage.	   	   This	   is	   based	   on	   in-­‐vitro	  work	   demonstrating	   that	   cells	   expressing	   the	   glial	  
marker	   GFAP	   have	   the	   capability	   to	   differentiate	   into	   functioning	   neurons	   (Joseph,	   et	   al	  
2011,	  Laranjeira,	  et	  al	  2011).	  	  This	  is	  also	  consistent	  with	  studies	  looking	  at	  the	  developing	  
CNS,	  which	  have	   shown	   that	   cells	   expressing	   the	  astrocyte/glial	  marker	  GFAP	  give	   rise	   to	  
neurons	  (Garcia,	  et	  al.	  2004).	  	  However,	  these	  findings	  have	  yet	  to	  be	  consistently	  repeated	  
in-­‐vivo	  within	  the	  ENS	  (Joseph,	  et	  al	  2011).	  	  Furthermore	  what	  we	  have	  yet	  to	  ascertain	  is	  
whether	  it	  is	  the	  mature	  glia	  within	  the	  bowel	  that	  under	  the	  right	  conditions	  revert	  back	  to	  
a	  more	  ‘stem’	  cell-­‐like	  behaviour,	  or	  whether	  the	  progenitor	  cells	  are	  a	  separate	  population	  
themselves	  which	  also	  express	  glial	  cell	  markers.	   	  Even	  when	  the	   identity	  of	   the	  ENSPC	   is	  
resolved	  we	  will	  still	  need	  to	  ascertain	  whether	  it	  is	  more	  effective	  to	  transplant	  a	  purified	  
sub-­‐population	  of	  ENSPC	  or	  fully	  differentiated	  neurons,	  or	  indeed	  whether	  it	  needs	  to	  be	  
the	   mixed	   population	   contained	   within	   neurospheres.	   Studies	   are	   needed	   to	   determine	  
which	  of	   these	   cell	   types	  will	   provide	   the	  best	   functional	  outcome	  and	  more	   importantly	  
which	  type	  will	  be	  the	  safest?	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1.6.5.4.	  What	  is	  the	  most	  effective	  route	  to	  deliver	  cells?	  
Aside	  from	  optimising	  the	  behaviour	  of	  ENSPC	  and	  the	  recipient’s	  colon	  there	  are	  also	  more	  
practical	   issues	   that	   need	   to	   be	   considered	   before	   bringing	   these	   therapies	   into	   clinical	  
trials.	   	   Such	  as,	  what	   is	   the	  most	  effect	  method	  of	  delivery	   for	   transplanted	  ENSPC?	   	   Is	   it	  
most	  effective	  to	  transplant	  ENSPC	  in	  their	  cultured	  form	  as	  neurospheres,	  or	  should	  they	  
be	  dissociated	  first	  and	  injected	  as	  a	  cell	  suspension?	  Where	  is	  the	  optimal	  site	  for	  delivery,	  
should	  we	   be	   aiming	   to	   transplant	   them	   in	   to	   the	   region	   of	   the	   sub-­‐mucosal	   plexus,	   the	  
myenteric	   plexus	   or	   elsewhere.	   	   Preliminary	   data	   is	   available	   from	   early	   animal	  
transplantation	  studies,	  which	  either	  place	  transplanted	  cells	  directly	  into	  muscular	  wall	  of	  
the	  gut	  or	  simply	  inject	  cells	  directly	  into	  the	  peritoneum.	  	  	  Of	  these	  two	  techniques	  direct	  
placement	   into	  the	  gut	  wall	   itself	  appears	  to	  be	  more	  promising	  because	  although	  ENSPC	  
injected	  into	  the	  peritoneum	  were	  found	  to	  have	  started	  to	  differentiate	  into	  neurons	  and	  
glia	  none	  were	  identified	  in	  the	  aganglionic	  colon	  of	  the	  mouse	  (Micci,	  et	  al	  2005,	  Tsai,	  et	  al.	  
2010).	  	  	  In	  addition	  to	  these	  techniques	  there	  remains	  the	  possibility	  of	  using	  microinjection,	  
delivering	  cells	  either	  endoscopically	  or	  under	  ultrasound-­‐guidance.	   	  These	  microinjection	  
techniques	  may	  be	  of	  particular	  benefit	   for	  therapies	  targeting	  residual	  aganglionic	  bowel	  
adjacent	   to	   the	   internal	   anal	   sphincters.	   	  What	   is	   needed	   is	   a	   systematic	   study	  using	   the	  
same	  animal	  model	  to	  compare	  delivery	  methods	  in	  terms	  of	  the	  specificity	  of	  their	  delivery	  
to	   the	   colon	   and	   the	   subsequent	   integration	   with	   the	   host	   environment	   and	   function	  
response.	  	  
	   	  
Chapter	  1	  |	  Introduction	  
	   Page	  |	  38	  
1.7	   Aims	  of	  the	  thesis	  
The	   aims	   of	   this	   thesis	  were	   largely	   to	   address	   the	   first	   two	   questions	   outlined	   in	   1.6.5.	  	  
Firstly,	   is	   transplantation	  of	  autologous	  ENSPC	  safe	  and	  secondly,	  will	   transplanted	  ENSPC	  
survive	  in	  human	  post-­‐natal	  aganglionic	  bowel?	  	   In	  order	  for	  ENSPC-­‐based	  transplantation	  
therapies	  to	  progress	  towards	  clinical	  trials	  we	  need	  a	  better	  understanding	  of	  what	  these	  
cells	   are	   and	   how	   they	   behave.	   	   As	   well	   as	   the	   control	   mechanisms	   responsible	   for	   the	  
change	  in	  behaviour	  seen	  during	  the	  transition	  from	  in-­‐vivo	  to	  in-­‐vitro	  and	  again	  following	  
transplantation.	  	  Specifically	  the	  original	  aims	  of	  this	  thesis	  were	  to:	  
1. Determine	   the	   behaviour,	   with	   specific	   regard	   to	   proliferation	   of	   both	   mouse	   and	  
human-­‐derived	  ENSPC	  in-­‐vitro.	  
2. Determine	  the	  role	  of	  the	  Notch	  signalling	  pathway	  in	  the	  regulation	  of	  this	  behaviour.	  
3. Develop	   an	   ex-­‐vivo	  model	   of	   postnatal	   human	   aganglionic	   colonic	   smooth	  muscle	   in	  
which	  the	  behaviour	  and	  functional	  effect	  of	  transplanted	  ENSPC	  can	  be	  investigated.	  
While	   carrying	   out	   experiments	   to	   meet	   the	   third	   aim	   an	   unexpected	   observation	   was	  
made,	  which	  brought	  about	  the	  fourth	  and	  final	  aim:	  	  
4. To	  determine	  whether	  neural	  progenitors	  are	  present	  within	  the	  aganglionic	  bowel	  of	  
children	  with	  HSCR	  and	  whether	  these	  cells	  have	  the	  same	  functional	  potential	  as	  those	  
isolated	  from	  normal	  ganglionic	  bowel.	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Chapter	  2:	  Materials	  and	  Methods	  
2.1.	   Standard	  sample	  isolation	  techniques	  
2.1.1.	   Embryonic	  mouse	  
A	  Home	  Office	  project	   license	  was	  not	  required	  for	  the	  work	  detailed	  within	  this	  thesis	  as	  
no	   regulated	  procedures	  were	  performed.	   	   Female	  CD1	  mice	   (Charles	  River	   Laboratories,	  
Kent,	  UK)	  were	  time	  mated	  and	  sacrificed	  under	  UK	  Home	  Office	  Schedule	  1	  conditions	  by	  
CO2	  asphyxiation	  at	  11.5	  days	  post	  coitum	  (dpc).	  Vaginal	  plug	  =	  0.5dpc.	  	  A	  laparotomy	  was	  
performed	  under	  sterile	  conditions,	  using	  70%	  (v/v)	  ethanol	  as	  a	  disinfectant,	  at	  which	  time	  
the	   peritoneal	   cavity	   was	   opened,	   uterus	   excised	   en-­‐block	   and	   placed	   in	   warmed	   high	  
glucose	  (4.5g/l)	  Dulbecco’s	  modified	  Eagle	  medium	  with	  L-­‐glutamine	  and	  sodium	  pyruvate	  
(DMEM,	   Life	   Technologies,	   Paisley,	   UK).	   	   9cm	   plastic	   petri	   dishes	   prepared	   with	   25ml	  
Sylgard®	  184	  (Dow	  Corning,	  Midland	  MI,	  USA)	  were	  used	  as	  dissection	  plates	  and	  sterilised	  
using	   70%	   (v/v)	   ethanol	   and	   exposure	   to	   UV	   light	   for	   30	   minutes.	   	   Each	   embryo	   was	  
removed	  from	  the	  uterus	  intact	  and	  the	  decapitated	  before	  proceeding	  further.	  	  Dissection	  
was	   performed	   aseptically	   using	   a	   dissection	   microscope	   (M165FC,	   Leica	   Microsystems,	  
Bucks,	  UK)	   to	   remove	  any	  attached	  mesentery	  and	   to	   isolate	   the	  desired	   region	  of	  bowel	  
(Fig	  2.1).	   	   Resected	   specimens	  were	  kept	   for	   a	  maximum	  of	  2h	   in	  high	  glucose	  DMEM	  at	  
37°C	   supplemented	   with	   10ng/ml	   gentamycin,	   100	   Units/ml	   penicillin,	   and	   100	   μg/ml	  
streptomycin	  (Life	  Technologies)	  until	  required.	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2.1.2.	   Adult	  and	  neonatal	  mouse	  
Adult	  CD1	  mice	  or	  postnatal	  day	  1	  pups	  from	  female	  CD1	  mice	  (Charles	  River	  Laboratories)	  
were	  sacrificed	  under	  Schedule	  1	  by	  CO2	  asphyxiation	  and	  cervical	  dislocation.	   	  Dissection	  
was	   performed	   under	   the	   same	   conditions	   as	   embryonic	   mice.	   	   A	   laparotomy	   was	  
performed,	  the	  colon	  removed	  intact	  and	  kept	  as	  per	  embryonic	  bowel	  until	  required.	  
2.1.3.	   Postnatal	  human	  
Ethical	   approval	   was	   obtained	   from	   the	   North	   West	   3	   Research	   Ethics	   Committee	  
(Ref:10/H1002/77)	   to	   collect	   human	   colonic	   samples	   during	   elective	   surgical	   procedures.	  	  
Individual	  consent	  was	  obtained	  from	  the	  parents	  of	  each	  child	  recruited	  into	  the	  study	  and	  
included	  samples	   from	  both	  patients	  with	  Hirschsprung’s	  disease	   (HSCR)	  and	  controls,	   i.e.	  
those	  undergoing	  either	  the	  formation	  or	  closure	  of	  colostomy	  for	  pathology	  not	  thought	  to	  
affect	   the	   innervation	   of	   the	   bowel	   (Table	   2.1).	   	   Samples	   were	   anonymised	   before	  
processing	  and	  all	  human	  tissue	  was	  both	  stored	  and	  destroyed	  according	  to	  guidelines	  set	  
down	  in	  the	  Human	  Tissue	  Act	  2004.	  	  1cm2	  specimens	  of	  bowel	  were	  taken	  from	  both	  the	  
ganglionic	   and	   aganglionic	   regions	   of	   the	   resected	   colon	   –	   confirmed	   by	   an	   absence	   of	  
ganglion	   cells	   on	   fresh	   frozen	   sections	   examined	   by	   a	   consultant	   paediatric	   pathologist	  
intraoperatively.	   	   A	   small	   2mm	   section	   was	   immediately	   fixed	   in	   4%	   (w/v)	  
paraformaldehyde,	   and	   the	   remaining	   specimen	  was	   transported	   back	   to	   the	   laboratory,	  
wrapped	  in	  sterile	  saline	  soaked	  gauze	  on	  ice	  at	  4°C	  within	  4	  hours.	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Figure	  2.1	  Dissection	  of	  Embryonic	  mouse	  bowel	   	  
Figure	   2.1.	   	   (A)	  Embryonic	  murine	  colon	  +/-­‐caecum	  were	  harvested	  at	  E11.5	  at	  which	  time	  the	  wave	  
front	  of	  migratory	  ENS	  progenitors	  will	  have	   just	   reached	  the	  caecum(Druckenbrod,	   et	  al.	   2005).	   	  For	  
generation	  of	  embryonic	  neurospheres	  the	  caecum	  was	  removed	  intact.	  	  Ganglionic	  specimens	  (D)	  for	  
transplantation	   experiments	   were	   created	   by	   dividing	   the	   caecum	   at	  A1.	   	   Aganglionic	   samples	   were	  
taken	   at	  A2,	   distal	   to	   the	  migratory	  wave	   front	   and	   either	   cultured	   alone	   (B)	  or	   transplanted	  with	   a	  
neurosphere	  at	  the	  proximal	  end	  (C).	  	  Any	  mesentery	  attached	  to	  the	  bowel	  was	  removed.	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Table	  2.1.	  	  Underlying	  pathology	  and	  age	  of	  study	  recruits.	  	  
	  
Table	  2.1.	   	  Successful	  progenitor	  cell	   isolation	   is	  taken	  as	  the	  formation	  of	  neurospheres	  within	  28	  
days	   of	   culture.	   	   Term	   gestation	   is	   taken	   as	   birth	   a	   between	   37	   and	   42	   weeks	   gestation.	   	   The	  
gestational	  age	  of	  all	  births	  outside	  this	  range	  are	  given.	  
	   	  
Patient	   Pathology	   Age	  at	   Gestation	   Successful	  progenitor	  cell	  isolation	  
from:	  




H001	   Hirschsprung’s	  –	  Short	  segment	   1	  month	   Term	   Yes	   Not	  attempted	  
H002	   Hirschsprung’s	  –	  Short	  segment	   1	  month	   Term	   Yes	   Not	  attempted	  
H003	   Hirschsprung’s	  –	  Short	  segment	   2	  months	   Term	   Yes	   Not	  attempted	  
H004	   Hirschsprung’s	  –	  Short	  segment	   2	  months	   Term	   Yes	   Not	  attempted	  
H005	   Hirschsprung’s	  –	  Short	  segment	   1	  month	   Term	   Yes	   Not	  attempted	  
H006	   Hirschsprung’s	  –	  Short	  segment	   4	  months	   Term	   Yes	   Not	  attempted	  
H007	   Hirschsprung’s	  –	  Short	  segment	   1	  year	   36	   Yes	   Not	  attempted	  
H008	   Hirschsprung’s	  –	  Short	  segment	   2	  months	   Term	   Yes	   Not	  attempted	  
H009	   Hirschsprung’s	  –	  Short	  segment	   1	  month	   Term	   Yes	   Not	  attempted	  
H010	   Hirschsprung’s	  –	  Short	  segment	   2	  months	   Term	   Yes	   Not	  attempted	  
H011	   Hirschsprung’s	  –	  Short	  segment	   2	  months	   Term	   Yes	   Not	  attempted	  
H012	   Hirschsprung’s	  –	  Short	  segment	   3	  months	   Term	   Yes	   Not	  attempted	  
H013	   Hirschsprung’s	  –	  Short	  segment	   6	  months	   Term	   Yes	   Yes	  
H014	   Hirschsprung’s	  –	  Short	  segment	   3	  months	   Term	   Yes	   Yes	  
H015	   Hirschsprung’s	  –	  Short	  segment	   3	  months	   Term	   Yes	   Yes	  
H016	   Hirschsprung’s	  –	  Long	  segment	   3	  months	   Term	   Yes	   Yes	  
H017	   Hirschsprung’s	  –	  Short	  segment	   3	  months	   Term	   Yes	   Yes	  
H018	   Hirschsprung’s	  –	  Short	  segment	   3	  months	   Term	   Yes	   Yes	  
H019	   Hirschsprung’s	  –	  Short	  segment	   1	  year	   Term	   Yes	   Yes	  
H020	   Hirschsprung’s–Ileal/Total	  colonic	  	   2	  weeks	   Term	   Yes	   No	  
H021	   Hirschsprung’s	  –	  Short	  segment	   5	  weeks	   Term	   Yes	   Yes	  
H022	   Hirschsprung’s	  –	  Short	  segment	   4	  months	   Term	   Yes	   Yes	  
H023	   Hirschsprung’s	  –	  Total	  colonic	   3	  weeks	   Term	   Yes	   No	  
C001	   Anorectal	  Malformation	   1	  year	   Term	   Yes	   N/A	  
C002	   Gastroschisis	   2	  months	   35	   Yes	   N/A	  
C003	   Anorectal	  Malformation	   1	  day	   Term	   Yes	   N/A	  
C004	   Constipation	  –	  Sigmoid	  colectomy	   5	  years	   Term	   Failed	   N/A	  
C005	   Constipation	  –	  Sigmoid	  colectomy	   16	  years	   Term	   Failed	   N/A	  
C006	   Anorectal	  Malformation	   6	  months	   Term	   Yes	   N/A	  
C007	   NEC	  –	  Closure	  of	  stoma	   3	  months	   29	   Yes	   N/A	  
C008	   Anorectal	  Malformation	   3	  months	   Term	   Yes	   N/A	  
C009	   Isolated	  colonic	  perforation	   6	  months	   28	   Yes	   N/A	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2.2.	   Standard	  buffers	  and	  tissue	  culture	  media	  
	  
2.2.1.	   Standard	  neurosphere	  medium	  (SN	  Medium)	  
DMEM	  low	  (1%	  w/v)	  glucose,	  (Gibco®,	  Life	  Technologies,	  Paisley,	  UK),	  supplemented	  with:	  
• 2%	  v/v	  chicken	  embryo	  extract	  (Sera	  Laboratories,	  West	  Sussex,	  UK)	  
• 1%	  v/v	  Fetal	  calf	  serum	  (Sigma-­‐Aldrich,	  Dorset,	  UK)	  
• 2mM	  final	  concentration	  L-­‐glutamine	  (Gibco®)	  
• 100	  Units/ml	  Penicillin	  /	  100	  μg/ml	  streptomycin	  
• 0.05mM	  final	  concentration	  mercaptoethanol	  (Gibco®)	  
• 20ng/ml	   final	   concentration	   fibroblast	   growth	   factor	   II	   (Source	   Bioscience,	  
Nottinghamshire,	  UK)	  
• 20ng/ml	  final	  concentration	  Epidermal	  growth	  factor	  (Sigma-­‐Aldrich)	  
	  
	  
2.2.2.	   Fetal	  Bovine	  Medium	  (FB	  Medium)	  
DMEM	  high	  glucose	  (4.5%	  w/v,	  Gibco®),	  supplemented	  with:	  
• 10%	  v/v	  Fetal	  calf	  serum	  
• 2mM	  final	  concentration	  L-­‐glutamine	  
• 100	  Units/ml	  Penicillin	  /	  100	  μg/ml	  streptomycin	  
	  
	  
2.2.3.	   Horse	  Serum	  Medium	  (HS	  Medium)	  
DMEM	  high	  glucose	  (4.5%	  w/v),	  supplemented	  with:	  
• 20%	  v/v	  Medium	  199	  (Gibco®)	  
• 7%	  v/v	  Heat	  inactivated	  horse	  serum	  (Gibco®)	  
• 100	  Units/ml	  Penicillin	  /	  100	  μg/ml	  streptomycin	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2.2.4.	   Tissue	  Culture	  Medium	  (TC	  Medium)	  
DMEM	  high	  glucose	  (4.5%	  w/v),	  supplemented	  with:	  
• 1%	  v/v	  Fetal	  calf	  serum	  
• 2mM	  final	  concentration	  L-­‐glutamine	  
• 100	  Units/ml	  Penicillin	  /	  100	  μg/ml	  streptomycin	  
• 0.05mM	  final	  concentration	  mercaptoethanol	  
	  
2.2.5.	   Immunofluorescence	  Blocking	  Buffer	  (IBB)	  
PBS	  (CaCl2	  /	  MgCl2	  free,	  Gibco®)	  supplemented	  with:	  
• 20%	  v/v	  Goat	  serum	  (Gibco®)	  
• 0.1%	  w/v	  NaN3	  (Sigma-­‐Aldrich)	  	  
• 0.1%	  v/v	  Triton	  X	  (VWR,	  Leicestershire,	  UK)	  
• 1%	  w/v	  Bovine	  serum	  albumin	  (Sigma-­‐Aldrich)	  
(For	  staining	  of	  cell	  surface	  receptors	  0.1%	  triton	  was	  replaced	  with	  0.1%	  Saponin	  (Sigma-­‐
Aldrich)	  to	  preserve	  the	  architecture	  of	  the	  cell	  membrane.)	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2.3.	   Cell	  Culture	  Techniques	  
2.3.1.	   Generation	  of	  neurospheres	  from	  primary	  cultures	  
The	   techniques	   for	   generating	   neurospheres	   from	   both	  mouse	   and	   human	   sources	  were	  
based	   on	   previously	   published	   work	   from	   our	   group	   (Almond,	   et	   al	   2007,	   Lindley,	   et	   al	  
2008).	  
	  
2.3.1.1.	  Embryonic	  mouse	  
To	  generate	  a	  single	  cell	  suspension	  E11.5	  mouse	  caeca	  (2.1.1)	  were	  incubated	  with	  0.05%	  
(w/v)	  trypsin	  (Sigma-­‐Aldrich)	  at	  37°C	  for	  1h.	  	  The	  sample	  was	  then	  centrifuged	  at	  150g	  for	  5	  
minutes,	  supernatant	  removed	  and	  1ml	  of	  SN	  culture	  medium	  added	  before	  mechanically	  
dissociating	  the	  suspension	  by	  trituration	  using	  a	  1000µl	  pipette.	   	  The	  resultant	  single	  cell	  
suspension	  was	  counted	  using	  a	  haemocytometer	  and	  aliquots	  of	  2-­‐5x105	  cells	  transferred	  
to	  non-­‐adherent	  35mm	  dishes	  (530588,	  Corning	  BV	  Life	  Sciences,	  Amsterdam,	  Netherlands).	  	  
Additional	   standard	   neurosphere	   (SN)	   medium	   was	   added	   to	   reach	   a	   final	   volume	   of	  
6ml/dish	  and	  dishes	  kept	  in	  a	  Sanyo	  MCO	  humidified	  incubator	  at	  37°C	  and	  in	  the	  presence	  
of	  5%	  CO2	  (Panasonic	  Biomedical,	  Loughborough,	  UK).	  SN	  medium	  was	  supplemented	  with	  
gentamicin	  (50µg/ml,	  Gibco®)	  for	  the	  first	  7	  days	  in	  culture.	  
3ml	  of	  medium	  was	  removed	  and	  replaced	  with	   fresh	  SN	  culture	  medium	  every	  3-­‐4	  days.	  	  
The	  majority	   of	   embryonic	  mouse	   derived	   (eM)	   neurospheres	  were	   expected	   to	   develop	  
within	  10-­‐14	  days	  of	  the	  cells	  being	  placed	  in	  culture	  (Almond,	  et	  al	  2007).	   	  Neurospheres	  
were	  passaged	  using	  a	  further	  combination	  of	  trypsin	  digestion	  and	  mechanical	  dissociation.	  	  
Neurospheres	   were	   washed	   with	   PBS,	   centrifuged	   at	   150g	   for	   5	   minutes	   and	   then	  
incubated	   at	   37°C	  with	   0.05%	   (w/v)	   trypsin	   for	   15	  minutes.	   	  Mechanical	   dissociation	  was	  
then	   performed	   as	   above	   and	   5x105	   cells	   placed	   in	   fresh	   60mm	   non-­‐adherent	   dishes	  
(751750,	  Sterilin,	  Newport,	  UK)	  with	  a	  final	  volume	  of	  6ml	  of	  SN	  medium.	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2.3.1.2.	  Neonatal	  mouse	  
To	   generate	   neonatal	   mouse	   (nM)	   neurospheres,	   residual	   faecal	   material	   left	   within	   the	  
neonatal	   mouse	   colons	   (prepared	   in	   2.1.2)	   was	   removed	   by	   gentle	   pressure	   using	   non-­‐
toothed	   forceps.	   	   Colons	   were	   transferred	   to	   a	   fresh	   dish	   containing	   DMEM	   (2.1.1)	  
supplemented	   with	   gentamycin	   (10ng/ml),	   penicillin	   (100	   U/ml)	   and	   streptomycin	   (0.1%	  
w/v)	  and	  cut	   into	  1mm	  x	  1mm	  pieces.	   	  These	  were	  then	  placed	   in	  a	  15ml	  centrifuge	  tube	  
with	  collagenase	  and	  dispase	  (both	  1%	  (w/v),	  Gibco®)	  and	  incubated	  in	  a	  water	  bath	  at	  37°C	  
for	  1h.	   	  The	  sample	  was	  then	  briefly	  vortexed	  before	  centrifugation	  at	  150g	  for	  5	  minutes	  
and	  two	  PBS	  washes.	  	  Following	  the	  final	  wash	  the	  cells	  were	  filtered	  through	  a	  40µm	  cell	  
strainer	   (Falcon®,	   BD	   Biosciences,	   UK),	   centrifuged	   one	   further	   time	   at	   150g,	   the	  
supernatant	  removed	  and	  the	  cells	  resuspended	  in	  1ml	  SN	  medium.	  	  Cells	  were	  then	  placed	  
in	   3cm	   dishes	   and	   cultured	   as	   per	   embryonic	   samples	   (2.3.1.1)	   with	   the	   addition	   of	  
0.5µg/ml	  amphotericin	  B	  (Fungizone®,	  Gibco®)	  for	  the	  first	  week	  in	  culture.	  	  Neurospheres	  
from	  4-­‐week-­‐old	  adult	  mice	  (aMD	  neurospheres)	  were	  generated	  using	  the	  neonatal	  mouse	  
protocol.	  
	  
2.3.1.3.	  Ganglionic-­‐derived	  human	  neurospheres	  
To	   generate	   human	   ganglionic-­‐derived	   neurospheres	   from	   both	   patients	   with	   HSCR	   and	  
controls	   the	   colonic	   biopsies	   (2.1.3)	   were	   washed	   twice	   with	   PBS	   (supplemented	   with	  
gentamicin	   at	   50µg/ml).	   	   Mucosa	   and	   sub	   mucosa	   were	   removed	   using	   the	   dissecting	  
microscope	  and	  the	  serosal	  surface	  was	  cleaned	  of	  any	  residual	  blood	  vessels	  of	  mesentery.	  	  
The	  residual	  tissue	  (longitudinal/circular	  muscle	  and	  myenteric	  plexus)	  was	  cut	  into	  1mm	  x	  
1mm	  pieces	  before	  incubating	  with	  collagenase/dispase	  (as	  per	  2.3.1.2).	  
After	   the	   first	   1h	   incubation	   samples	   were	   vortexed	   briefly	   and	   inspected	   macro	   and	  
microscopically.	   	   The	   collagenase/dispase	   step	   was	   then	   repeated	   until	   a	   single	   cell	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suspension	   had	   been	   obtained,	   with	   the	   majority	   of	   samples	   requiring	   2-­‐3	   cycles.	   	   The	  
samples	  were	  then	  processed	  and	  cultured	  as	  per	  neonatal	  samples	  (2.3.1.2).	  
	  
2.3.1.4.	  Aganglionic-­‐derived	  human	  neurospheres	  
Samples	  used	  to	  generate	  neurospheres	  from	  the	  aganglionic	  bowel	  of	  patients	  with	  HSCR	  
were	   processed	   using	   the	   same	   protocol	   as	   ganglionic	   specimens	   to	   obtain	   a	   single	   cell	  
suspension.	   	  The	  subsequent	  culture	   technique	  was	   identical	  except	   that	  HS	  medium	  was	  
used	  instead	  of	  SN	  medium	  unless	  specifically	  stated	  otherwise,	  as	  cells	  were	  found	  to	  grow	  
more	  consistently	  under	  these	  conditions.	  	  Human	  ganglionic-­‐derived	  neurospheres	  used	  as	  
comparisons	   to	   those	  derived	   from	   the	   aganglionic	   bowel	  were	   cultured	  under	   the	   same	  
conditions	  as	  human	  aganglionic-­‐derived	  neurospheres.	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2.3.2.	   Colonic	  smooth	  muscle	  cultures	  
2.3.2.1.	  Mouse	  colonic	  smooth	  muscle	  
Colon	  from	  adult	  mice	  was	  removed	  (2.1.2)	  and	  pinned	  onto	  a	  pre-­‐prepared	  dissection	  dish	  
containing	  sterile	  PBS.	   	   	  The	  colon	  was	  opened	   longitudinally,	  any	  residual	   faecal	  material	  
removed,	   and	   the	   mucosa	   and	   submucosa	   separated	   from	   the	   underlying	   muscle	   and	  
discarded.	   	   The	   remaining	   muscle	   was	   cut	   into	   1mm	   x	   1mm	   pieces	   and	   incubated	   with	  
collagenase/dispase	   (see	   2.3.1.2)	   until	   a	   single	   cell	   suspension	  was	   obtained.	   	   Cells	  were	  
counted	  and	  1-­‐2x106	  cells	  transferred	  to	  adherent	  6cm	  dishes	  (Nalge	  Nunc,	  New	  York,	  USA)	  
in	  a	  total	  of	  6ml	  FB	  medium,	  supplemented	  for	  the	  first	  7	  days	  with	  0.5µg/ml	  amphotericin	  
B	   and	   gentamicin	   (50µg/ml).	   	   Confluent	   dishes	   were	   dissociated	   by	   a	   combination	   of	  
enzymatic	  digestion	  (0.05%	  w/v	  trypsin	  for	  10mins	  at	  37˚C)	  and	  mechanical	  dissociation	  and	  
transferred	   to	  T75	   flasks	   (Corning).	   	  Flasks	  were	  passaged	  every	  7	  days	  or	  when	  cells	  had	  
reached	  confluence.	  
2.3.2.2.	  Human	  colonic	  smooth	  muscle	  
Primary	   human	   colonic	   smooth	  muscle	   cultures	  were	   obtained	   from	   both	  Hirschsprung’s	  
patients	  (ganglionic	  and	  aganglionic	  colonic	  biopsies)	  and	  controls	  (see	  table	  2.1).	  	  Cultures	  
were	  established	  using	  the	  same	  methods	  as	  for	  adult	  mouse	  (2.3.2.1).	  
2.3.3.	   HEK293T	  cell	  culture	  
The	  human	  HEK293T	  cell	  line	  (provided	  by	  Dr	  T	  McKay,	  University	  of	  Manchester)	  was	  used	  
to	  amplify	  lentiviral	  particles	  (Demaison,	  et	  al.	  2002)	  (see	  2.6).	  	  Aliquots	  of	  cells	  were	  stored	  
in	  DMSO	  cell	  freezing	  medium	  (Life	  Technologies)	  in	  liquid	  nitrogen	  until	  needed.	  	  Aliquots	  
were	  defrosted	  and	  grown	   in	  T75	   flasks	   (Corning)	   in	  FB	  medium	  until	   confluent,	  at	  which	  
point	   cells	  were	   incubated	  with	   0.05%	   (w/v)	   trypsin	   for	   10	  minutes	   at	   37˚C	   before	   being	  
mechanically	   dissociated	   and	   transferred	   to	   a	   T125	   flask	   (Corning)	   in	   FB	   medium	   until	  
required.	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2.4.	   Notch	  Inhibition	  
2.4.1.	   Gamma	  secretase	  inhibition	  
The	   gamma	   secretase	   inhibitor	   N-­‐[N-­‐(3,5-­‐Difluorophenacetyl)-­‐L-­‐alanyl]-­‐S-­‐phenylglycine	   t-­‐
butyl	   ester	   (DAPT,	   Sigma-­‐Aldrich,	   see	   1.1.4)	   was	   used	   to	   inhibit	   the	   Notch	   signalling	  
pathway	  (Dovey,	  et	  al.	  2001,	  Sastre,	  et	  al.	  2001).	   	  This	  was	  dissolved	  in	  dimethyl	  sulfoxide	  
(DMSO)	  to	  obtain	  a	  10mM	  concentration,	  before	  adding	  it	  to	  the	  required	  culture	  dish	  at	  a	  
final	  concentration	  of	  20µM.	  	  An	  equal	  volume	  of	  DMSO	  was	  applied	  to	  control	  dishes.	  	  The	  
length	   of	   incubation	   was	   determined	   by	   the	   experiment	   conducted	   and	   is	   given	   in	   the	  
appropriate	  result	  section	  (Chapter	  4.2)	  
2.4.2.	   siRNA	  inhibition	  of	  RBP-­‐Jκ	  
Although	  the	  administration	  of	  DAPT	  is	  a	  common	  technique	  to	  inhibit	  Notch	  signalling,	  the	  
membrane	   complex	   that	   it	   targets	   (gamma	   secretase)	   is	   known	   to	   be	   implicated	   in	   the	  
intramembrane	  proteolysis	  of	  >100	  other	  substrates	  (Groth,	  et	  al.	  2012).	  	  Therefore	  a	  more	  
selective	   approach	   was	   taken	   to	   specifically	   target	   the	   Notch	   pathway	   using	   siRNA	  
knockdown	  of	  the	  core	  component	  of	  the	  canonical	  pathway	  RBP-­‐Jκ	  (Fig	  1.2).	  
Neurospheres	  were	  dissociated	   (as	  per	  2.3.1.1)	  and	  1-­‐2x104	   cells	   seeded	  onto	   fibronectin	  
coated	  8-­‐well	  chamber	  slides	  (2.7.2.1,	  Thermo	  Scientific,	  Leicestershire,	  UK)	  in	  a	  volume	  of	  
500µl	   (SN	   medium).	   	   Cells	   were	   allowed	   to	   adhere	   for	   3	   hours	   prior	   to	   transfection.	  	  
Transfection	  was	  performed	  according	  to	  the	  manufacturer’s	  instructions	  using	  1.5µl	  of	  the	  
transfection	   reagent	   (HiPerFect,	   Qiagen,	  Manchester,	   UK)	   and	   10nM	   of	   each	   siRNA	   oligo	  
(Table	   2.2).	   	   Cells	  were	   fixed	   at	   72hrs	  with	   4%	   (w/v)	   paraformaldehyde	   prior	   to	   analysis.	  
Table	  2.2.	  	  List	  of	  siRNA	  oligos	  used	  
siRNA	   Sequence	   Manufacturer	  
hsRBPJ_1	   TAGGGAAGCTATGCFAAATTA	   Qiagen	  
hsRBPJ_2	   GTGGCTGGAATACAAGTTGAA	   Qiagen	  
hsRBPJ_3	   CACGGTATTATAGTACACCTT	   Qiagen	  
All	  Stars	  Human	  cell	  death	  control	   Proprietary	   Qiagen	  
All	  Stars	  negative	  control	   Proprietary	   Qiagen	  
Table	  2.2.	  	  siRNA	  oligos	  were	  a	  standard	  panel	  targeting	  independent	  regions	  of	  RBP-­‐Jκ	  produced	  by	  
Qiagen	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2.5.	   Transplantation	  Assays	  
To	   determine	   the	   functional	   potential	   of	   human	   aganglionic-­‐derived	   neurospheres	   we	  
transplanted	   human	   neurospheres	   into	   an	   embryonic,	   aganglionic	   bowel	   model	   and	  
measured	  the	  effect	  on	  bowel	  contractility	  (Lindley,	  et	  al	  2008).	  
	  
2.5.1.	   Bowel	  explant	  culture	  
Time-­‐mated	  CD1	  female	  mice	  were	  culled	  at	  11.5dpc	  and	  the	  distal	  hindgut	  harvested	  from	  
the	   embryos	   as	   detailed	   in	   shown	   in	   Fig.	   2.1.	   	   Aganglionic	   explants	  were	   either	   cultured	  
alone	   as	   negative	   a	   control	   or	   transplanted	   by	   placing	   a	   single	   aganglionic-­‐derived	  
neurosphere	   at	   its	   proximal	   end	   (Fig.	   2.2).	   	   Ganglionic	   explants	   were	   cultured	   without	  
transplantation	   as	   a	   positive	   control.	   	   Up	   to	   a	   maximum	   of	   four	   hindgut	   samples	   were	  
maintained	  on	  each	   insert	  and	  were	  maintained	   in	  culture	   (37°C,	  5%	  CO2)	   for	  a	   total	  of	  8	  
days	  before	  assessment.	  
	  
	  




Figure	   2.2.	   	   Distal	   hindgut	   explants	   were	   cultured	   on	   a	   semi-­‐permeable	   0.4µm	   Millicell®	   insert	  
(Merck	  Millipore,	  Hertfordshire,	  UK)	  placed	  within	  a	  6cm	  culture	  dish	  containing	  5ml	  of	  TC	  medium.	  	  
At	  24h	  40µl	  of	  TC	  medium	  was	  pipetted	  on	  top	  of	  the	  explant.	  	  Culture	  medium	  was	  changed	  every	  2	  
days.	  
	   	  
Explant	  Neurosphere	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2.5.2.	   Assessment	  of	  bowel	  contractility	  
The	  6cm	  dishes	  containing	  the	  Millicell®	  inserts	  were	  transferred	  directly	  to	  a	  Nikon	  TMS-­‐F	  
inverted	   microscope	   (Nikon	   UK,	   Surrey,	   UK)	   for	   analysis.	   	   The	   microscope	   stage	   was	  
maintained	   at	   37°C	  using	   a	   Techne	  MS2	  hotplate	   (Bibby	   Scientific,	   Staffordshire,	  UK)	   and	  
35mm	   thick	   custom	  made	   polystyrene	   hood.	   	   Bowel	   contractions	  were	   recorded	   using	   a	  
KP143	   video	   camera	   (Hitachi	   Europe,	   Berkshire,	   UK)	   and	   Piccolo	   video	   card	   (Euresys,	  
Angleur	   Belgium).	   Diamtrak	   software	   (Prof	   Nield,	   Flinders	   University,	   Adelaide,	   Australia)	  
was	  used	  to	  measure	  both	  the	  frequency	  and	  amplitude	  of	  contractions	  (Lindley,	  et	  al	  2008).	  	  
5-­‐minute	  recordings	  were	  taken	  from	  each	  explant	  and	  individual	  contractions	  defined	  as	  a	  
≥	  5%	  displacement	  of	  the	  bowel	  wall,	  measured	  at	  the	  point	  of	  maximal	  displacement.	  	  To	  
prevent	  a	  decrease	   in	  contractility	  due	  to	  cooling,	  a	  maximum	  of	  2	  recordings	  were	  made	  
with	  each	  explant	  before	  returning	  to	  the	  incubator	  for	  ≥30minutes.	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2.6.	   Lentiviral	  transfection	  
To	   enable	   live	   cell	   tracking	   lentiviral	   transfection	   techniques	   were	   used	   to	   induce	   the	  
expression	  of	  green	  fluorescent	  protein	  (GFP)	  in	  cells.	  
2.6.1.	   Plasmid	  cloning	  
A	   combination	   of	   three	   plasmids	  was	   used	   to	   produce	   a	  GFP	   expressing	   lentivirus	   (Table	  
2.3).	  	  Plasmids	  were	  transformed	  using	  One	  Shot®	  TOP10	  chemically	  competent	  Escherichia	  
coli	   according	   to	   the	   manufacturer’s	   instruction	   (1µg	   of	   plasmid,	   Life	   Technologies).	  	  
Bacteria	   were	   plated	   onto	   Lysogeny	   broth	   (LB)	   agar	   coated	   dishes	   in	   the	   presence	   of	  
100µg/ml	   ampicillin	   (Sigma-­‐Aldrich),	   successful	   colonies	   were	   selected	   and	   plasmid	  
purification	   performed	   using	   a	   Plasmid	   Plus	   Maxi-­‐prep	   (Qiagen)	   following	   the	  
manufacturer’s	  instructions.	  
Table	  2.3.	  	  List	  of	  plasmids	  used	  
Plasmid	   Size	   Role	  
pMDG.2	   5824bp	   Encodes	   the	   envelope	   protein	   (Vesicular-­‐stomatitis-­‐cirus	  
glycoprotein)	   that	   help	   stabilise	   the	   vector	   and	   improve	   the	  
ability	  to	  infect	  target	  cells	  
	  
pCMVΔ8.64	   13463bp	   Encodes	   the	   packaging	   plasmid	   which	   includes	   the	   Group	  
specific	   antigen	   (GAG)	   gene	   (capsid	   protein)	   and	   Pol	  
gene(reverse	  transcriptase/integrase	  activity)	  
pHR-­‐SFFV-­‐eGFP	   9662bp	   Contains	   the	   restriction	   sites	   and	   reporting	   (GFP)	   gene	   to	  
promote	  GFP	  expression	   in	   the	  host	  cell.	   	  SFFV	  =	  spleen	  focus	  
forming	  promoter.	  
(All	  provided	  by	  Dr	  T	  McKay,	  University	  of	  Manchester)	  
2.6.2.	   HEK293T	  transfection	  
1.2-­‐1.5x107	  HEK293T	   cells	  were	   seeded	   into	  a	   fresh	  T125flask	  and	   cultured	   in	   FB	  medium	  
overnight	  at	  37°C	   in	   the	  presence	  of	  5%CO2.	   	   5ml	  of	  DMEM	   (4.5g	  glucose/100ml,	  25mM,	  
Life	  Technologies)	  was	  supplemented	  with	  250µl	  of	  1M	  CaCl2	  before	  bringing	  the	  pH	  to	  7.1	  
with	   1M	   HCl	   and	   passing	   it	   through	   a	   0.2µm	   sterile	   filter	   (Whatman™	   International	   Ltd,	  
Kent,	  UK).	   	  The	  plasmids	  were	  then	  added	  to	  this	  solution	  in	  the	  following	  amounts:	  50µg	  
pHR-­‐SFFV-­‐EGFP,	   32.5µg	   pCMVΔ8.64	   and	   17.5µg	   pMDG.2.	   	   After	  maintaining	   the	   plasmid	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solution	  for	  20minutes	  at	  room	  temperature	  20ml	  of	  FB	  medium	  (pH	  adjusted	  to	  7.9)	  was	  
added	  to	  make	  a	  final	  volume	  of	  25ml.	  	  The	  HEK293T	  medium	  was	  then	  removed,	  replaced	  
with	   the	   plasmid	   solution	   and	   the	   flask	   returned	   to	   the	   incubator	   for	   48h	   (replacing	   the	  
medium	  with	  20ml	  FB	  medium	  again	  at	  24h).	  	  At	  the	  end	  of	  the	  final	  incubation	  period	  the	  
culture	  medium	  was	  removed,	  filtered	  to	  remove	  cell	  debris	  (0.2µm)	  before	  transferring	  to	  
a	   Vivaspin®	   20	   separation	   tubes	   (Sartorius	   Stedim,	   Surrey,	   UK)	   and	   spun	   down	   for	  
60minutes	  at	  1500g	  (4°C).	   	  The	  resulting	  concentrated	  viral	  suspension	  was	  aliquoted	  into	  
cyrovials	  (200µl,	  Corning)	  and	  stored	  at	  -­‐80°C	  until	  required.	  
	  
2.6.3.	   Viral	  transductions	  
Lentiviral	   transduction	   was	   performed	   on	   mature,	   passage	   3	   human	   ganglionic-­‐derived	  
neurospheres	   cultured	   in	   SN	  medium.	   	   All	   neurospheres	   from	   a	   single	   60mm	   dish	   were	  
selected	  and	   incubated	  with	  0.05%	   (w/v)	  Trypsin	   for	  15	  minutes,	  after	  which	  a	   single	  cell	  
suspension	  was	   produced	  with	   gentle	  mechanical	   dissociation.	   	   Cells	  were	   centrifuged	   at	  
150g	  for	  5min	  and	  seeded	  into	  a	  fresh	  60mm	  non-­‐adherent	  dish	  in	  SN	  medium	  mixed	  with	  
1	   aliquot	   of	   viral	   suspension	   (2.6.2).	   	   Cells	   were	   maintained	   under	   standard	   conditions,	  
replacing	   the	   SN	   medium	   at	   24h,	   GFP	   expression	   was	   typically	   >90%	   and	   GFP+ve	  
neurospheres	  developed	  by	  day	  10	  to	  14.	  






Figure	  2.3.	  A	  dissociated	  cells	  48h	  after	  transfection.	  	  B	  GFP	  neurospheres	  at	  2	  weeks	  demonstrating	  
GFP	  expression	  in	  the	  majority	  of	  cells.	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2.7.	   Immunohistochemistry	  
2.7.1.	   Tissue	  section	  preparation	  
2.7.1.1.	  Full	  thickness	  colonic	  frozen	  sections	  
Full	   thickness	   sections	   were	   taken	   from	   specimens	   of	   human	   colon,	   mouse	   colon	   and	  
colonic	   smooth	  muscle	  models	   (CSMMs)	   with	   a	  maximum	   size	   of	   3x3x3mm.	   	   Specimens	  
were	  fixed	   in	  4%	  (w/v)	  paraformaldehyde	  for	  1-­‐2h	  at	  room	  temperature,	  washed	  twice	   in	  
PBS	  before	  placing	  in	  20%	  (w/v)	  sucrose	  overnight	  at	  4°C	  for	  cryoprotection.	  	  The	  following	  
morning	   specimens	   were	   transferred	   into	   Peel-­‐A-­‐Way®	   moulds	   (Polysciences	   Europe,	  
Eppelheim,	  Germany),	  embedded	   in	  500µl	  of	  Shandon	  Cyromatrix	   (Thermo	  Scientific)	  and	  
stored	  at	  -­‐80°C	  until	  sectioning.	  
Sections	   were	   cut	   at	   7µm	   (unless	   otherwise	   stated)	   using	   a	  MX35	  microtome	   blade	   and	  
HM505N	   cryostat	   at	   -­‐22˚C	   before	  mounting	   onto	   Superfrost®	   Plus	   microscope	   slides	   (all	  
Thermo	  Scientific).	  	  Slides	  were	  stored	  at	  -­‐80°C	  until	  required.	  
	  
2.7.1.2.	  Neurosphere	  frozen	  sections	  
Frozen	  sections	  of	  neurospheres	  were	  fixed	  and	  transferred	  into	  embedding	  moulds	  using	  
the	  same	  protocol.	   	  To	  ensure	  that	  neurospheres	  were	  correctly	  orientated	  at	  the	  bottom	  
of	  each	  mould,	  moulds	  were	  centrifuged	  at	  150g	  for	  3	  minutes	  before	  transferring	  to	  -­‐80°C.	  	  
Sections	  were	  cut	  as	  per	  2.7.1.1.	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2.7.1.3.	  Paraffin	  sections	  
	  Paraffin	   sections	   were	   taken	   from	   CSMMs	   to	   allow	   more	   detailed	   analysis	   of	   the	  
architecture	  within	  tissue	  sections.	  	  Specimens	  were	  fixed	  with	  4%	  (w/v)	  paraformaldehyde	  
as	  per	  2.7.1.1	  before	  dehydrating	  and	  embedding	  in	  paraffin	  (see	  table	  2.4).	  









Blocks	  were	  allowed	  to	  set	  at	  room	  temperature	  overnight	  and	  stored	  at	  4°C	  until	  required.	  	  
Ribbons	   were	   cut	   from	   blocks	   at	   4-­‐7µm	   using	   S35	   microtome	   blades	   (Feather®,	   Osaka,	  
Japan)	   and	   a	   Shandon	   Finesse	   325	   microtome	   before	   mounting	   onto	   Superfrost®	   Plus	  
microscope	   slides	   using	   a	   Raymond	   Lamb	   section	  mounting	   bath	   (All	   Thermo	   Scientific).	  	  
Once	  mounted	  slides	  were	  kept	  at	  4°C	  until	  required.	  
	   	  
Time	   Solution	   Temperature	  
15mins	   50%	  ethanol	   Room	  Temp	  
15mins	   75%	   Room	  Temp	  
15mins	   96%	   Room	  Temp	  
15mins	   100%	  ethanol	   Room	  Temp	  
30mins	   50%	  isopropanol	  50%	  paraffin	   60°C	  
30mins	   100%	  paraffin	  wax	  	   60°C	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2.7.2.	   Dissociated	  neurosphere	  preparations	  
To	  allow	  determination	  of	  expression	  at	  single	  cell	  level	  neurospheres	  were	  dissociated	  (as	  
per	  2.3.1.1)	  and	  either	  seeded	  onto	  coated	  glass	  chamber	  slides	  and	  maintained	  in	  culture	  
or	  immediately	  spun	  down	  onto	  slides	  to	  allow	  a	  more	  accurate	  assessment	  of	  expression	  
in	  a	  freshly	  dissociated	  neurospheres.	  
	  
2.7.2.1.	  Chamber	  slide	  preparation	  
To	   improve	   cell	   adherence	   glass	   8-­‐well	   chamber	   slides	   (Thermo	   Scientific)	   were	   coated	  
under	   aseptic	   conditions	  with	   Fibronectin	   (Merck	  Millipore)	   or	   Poly-­‐D-­‐Lysine	   and	   Laminin	  
(both	  Sigma-­‐Aldrich)	  to	  promote	  neuronal	  differentiation:	  
Fibronectin	  coating:	  	  Each	  chamber	  was	  coated	  with	  1µg	  of	  Fibronectin	  in	  200µl	  PBS.	  	  This	  
was	  left	  for	  1h	  at	  37°C	  before	  washing	  once	  with	  sterile	  PBS	  and	  using	  immediately.	  
Poly-­‐D-­‐Lysine	  &	   Laminin	   Coating:	   	   Chambers	  were	   first	   coated	  with	  10µg/cm2	  of	   Poly-­‐D-­‐
Lysine	  (Sigma-­‐Aldrich),	  in	  200µl	  PBS,	  for	  8h	  at	  room	  temperature.	  	  Slides	  were	  washed	  twice	  
with	  distilled	  H2O	  and	  then	  coated	  with	  1µg/cm2	  of	  Laminin	  in	  200µl	  PBS.	  	  Slides	  were	  left	  
for	   a	   further	   8h	   at	   room	   temperature	   to	   allow	   full	   coverage	   before	   washing	   twice	   with	  
distilled	  H2O	  and	  allowing	  to	  air	  dry.	  	  Slides	  were	  stored	  at	  4°C	  until	  required.	  
	  
2.7.2.2.	  Cell	  centrifugation	  for	  single	  cell	  analysis	  
To	   minimise	   changes	   in	   expression	   following	   dissociation	   of	   neurospheres,	   freshly	  
dissociated	   cells	   were	   immediately	   spun	   down	   onto	   slides	   using	   a	   Shandon	   Cytospin3	  
(Thermo	  Scientific).	  	  Neurospheres	  were	  incubated	  with	  0.05%	  (w/v)	  Trypsin	  for	  15mins	  at	  
37°C	  before	  adding	  2ml	  of	  the	  medium	  the	  neurospheres	  had	  previously	  been	  cultured	  in	  to	  
stop	  any	  further	  digestion.	  	  Samples	  were	  centrifuged	  at	  150g	  for	  5min	  and	  resuspended	  in	  
1ml	   of	   PBS.	   	   The	   cell	   concentration	   was	   determined	   using	   a	   haemocytometer	   and	   the	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concentrated	  adjusted	  to	  1x104	  cells/ml	  with	  PBS.	   	  500µl	  of	  this	  suspension	  was	  added	  to	  
each	   cytospin	   funnel	   and	   spun	  onto	   Superfrost®	   Plus	   slides	   at	   60g	   for	   10minutes.	   	   Slides	  
were	  fixed	  with	  4%	  (w/v)	  paraformaldehyde	  and	  processed	  immediately.	  
	  
2.7.3.	   Staining	  protocols	  
2.7.3.1.	  Haematoxylin	  and	  eosin	  (H&E)	  
Slides	  were	  stained	  with	  H&E	  using	  the	  steps	  in	  table	  2.5.	  	  For	  frozen	  sections	  steps	  1	  and	  2	  
were	  omitted.	   	  Following	  the	  final	  Histoclear	  step	  slides	  were	  air-­‐dried	  and	  mounted	  with	  
ProLong®	   Gold	   antifade	   reagent	   (Life	   Technologies),	   and	   left	   to	   cure	   overnight	   at	   room	  
temperature.	  
Table	  2.5.	  	  Steps	  for	  H&E	  staining	  of	  paraffin	  sections	  
Step	   Solution	   Time	  
1	   Histoclear	  I	  /	  II	  (Thermo	  Scientific)	   5mins	  each	  
2	   100%	  /	  96%	  /	  75%	  /	  50%	  Ethanol	   2mins	  each	  
3	   Haematoxylin	   10mins	  
4	   Tap	  water	   Briefly	  
5	   0.1%	  HCl	   10secs	  
6	   Warm	  tap	  water	   5mins	  
7	   Eosin	   2mins	  
8	   Tap	  water	   Briefly	  
9	   50%	  /	  75%	  /	  96%	  /	  100%	  ethanol	   2mins	  each	  
10	   Histoclear	  II	  /	  I	   2mins	  each	  
	  
Table	  2.5	  The	  same	  protocol	  was	  used	  for	  frozen	  sections	  omitting	  steps	  1	  and	  2.	  
	  
2.7.3.2.	  Standard	  immunofluorescence	  
To	  prepare	  for	  staining	  slides	  were	  washed	  with	  PBS	  (3X)	  before	  regions	  of	  interest	  to	  stain	  
were	   marked	   out	   with	   a	   hydrophobic	   PAP	   marker	   pen	   (DAKO,	   Cambridgeshire,	   UK).	  	  
Unfixed	   slides	  were	   then	   incubated	  with	   4%	   (w/v)	   paraformaldehyde	   for	   10min	   at	   room	  
temperature	  before	  a	  further	  3	  PBS	  washes	  followed	  by	  the	  immunofluorescence	  blocking	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buffer	  (IBB)	  (see	  2.9.1)	  for	  at	   least	  1h	  at	  room	  temperature	  to	  block	  and	  permeabilise	  the	  
cells.	   	  Primary	  antibodies	  were	  diluted	   to	   the	   required	  concentration	   in	  PGN,	  applied	  and	  
incubated	  overnight	  at	  4°C.	  	  
	  
The	  following	  day,	  slides	  were	  washed	  with	  PBS	  (X3)	  before	  incubating	  with	  the	  appropriate	  
secondary	   antibody	   (in	   PGN)	   for	   1h	   at	   room	   temperature.	   	   Following	   a	   further	   3	  washes	  
with	   PBS	   cells	   were	   mounted	   using	   ProLong®	   Gold	   antifade	   reagent	   with	   DAPI	   (Life	  
Technologies)	  and	  coverslips	   (Thermo	  scientific).	   	   Slides	  were	  cured	  at	   room	  temperature	  
before	  analysis.	  
2.7.3.3.	  Assessment	  of	  proliferation	  	  
To	  identify	  proliferating	  cells	  within	  a	  cultured	  population	  either	  bromo-­‐deoxyuridine	  (BrDU,	  
Beckton	   Dickinson)	   or	   a	   5-­‐ethynyl-­‐2’-­‐deoxyuridine	   (EdU)	   ClickITTM	   Imaging	   kit	   (Life	  
Technologies)	   was	   used.	   	   BrDU	   and	   EdU	   are	   nucleoside	   analogues	   of	   thymidine	   that	   are	  
incorporated	  into	  DNA	  during	  the	  S	  phase	  of	  the	  cell	  cycle	  (Salic,	  et	  al.	  2008).	  	  
BrDU	  was	  added	  to	  cell	  cultures	  at	  a	  final	  concentration	  of	  10µM	  for	  the	  desired	  length	  of	  
time	   specific	   to	   each	   experiment.	   	   Subsequently,	   frozen	   sections	   would	   be	   prepared	   as	  
described	  in	  2.7.1.1/2	  except	  that	  prior	  to	  the	  addition	  of	  Triton,	  4M	  hydrochloric	  acid	  was	  
applied	  to	  each	  slide	  for	  15	  mins	  in	  order	  to	  denature	  the	  DNA	  and	  expose	  the	  BrDU	  group.	  	  
In	   contrast,	   when	   using	   EdU	   the	   incorporated	   EdU	   can	   then	   be	   detected	   using	   an	  
AlexaFluor®594	  conjugated	  azide,	  which	  binds	   covalently	   to	   the	  alkyne	  group	  of	  EdU	   in	  a	  
copper-­‐catalysed	  reaction.	  	  This	  has	  the	  advantage	  over	  BrDU	  as	  it	  does	  not	  require	  a	  DNA	  
denaturation	  step	  and	  allows	  co-­‐stained	  for	  other	  antibodies.	  
Cells	   were	   incubated	   with	   20mM	   EdU	   for	   the	   desired	   length	   of	   time	   according	   to	   the	  
individual	   experiment	   design.	   	   Samples	   were	   then	   fixed	   and	   permeabilised	   using	   the	  
standard	  protocol	  (2.6.3.2).	  	  Detection	  of	  incorporated	  EdU	  was	  detected	  using	  according	  to	  
the	  ClickITTM	  manufacturer’s	  instructions.	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2.7.4.	   Primary	  antibodies	  
Table	  2.6.	  	  Primary	  antibodies	  used	  in	  immunofluorescence	  assays.	  
Antibody	   Host	   Supplier	   Dilution	  
Calretinin	  (ab702)	   Rabbit	  Polyclonal	  IgG	   Abcam1	   1:25	  
Caspase	  3	  (ab2171)	   Mouse	  monoclonal	  IgG2a	   Abcam	   1:50	  
ChAT	  (ab68779)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:200	  
GFAP	  (Z0334)	   Rabbit	  Polyclonal	  IgG	   Dako	   1:250	  
GFAP	  (G3893)	   Mouse	  Monoclonal	  IgG1	   Sigma-­‐Aldrich	   1:250	  
Jagged	  1	  (ab7771)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:500	  
Ki67	  (ab15580)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:100	  
PGP	  9.5	  (ab8189)	   Mouse	  Monoclonal	  IgG2a	   Abcam	   1:100	  
P75	  (ab3125)	   Mouse	  Monoclonal	  IgG1	   Abcam	   1:1000	  
P75	  (ab8874)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:1000	  
P75-­‐PerCP/Cy5.5	  (345112)	   Mouse	  monoclonal	  IgG1К	   Biolegend
2	   1:500	  
nNOS	  (ab63602)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:500	  
Notch	  1	  (ab5267)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:200	  
Notch	  1	  NICD	  (ab52301)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:100	  
Notch	  2	  (ab8926)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:500	  
Notch	  3	  (ab23426)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:500	  
Notch	  4	  (N5163)	   Rabbit	  Polyclonal	  IgG	   Sigma-­‐Aldrich	   1:500	  
SMA	  (ab7817)	   Mouse	  Monoclonal	  IgG2a	   Abcam	   1:200	  
S100	  (ab868)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:500	  
Tuj	  (MMS-­‐435P)	   Mouse	  Monoclonal	  IgG2a	   Convance3	   1:500	  
VIP	  (ab43841)	   Rabbit	  Polyclonal	  IgG	   Abcam	   1:1000	  
	  
Table	   2.6.	   	   Supplier	   contact	   details:	   1Abcam,	   Cambridgeshire,	   UK.	   	   2Biolegend	   UK,	   London,	   UK.	  	  
3Convance	  UK,	  Berkshire,	  UK.	  
	  
2.7.5.	   Secondary	  antibodies	  
Table	  2.7.	  	  Secondary	  antibodies	  used	  in	  immunofluorescence	  assays	  
Antibody	   Host	   Supplier	   Dilution	  
Alexa	  Fluor	  594	  -­‐	  Anti-­‐rabbit	  	   Goat	  IgG	   Life	  Technologies	   1:1000	  
Alexa	  Fluor	  488	  -­‐	  Anti-­‐rabbit	  	   Goat	  IgG	   Life	  Technologies	   1:1000	  
Alexa	  Fluor	  594	  -­‐	  Anti-­‐mouse	  	   Goat	  IgG	   Life	  Technologies	   1:1000	  
Alexa	  Fluor	  488	  -­‐	  Anti-­‐mouse	  	   Goat	  IgG	   Life	  Technologies	   1:1000	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2.8.	   Molecular	  biology	  
2.8.1.	   RNA	  extraction	  
RNA	  was	  extracted	  from	  both	  neurospheres	  and	  freshly	  isolated	  colonic	  tissue.	  
2.8.1.1.	  Neurospheres	  
50-­‐100	   spheres	   were	   individually	   isolated	   from	   a	   culture	   dish	   using	   a	   100µl	   pipette	   and	  
placed	  in	  sterile	  PBS.	  	  This	  suspension	  was	  centrifuged,	  at	  100g	  for	  5	  minutes,	  resuspended	  
in	   1ml	   TRIzol®	   (Life	   Technologies)	   to	   lyse	   the	   cells	   and	   transferred	   into	   a	   1.5ml	  
microcentrifuge	   tube	   (Starlab,	   Hertfordshire,	   UK).	   	   After	   5	  min	   200µl	   chloroform	   (Sigma-­‐
Aldrich)	   was	   added	   and	   the	   suspension	   agitated	   vigorously.	   	   The	   sample	   was	   then	  
centrifuged	  at	  12	  000g	  for	  15	  minutes	  (4°C).	  	  The	  resultant	  upper	  aqueous	  layer	  containing	  
RNA	   was	   then	   transferred	   to	   a	   fresh	   microcentrifuge	   tube	   and	   an	   equal	   volume	   of	  
isopropanol	  (Sigma-­‐Aldrich)	  and	  1µg	  of	  glycogen	  (Life	  Technologies)	  added.	  	  Samples	  were	  
then	  kept	  at	  -­‐20°C	  overnight.	  
	  
2.8.1.2.	  Colonic	  tissue	  
Samples	  were	  cut	  into	  pieces	  (<1x1x1mm),	  transferred	  to	  a	  1.5ml	  microcentrifuge	  tube	  and	  
500µl	   of	   TRIzol®	  added.	   	   The	   sample	   was	   homogenised	   before	   adding	   a	   further	   500µl	   of	  
TRIzol®	  and	  continuing	  the	  protocol	  as	  for	  neurospheres.	  
Samples	  were	  stored	  at	  -­‐20°C	  for	  at	  least	  12h,	  to	  increase	  the	  RNA	  yield,	  before	  centrifuging	  
at	  12	  000g	  for	  10	  minutes	  (4°C).	   	  The	  supernatant	  was	  discarded	  and	  RNA/glycogen	  pellet	  
resuspended	  in	  75%	  (v/v)	  ethanol	  (Sigma-­‐Aldrich)	  in	  nuclease	  free	  water	  (Gibco®).	  	  Samples	  
were	  spun	  down	  a	  further	  time	  at	  4400g	  (5mins,	  4°C),	  supernatants	  discarded	  and	  pellets	  
briefly	  air-­‐dried.	  	  After	  resuspending	  in	  20	  µl	  of	  nuclease	  free	  water	  the	  RNA	  concentration	  
was	  determined	  using	  a	  Biophotometer	  spectrophotometer	  (Eppendorf	  UK,	  Hertfordshire,	  
UK)	  and	  samples	  diluted	  to	  200ng/µl	  in	  8µl	  aliquots.	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2.8.2.	   cDNA	  synthesis	  
DNase	   treatment	  was	   performed	   prior	   to	   cDNA	   synthesis	   to	   prevent	   contamination	  with	  
residual	  genomic	  DNA.	  	  To	  achieve	  this,	  1µl	  each	  of	  DNase	  and	  RQ1Buffer	  (both	  Promega,	  
Hampshire,	  UK)	  were	  added	  to	  each	  8µl	  RNA	  aliquot	  and	  the	  reaction	  incubated	  at	  37°C	  for	  
30	   minutes	   using	   a	   thermal	   cycler	   (2720,	   Applied	   Biosystems,	   Life	   Technologies).	   	   The	  
reaction	   was	   terminated	   by	   the	   addition	   of	   1µl	   of	   Stop	   Buffer	   (Promega)	   and	   a	   15min	  
incubation	  step	  at	  60°C.	  
To	   synthesise	   cDNA,	  1µl	   (100ng/µl)	  of	   random	  hexamers	   (Abgene,	  Thermo	  Scientific)	   and	  
1µl	  of	  a	  10mM	  dNTPs	  mix	  (Bioline	  Ltd,	  London,	  UK)	  were	  added	  to	  the	  DNase	  treated	  RNA	  
and	   incubated	   at	   4°C	   for	   3minutes.	   	   1µl	   of	   200U/µl	   Superscript	   III	   reverse	   transcriptase	  
(Promega),	  4µl	  of	  5X	  First	  strand	  buffer	  and	  1µl	  of	  100mM	  dithiothreitol	  (both	  Bioline)	  were	  
then	  added	  and	  the	  reaction	  mixture	  incubated	  at:	  25°C	  for	  5	  minutes,	  50°C	  for	  60	  minutes	  
and	  70°C	  for	  15	  minutes	  in	  the	  thermal	  cycler.	  	  The	  resultant	  cDNA	  product	  was	  then	  stored	  
at	  -­‐20°C	  until	  required.	  	  
	  
2.8.3.	   qRT-­‐PCR	  reaction	  
A	   Rotor	   Gene	   SYBR	   Green	   RT-­‐PCR	   kit	   (Qiagen)	   and	   Rotor-­‐Gene	   RG-­‐3000	   Thermal	   cycler	  
(Corbett	  Research,	  Qiagen,	  UK)	  were	  used	  for	  the	  final	  step	  of	  the	  qRT-­‐PCR	  reaction.	   	  The	  
reaction	  mix	  was	  prepared	  on	   ice	   (as	  per	   table	  2.8)	   to	  a	   final	   volume	  of	  25µl.	   	   The	  Rotor	  
Gene	  cycler	  was	  programmed	  as	  per	  the	  manufacturer’s	  fast	  two-­‐step	  RT-­‐PCR	  protocol	  for	  
a	  total	  of	  40	  cycles.	  	  The	  qPCR	  reaction	  step	  for	  RBPjΚ	  was	  kindly	  performed	  by	  Hannan	  Al-­‐
Lamee.	  	  
Table	  2.8.	  	  Reaction	  set	  up	  for	  qRT-­‐PCR	   	  
Component	   Volume	   Final	  concentration	  
2x	  Rotor-­‐Gene	  SYBR	  Green	  PCR	  master	  mix	   12.5µl	   1x	  
10x	  QuantiTect	  Primer	   2.5µ	   1x	  
Template	  cDNA	   1µl	   ≤100ng/reaction	  
RNase-­‐free	  water	   9µl	   -­‐	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2.8.4.	   Primers	  
Table	  2.8.	  	  List	  of	  primers	  used.	  
Gene	   Details	   Amplicon	  
length	  


































Table	  2.8.	  	  All	  primers	  and	  gene	  maps	  supplied	  by	  Qiagen.	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2.9.	   Image	  acquisition	  and	  analysis	  
2.9.1.	   Microscopy	  
Light	  microscopy	  was	  used	  for	  the	  majority	  of	  image	  acquisition	  and	  analysis	  either	  with	  a	  
Leica	   DM	   IRB	   Inverted	   microscope	   or	   Leica	   DMRB	   Upright	   microscope	   using	   a	   Leica	  
DFC420C	  camera	  (All	  Leica	  Microsystems).	  	  A	  Leica	  M165FC	  dissection	  microscope	  and	  Leica	  
DFC425C	   camera	   were	   used	   for	   live	   imaging	   of	   the	   CSMM	   and	   transplant	   experiments.	  	  
Confocal	  images	  were	  taken	  with	  a	  Leica	  TCS	  SPE	  microscope	  with	  integrated	  camera.	  
	  
2.9.2.	   Image	  analysis	  software	  
Adobe	  Photoshop	  (Adobe	  Inc.,	  California,	  USA)	  was	  used	  for	  merging,	  resizing	  and	  cropping.	  	  
Adobe	  Illustrator	  was	  used	  to	  assemble	  the	  Figures.	  	  Image	  J	  (National	  Institutes	  of	  Health,	  
USA)	  was	  used	  for	  automated	  cell	  counting.	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2.10.	   Smooth	  Muscle	  Physiology	  
Smooth	  muscle	  testing	  was	  performed	  with	  the	  assistance	  of	  Dr	  Rachel	  Floyd,	  post-­‐doctoral	  
fellow,	  Department	  of	  Cellular	  and	  Molecular	  Physiology,	  University	  of	  Liverpool.	  
	  
Constructs	   were	   cut	   into	   1cm	   lengths	   and	   buffered	   physiological	   saline	   (154mM	   NaCl,	  
5.6mM	  KCl,	  1.2mM	  MgSO4,	  2mM	  CaCl2,	  8mM	  glucose	  and	  10.9mM	  HEPES	  at	  pH	  7.4).	  	  Each	  
strip	  was	  loaded	  between	  a	  fixed	  stainless	  steel	  hook	  and	  a	  second	  hook	  attached	  to	  a	  force	  
transducer	   (Fort10g,	   World	   Precision	   Instruments,	   Hertfordshire,	   UK)	   in	   a	   custom-­‐made	  
Perspex	  tissue	  bath.	  	  Excess	  slack	  was	  taken	  up	  but	  no	  stretch	  applied,	  so	  as	  to	  not	  activate	  
stretch	  channels	  or	  rupture	  cells,	  causing	  aberrant	  contractions.	  
	  
A	  4	  channel	  peristaltic	  pump	  (Gilson,	  Wisconsin,	  USA)	  was	  used	  to	  perfuse	  the	  samples	  with	  
either	   physiological	   saline,	   120mM	   KCl	   (composition:	   39.6mM	  NaCl,	   120mM	   KCl,	   1.2mM	  
MgSO4,	  2mM	  CaCl2,	  8mM	  glucose	  and	  10.9mM	  HEPES)	  or	  100µm	  carbachol	  (in	  calcium	  free	  
physiological	  saline	  with	  2mM	  EGTA).	  	  All	  chemicals	  obtained	  from	  Sigma,	  UK.	  
For	   each	   run,	   samples	   were	   superfused	   with	   buffered	   physiological	   saline	   (7.8ml/ml	   at	  
30˚C)	  for	  5	  minutes	  before	  beginning	  testing.	  	  
KCl	   Testing:	   	   Samples	  were	  perfused	  with	  120mM	  KCl	   for	  5	  minutes	  before	  washing	  with	  
buffered	  physiological	  saline	  for	  10	  minutes.	  
Carbachol	   Testing:	   	   Samples	  were	   perfused	  with	   100µM	  Carbachol	   for	   2	  minutes	   before	  
washing	  with	  buffered	  physiological	  saline	  for	  a	  further	  10	  minutes.	  
	  
Data	  was	  acquired	  using	  a	  LAB-­‐TRAX-­‐4	  sata	  acquisition	  system	  coupled	  with	  a	  Transbridge	  
Transducer	   Amplifier	   (SYS-­‐TBM4M,	   World	   Precision	   Instruments).	   	   Data	   analysis	   was	  
performed	  using	  OriginPro	  8.5	  software	  (Origin	  Lab,	  Massachusetts,	  USA).	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2.11.	   Statistical	  Analysis	  
Non-­‐parametric	  continuous	  data	  were	  analysed	  using	  Mann-­‐U	  Whitney,	  a	  two-­‐tailed	  t	  test	  
was	  used	  for	  parametric	  data	  and	  Fisher’s	  exact	  test	  for	  categorical	  data.	  	  A	  1	  -­‐way	  ANOVA	  
analysis	  with	  Tukeys	  correction	  was	  used	  for	  parametric	  grouped	  data	  and	  a	  Krustal-­‐Wallis	  
test	   for	   non	   parametric.	   	  p	   <0.05	  was	   taken	   as	   significant.	   	   All	   analyses	  were	   performed	  
using	  GraphPad	  Prism	  Version	  5	  (GraphPad	  Software	  Corp.,	  California,	  USA).	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Chapter	   3:	   Cell	   Proliferation	   within	   Mouse	  
and	  Human	  Neurospheres	  	  
	  
3.1.	   Introduction	  
3.1.1.	   Background	  
Defects	  during	  the	  initial	  colonisation	  of	  the	  gut	  by	  cells	  originating	  in	  the	  vagal	  neural	  crest	  
are	  thought	  to	  be	  key	  to	  the	  development	  of	  neurocristopathies.	  	  The	  downstream	  pressure	  
created	  by	  the	  rapidly	  proliferating	  neural	  crest	  wave-­‐front	   is	  thought	  to	  play	  a	  significant	  
role	   in	   this	   process	   (Young,	   et	   al	   2004)	   (see	   1.1.1).	   	   Furthermore,	   previous	   studies	   have	  
shown	  that	  the	  small	  number	  of	  cells	  at	  this	  wave-­‐front	  have	  the	  capacity	  to	  colonise	  the	  
entire	   distal	   colon	   during	   embryonic	   development	   (Sidebotham,	   et	   al	   2002).	   	   Such	  
embryonic	   cells	   and	   also	   cells	   with	   similar	   properties	   have	   been	   isolated	   from	   the	   post-­‐
natal	   human	   colon	   and	   have	   then	   been	  maintained	   in-­‐vitro	   in	   the	   form	   of	   neurospheres	  
with	  the	  goal	  of	  using	  them	  in	  future	  transplantation	  therapies	  (Rauch,	  et	  al	  2006,	  Almond,	  
et	  al	  2007,	  Lindley,	  et	  al	  2008,	  Metzger,	  et	  al	  2009,	  Hotta,	  et	  al	  2013).	  	  Current	  studies	  use	  
both	  neurospheres	  derived	  from	  embryonic	  mouse	  and	  postnatal	  human	  sources,	  however	  
there	   has	   been	   little	   work	   to	   directly	   compare	   the	   behaviour	   of	   these	   cells	   within	   the	  
microenvironment	  of	  the	  neurosphere	  in	  order	  to	  determine	  to	  what	  extent	  the	  behaviour	  
of	  cells	  derived	  from	  each	  source	  is	  comparable.	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3.1.2.	   Attribution	  of	  work	  in	  this	  chapter	  
The	   results	   in	   sections	   3.3.1	   and	   3.3.2	   include	   work	   carried	   out	   by	   the	   author	   and	   Dr	   S	  
Theocharatos,	  a	  previous	  PhD	  student	  within	  the	  lab.	  	  Part	  of	  the	  work	  in	  this	  chapter	  has	  
been	  published	  in	  Plos	  One	  (Theocharatos,	  et	  al.	  2013)	  
	  
3.1.3.	   Aims	  
The	   current	   literature	   includes	   studies	   using	   neurospheres	   derived	   from	   both	   embryonic	  
mouse	  and	  postnatal	  human	   sources	   to	   investigate	   the	  possibility	  of	  using	   these	   cells	   for	  
transplantation-­‐based	   therapies.	   	   Therefore,	   the	   aim	   of	   this	   chapter	   is	   to	   compare	   the	  
proliferative	  behaviour	  of	  ENSPC	  derived	  from	  both	  sources	  in	  the	  microenvironment	  of	  the	  
neurosphere,	   and	   also	   to	   determine	   if	   any	   differences	   were	   due	   to	   differing	   ages	  
(embryonic	  vs.	  postnatal,	  or	  species	  (mouse	  vs.	  human).	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A	  
3.2.	   Results	  
3.2.1.	   Neurosphere	  formation	  is	  influenced	  by	  cell	  density	  
Before	  focusing	  on	  the	  behaviour	  of	  cells	  within	  the	  microenvironment	  of	  the	  neurosphere,	  
initial	   experiments	   looked	   at	   the	   process	   of	   neurosphere	   formation	   itself.	   	   Questions	  
remain	   regarding	   whether	   neurospheres	   form	   from	   single	   ‘stem	   cell’	   or	   arise	   from	   cells	  
aggregating	   together.	   	   On	   observing	   the	   formation	   of	   neurospheres	   four	   distinct	   phases	  
could	  be	   identified:	   	   Initially,	   freshly	   isolated	   cells	  were	   seen	   to	   adhere	   to	   the	  bottom	  of	  
culture	  dishes,	  cells	  would	  undergo	  a	  period	  of	  proliferation	  before	  bunching	  together	  and	  
then	  finally	  ‘budding-­‐off’	  free	  floating	  neurospheres	  (Fig	  3.1).	  






It	   was	   found	   that	   increasing	   the	   density	   at	   which	   cells	   were	   seeded	   after	   neurosphere	  
dissociation	  could	  decrease	  the	  time	  taken	  for	  neurospheres	  to	  begin	  to	  form.	  	  After	  1	  week	  
in	  culture	  cells	  seeded	  at	  50K/	  3cm	  dish	  were	  found	  to	  have	  become	  almost	  fully	  confluent	  
(Fig	  3.2A),	  a	  marked	  increase	  in	  cell	  confluence	  could	  be	  seen	  in	  dishes	  seeded	  at	  100K/dish	  
(Fig	   3.2B).	   	   However	   there	  was	   no	   evidence	   of	   neurosphere	   formation.	   	   This	   changed	   in	  
dishes	  seeded	  with	  250K	  cells,	  were	  cells	  could	  be	  seen	  to	  bunch	  together	  which	  is	  the	  first	  
phase	  before	  neurospheres	  form	  and	  ‘bud’	  off	  (Figure	  3.2C).	  	  Doubling	  the	  cell	  density	  again	  
led	  to	  the	  formation	  of	  free	  floating	  neurospheres	  in	  the	  same	  time	  period	  demonstrating	  
that	   increasing	   cell	   density	   decreases	   the	   time	   taken	   for	   neurosphere	   formation	   (Figure	  
3.2D).	  
Figure	  3.1.	  	  Schematic	  representation	  of	  neurosphere	  formation	  in–vitro.	  	  A:	  	  Freshly	  isolated	  cells	  
adhere	   to	   the	   bottom	  of	   culture	   dishes.	  B:	   Cells	   then	  proliferate	  before	   bunching	   together.	   	  C:	  	  
Neurospheres	  begin	  to	  form.	  	  D:	  Neurospheres	  eventually	  ‘bud-­‐off’.	   	  E:.	  neurospheres	  then	  float	  
freely	  
B	   C	   D E
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3.2.2.	   Expression	  and	  localisation	  of	  typical	  ENS	  markers	  
Neurospheres	  were	  generated	  from	  both	  embryonic	  mouse	  and	  post-­‐natal	  human	  sources	  
as	  previously	  described	  (see	  2.1).	  	  Established,	  third	  generation	  neurospheres	  were	  selected	  
from	   both	   sources	   and	   frozen	   sections	   prepared	   for	   immunostaining	   for	   typical	   markers	  
expressed	  within	  the	  ENS	  (Figure	  3.3).	  
The	  neural	  crest	  marker	  P75	  was	  found	  to	  be	  expressed	  by	  the	  majority	  of	  cells	  within	  both	  
human	  and	  mouse	  neurospheres.	  	  Expression	  was	  seen	  throughout	  neurospheres,	  with	  no	  
significant	   difference	   discernable	   between	   either	   species	   (Figure	   3.3A-­‐B).	   	   Similarly,	  
expression	  of	  the	  glial	  marker	  GFAP	  was	  widespread	  with	  no	  specific	  localisation	  identified	  
(Figure	  3.3C-­‐D).	  	  Expression	  of	  the	  mature	  glial	  marker	  S100	  was	  more	  limited,	  seen	  only	  in	  
a	   minority	   of	   cells	   which	   were	   predominantly	   located	   away	   from	   the	   peripheries	   of	   the	  
neurosphere	  (Figure	  3.3E-­‐F).	   	   In	  contrast,	  the	  early	  neuronal	  marker	  ß-­‐tubulin	  III	   (Tuj)	  was	  
found	  to	  be	  expressed	  predominantly	  by	  cells	  at	  the	  periphery	  of	  both	  mouse	  and	  human	  
neurospheres	  (Figure	  3.3G-­‐H).	   	  
Figure	   3.2.	   	   Primary	   human	  
neurospheres	   were	   dissociated,	  
counted,	   and	   then	   seeded	   into	  
3cm	   dishes	   at	   cells	   densities	   of	  
50K	  cells/dish	   (A),	   100K	  cells	   (B),	  
250K	  cells	   (C)	  and	  500K	  cells	   (D).	  	  
Dishes	  were	  kept	  in	  culture	  under	  
standard	   conditions	   for	   7	   days	  
prior	   to	   analysis.	   	   The	   rate	   of	  
neurosphere	  formation	  increased	  
with	   higher	   cell	   densities.	   	   Cells	  
can	   be	   seen	   to	   bunch	   together,	  
the	   first	   stage	   of	   neurosphere	  
formation,	   in	   C	   (arrow).	   	   Free-­‐
floating	   formed	   neurospheres	  
were	   identified	  at	   7	   days	  only	   in	  
dishes	  seeded	  with	  500K	  cells	  (D,	  
arrow).	  	  Scale	  bars	  =	  50µm.	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Figure	   3.3.	   	   7µm	   PFA	   fixed	  
frozen	  sections	  taken	  from	  3rd	  
generation	   mouse	   (A,C,E,G)	  
and	   human	   (B,D,F,H)	  
neurospheres.	   	   Sections	   used	  
for	   analysis	   were	   taken	  
through	   the	   centre	   of	   each	  
neurosphere,	   defined	   as	   the	  
sections	   with	   the	   maximal	  
diameter	   taken	   from	   each	  
individual	   neurosphere.	  	  
Antibodies	  were	   used	   against	  
the	   neural	   crest	   marker	   P75,	  
the	   immature	   glial	   marker	  
GFAP,	   mature	   glial	   marker	  
S100,	   early	   neuronal	   marker	  
Tuj	   and	   smooth	   muscle	   actin	  
(Taken	   from	   1st	   generation	  
neurospheres).	   	   A-­‐B:	   P75	  
expression	   is	   expressed	  
throughout	   both	   mouse	   (A)	  
and	  human	  (B)	  neurospheres.	  	  
C-­‐D:	   Similarly,	   GFAP	  
expression	   has	   a	   widespread	  
distribution	   in	   sections	   taken	  
from	   both	   mouse	   (C)	   and	  
human	   (D)	   neurospheres.	   	   E-­‐
F:	  S100	  is	  only	  expressed	  by	  a	  
minority	  of	   cells	   in	  mouse	   (E)	  
and	  human	   (F)	  neurospheres.	  	  
G-­‐H:	  The	  neuronal	  marker	  Tuj	  
has	   a	   predominantly	  
peripheral	  distribution	  in	  both	  
mouse	   (G)	   and	   human	   (H)	  
neurospheres.	   	   I-­‐J:	   	   The	  
smooth	   muscle	   marker	   SMA	  
can	  be	  seen	  throughout	  early	  
(primary)	  neurospheres.	  	  This	  
expression	  drops	  markedly	  in	  
later	   generations	   (data	   not	  
shown).	  	  Scale	  bars	  =	  50µm	  
Figure	  3.3.	  	  Expression	  of	  typical	  ENS	  markers	  in	  mouse	  and	  human	  neurospheres	   	  
Mouse	   Human	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3.2.3.	   Localisation	   of	   proliferation	   in	   embryonic	   mouse	   neurospheres	   is	  
predominantly	  peripheral	  
Having	   identified	   a	   difference	   in	   the	   localisation	   of	   cells	   expressing	   glial	   and	   neuronal	  
markers	  attention	  was	  turned	  to	  proliferation.	  	  The	  use	  of	  thymidine	  analogues	  as	  a	  proxy	  
for	  proliferation	  is	  well	  documented	  in	  the	  literature	  (Salic,	  et	  al	  2008).	  	  Initial	  experiments	  
in	  this	  chapter	  use	  the	  traditional	  analogue	  BrdU,	  however	  the	  need	  to	  treat	  the	  cells	  with	  
hydrochloric	  acid	   to	  detect	   the	   incorporated	  BrdU	   limited	   the	  ability	   to	  counterstain	  cells	  
for	  additional	  markers.	  	  Therefore,	  later	  experiments	  utilised	  the	  alternative	  analogue	  EdU,	  
eliminating	   the	   need	   for	   acid	   treatment.	   	   Studies	   have	   demonstrated	   that	   there	   is	   no	  
difference	   in	   the	   detection	   of	   cells	   entering	   S	   phase	   between	   EdU	   and	   BrdU	   in	   skeletal	  
tissues	  (Salic,	  et	  al	  2008,	  Mead,	  et	  al.	  2014),	  and	  although	  not	  included	  in	  this	  thesis,	  work	  
performed	  by	  colleagues	  within	   the	   lab	   found	  no	  difference	  using	  either	  analogue	   in	  ENS	  
cells	  (Theocharatos	  2011).	  
Initial	   experiments	   in	   embryonic	   mouse	   neurospheres	   used	   the	   incorporation	   of	   a	  
detectable	  thymidine	  analogue	  (BrdU)	  as	  a	  proxy	  for	  proliferation	  (Figure	  3.4).	  	  Following	  a	  
6h	   incubation	  period	  with	  the	  thymidine	  analogue	  the	  most	  striking	  observation	  was	  that	  
almost	  all	  cells	  had	  been	  in	  S-­‐phase	  at	  some	  point	  during	  the	  incubation	  period,	  and	  were	  
located	  at	  or	  very	  close	  to	  the	  periphery	  of	  the	  neurosphere	  (figure	  3.4A,C).	  	  Neurospheres	  
continuously	   incubated	  with	   the	   analogue	   for	   a	   further	   90h	   showed	   that	   the	  majority	   of	  
cells	   appear	   to	   have	   undergone	   proliferation	   with	   positive	   cells	   seen	   throughout	   the	  
neurosphere	  (Figure	  3.4B).	  
In	  contrast,	   if	  BrdU	  was	  removed	  from	  the	  culture	  conditions	  after	  an	   initial	  6h	  pulse	  and	  
the	   cells	   analysed	   after	   a	   further	   90h,	   strongly	   labelled	   cells	  were	  predominantly	   seen	   at	  
the	  centre	  of	  the	  neurosphere,	  with	  weakly	  positive	  cells	  still	  seen	  towards	  the	  peripheries	  
(figure	  3.4D).	  	  These	  results	  are	  represented	  graphically	  in	  figure	  3.4E,	  using	  a	  comparison	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Figure	   3.4.	   	   Standard	  7µm	   frozen	  
sections	   through	   the	   centre	   of	  
embryonic	   mouse	   neurospheres	  
cultured	   under	   standard	  
conditions.	   	   A-­‐B:	   Neurospheres	  
were	  incubated	  continuously	  with	  
10µM	   BrdU	   (red)	   for	   6h	   (A)	   and	  
96h	  (B).	  	  C,D:	  	  Neurospheres	  after	  
an	  initial	  1h	  incubation	  with	  BrdU	  
(C)	  and	  after	  a	   further	  90h	   in	   the	  
absence	   of	   BrdU	   (D).	   	   Cells	   are	  
counterstained	   with	   DAPI	   (blue).	  	  
E:	   	   Ratio	   of	   proliferating	   cells	  
(incorporating	  BrdU)	  between	  the	  
inner	  50%	  and	  outer	  50%	  of	  each	  
section.	  	  Scale	  bars	  =	  50µm.	  	  Error	  
bars	   represent	   standard	   error	   of	  
the	   mean	   (SEM)	   from	   5	  
experiments.	  *	  denotes	  P<	  0.01	  
	  
Figure	  3.4.	  	  Localisation	  of	  proliferation	  in	  mouse	  neurospheres	  
	  
	   	  
	   	  









between	   the	  proportion	  of	   cells	   incorporating	  BrdU	   in	   the	   inner	   zone	   (inner	  50%	  of	   total	  
area)	  of	   the	  neurosphere	  against	   the	  proportion	  of	  positive	   cells	   found	   in	   the	  outer	   zone	  
(outer	  50%).	  	  This	  demonstrates	  an	  almost	  even	  distribution	  between	  inner	  and	  outer	  zones	  
in	   neurospheres	   cultured	   continuously	   in	   the	   presence	   of	   BrdU,	   with	   a	   significant	   shift	  
towards	   the	   proportion	   of	   positive	   cells	   found	   in	   the	   inner	   zone	   under	   pulse-­‐chase	  
conditions	   (Figure	   3.4E).	   	   These	   results	   provide	   evidence	   that	   the	   environment	   within	  
neurospheres	   is	   dynamic,	   with	   on	   going	   cell	   movement	   rather	   than	   possessing	   a	   fixed	  
architecture.	  	   	  
E	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3.2.4.	   Following	  proliferation	  cells	  are	  predominantly	  located	  in	  the	  central	  zone	  
of	  both	  mouse	  and	  human	  neurospheres	  
Having	   seen	   the	   apparent	  movement	   of	   post-­‐mitotic	   cells	   from	   a	   peripheral	   to	   a	   central	  
location	  within	   neurospheres	   the	   experiments	  were	   repeated	   in	   both	  mouse	   and	   human	  
neurospheres	  using	  an	  alternative	  thymidine	  analogue	  EdU	  (Figure	  3.5).	  
	  
Figure	   3.5.	   	   Post-­‐proliferation	   cells	   incorporating	   EdU	   are	   found	   in	   the	   central	  












	   	  
Figure	  3.5.	  	  3rd	  generation	  embryonic	  mouse	  and	  human	  neurospheres	  were	  incubated	  in	  the	  presence	  of	  EdU	  for	  
1h,	   following	  which	   it	  was	   removed	   and	   the	   neurospheres	  were	   cultured	   under	   standard	   conditions	   for	   up	   to	  
96h.	   	  Neurospheres	  were	   fixed	  with	  4%PFA	  and	   standard	  7µm	  frozen	  sections	  prepared	   through	   the	  centre	  of	  
each	  neurosphere	  at	  set	  time	  points.	  	  Sections	  were	  stained	  for	  EdU	  incorporation	  (red)	  and	  DAPI	  (blue).	  	  	  	  A-­‐D:	  
Demonstrates	   the	   initial	   peripheral	   localisation	   of	   cells	   incorporating	   EdU	   at	   1h	   in	   embryonic	   mouse	  
neurospheres	   (A).	   	   Over	   time	   cells	   can	   be	   seen	   throughout	   the	   neurosphere,	   with	   a	   predominantly	   central	  
distribution	   by	   96h	   (D).	   	   E-­‐H:	   Pulse-­‐chase	   experiment	   repeated	   with	   human	   neurospheres	   demonstrating	   a	  
similar	  pattern	  of	  distribution	  with	  a	  marked	   decrease	   in	   the	  number	  of	   cells	   incorporating	   EdU.	   	   Scale	  bars	  =	  
50µm	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There	   is	   a	   marked	   reduction	   in	   the	   number	   of	   cells	   incorporating	   EdU	   in	   the	   human	  
neurospheres	   (Figure	  3.5	  E-­‐H).	   	  However,	   as	   seen	   in	   the	  murine	  neurospheres,	  over	   time	  
EdU	  incorporation	  was	  seen	  in	  cells	  in	  the	  centre	  of	  the	  neurosphere.	  	  As	  was	  seen	  with	  the	  
BrdU	   incorporation	   assays	   in	   mouse	   neurospheres,	   incorporation	   of	   a	   pulse	   of	   Edu	   in	  
human	   neurospheres	   followed	   a	   similar	   pattern,	   initially	   occurring	   predominantly	   at	   the	  
periphery	  of	  the	  neurosphere	  (Figure	  3.5	  A-­‐D).	  	  Over	  time	  cells	  that	  had	  incorporated	  EdU	  
are	   progressively	   seen	   towards	   the	   centre	   of	   the	   neurosphere,	   with	   the	   central	   cells	  
exhibiting	  a	  strong	  signal	  for	  EdU	  incorporation	  and	  a	  much	  weaker	  signal	  in	  the	  peripheral	  
cells	  at	  later	  time	  periods	  after	  the	  pulse.	  
To	   eliminate	   the	   possibility	   that	   the	   presence	   of	   proliferating	   cells	   predominantly	   at	   the	  
periphery	  of	  neurospheres	  was	  a	  penetration	  artefact	  due	  to	  delayed	  uptake	  in	  central	  cells,	  
the	   proliferation	   marker	   Ki67	   was	   used	   on	   frozen	   neurosphere	   sections	   to	   demonstrate	  
labelling	   at	   the	   periphery	   of	   neurosphere,	   thereby	   supporting	   the	   hypothesis	   that	  
proliferation	  predominantly	  occurs	   in	   these	  peripheral	  zones	   (Figure	  3.6).	   	  The	  proportion	  
of	  cells	  expressing	  Ki67	  was	  more	  than	  3	  times	  greater	  than	  those	  incorporating	  EdU.	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Figure	  3.6.	  	  Proliferation	  predominantly	  occurs	  at	  the	  periphery	  of	  neurospheres	  
	   	  
Figure	  3.6.	  	  Third	  generation	  embryonic	  mouse	  neurospheres	  were	  cultured	  in	  the	  presence	  of	  EdU	  
for	   1h	   prior	   to	   fixation	   and	   preparation	   of	   7µm	   frozen	   sections	   taken	   through	   the	   centre	   of	   each	  
neurosphere.	  	  Sections	  were	  analysed	  for	  incorporation	  of	  EdU	  (red)	  and	  expression	  of	  Ki67(green).	  	  
Cell	  nuclei	  were	  stained	  with	  dapi	  (blue).	  	  A-­‐B:	  Demonstrate	  the	  peripheral	  localisation	  of	  both	  EdU	  
incorporation	   and	   Ki67	   expression.	   	   D-­‐E:	   To	   enable	   quantitative	   analysis	   neurospheres	   were	  
dissociated	  spun	  down	  onto	  slides	  with	  a	  cytospin	  to	  determine	  expression	  within	  individual	  cells.	  	  C:	  
Expression	  of	  Ki67	  is	  significantly	  higher	  than	  incorporation	  of	  EdU	  (p	  <	  0.0001).	  Scale	  bars	  =	  25µm.	  	  
Error	  bars	  represent	  standard	  error	  of	  the	  mean	  (SEM)	  from	  5	  experiments.	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3.2.5.	   Rate	  of	  proliferation	  in	  neurospheres	  is	  determined	  by	  cell	  age	  
Having	   seen	  a	  difference	   in	   the	  proportion	  of	   cells	  apparently	  undergoing	  proliferation	   in	  
mouse	  and	  human	  neurospheres	  raises	  the	  question	  as	  to	  whether	  this	  difference	  was	  due	  
to	  species	  difference	  or	  the	  difference	  between	  embryonic	  and	  postnatal	  cells.	  	  Following	  a	  
24h	  incubation	  with	  EdU	  25%	  of	  cells	  in	  embryonic	  mouse	  neurospheres	  incorporated	  EdU,	  
which	  fell	  to	  20%	  in	  neurospheres	  isolated	  from	  day	  1	  (P1)	  postnatal	  mice	  (Figure	  3.7).	  	  The	  
most	  dramatic	  difference	  was	  seen	  in	  the	  behaviour	  of	  cells	  isolated	  from	  P1	  mice	  and	  28-­‐
day	  old	  (P28)	  mice,	  with	  a	  four-­‐fold	  reduction	  seen	  over	  this	  time	  period.	  	  Importantly,	  no	  
significant	  difference	   in	   the	  proportion	  of	  cells	   incorporating	  EdU	  was	  seen	  between	  cells	  
isolated	  from	  mature	  (P28)	  mice	  and	  3-­‐month	  old	  human	  samples.	  




	   	  
Figure	  3.7.	  	  Primary	  neurospheres	  were	  isolated	  from	  both	  embryonic	  (E11.5),	  1	  day	  old	  (P1)	  and	  28	  
day	   old	   (P28)	  mice	   and	   3-­‐month	   old	   human	   samples.	   	   Primary	   neurospheres	   were	   cultured	   in	   the	  
presence	   of	  EdU	   for	   24h	   then	   immediately	   dissociated	  and	   spun	   down	   onto	   slides	   for	   fixation	   and	  
analysis.	  	  The	  proportion	  of	  cells	  incorporating	  Edu	  fell	  significantly	  between	  E11.5,	  P1	  and	  P28	  mice	  
(P	   <0.001).	   	   No	   significant	   difference	   was	   found	   between	   P28	   mouse	   and	   post-­‐natal	   human	  
neurospheres	  (P>0.05).	  	  Error	  bars	  represent	  standard	  error	  of	  the	  mean	  (SEM)	  from	  3	  experiments.	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3.3.	   Discussion	  
The	  proliferative	  capacity	  of	  NCCs	  during	  the	  development	  of	  the	  ENS	  is	  a	  key	  factor	  in	  the	  
normal	  colonisation	  of	  the	  bowel.	  	  Coupled	  with	  the	  observation	  that	  there	  is	  an	  apparent	  
increase	  in	  proliferation	  when	  ENSPC	  when	  cells	  are	  isolated	  from	  postnatal	  bowel	  there	  is	  
a	  need	  to	  understand	  firstly	  what	  is	  happening	  regarding	  cell	  behaviour	  within	  the	  artificial	  
microenvironment	  of	  the	  neurosphere	  niche	  and	  secondly	  whether	  there	  are	  differences	  in	  
behaviour	  related	  to	  the	  source	  of	  the	  ENPSC.	  	  This	  chapter	  details	  the	  similarities	  in	  both	  
the	   expression	   profiles	   of	   typical	   ENS	   markers	   between	   neurospheres	   derived	   from	  
embryonic	  mouse	  and	  postnatal	  human	  sources	  and	  also	  in	  the	  localisation	  of	  proliferation	  
within	   the	  neurosphere.	   	   Furthermore,	   this	   chapter	   confirms	   that	   there	   is	   a	  difference	   in	  
the	  proliferative	  behaviour	  dependent	  on	   the	  development	  maturity	  of	   the	  source	   tissue,	  
but	  not	  between	  mouse	  and	  postnatal	  human	  samples.	  
	  
3.3.1.	   Rate	  of	  neurosphere	  formation	  is	  influenced	  by	  cell	  density	  
The	   majority	   of	   studies	   looking	   at	   the	   formation	   of	   ENS	   derived	   neurospheres	   use	  
suspension	   based	   cultures	   (Rauch,	   et	   al	   2006,	   Almond,	   et	   al	   2007,	  Metzger,	   et	   al.	   2009),	  
however	   studies	   using	   CNS	   derived	   neurospheres	   have	   found	   that	   under	   adherent	  
conditions	   the	   time	   to	   neurosphere	   formation	   is	   significantly	   reduced.(Konagaya,	   et	   al.	  
2011).	   	   This,	   coupled	  with	   similar	   observations	  within	   the	   lab	   led	   to	   the	   use	   of	   adherent	  
culture	   dishes	   for	   the	   generation	   of	   ENS	   derived	   neurospheres	   in	   this	   thesis.	   	   Using	   this	  
model,	   these	   preliminary	   results	   suggest	   that	   the	   density	   at	   which	   ENSPC	   are	   seeded	  
significantly	   reduces	   the	   time	   taken	   to	   for	   neurospheres	   to	   form.	   This	   could	   be	   due	   to	   a	  
number	  of	  possibilities	  such	  as:	  that	  by	  seeding	  an	  increased	  number	  of	  cells	  there	  will	  be	  
an	  increased	  number	  of	  ‘true’	  progenitors	  within	  the	  dish.	  	  Therefore,	  one	  would	  expect	  to	  
see	  more	  formed	  neurospheres.	  	  However,	  what	  was	  observed	  was	  not	  a	  small	  number	  of	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neurospheres	  in	  low	  density	  culture	  with	  greater	  numbers	  seen	  in	  the	  higher	  density	  dishes,	  
rather	   that	   at	   7days	   formed	   neurospheres	   were	   only	   seen	   in	   the	   dishes	   seeded	   at	   the	  
highest	   density.	   	   This	   makes	   the	   theory	   less	   likely	   and	   suggests	   that	   it	   is	   perhaps	   the	  
closer/increased	   interactions	  between	  cells	   that	   are	   responsible.	   	  Whether	   the	  decreased	  
time	   taken	   for	   neurosphere	   formation	   is	   due	   to	   an	   increased	   rate	   of	   proliferation	   or	   a	  
change	   in	  behaviour	   is	   yet	   to	  be	  determined.	   	  However,	   these	   findings	  prompted	   further	  
study	   in	   the	   control	   of	   ENSPC	   behaviour	   and	   in	   particular	   mechanisms	   known	   to	   be	  
influenced	  by	  cell-­‐cell	  interactions	  (Chapter	  4).	  
	  
3.3.2.	   Expression	   and	   localisation	   of	   typical	   ENS	   markers	   is	   similar	   between	  
neurospheres	  derived	  from	  mouse	  and	  human	  sources	  
Our	   finding	   that	   neurospheres	   derived	   from	   both	   mouse	   and	   human	   sources	   typically	  
express	  common	  ENS	  markers	  is	  unsurprising	  and	  consistent	  with	  previous	  studies	  (Rauch,	  
et	   al	   2006,	   Lindley,	   et	   al	   2008,	   Metzger,	   et	   al	   2009).	   	   However,	   it	   is	   important	   that	   no	  
significant	   differences	   in	   the	   localisation	   of	   each	   marker	   could	   be	   found	   between	  
neurospheres	  derivied	  from	  either	  species.	  	  
The	   two	   glial	   markers	   were	   used	   during	   this	   study	   GFAP	   and	   S100,	   both	   of	   which	   are	  
commonly	  used	   to	   label	  astrocytes	   in	   the	  CNS	  and	  have	  been	  shown	  to	  also	   label	  enteric	  
glia(Bondurand,	  et	  al	  2003,	  Young,	  et	  al.	  2003,	  Platel,	  et	  al.	  2009).	   	  Studies	  have	  reported	  
that	  within	  the	  CNS	  rapidly	  proliferating	  ‘immature’	  astrocytes	  express	  GFAP	  and	  are	  S100-­‐
ve,	  whereas	  the	  expression	  of	  S100	  is	  limited	  to	  more	  mature	  astrocytes	  (Bannerman,	  et	  al.	  
1988,	  Deloulme,	  et	  al.	  2004,	  Platel,	  et	  al	  2009).	  	  The	  same	  pattern	  is	  also	  seen	  in	  Schwann	  
cells	  within	   the	  peripheral	  nervous	   system	  with	   immature	   schwann	  cells	  expressing	  GFAP	  
and	  S100	  and	  more	  mature	  myelinating	  cells	  loosing	  their	  expression	  of	  GFAP	  (Mirsky,	  et	  al.	  
2008).	   	   In	   this	  study	  the	  more	   immature	  marker	  GFAP	  was	   found	  to	  be	  widely	  expressed,	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with	   perhaps	   a	   slight	   preponderance	   at	   the	   peripheries,	   whereas	   the	   expression	   of	   the	  
more	  mature	  marker	  S100	  was	   limited	  mainly	   to	  a	  more	  central	   location.	   	  This	  difference	  
may	  be	  linked	  with	  the	  zones	  of	  higher	  proliferation	  and	  is	  discussed	  further	  in	  3.3.3.	  	  The	  
analysis	  within	  this	  study	  was	  qualitative	  only	  and	  did	  not	  seek	  to	  determine	  the	  proportion	  
of	   cells	   expressing	   each	   individual	   marker,	   nor	   did	   it	   look	   at	   co-­‐expression	   of	   markers.	  	  
Experiments	   to	   further	   elucidate	   the	   differential	   temporal	   and	   spatial	   expression	   of	  
individual	   markers	   was	   outside	   the	   scope	   of	   this	   thesis,	   but	   has	   been	   performed	  
independently	  within	  the	  lab	  by	  S	  Theocharatos	  as	  part	  of	  his	  doctoral	  studies.	  	  His	  results	  
support	   the	  use	  of	  GFAP	  as	  a	  marker	  of	   immature,	  proliferating	  glial	  cells.	   	  He	   found	  that	  
the	  majority	  of	  proliferating	  cells	  were	  GFAP+ve,	  with	  a	  subpopulation	  of	  cells	  developing	  
expression	  of	  S100	  after	  a	  period	  of	  time	  (Theocharatos	  2011).	  
	  
3.3.3.	   Proliferation	  occurs	  predominantly	  at	  the	  periphery	  of	  neurospheres	  
Previous	  studies	  have	  demonstrated	  a	  similar	  predominant	  distribution	  of	  proliferating	  cells	  
at	   the	   peripheries	   of	   neurospheres	   derived	   from	   both	   the	   embryonic	   rat	   CNS	   and	  
embryonic	  mouse	  ENS	  (Campos,	  et	  al.	  2004,	  Almond,	  et	  al	  2007).	   	  However,	  those	  studies	  
were	  limited	  to	  short	  pulses	  of	  BrdU	  and	  were	  open	  to	  the	  criticism	  that	  such	  findings	  were	  
an	  artefact	  due	  to	  limited	  penetration	  of	  the	  thymidine	  analogue.	  	  The	  findings	  within	  this	  
chapter	   provide	   evidence	   to	   support	   the	   hypothesis	   that	   proliferation	   within	   the	  
neurosphere	   does	   indeed	   predominantly	   occurs	   in	   the	   periphery.	   	   Multiple	   lines	   of	  
evidence	  are	  provided	  to	  support	  this	  conclusion.	   	  Thus,	   following	  a	  chase	  period	  positive	  
cells	   remaining	   at	   the	   periphery	   are	   only	   weakly	   labelled,	   suggesting	   that	   they	   had	  
continued	   to	   proliferate	   and	   have	   ‘diluted’	   their	   levels	   of	   labelled	   analogue.	   	   Conversely,	  
cells	   which	   are	   located	   in	   the	   central	   zones	   of	   the	   neurospheres	   remain	   highly	   labelled,	  
which	  is	  consistent	  with	  these	  cells	  that	  having	  become	  post-­‐mitotic	  and	  moved	  away	  from	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the	  periphery	  towards	  the	  centre	  of	  the	  neurosphere.	  	  This	  is	  corroborated	  by	  analysing	  the	  
expression	  of	  the	  protein	  Ki67	  which	   is	   located	   in	  cell	  nuclei	  during	   interphase	  and	  would	  
not	  be	  affected	  by	   inadequate	  penetration	  as	   frozen	  sections	  of	  neurospheres	  were	  used	  
for	   staining	   (Scholzen,	   et	   al.	   2000).	   	   As	   with	   the	   thymidine	   analogues	   expression,	   Ki67	  
expression	  was	  predominantly	  located	  at	  the	  periphery	  of	  neurospheres.	  
	  
These	   findings	   suggest	   that	   the	   neurosphere	   is	   a	   dynamic	   environment,	  with	   continuous	  
proliferation	   at	   the	   peripheries	   and	   cell	   movement	   within	   it.	   	   The	   presence	   of	   both	   the	  
immature	  glial	  marker	  GFAP	  and	  early	  neuronal	  marker	  Tuj	  in	  these	  peripheral	  zones	  of	  the	  
neurosphere	  is	  consistent	  with	  the	  hypothesis	  that	  ENS	  progenitors	  are/arise	  from	  GFAP+ve	  
glia	  (Liu,	  et	  al	  2009,	  Joseph,	  et	  al	  2011,	  Laranjeira,	  et	  al	  2011).	  	  Experiments	  looking	  at	  the	  
temporal	   relationship	   of	   EdU	   incorporation	   and	   expression	   of	   immature	   and	   mature	  
glial/neuronal	  markers	  would	  help	  to	  confirm	  this	  hypothesis,	  however,	  as	  this	  was	  not	  part	  
of	  the	  original	  aims	  it	  was	  outside	  the	  remit	  of	  this	  chapter.	  
	  
Whether	  the	  differentiation	  state	  of	  a	  cell	  determines	   its	   location	  within	  the	  neurosphere	  
or	  whether	   the	   location	  of	   a	   cell	   influences	   its	   differentiation	   remains	   to	   be	  determined.	  	  
Possible	   factors	   that	  may	   influence	   this	   process	   include	   cell-­‐cell	   interactions,	   which	  may	  
change	  depending	  on	  a	   cells	  position	  within	   the	  neurosphere,	  or	  external	   factors	   such	  as	  
availability	   of	   nutrients	   or	   oxygen	   tension.	   	   Although	   studies	   in	   adipose	   tissue-­‐derived	  
neurospheres	  have	  found	  that	  low	  oxygen	  tensions	  promote	  the	  maintenance	  of	  progenitor	  
populations	  (Chung,	  et	  al.	  2014),	  given	  the	  peripheral	   location	  of	  proliferating	  cells	   in	  ENS	  
neurospheres	  such	  a	  role	  for	  oxygen	  tension	  seems	  very	  unlikely.	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With	  regard	  to	  the	  comparison	  between	  neurospheres	  derived	  from	  embryonic	  mouse	  and	  
postnatal	   human	   tissue	   the	   most	   striking	   observation	   was	   the	   proportion	   of	   cells	  
incorporating	  EdU	  within	  the	  human	  neurospheres	  was	  dramatically	  less	  than	  those	  derived	  
from	  embryonic	  mouse	  colon.	   	  This	  was	  the	  first	  obvious	  difference	  in	  behaviour	  between	  
neurospheres	  derived	  from	  each	  species,	  but	  it	  remained	  to	  be	  established	  whether	  these	  
were	  due	  to	  the	  species	  difference,	  or	  the	  developmental	  maturity	  of	  the	  source	  tissue.	  
	  
3.3.4.	   Rate	  of	  proliferation	  in	  neurospheres	  is	  determined	  by	  the	  developmental	  
maturity	  of	  the	  cells	  
Given	  the	  findings	  in	  3.3.5.,	  experiments	  were	  conducted	  to	  determine	  whether	  the	  species	  
(mouse	   vs.	   human)	   or	   age	   (embryonic	   vs.	   post-­‐natal)	   effect	   impacted	   on	   the	   rate	   of	  
proliferation	   in	   neurospheres.	   	   The	   experiments	   found	   that	   only	   the	   developmental	  
maturity	  of	   the	  source	   tissue	   from	  which	  neurospheres	  were	  derived	  and	  not	   the	  species	  
was	   found	   to	   have	   a	   significant	   effect	   on	   the	   rate	   of	   proliferation.	   	   This	   finding	   is	   not	  
surprising	  as	  many	  studies	  of	   the	  developing	  CNS	  have	  shown	  that	  proliferation	  of	  neural	  
progenitors	   predominantly	   occurs	   in	   the	   embryonic	   period,	   and	   furthermore,	   the	   small	  
amount	   of	   proliferation	   that	   does	   occur	   post-­‐natally	   also	   declines	   with	   age	   (Kuhn,	   et	   al.	  
2011,	   McGinn,	   et	   al.	   2012,	   	   Tan,	   et	   al.	   2013).	   	   However	   this	   finding,	   coupled	   with	   the	  
observation	   that	   there	  was	  no	   significant	   difference	  between	  neurospheres	  derived	   from	  
postnatal	  day	  28	  mice	  and	  human	  samples	  taken	  from	  3	  month	  old	  infants	  is	  of	  importance.	  	  
These	  results	  suggest	  that	  although	  neurospheres	  derived	  from	  embryonic	  mouse	  are	  not	  
significantly	  different	   in	   their	  expression	  of	   typical	  ENS	  markers	   to	   their	  postnatal	  human	  
counterparts	   there	   is	   a	   fundamental	   difference	   in	   their	   behaviour	   with	   regard	   to	  
proliferation.	   	   It	   is	   therefore	   difficult	   to	   use	   results	   based	   on	   neurospheres	   derived	   from	  
embryonic	   cells	   to	   predict	   behaviour	   of	   postnatal	   cells	   because	   of	   this	   fundamental	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difference	   in	   proliferative	   behaviour.	   	   As	   most	   clinical	   potential	   clinical	   therapies	   are	  
focused	   on	   using	   progenitors	   isolated	   from	   postnatal	   human	   sources	   this	   brings	   into	  
question	   the	   use	   of	   embryonic	   mouse	   neurospheres	   in	   studies	   designed	   to	   further	   our	  
understanding	  of	  the	  behaviour	  and	  indeed	  future	  safety	  of	  these	  cells.	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3.4.	   Conclusion	  
The	   work	   within	   this	   chapter	   has	   found	   that	   in	   ENS	   neurospheres	   proliferating	   cells	   are	  
predominantly	  to	  be	  found	  at	  the	  periphery,	  and	  this	   finding	   is	  the	  same	  in	  neurospheres	  
derived	  from	  both	  mouse	  and	  human	  sources.	  	  Similarly,	  no	  significant	  differences	  could	  be	  
identified	   in	  expression	  of	  typical	  ENS	  markers	  (P75,	  GFAP,	  S100)	   in	  neurospheres	  derived	  
from	  either	  source.	  	  
Significant	   differences	   were	   identified	   in	   the	   behaviour	   of	   these	   cells	   depending	   on	   the	  
developmental	   maturity	   of	   the	   donor	   tissue,	   with	   levels	   of	   proliferation	   seen	   within	  
embryonic	   neurospheres	   up	   to	   five	   times	   greater	   than	   those	   seen	   in	   post-­‐natal	  
neurospheres.	   	   This	   raises	   questions	   as	   to	   the	   validity	   of	   using	   embryonic	   mouse	  
neurospheres	  as	  a	  model	  for	  future	  human	  transplantation.	  	  
Both	   proliferation	   within	   the	   microenvironment	   of	   the	   neurosphere	   and	   the	   rate	   of	  
neurosphere	   formation	   appear	   to	   be	   dependent	   on	   the	   relationship	  with	   surround	   cells.	  	  
Therefore,	  given	  the	  known	  involvement	  of	  the	  Notch	  signalling	  pathway	  in	  the	  regulation	  
of	  proliferation	  and	  its	  strong	  dependence	  on	  cell-­‐cell	  interactions	  further	  study	  should	  be	  
directed	  into	  the	  role	  of	  Notch	  in	  the	  control	  this	  behaviour.	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Chapter	   4:	   The	   Role	   of	   Notch	   Signalling	   in	  
Human	  ENS	  Derived	  Cells	  
	  
4.1.	   Introduction	  
4.1.1.	   Background	  
Studies	  have	  highlighted	  the	  potential	  for	  autologous	  transplantation	  of	  ENSPC	  to	  improve	  
the	  function	  of	  aganglionic	  bowel	  in	  HSCR	  (Lindley,	  et	  al	  2008).	  One	  of	  the	  crucial	  questions	  
that	  needs	   to	  be	  answered	  before	  we	   can	  progress	   towards	   clinical	   trials	   is	  what	  are	   the	  
mechanisms	   that	   regulate	   progenitor	   cell	   proliferation,	   self-­‐renewal	   and	   differentiation	  
within	  the	  neurosphere	  niche?	  	  During	  the	  routine	  isolation	  and	  culture	  of	  ENSPC	  we	  have	  
noted	   the	   dramatic	   change	   in	   behaviour	   when	   ENSPC	   are	   removed	   from	   the	  
microenvironment	  of	  the	  human	  bowel,	  moving	  from	  an	  essentially	  quiescent	  state	  to	  that	  
of	   rapid	   proliferation.	   	   If	   this	   proliferation	   continues	   in	   an	   unregulated	   manner	   post-­‐
transplantation	  there	  remains	  the	  significant	  risk	  of	  tumour	  formation.	  	  Studies	  have	  shown	  
that	  the	  Notch	  signalling	  pathway	  is	  involved	  in	  the	  regulation	  of	  neural	  progenitors	  outside	  
of	  the	  ENS	  (Wakamatsu,	  et	  al.	  2000,	  Taylor,	  et	  al.	  2007,	  Tsarovina,	  et	  al.	  2008).	  	  In	  addition	  
there	  is	  evidence,	  limited	  to	  mouse	  models,	  suggesting	  that	  Notch	  signalling	  is	  necessary	  for	  
normal	  ENS	  development	  (Okamura,	  et	  al	  2008,	  Ngan,	  et	  al	  2011)	  (See	  1.1.4).	  	  However,	  the	  
role	  of	  Notch	  signalling	  in	  mature	  human	  ENS	  neural	  progenitors	  remains	  to	  be	  established	  
(see	  also	  1.4).	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4.1.2.	   Attribution	  of	  work	  in	  this	  chapter	  
Miss	  S	  Darling,	  a	  postgraduate	  MRes	  student,	  whilst	  working	  under	  my	  supervision	  assisted	  
with	   the	   siRNA	   experiments	   detailed	   within	   this	   chapter.	   All	   other	   work,	   including	  
conception,	  planning	  and	   interpretation	  of	  results	  were	  performed	  by	  myself.	   	  Part	  of	  the	  
work	  in	  this	  chapter	  has	  been	  published	  in	  Plos	  One	  (Theocharatos,	  et	  al	  2013)	  
	  
4.1.3.	   Aims	  
Given	   the	   importance	   of	   understanding	   the	   mechanisms	   that	   regulate	   the	   behaviour	   of	  
neural	   progenitors	   within	   the	   ENS	   the	   aim	   of	   this	   chapter	   is	   to	   determine	   whether	   the	  
Notch	  signalling	  pathway	  regulates	  the	  proliferation	  and	  neuronal	  differentiation	  of	  mature	  
human	  ENSPC	  in-­‐vitro,	  and	  to	  begin	  to	  elucidate	  the	  state	  of	  Notch	  signalling	  in-­‐vivo.	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4.2.	   Results	  
4.2.1.	   Key	   components	   of	   the	   Notch	   signalling	   pathway	   are	   present	   in	   both	  
human	  post-­‐natal	  bowel	  and	  neurospheres.	  
Frozen	   ganglionic	   colonic	   sections	   were	   fixed	   and	   processed	   immediately	   after	   isolation.	  	  
Using	   immunofluorescence	   and	   confocal	   microscopy,	   all	   four	   of	   the	   known	   mammalian	  
Notch	  receptors	  were	  found	  to	  co-­‐localise	  with	  components	  of	  the	  ENS	  (Figure	  4.1)	  with	  the	  
most	  prominent	  expression	  seen	  for	  Notch	  1	  and	  Notch	  4.	  	  Expression	  was	  less	  widely	  seen	  
for	  Notch	  2	  and	  3.	  	  The	  antibodies	  used	  for	  the	  Notch	  receptors	  recognise	  both	  the	  inactive	  
and	   activated	   components	   of	   the	   receptor,	   therefore	   no	   comment	   can	   be	  made	   on	   the	  
activity	  of	  Notch	  signalling	  only	  the	  presence	  of	  its	  components	  in-­‐vivo.	  
Similarly,	  when	  primary	  neurospheres	  were	  generated	  from	  colonic	  biopsies	  from	  the	  same	  
patients,	   expression	   of	   all	   four	   Notch	   receptors	   was	   identified	   (Figure	   4.2).	   	   When	  
neurospheres	  were	   examined	   through	   their	   central	   section	   the	   localisation	   of	   expression	  
was	   predominantly	   found	   to	   be	   at	   the	   periphery	   of	   the	   neurosphere,	   and	   with	   the	  
exception	   of	   Notch	   3,	   which	   had	   expression	   throughout,	   neurospheres	   demonstrated	   a	  
marked	  decrease	  in	  expression	  at	  their	  centres.	   	  Confocal	   images	  of	  cells	  dissociated	  from	  
such	  neurospheres	  also	  expressed	  the	  Notch	  receptors	  in	  80-­‐90%	  of	  cells.	  	  The	  appearance	  
of	  the	  immunoreactivity	  at	  the	  cellular	  level	  was	  predominantly	  punctate,	  seen	  both	  in	  the	  
cell	  membrane	  and	  within	  the	  intracellular	  domain.	  	  It	  should	  be	  noted	  that	  the	  antibodies	  
used	  detect	  Notch	  do	  not	  distinguish	  between	  activated	  and	  inactive	  states	  of	  the	  receptors.	  
Having	   confirmed	   the	   presence	   of	   Notch	   receptors	   both	   in-­‐vivo	   and	   in-­‐vitro,	   we	   then	  
moved	   on	   to	   analyse	   the	   expression	   of	   the	   common	   Notch	   ligand	   Jagged	   1,	   which	   has	  
previously	  been	  shown	  to	  be	  present	  in	  the	  murine	  ENS	  (Okamura,	  et	  al	  2008)	  (Figure	  4.3).	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Jagged	   immunoreactivity	  was	   expressed	   in	   a	   pattern	   similar	   to	   that	   seen	  with	   the	  Notch	  
receptors	  co-­‐stained	  with	  the	  mature	  neuronal	  marker	  Hu	  in	  human	  colonic	  biopsies.	  
	  Figure	  4.1.	  	  Expression	  of	  Notch	  receptor	  markers	  1-­‐4	  in	  human	  colonic	  tissue.	  	  	   	  
Figure	   4.1.	   	   Confocal	  
immunofluorescence	  of	   fixed	  
frozen	  sections	  of	  the	  colonic	  
myenteric	   plexus	   from	  
control	  patients	  (3	  month	  old	  
infants	   with	   previous	  
anorectal	   malformations).	  	  	  
Antibodies	  used	  were	  against	  
the	   neuronal	   marker	   Hu	  
(green),	   Notch	   receptors	   1-­‐4	  
(red)	   and	   DAPI	   (blue).	  	  
B,D,F,H	   show	   higher	  
magnifications	   of	   the	   insert	  
boxes	   drawn	   on	   A,C,E,G	  
respectively	   with	   the	   Hu	  
signal	   removed	   to	   clearly	  
display	   expression	   of	   Notch	  
receptors.	  	  Scale	  bar	  =	  25µm	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Figure	  4.2.	  Notch	  receptors	  1-­‐4	  are	  expressed	  in	  human	  neurospheres	  
Figure	  4.2.	  	  7µm	  frozen	  sections	  of	  28d	  old	  human	  neurospheres	  derived	  from	  the	  same	  
patients	  as	  Fig	  4.1.	  	  	  A-­‐D:	  Standard	  immunofluorescence	  images	  for	  antibodies	  against	  the	  
Notch	  receptors	  (Red)	  and	  Dapi	  (Blue).	  Scale	  bar	  A-­‐D	  =	  100µm	  	  E-­‐H:	  Confocal	  images	  of	  single	  
neurosphere	  cells	  isolated	  from	  the	  same	  patients	  fixed	  3h	  after	  dissociation	  and	  stained	  as	  
per	  A-­‐D.	  Scale	  bar	  =	  10µm	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Of	  note,	  as	  previously	  described,	  high	  levels	  of	  expression	  were	  found	  on	  the	  endothelium	  
of	  blood	  vessels	  within	  the	  colonic	  mucosa	  and	  muscle	  wall,	  which	  was	  also	  seen	  with	  
Notch	  1	  (Sander,	  et	  al	  2004).	  	  Within	  neurospheres,	  the	  pattern	  of	  Jagged	  1	  expression	  was	  
similar	  to	  that	  of	  Notch	  1,2	  and	  4	  with	  a	  more	  pronounced	  expression	  in	  the	  periphery	  than	  
that	  seen	  with	  the	  Notch	  receptors.	  Almost	  all	  cells	  demonstrated	  expressed	  of	  Jagged	  1,	  
with	  the	  cells	  within	  the	  first	  few	  layers	  at	  the	  periphery	  of	  neurospheres	  showing	  much	  
higher	  levels	  of	  expression.	  
Figure	  4.3.	  	  Expression	  of	  Jagged	  1	  in-­‐vivo	  and	  in	  neurospheres.	  	  
Figure	   4.3.	   	   Frozen	   sections	  were	   prepared	   as	   previously.	  A:	   Immunofluorescence	   image	   from	   a	  
colonic	   sections	   with	   antibodies	   against	   neuronal	   marker	   Hu	   (green),	   Jagged	   1	   (Red)	   and	   Dapi	  
(Blue).	  B:	  Higher	  magnification	  image	  of	  insert	  shown	  in	  A.	  	  C-­‐D:	  Immunofluorescence	  images	  from	  
neurospheres	   generated	   from	   the	   same	   patients	  with	   antibodies	   against	   Jagged	   1(Red)	   and	  Dapi	  
(Blue).	  Scale	  bar	  =	  100µm.	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4.2.2.	   Inhibition	   of	   the	   Notch	   signalling	   pathway	   inhibits	   cell	   proliferation	   and	  
promotes	  neuronal	  differentiation	  
Preliminary	   experiments	   to	   investigate	   the	   effect	   of	   Notch	   inhibition	   on	   human	   (HSCR)	  
neurospheres	   were	   carried	   out	   using	   the	   γ-­‐secretase	   inhibitor	   N-­‐[N-­‐(3,5-­‐
Difluorophenacetyl)-­‐L-­‐alanyl]-­‐S-­‐phenylglycine	   t-­‐butyl	   ester	   (DAPT).	   	   Following	   a	   4-­‐day	  
incubation	   period	   proliferation,	   as	   demonstrated	   by	   incorporation	   of	   the	   thymidine	  
analogue	  EdU	   into	  nuclei,	  was	   found	  to	  be	  significantly	  reduced	  by	  more	  than	  70%	   in	  the	  
neurospheres	  exposed	  to	  DAPT	  compared	  with	  the	  DMSO	  vehicle	  controls	  (Figure	  4.4	  A,C,E).	  
	  
Figure	  4.4.	  Effect	  of	  DAPT	  administration	  on	  intact	  neurospheres.
Figure	   4.4.	   	   Human	   HSCR	  
neurospheres	   were	   maintained	  
under	   standard	   conditions	   for	   10	  
days	   following	   their	   third	   passage	  
before	   adding	   the	   Notch	   inhibitor	  
DAPT	   (20uM)	   or	   DMSO	   to	   controls	  
for	   a	   further	   4d	   incubation.	   A-­‐D:	  	  
Frozen	   sections	   prepared	   as	   per	  
previous	   figures.	   	   A,C,E	  
demonstrates	  a	  significant	  decrease	  
in	   the	   proportion	   of	   cells	  
incorporating	   EdU	   (red)	   following	  
DAPT	   administration	   (p=0.002).	   	   B,	  
D	   shows	   that	   DAPT	   administration	  
increases	   the	   expression	   of	   the	  
early	   neuronal	   marker	   Tuj	   (green).	  	  
Nuclei	   stained	   with	   dapi	   (blue).	  	  
Scale	   bars	   =	   50µm.	   	   Error	   bars	  
represent	   standard	   error	   of	   the	  
mean	  (SEM)	  from	  3	  experiments.	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Conversely,	  the	  expression	  of	  the	  immature	  neuronal	  marker	  Tuj	  was	  seen	  to	  increase	  
dramatically	  in	  its	  intensity	  and	  was	  predominantly	  found	  in	  the	  centre	  of	  neurospheres	  
rather	  than	  the	  periphery	  (Figure	  4.4	  B,D).	  	  However,	  even	  with	  confocal	  microscopy	  it	  was	  
not	  possible	  to	  give	  a	  quantitative	  result	  by	  analysing	  neurosphere	  sections	  as	  expression	  
could	  not	  be	  localised	  to	  individual	  cells,	  as	  could	  be	  done	  with	  EdU	  which	  stains	  individual	  
cell	  nuclei.	  
4.2.3.	   DAPT	   administration	   does	   not	   appear	   to	   reduce	   the	   proportion	   of	  
proliferating	  cells	  by	  induction	  of	  apoptosis	  
Caspase-­‐3	   is	  part	  of	   the	  cysteine-­‐aspartic	  acid	  protease	   family	  and	   is	   involved	   in	  both	   the	  
extrinsic	  and	  intrinsic	  apoptosis	  pathways	  (Salvesen	  2002)	  and	  its	  expression	  can	  be	  used	  as	  
a	  marker	  for	  active	  apoptosis	  within	  a	  cell	  population.	  	  Therefore,	  expression	  of	  caspase-­‐3	  
was	  analysed	  within	  neurospheres	  to	   investigate	  whether	  the	  reduction	   in	  the	  proportion	  
of	   cells	   undergoing	   proliferation	  within	   neurospheres	   following	   Notch	   inhibition	   could	   at	  
least	   in	  part	  be	  accounted	   for	  by	  an	   increase	   in	  apoptosis.	   	  Using	   the	   same	  conditions	  as	  
4.2.2,	  no	  significant	  increase	  in	  the	  expression	  of	  caspase-­‐3	  was	  identified	  in	  neurospheres	  
cultured	   in	   the	   presence	   of	   the	   γ-­‐secretase	   inhibitor	   in	   comparison	   to	   DMSO	   controls,	  
either	  in	  terms	  of	  the	  percentage	  of	  the	  population	  expressing	  caspase	  3(Figure	  4.5)	  or	  the	  
average	  cell	  number	  per	  high	  power	   field	   (hpf)	   (DMSO	  8.9+/-­‐	  3.0	  cells/hpf,	  DAPT	  11.1	  +/-­‐	  
4.8	  cells/hpf)	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4.2.4.	   Dissociation	   of	   mature	   human	   neurospheres	   increases	   cell	   proliferation	  
and	  neuronal	  differentiation.	  
To	   enable	   a	   quantitative	   assessment	   of	   the	   effect	   of	   Notch	   inhibition	   on	   neuronal	  
differentiation	  human	  HSCR	  neurospheres	  were	  dissociated	  to	  allow	  expression	  of	  markers	  
within	  individual	  cells	  to	  be	  determined.	  	  Therefore,	  the	  effect	  dissociating	  the	  cells	  on	  their	  
behaviour,	  specifically	  proliferation	  and	  differentiation	  was	  first	  determined.	  	  The	  effect	  of	  
dissociation	   was	   found	   to	   produce	   a	   linear	   relationship	   between	   the	   proportion	   of	   cells	  
incorporating	   the	   thymidine	   analogue	   Edu	   and	   time	   following	   dissociation.	   	   After	   8	   days	  
almost	  a	   third	  of	   the	   total	  population	  had	  were	   found	  to	  have	  proliferated	   (Figure	  4.6	  F).	  	  
The	   increase	  seen	  in	  the	  proportion	  of	  cells	  expressing	  the	  early	  neuronal	  marker	  Tuj	  was	  
similar	  following	  a	  linear	  relationship	  with	  time	  after	  dissociation,	  however	  the	  proportion	  
of	   positive	   cells	   increased	   at	   more	   than	   twice	   the	   rate	   as	   seen	   with	   regard	   to	   EdU	  
incorporation	  (Figure	  4.6).	  	  Cells	  expressing	  Tuj	  tended	  to	  be	  located	  together	  (Figure	  4.6	  C	  
and	  D).	  	  Ultimately,	  up	  to	  50%	  of	  cells	  expressed	  the	  marker	  (Tuj)	  8	  days	  after	  dissociation.
Figure	   4.5.	   	   7µm	   frozen	  
sections	   were	   prepared	  
from	   human	   neurospheres	  
that	   had	   been	   incubated	  
with	  DAPT	  or	  DMSO	  for	  4d.	  
A:	  No	  significant	  difference	  
in	   the	   proportion	   of	   cells	  
expressing	   caspase	   3	   was	  
determined	   between	  
either	   condition	   (p=0.4).	  
Error	   bars	   represent	   SEM	  
from	   3	   experiments.B:	  
Representative	   section	  
from	   a	   neurosphere	   under	  
control	   conditions.	   	   C:	  
Representative	   section	  
from	   a	   neurosphere	  
incubated	  with	  DAPT.	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Figure	  4.6.	  Changes	  in	  proliferation	  and	  early	  neuronal	  differentiation	  over	  time	  in	  
dissociated	  neurospheres.	  
Figure	  4.6.	  	  Mature	  human	  neurospheres	  were	  dissociated	  and	  cultured	  on	  chamber	  slides	  for	  up	  
to	  8	  days.	  A-­‐E	  demonstrate	  a	  steady	  increase	  in	  expression	  of	  the	  early	  neuronal	  marker	  Tuj	  (green)	  
over	  time,	  with	  >50%	  of	  cells	  expressing	  Tuj	  by	  192h	  (D,E,	   linear	  regression	  slope	  =	  0.25,	  r2=	  0.72,	  
p<0.001).	  	  Nuclei	  stained	  with	  dapi	  (blue).	  	  Similarly,	  F	  demonstrates	  a	  linear	  relationship	  between	  
the	  proportion	  of	  cells	   incorporating	  EdU	  and	  time	  in	  culture,	  however	  the	  rate	  of	  increase	  is	  less	  
than	  50%	  of	  that	  seen	  with	  expression	  of	  Tuj	  (linear	  regression	  slope=0.12,	  r2=0.9,	  p<0.001).	  	  Scale	  
bars	  =	  50µm.	  Error	  bars	  represent	  SEM	  from	  3	  experiments.	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4.2.5.	   Selective	  siRNA	  knockdown	  of	   the	  canonical	  Notch	  pathway	  confirms	  the	  
involvement	  Notch	  in	  regulating	  cell	  proliferation	  and	  neuronal	  differentiation.	  
Although	   the	   results	  of	   γ-­‐secretase	   (DAPT)	   inhibition	  are	   consistent	  with	  a	   role	   for	  Notch	  
signalling	   in	   the	   regulation	   of	   ENS	   progenitor	   cell	   proliferation	   and	   differentiation	   in	  
neurospheres,	   they	   do	   not	   prove	   it	   because	   DAPT	   inhibition	   may	   affect	   other	   signalling	  
pathways	  with	  which	   γ-­‐secretase	   has	   been	   implicated	   (Groth,	   et	   al	   2012).	   	   Therefore,	   in	  
order	  to	  confirm	  that	  the	  decrease	  in	  proliferation	  and	  increase	  in	  neuronal	  differentiation	  
previously	   seen	   (in	  4.2.2)	  were	  due	   to	  Notch	   inhibition	  a	   selective	   siRNA	  knockdown	  was	  
performed.	  
Predesigned,	  commercial	  siRNA	  oligomers	  (HsRBPJ-­‐1/2/3	  –	  see	  2.4.2)	  were	  obtained	  against	  
RBP-­‐Jκ,	  a	  core	  component	  of	  the	  canonical	  Notch	  signalling	  pathway.	  	  To	  assess	  the	  efficacy	  
of	  transfection	  a	  positive	  control	  (All	  Star®,	  Qiagen),	  which	  is	  known	  to	  induce	  cell	  death	  by	  
targeting	   ubiquitously	   expressed	   genes	   which	   are	   essential	   to	   cell	   survival,	   was	   used.	  	  
However,	  this	  was	  found	  to	  be	  unable	  to	  transfect	  central	  cells	  within	  human	  neurospheres.	  	  
In	  contrast,	  in	  dissociated	  cells	  more	  than	  80%	  of	  cells	  underwent	  cell	  death	  within	  48hrs	  of	  
transfection.	  	  Cell	  death	  was	  only	  seen	  in	  5%	  of	  cells	  using	  a	  corresponding	  negative	  control.	  	  
Therefore,	   to	  ensure	  an	  appropriate	  comparison	  could	  be	  made	  to	   those	  seen	  with	  DAPT	  
administration	   in	   intact	   neurospheres,	   these	   experiments	   were	   repeated	   on	   dissociated	  
neurospheres	   with	   similar	   results	   (Figure	   4.7).	   	   Transfection	   of	   dissociated	   neurospheres	  
with	  the	  HsRBPJ_3	  oligomer	  was	  found	  to	  have	  an	  almost	  identical	  effect.	  	  Knocking	  down	  
RBP-­‐Jκ,	  resulting	  in	  an	  almost	  three-­‐fold	  reduction	  in	  the	  number	  of	  cells	  incorporating	  EdU	  
(Figure	  4.8A-­‐C).	  	  Furthermore,	  the	  knockdown	  promoted	  a	  dramatic,	  greater	  than	  five-­‐fold,	  
increase	   in	  neuronal	  differentiation	  to	  almost	  50%	  of	  cells	   (Figure	  4.8	  A-­‐D).	  Similar	  results	  
were	  seen	  with	  two	  further	  siRNA	  oligomers	  HsRBPJ_1	  and	  HsRBPJ_2	  (data	  not	  shown).	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The	  effectiveness	  of	  the	  knockdown	  was	  confirmed	  by	  a	  reduction	  of	  mRNA	  levels	  of	  RBP-­‐Jκ	  
with	  qRT-­‐PCR	  using	   the	  ∆∆Ct	  method,	   referencing	   to	   the	  housekeeping	  gene	  ß-­‐Actin	   (see	  
2.8).	  	  Following	  siRNA	  treatment	  using	  the	  HsRBPJ_3	  oligomer	  under	  the	  same	  conditions	  as	  
above,	   mRNA	   levels	   of	   RBP-­‐Jκ	   fell	   to	   one	   third	   of	   the	   level	   seen	   in	   human	   control	  
neurospheres	  (Figure	  4.8E).	  
	  
Figure	   4.7.	   Effect	   of	   Notch	   inhibition	   on	   cell	   proliferation	   in	   dissociated	  
neurospheres	  
Figure	   4.7.	   	   Human	   neurospheres	   were	   dissociated	   with	   trypsin	   and	   immediately	   plated	   onto	  
fibronectin	   coated	   glass	   chamber	   slides	   in	   the	   presence	   of	   DAPT	   or	   DMSO	   control.	   	   A-­‐C	  
demonstrates	  a	  significant	  reduction	  in	  incorporation	  of	  EdU	  (red)	  in	  cells	  incubated	  with	  the	  Notch	  
inhibitor	  DAPT	  (p<0.0001).	  	  Nuclei	  stained	  with	  dapi	  (blue).	  	  Scale	  bars	  =	  50µm.	  Error	  bars	  represent	  
SEM	  from	  3	  experiments.	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Figure	   4.8.	   	   Selective	   siRNA	   knockdown	   of	   Notch	   inhibits	   cell	   proliferation	   and	  








	   	  
Figure	  4.8.	  	  Dissociated	  human	  neurospheres	  were	  plated	  onto	  glass	  chamber	  slides	  (as	  per	  figure	  3.5).	  	  
72h	  after	  transfection	  with	  either	  an	  siRNA	  against	  RBP-­‐Jκ	  or	  a	  negative	  control	  cells	  were	  assessed	  for	  
incorporation	   of	  EdU	   and	   expression	   the	   neuronal	  marker	  Tuj.	   	  A-­‐B:	   	  Expression	  of	   Tuj	   (green)	   and	  
incorporation	  of	  EdU	  (red)	  at	  72h.	   	  Nuclei	   stained	  with	  dapi	   (blue).	   	  C-­‐D:	   	  Quantitative	   confirmation	  
that	  knockdown	  of	  RBP-­‐Jκ	  results	  in	  a	  significant	  decrease	  in	  the	  incorporation	  of	  EdU	  and	  increase	  in	  
expression	  of	  Tuj	  (p<0.0001).	  	  E:	  Confirmation	  of	  the	  specificity	  of	  knockdown.	  Three-­‐fold	  reduction	  in	  
the	  mRNA	  levels	  of	  RBP-­‐Jκ	  following	  transfection	  with	  the	  HsRBPJ_3	  oligomer	  (p<0.001).	  	  Scale	  bars	  =	  
50µm.	  	  Error	  bars	  represent	  SEM	  from	  3	  experiments.	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4.2.6	   Rate	  of	  neuronal	  differentiation	   is	   increased	  following	  Notch	   inhibition	   in	  
cells	  dissociated	  from	  neurospheres.	  
Having	   determined	   the	   effect	   of	   dissociation	   on	   the	   proportion	   of	   cells	   from	   human	  
neurospheres	   undergoing	   neuronal	   differentiation,	   the	   next	   step	  was	   to	   perform	   a	  more	  
detailed	  analysis	  to	  identify	  the	  effect	  of	  Notch	  inhibition.	  	  Using	  DAPT	  inhibition	  over	  an	  8-­‐
day	   time	   course	   experiment,	   Notch	   inhibition	   was	   found	   to	   significantly	   increase	   the	  
proportion	  of	  cells	  from	  dissociated	  neurospheres	  expressing	  the	  early	  neuronal	  marker	  Tuj	  
(Figure	  4.9).	  	  However,	  this	  increase	  was	  less	  pronounced	  relative	  to	  the	  proportion	  of	  cells	  
expressing	  Tuj	  under	  control	  conditions	  at	  the	  later	  time	  points	  (Figure	  4.9	  I).	  
Notch	   inhibition	  was	  also	   found	  to	   increase	   the	  proportion	  of	  dissociated	  cells	  expressing	  
the	  more	  mature	  neuronal	  marker	  neuronal	  nitric	  oxide	  synthase	  (nNOS).	  	  However,	  there	  
appears	   to	   be	   a	   lag	   time	   before	   the	   increase	   becomes	   significant	   (Figures	   4.10).	   	   No	  
significant	  increase	  in	  the	  proportion	  of	  cells	  expressing	  nNOS	  was	  seen	  at	  either	  the	  24h	  or	  
48h	  time	  points.	   	  However,	  an	   increase	  was	   identified	  at	  both	  96h	  and	  192h,	  with	  almost	  
one	   third	  of	   cells	   (32%)	  expressing	  nNOS	  at	   192h.	   	   This	   represents	   a	   40%	   increase	   in	   the	  
proportion	  of	  cells	  expressing	  the	  marker	  relative	  to	  controls	  (Figure	  4.10	  E).	  
In	  contrast	  to	  the	  expression	  of	  nNOS,	  no	  significant	  increase	  in	  the	  expression	  of	  another	  
mature	   neuronal	   marker	   ChAT	   is	   seen	   as	   a	   result	   of	   Notch	   inhibition	   at	   any	   time	   point	  
(Figure	   4.11).	   	   However,	   in	   both	   inhibited	   and	   control	   cells	   the	   proportion	   of	   ChAT	   did	  
increase	   over	   time,	   with	   a	   4-­‐fold	   increase	   in	   expression	   seen	   during	   the	   first	   and	  
subsequent	  96h	  incubation	  periods.	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Figure	   4.9.	   	   Notch	   inhibition	   increases	   the	   rate	   of	   neuronal	   differentiation	   in	  
dissociated	  neural	  progenitor	  cells	  
Figure	  4.9.	  Mature	  human	  neurospheres	  were	  dissociated	  and	  cultured	  on	  chamber	  slides	  for	  up	  
to	  8	  days	  either	  in	  the	  presence	  of	  the	  Notch	  inhibitor	  DAPT	  or	  DMSO	  control.	  A-­‐H	  demonstrates	  
a	   steady	   increase	   in	   expression	   of	   the	   early	   neuronal	   marker	   Tuj	   (green)	   over	   time	   in	   both	  
conditions,	   but	  with	   significantly	  more	   in	   the	  Notch	   inhibited	   group.	   	   Nuclei	   stained	  with	   dapi	  
(blue).	   	   I:	   The	   proportion	   of	   cells	   expressing	   Tuj	   is	   significantly	   higher	   at	   all	   time	  points	   in	   the	  
Notch	  inhibited	  group.	  	  Scale	  bars	  =	  50µm.	  	  Error	  bars	  represent	  SEM	  from	  5	  experiments.	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Figure	   4.10.	   	   Notch	   inhibition	   increases	   the	   expression	   of	   the	  mature	   neuronal	  
marker	  nNOS	  
	   	  
Figure	  4.10.	  Mature	  human	  neurospheres	  were	  dissociated	  and	  cultured	  on	  chamber	  slides	  for	  up	  to	  
8	   days	  either	   in	   the	   presence	   of	   the	  Notch	   inhibitor	   DAPT	  or	  DMSO	   control.	  A-­‐D	  Demonstrate	   an	  
increase	  in	  the	  expression	  of	  the	  mature	  neuronal	  marker	  neuronal	  nitric	  oxide	  synthase	  (nNOS,	  red)	  
with	   a	   greater	   proportion	  of	   positive	   cells	   in	   the	  Notch	   inhibited	   group.	   	  Nuclei	   stained	  with	   dapi	  
(blue).	   	  E:	  The	  proportion	  of	  cells	  expressing	  nNOS	  is	  not	  significantly	  higher	   in	  the	  Notch	   inhibited	  
group	  until	  the	  96h	  time	  point.	   	  A	  third	  of	  Notch	  inhibited	  cells	  express	  nNOS	  at	  192h	  compared	  to	  
less	  than	  a	  quarter	  of	  cells	  in	  the	  control	  population.	  	  Scale	  bars	  =	  50µm.	  	  Error	  bars	  represent	  SEM	  
from	  3	  experiments.	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Figure	  4.11.	  	  Expression	  of	  the	  mature	  neuronal	  marker	  ChAT	  increases	  with	  time	  
in	  culture	  independent	  of	  Notch	  inhibition	  
Figure	  4.11.	  Mature	  human	  neurospheres	  were	  dissociated	  and	  cultured	  on	  chamber	  slides	  for	  up	  
to	  8	  days	  either	  in	  the	  presence	  of	  the	  Notch	  inhibitor	  DAPT	  or	  DMSO	  control.	  A-­‐D	  Demonstrate	  an	  
increase	  in	  the	  expression	  of	  the	  mature	  neuronal	  marker	  choline	  acetyltransferase	  (ChAT,	  red)	  with	  
time	  in	  culture.	   	  Nuclei	  stained	  with	  dapi	   (blue).	  	  E:	  The	  proportion	  of	  cells	  expressing	  ChAT	   is	  not	  
significantly	  higher	  in	  the	  Notch	   inhibited	  group	  at	  any	  time	  point.	  	  Scale	  bars	  =	  50µm.	   	  Error	  bars	  
represent	  SEM	  from	  3	  experiments.	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4.2.7.	   Notch	  signalling	  is	  disrupted	  by	  dissociation	  of	  neurospheres	  	  
Having	  demonstrated	  an	  increase	  in	  neuronal	  differentiation	  following	  either	  neurosphere	  
dissociation	   or	   inhibition	   of	   the	   Notch	   signalling	   pathway	   we	   wanted	   to	   determine	   the	  
activity	   of	   the	   Notch	   signalling	   pathway	   under	   both	   of	   these	   conditions.	   	   To	   do	   this	   we	  
looked	   at	   the	   expression	   of	   the	   unbound	   Notch	   intracellular	   domain	   (NICD)	   within	  
individual	   cells.	   	   In	   canonical	   Notch	   signalling	   activation	   of	   the	   pathway	   is	   initiated	   by	  
corresponding	   ligand,	  which	   initiates	   the	   intracellular	   cleavage	  of	   the	  NICD,	  which	   in	   turn	  
translocates	  to	  the	  cell	  nucleus	  to	  bind	  with	  RBP-­‐Jκ	  and	  activate	  the	  downstream	  effectors	  
(see	  1.1.4).	   	   Therefore,	  using	   immunofluorescence	   techniques	   to	   identify	   the	  presence	  of	  
cleaved	  NICD	  allows	  visualisation	  of	  cells	  in	  which	  the	  Notch	  pathway	  is	  activated.	  
Using	  an	  antibody	  against	  cleaved	  NICD	  at	  val1744,(Chen,	  et	  al.	  2013),	  NICD	  expression	  was	  
identified	   in	  more	  than	  80%	  of	  cells	   in	   freshly	  dissociated	  neurospheres	  (Figure	  4.12	  A,D).	  	  
Under	  control	  conditions	  the	  proportion	  of	  cells	  expressing	  NICD	  fell	  quickly	  to	  35%	  by	  12h,	  
20%	  by	  24h	  and	  under	  10%	  at	  48h,	  after	  which	  point	  remained	  between	  8-­‐12%	  until	  200h	  
(Figure	   4.12	   D).	   	   Notch	   inhibition	   with	   DAPT	   accelerated	   this	   decrease,	   and	   low	   levels	  
similar	  to	  those	  of	  the	  DMSO	  controls	  were	  maintained	  up	  to	  200h	  (Figure	  4.12	  D).	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Figure	   4.12.	   Dissociation	   of	   neurospheres	   decreases	   the	   expression	   of	   NICD
Figure	   4.12.	   	   Neurospheres	   were	   dissociated,	   and	   the	   cells	   plated	   onto	   fibronectin-­‐
coated	  chamber	  slides	  and	  fixed	  at	  1h,	  6h,	  12h,	  24h,	  48h,	  96h	  and	  192h	  time	  points.	  	  A-­‐B:	  
Demonstrate	  the	  loss	  of	  expression	  of	  cleaved	  NICD	  (red)	  following	  dissociation,	  1h	  (A),	  
12h	  (B)	  and	  24h	  (C).	   	  Nuclei	  stained	  with	  dapi	   (blue).	   	  D:	   	  Proportion	  of	  cells	  expressing	  
NICD	  against	  time	  with	  and	  without	  Notch	  inhibition	  (DAPT).	  	  	  	  Scale	  bars	  =	  50µm.	  	  Error	  
bars	  represent	  SEM	  from	  3	  experiments.	  
Chapter	  4	  |	  Notch	  Signalling	  
P a g e 	  |	  103	  
4.2.8.	   Activated	  NICD	  is	  expressed	  in	  the	  ENS	  in-­‐vivo	  and	  in-­‐vitro	  
Given	  the	  changes	  in	  Notch	  activation	  as	  demonstrated	  by	  levels	  of	  NICD	  the	  next	  question	  
was	  whether	  we	  could	  see	  any	  change	  in	  its	  activation	  state	  when	  isolating	  these	  cells	  from	  
their	  original	  niche	  within	  the	  bowel	  and	  culturing	  them	  as	  neurospheres.	  
Looking	   at	   frozen	   colonic	   sections,	   fixed	   immediately	   after	   isolation,	   expression	   of	   NICD	  
could	  be	  identified	  within	  elements	  of	  the	  ENS	  in-­‐vivo	  (figure	  4.13	  A-­‐D	  arrows).	  	  	  Similarly,	  
the	  cleaved	  form	  of	  NICD	  was	  expressed	  in	  neurospheres	  cultured	  from	  biopsies	  taken	  from	  
the	  same	  colonic	  sections.	  	  Consistent	  with	  localisation	  of	  both	  Notch	  receptors	  and	  ligands,	  
the	  expression	  was	  predominantly	  found	  at	  the	  periphery	  of	  the	  neurospheres	  (Figure	  4.13	  
E-­‐F).	  
Figure	  4.13.	  Expression	  of	  cleaved	  NICD	  in-­‐vivo	  and	  in-­‐vitro	  
	   	  
Figure	   4.13.	   	   Expression	  of	   the	  NICD	  
in	   human	   ganglionic	   colonic	  
submucosa.	   	   A-­‐D:	   Images	   from	   the	  
same	   7	   µm	   colonic	   frozen	   section	  
demonstrating	   NICD	   expression	  
within	   components	   of	   the	   ENS.	   	   A	  
Phase	   contrast.	   	  B:	   NICD	   expression	  
(red),	  nuclei	  stained	  with	  dapi	  (blue).	  	  
C:	   mature	   neuronal	   maker	   Hu	  
(green).	  	  D:	  Merge.	  	  	  
E-­‐F:	   7µm	   central	   frozen	   section	   of	  
neurosphere	   demonstrating	   NICD	  
expression	   predominantly	   localised	  
at	  the	  periphery.	  Scale	  bars	  =	  50µm	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4.3.	   Discussion	  
Given	   the	   dramatic	   change	   in	   behaviour	   that	   is	   seen	   in	   ENS	   progenitors	   when	   removed	  
from	   their	   niche	   in-­‐vivo,	   where	   only	   low	   levels	   of	   proliferation	   and	   neurogenesis	   are	  
detected	   (Pham,	   et	   al.	   1991,	   Li,	   et	   al.	   2011)	   and	   brought	   into	   culture	   there	   is	  
understandably	   a	   concern	   regarding	   any	   future	   therapeutic	   use	   of	   such	   cells.	   	   Therefore,	  
the	  need	  to	  identify	  the	  mechanisms	  that	  regulate	  this	  behaviour	  is	  important	  to	  enable	  us	  
to	   predict	   and	   indeed	   manipulate	   their	   behaviour	   prior	   to	   human	   transplantation.	   	   This	  
chapter	   demonstrates	   that	   components	   of	   the	   Notch	   signalling	   pathway	   (receptors	   and	  
their	   ligand,	   Jagged-­‐1)	   are	   expressed	   in	   both	   the	   human	  post-­‐natal	   ENS	   and	   ENS	   derived	  
cultures	  in-­‐vitro.	  	  Furthermore,	  this	  chapter	  confirms	  that	  Notch	  signalling	  is	  involved	  in	  the	  
regulation	  of	  proliferation	  and	  neuronal	  differentiation	  in-­‐vitro.	  
	  
4.3.1.	   Notch	  ligands	  and	  receptors	  are	  present	  the	  human	  post-­‐natal	  ENS	  
All	   four	   known	   notch	   receptors,	   Delta-­‐like	   ligands	   and	   Jagged	   1	   and	   Jagged	   2	   have	   been	  
shown	  to	  be	  present	  in	  the	  mouse/rat	  gut	  (Sander,	  et	  al.	  2003,	  Sander,	  et	  al	  2004,	  Okamura,	  
et	  al	  2008,	  Ngan,	  et	  al	  2011).	   	  Hence	  it	   is	  of	  no	  surprise	  that	  we	  identified	  components	  of	  
the	  Notch	   signalling	  pathway	  within	   the	  ENS	  of	   the	  postnatal	  human	  colon.	   	  No	  previous	  
study	  has	  reported	  the	  presence	  of	  the	  Notch	  3	  receptor,	  most	  having	  focussed	  on	  Notch	  1	  
and	  2.	  	  Caution	  must	  be	  applied	  to	  our	  preliminary	  finding	  indicating	  the	  presence	  of	  Notch	  
3	  due	  to	  the	  specificity	  of	  the	  antibodies	  used.	  	  Little	  detail	  is	  given	  from	  the	  manufacturers	  
regarding	   the	   precise	   target	   for	   their	   anti-­‐Notch	   3	   antibody	   and	   although	   we	   used	   IgG	  
controls	   to	   determine	   the	   specificity	   of	   immunofluorescence	   (not	   shown),	   there	   remains	  
the	   possibility	   that	   there	   was	   some	   cross-­‐reactivity	   with	   other	   Notch	   receptors.	  	  
Nevertheless,	   the	   experiments	   reported	   demonstrate	   that	   multiple	   components	   of	   the	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Notch	   ligand/receptor	   system	  were	  present	  both	   in-­‐vivo	  and	   in	  cultured	  ENS	  progenitors,	  
and	  it	  was	  outside	  the	  scope	  of	  the	  present	  chapter	  to	  take	  this	  finding	  further.	  	  
Notch	   receptors	   and	   their	   ligands	   within	   neurospheres	   were	   found	   to	   be	   predominantly	  
localised	   in	   the	   outer/peripheral	   layers	   of	   cells	   within	   neurospheres.	   	   The	   localisation	   of	  
Notch	   signalling	   and	   indeed	   the	   behaviour	   of	   cells	   within	   neurospheres	   is	   not	   well	  
documented	   either	   within	   the	   CNS	   or	   ENS.	   	   However,	   this	   finding	   is	   consistent	   with	   our	  
findings	   in	   chapter	   3	   which	   found	   that	   proliferation	   in	   neurospheres	   is	   predominantly	  
located	  at	  the	  peripheries,	  with	  more	  mature	  cells	  migrating	  towards	  the	  centre.	  
	  
4.3.2.	   Notch	  inhibition	  reduces	  proliferation	  in	  human	  ENS	  progenitor	  cells	  
Notch	   inhibition,	   with	   the	   γ-­‐secretase	   inhibitor	   DAPT	   was	   found	   to	   cause	   a	   significant	  
reduction	   in	   ENS	   cell	   proliferation	   in-­‐vitro,	   using	   the	   incorporation	   of	   the	   thymidine	  
analogue	  EdU	  into	  nuclei	  to	  demonstrate	  DNA	  synthesis.	  	  A	  four-­‐day	  treatment	  with	  DAPT	  
resulted	   in	   a	   70%	   reduction	   in	   EdU	   incorporation	   in	   both	   intact	   neurospheres	   and	   cells	  
dissociated	  from	  them,	  which	  is	  consistent	  with	  previous	  studies	  in	  both	  the	  CNS	  (Gao,	  et	  al	  
2009,	   Imayoshi,	  et	  al	  2010)	  and	  embryonic	  murine	  ENS	   (Okamura,	  et	  al	  2008,	  Ngan,	  et	  al	  
2011).	  	  However,	  both	  the	  results	  of	  this	  chapter,	  using	  DAPT	  and	  those	  in	  the	  murine	  ENS	  
leave	  open	  the	  possibility	  of	  the	  reduction	  in	  proliferation	  being	  caused	  by	  off-­‐target,	  non-­‐
specific	   effects	   of	   inhibition.	   	   The	   γ-­‐secretase	   complex	   inhibited	   by	  DAPT	   is	   known	   to	   be	  
involved	  in	  the	  membrane	  proteolysis	  of	  more	  than	  80	  other	  substrates	  (Groth,	  et	  al	  2012).	  	  
Although	   previous	   findings	   within	   our	   lab	   confirmed	   that	   DAPT	   inhibition	   resulted	   in	   a	  
down-­‐regulation	   of	   the	   downstream	   Notch	   transcription	   factors	   Hes1	   and	   Hes5	  
(Theocharatos,	   et	   al	   2013),	   this	   still	   did	   not	   prove	   that	   the	   changes	   in	   cell	   behaviour	   are	  
directly	  due	  to	  the	  inhibition	  of	  Notch	  signalling.	  	  Similarly,	  the	  approach	  of	  Okamura	  et	  al	  
used	   a	   conditional	   knockout	   of	   the	   widely	   expressed	   glycosyl-­‐transferase	   POFUT-­‐1	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(Okamura,	  et	  al	  2008),	  the	  effects	  of	  which	  may	  not	  be	  restricted	  to	  inhibition	  of	  the	  	  Notch	  
signalling	  pathway	  within	  the	  ENS.	  	  
This	   chapter	   provides	   definitive	   evidence	   that	   Notch	   signalling	   is	   required	   to	   maintain	   a	  
proliferative	   state.	   	   Transfection	   with	   the	   Notch	   specific	   anti-­‐RBP-­‐Jκ	   siRNA	  was	   found	   to	  
reduce	   the	   proportion	   of	   cells	   incorporating	   EdU	   by	   almost	   70%	   at	   72h.	   	   This	   selective	  
approach	   confirms	   that	   the	   reduction	   in	   proliferation	   seen	   was	   due	   to	   Notch	   inhibition	  
rather	  than	  other	  off-­‐target	  effects.	  
	  
The	  second	  assumption	  that	  required	  clarification	  was	  whether	  the	  decrease	  in	  number	  of	  
cells	  incorporating	  EdU	  was	  due	  to	  a	  reduction	  in	  the	  rate	  of	  proliferation	  or	  whether	  it	  was	  
due	  to	  an	  increase	  in	  apoptosis.	  	  One	  study	  looking	  at	  the	  affect	  of	  DAPT	  administration	  on	  
human	  tongue	  carcinoma	  cells	  found	  a	  dose-­‐dependent	  increase	  in	  apoptosis,	  as	  revealed	  
by	  the	  expression	  of	  caspase-­‐3	  (Grottkau,	  et	  al.	  2009).	  	  
The	   results	   in	   this	   chapter	   did	   not	   show	   a	   significant	   difference	   either	   in	   the	   number	   or	  
proportion	   of	   cells	   expressing	   Caspase-­‐3	   expression	   in	   human	   ENS	   neural	   progenitors	  
treated	  with	   DAPT.	   This	   is	   consistent	  with	   the	   findings	   of	   Okamura	   et	   al,	   who	   could	   not	  
identify	   apoptosis	   following	   their	   model	   of	   Notch	   inhibition	   in	   the	   developing	   ENS	  
(Okamura,	  et	  al	  2008).	  	  Although	  caspase-­‐3	  expressed	  is	  not	  identified	  in	  all	  apoptotic	  cells,	  
it	  was	  decided	  not	  to	  pursue	  this	  exhaustively	  as	  there	  were	  no	  other	  indicators	  to	  suggest	  
on	   going	   cell	   death	  within	   the	   neurospheres,	   i.e.	   a	   decrease	   in	   size	   of	   neurosphere	   over	  
time	  in	  culture	  in	  the	  presence	  of	  DAPT.	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4.3.3.	   Notch	  inhibition	  increases	  the	  neuronal	  differentiation	  human	  ENS	  neural	  
progenitor	  cells.	  	  
Inhibiting	   the	   Notch	   signalling	   pathway	   with	   either	   the	   γ-­‐secretase	   inhibitor	   DAPT	   or	  
following	  siRNA	  knockdown	  of	  RBP-­‐Jκ	  was	  found	  to	  result	  in	  an	  almost	  8-­‐fold	  increase	  in	  the	  
expression	  of	  the	  immature	  neuronal	  marker	  Tuj,	  with	  positive	  cells	  demonstrating	  a	  typical	  
neuronal	   phenotype.	   	   Unsurprisingly,	   this	   increase	   mirrors	   the	   findings	   in	   ENS	   mouse	  
models	  in	  which	  Notch	  is	  inhibited	  via	  either	  a	  PTCH1	  or	  POFUT1	  knockout	  confirming	  that	  
these	  studies	  were	  reflecting	  the	  consequences	  of	  Notch	  inhibition	  rather	  than	  some	  other	  
unidentified	  effect	  of	  the	  knockouts	  (Okamura,	  et	  al	  2008,	  Ngan,	  et	  al	  2011).	  
Importantly,	  Notch	   inhibition	  also	  promoted	  the	  expression	  of	   the	  more	  mature	  neuronal	  
marker	  nNOS.	  	  Unsurprisingly	  this	  lagged	  behind	  the	  expression	  of	  the	  immature	  marker	  Tuj,	  
with	   nNOS	   showing	   a	   significant	   increase	   after	   96h	   compared	   to	   24h.	   	   The	   overall	  
expression	   of	   ChAT	   was	   not	   significantly	   higher	   in	   Notch	   inhibited	   cells	   than	   in	   controls	  
after	  the	  full	  192h	  incubation	  period,	  even	  though	  there	  had	  been	  a	  significant	  increase	  in	  
the	  proportion	  of	  cells	  expressing	  ChAT	  (4-­‐fold	  increase	  between	  96h	  and	  192h).	  	  	  
The	  development	  of	  nitrergic	  and	  cholinergic	  neurons	  is	  known	  to	  differ.	  	  During	  embryonic	  
development	  ENS	  cholinergic	  neurons	  differentiate	  and	  exit	  the	  cell	  cycle	  earlier	  than	  their	  
nitrergic	  counterparts	  (Pham,	  et	  al	  1991).	  	  Although,	  there	  is	  a	  paucity	  of	  evidence	  detailing	  
the	   timing	  of	   nitrergic	   and	   cholinergic	   differentiation	   in-­‐vitro,	   the	   literature	   suggests	   that	  
nitrergic	   differentiation	   may	   occur	   earlier.	   	   Papers	   report	   increases	   in	   the	   expression	   of	  
nNOS	  after	  a	  period	  of	  24-­‐48h	  (Anitha,	  et	  al.	  2010),	  whereas	  increases	  in	  ChAT	  are	  reported	  
after	  longer	  time	  periods,	  e.g.	  18	  days	  (Nilbratt,	  et	  al.	  2010).	  However,	  these	  observations	  
must	   be	   treated	   with	   caution	   as	   there	   are	   no	   studies	   providing	   a	   direct	   comparison	  
between	  cholinergic	  and	  nitrergic	  differentiation	  in-­‐vitro	  under	  controlled	  conditions.	  
Chapter	  4	  |	  Notch	  Signalling	  
P a g e 	  |	  108	  
It	   has	   been	   shown	   that	   neuronal	   subtypes	   respond	   differently	   to	   inflammatory	   insults	  
within	  the	  gut	  (Winston,	  et	  al.	  2013)and	  it	  is	  equally	  plausible	  that	  these	  neuronal	  subtypes	  
respond	   differently	   to	   changes	   Notch	   signalling.	   	   Preliminary	   evidence	   from	   Sander	   et	   al	  
provides	   some	   support	   for	   this	   premise,	   in	   finding	   differential	   expression	   of	   the	  Notch	   1	  
receptor	   between	   enteric	   cholinergic	   and	   nitrergic	   neurons.	   	   However	   their	   report	   was	  
limited	  to	  in-­‐situ	  hybridisation	  results	  of	  one	  single	  Notch	  receptor	  and	  did	  not	  attempt	  to	  
correlate	  these	  findings	  with	  function.	  
It	   is	  not	   clear	   from	  these	   results	  whether	   the	  Notch	   is	   just	   responsible	   for	  promoting	   the	  
initial	  switch	  to	  an	  immature	  neuronal	  lineage,	  or	  whether	  prolonged	  inhibition	  is	  required	  
to	  promote	  mature	  neuronal	  differentiation.	  	  There	  is	  not	  enough	  evidence	  provided	  in	  this	  
chapter	   to	   draw	   any	   definitive	   conclusions	   as	   to	   whether	   these	   results	   are	   due	   to	  
differences	   in	  the	  timing	  of	  differentiation	  or	  the	  response	  to	  changes	   in	  Notch	  signalling.	  	  
However,	   it	   does	   warrant	   further	   study	   because	   if	   it	   is	   possible	   to	   promote	   the	  
differentiation	  of	   inhibitory	   neurons	   in	   progenitors	   prior	   this	  may	   improve	   the	   functional	  
response	  of	  any	  future	  cell-­‐based	  transplantation	  therapies.	  
	  
4.3.4.	   Notch	  signalling	  is	  disrupted	  by	  dissociation	  of	  neurospheres	  
In	   this	   chapter	   we	   have	   used	   standard	   immunofluorescence	   techniques	   to	   detect	   the	  
cleaved	   form	  of	  NICD,	   to	  determine	   the	  activation	   state	  of	   the	  Notch	   signalling	  pathway.	  	  
We	   found	   that	   the	   proportion	   of	   cells	   in	  which	  NICD	   could	   be	   detected	   fell	   quickly	   after	  
dissociation,	   a	   process	   that	   was	   accelerated	   by	   Notch	   inhibition.	   	   This	   decrease	   in	   the	  
expression	   of	   cleaved	   NICD	   following	   dissociation	   is	   not	   unexpected.	   	   Notch	   signalling	   is	  
classically	  activated	  by	   transmembrane	   ligands	  on	  adjacent	  cells,	  hence	  disruption	  of	  cell-­‐
cell	   interactions	   will	   interrupt	   canonical	   Notch	   activation.	   	   Following	   dissociation,	   the	  
proportion	  of	  cells	  expressing	  NICD	  under	  uninhibited	  conditions	  gradually	  increases	  again,	  
Chapter	  4	  |	  Notch	  Signalling	  
P a g e 	  |	  109	  
as	  the	  cells	  become	  more	  confluent.	   	  Although,	  the	  expression	  of	  NICD	  does	  fall	   following	  
either	  cell	  dissociation	  or	  Notch	  inhibition	  it	  is	  not	  immediate.	  	  Other	  groups	  have	  used	  the	  
expression	  of	  NICD	  as	  a	  proxy	  for	  Notch	  activation	  (Hansson,	  et	  al.	  2006,	  Del	  Monte,	  et	  al.	  
2007),	  however	  it	  still	  has	  its	  drawbacks,	  the	  detection	  of	  cleaved	  NICD	  may	  lag	  behind	  the	  
true	  activation	  state,	  for	  example,	  although	  the	  antibodies	  only	  detect	  the	  cleaved	  form	  of	  
NICD,	   it	   is	   unclear	   how	   long	   NICD	  may	   remain	   detectable	   following	   cleavage	   before	   it	   is	  
broken	  down	  and	  recycled.	  	  Furthermore,	  the	  Notch	  signalling	  pathway	  can	  be	  activated	  in	  
a	   non-­‐canonical,	   NICD	   independent,	   manner	   (Martinez	   Arias,	   et	   al.	   2002),	   which	   this	  
technique	  would	  not	  detect.	   	   In	  order	   to	  more	  precisely	  determine	   the	   changes	   in	  Notch	  
activation	   ‘live-­‐reporting’	   techniques	   such	   as	   using	   a	   luciferase-­‐base	   reporter	   to	   assess	  
levels	  of	  activated	  RBP-­‐Jκ	  would	  be	  required	  (Ilagan,	  et	  al.	  2011).	  
The	   presence	   of	   cleaved	   NICD	   was	   also	   used	   to	   determine	   activation	   firstly	   within	   the	  
microenvironment	   of	   the	   neurosphere,	  where	   its	   distribution	   is	   predominantly	   in	   cells	   at	  
the	  periphery,	  suggesting	  that	  Notch	  signalling	   is	  most	  active	   in	  this	  region,	  which	   itself	   is	  
consistent	   with	   the	   previous	   findings	   regarding	   the	   expression	   of	   Notch	   receptors	   and	  
ligands	   (4.2.1).	   	   Secondly,	   it	   is	   also	   seen	  within	   the	  ENS	   in-­‐vivo,	  which	   is	  more	   surprising.	  	  
The	  initial	  hypothesis	  was	  that	  Notch	  was	  inactive	  in-­‐vivo,	  and	  following	  an	  ‘injury’,	  such	  as	  
isolating	  neural	  progenitors,	   it	  became	  active	   thus	  explaining	   the	   increase	   in	  proliferation	  
and	   maintenance	   of	   a	   stem	   cell	   like	   state.	   	   If	   cleaved	   NICD	   is	   present	   in-­‐vivo	   this	   may	  
suggest	   that	  Notch	   is	   necessary	  but	  not	   sufficient	   for	  progenitor	   cell	   self-­‐renewal	   in-­‐vivo.	  	  
More	   importantly,	   it	  suggests	   that	   the	  environment	   in-­‐vivo	  exerts	  a	  dominating	   inhibitory	  
action	   on	   ENS	   progenitor	   cell	   self-­‐renewal,	   irrespective	   of	   the	   activity	   of	   the	   Notch	  
signalling	  pathway.	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4.4.	   Conclusions	  
The	   work	   within	   this	   chapter	   confirms	   that	   Notch	   signalling	   plays	   an	   active	   role	   in	   the	  
maintenance	  of	  a	  proliferative,	  progenitor-­‐like	  state	  within	  post-­‐natal	  ENS.	   	   It	   is	  clear	  that	  
although	  Notch	  signalling	  is	  required	  it	  is	  not	  sufficient	  to	  fully	  explain	  the	  regulation	  of	  ENS	  
progenitor	   behaviour,	   which	   is	   consistent	   with	   our	   growing	   understanding	   of	   the	  
complexity	  of	   both	  Notch	   signalling	   and	   cell	   regulation.	   	   It	   still	   remains	   to	  be	  established	  
what	  other	  factors	  play	  a	  role,	  but	  the	  work	  here	  provides	  a	  basis	  for	  future	  experiments	  to	  
determine	   firstly,	   whether	   Notch	   signalling	   regulates	   ENS	   progenitor	   behaviour	   post	  
transplantation	   and	   secondly,	   whether	   this	   can	   be	   manipulated	   to	   improve	   both	   the	  
effectiveness	  and	  safety	  of	  any	  future	  therapy.	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Chapter	  5:	  Development	  of	  a	  mature	  human	  
colonic	  smooth	  muscle	  model	  
	  
5.1.	   Introduction	  
5.1.1.	   Background	  
Previous	  work	  has	  demonstrated	  the	  therapeutic	  potential	  of	  using	  ENPSC	  as	  an	  autologous	  
transplant	   therapy	   for	   HSCR.	   	   Studies	   have	   shown	   their	   ability	   to	  migrate	   and	   form	   new	  
neurons	   post-­‐transplantation	   in-­‐vivo,	   and	   within	   lab	  models	   restore	   a	   normal	   pattern	   of	  
contraction	  (Dong,	  et	  al	  2008,	  Lindley,	  et	  al	  2008,	  Hotta,	  et	  al	  2013).	  	  	  The	  major	  limitation	  
of	  these	  studies	  is	  that	  they	  have	  all	  used	  animal	  tissue	  as	  the	  host	  for	  transplanted	  ENSPC.	  	  
Therefore,	   although	   providing	   encouragement	   that	   transplantation	   may	   provide	   a	  
therapeutic	  benefit,	  questions	  still	   remain	  with	  regard	  to	  how	  these	  cells	  might	  behave	   in	  
the	  microenvironment	  of	  the	  mature	  human	  colon.	  	  Although,	  ENSPC	  derived	  from	  patients	  
with	  HSCR	  can	  be	   transplanted	   into	   laboratory-­‐based	  animal	  models	   (Lindley,	  et	  al	  2008),	  
currently	  they	  cannot	  be	  injected	  into	  mice	  with	  a	  HSCR	  phenotype	  because	  of	  issues	  with	  
rejection.	   	   Given	   observations	   such	   as	   the	   dramatic	   change	   in	   behaviour	   seen	   from	   an	  
essentially	   quiescent	   state	   in-­‐vivo	   to	   that	   of	   uncontrolled	   growth	   and	   differentiation	   in	  
tissue	   culture,	   there	   is	   a	   need	   to	   predict,	   as	   closely	   as	   possible	  what	  will	   happen	   to	   the	  
behaviour	   of	   ENSPC	  when	   transplanted	   back	   into	   the	   environment	   of	   the	   human	   bowel.	  	  
Will	  these	  cells	  come	  back	  under	  control	  of	  the	  host	  environment	  or	  will	  they	  continue	  to	  
proliferate	  and	  develop	  into	  potential	  tumour?	  	  	  
Currently	   it	   is	   not	  possible	   to	  maintain	  human	  bowel	  explants	   in	   culture	   for	  much	   longer	  
than	   24h,	   predominantly	   due	   to	   the	   limited	   diffusion	   of	   oxygen	   and	   nutrients	   beyond	   a	  
thickness	   of	   2mm	   (Griffith,	   et	   al.	   2005).	   	   The	   development	   of	   an	   ex-­‐vivo	  mature	   human	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colonic	  smooth	  muscle	  model	  (HCSMM)	  that	  could	  be	  maintained	  in	  culture	  for	  prolonged	  
periods	  of	  time	  would	  provide	  the	  ability	  to	  observe	  the	  behaviour	  and	  the	  functional	  effect	  
of	   transplanted	   human	   ENSPC	   in	   the	   microenvironment	   of	   aganglionic	   human	   smooth	  
muscle.	   	   This	   would	   provide	   a	   stepping-­‐stone	   between	   the	   existing	   animal	   models	   and	  
future	  human	  clinical	  trials	  enabling	  us	  to	  more	  accurately	  predict	  both	  the	  potential	  safety	  
and	  functional	  outcome	  of	  autologous	  transplantation	  of	  ENSPC	  for	  HSCR.	  	  
	  
5.1.2.	   Attribution	  of	  work	  contained	  within	  this	  chapter	  
Functional	  physiological	  assessment	  of	  HCSMMs	  for	  smooth	  muscle	  activity	  was	  carried	  out	  
with	  Dr	  Rachel	  Floyd,	  University	  of	  Liverpool.	  	  All	  other	  work	  was	  carried	  out	  by	  the	  author.	  
	  
5.1.3.	   Aims	  
Studies	  have	  demonstrated	  that	  it	  is	  possible	  to	  culture	  layers	  of	  physiological	  active	  human	  
smooth	  muscle	   on	   a	   fibrin	   scaffold	   (Hecker	   2005,	   Somara,	   et	   al.	   2009).	   	   The	   aim	   of	   this	  
chapter	   is	   to	   develop	   a	   HCSMM	   using	   aganglionic	   colonic	   smooth	   muscle	   in	   which	   the	  
behaviour	  and	  functional	  response	  of	  transplanted	  ENSPC	  can	  be	  investigated.	  	  The	  model	  
must:	   (1)	   Contain	   functional	   smooth	   muscle	   (2)	   Be	   reproducible	   (2)	   Be	   maintained	   in	  
culture	   for	   >2	   weeks	   (3)	   Allow	   physiological	   testing	   both	   pre	   and	   post	   ENSPC	  
transplantation.	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5.2.	   Results	  
5.2.1.	   Development	  of	  a	  fibrin	  based	  human	  colonic	  smooth	  muscle	  model	  
Following	   a	   review	   of	   the	   current	   literature	   it	   was	   decided	   to	   base	   the	   first	   attempts	   at	  
developing	  a	  HCSMM	  on	  the	  model	  described	  by	  the	  group	  led	  by	  Khalil	  Bitar	  (Hecker	  2005,	  
Somara,	   et	  al	   2009).	   	   35mm	  standard	  cell	   culture	  dishes	   (Nalge-­‐Nunc)	  were	   firstly	   coated	  
with	  1ml	  of	  Sylgard®	  184	  (Dow	  Corning)	  and	  a	  prepared	  5mm	  diameter	  Sylgard	  cylinder	  was	  
placed	  in	  the	  centre	  of	  each	  dish	  before	  allowing	  to	  cure	  for	  a	  minimum	  of	  24h	  (Figure	  5.1).	  	  
Each	   dish	   was	   sterilised	   using	   a	   two-­‐step	   70%	   ethanol	   and	   UV	   light	   process,	   with	   a	   1h	  
incubation	   period	   for	   each	   step.	   	   Immediately	   prior	   to	   use,	   500µl	   of	   FB	   medium,	  
supplemented	   with	   both	   thrombin	   and	   fibrinogen	   (Sigma-­‐Aldrich)	   at	   concentrations	  
detailed	  in	  table	  6.1,	  was	  added	  to	  each	  dish,	  briefly	  swirled	  and	  left	  for	  15minutes	  at	  37˚C	  
for	  the	  fibrin	  to	  polymerise.	  A	  single	  cell	  suspension	  of	  aganglionic	  human	  colonic	  smooth	  
muscle	  cells	  (2.3.1.3)	  was	  then	  seeded	  at	  concentrations	  again	  detailed	  in	  table	  5.1.	  
The	  fibrin	  contracts	  to	  form	  a	  ring	  around	  the	  central	  pole	  on	  the	  dish	  over	  a	  period	  of	  5-­‐10	  
days,	  with	  the	  media	  being	  replaced	  every	  48h	  (figure	  5.1).	   	  Once	  a	  tight	  ring	  had	  formed	  
the	  standard	  FB	  culture	  medium	  was	  changed	   to	  HS	  medium	  to	  promote	  mature	  smooth	  
muscle	  differentiation.	  	  HCSMMs	  were	  maintained	  under	  these	  conditions	  until	  required	  for	  
further	  testing	  or	  they	  became	  unstable	  (Table	  5.1).	  	  
	  
44	   individual	   constructs	   were	   seeded,	   with	   the	   main	   finding	   following	   these	   Initial	  
experiments	  that,	  despite	  attempted	  optimisation	  of	  the	  conditions,	  the	  overall	  reliability,	  
i.e.	  the	  success	  rate	  of	  forming	  a	  stable	  ring	  by	  day	  14	  in	  culture	  was	  low	  23/44	  (52%,	  Table	  
5.1).	   	  Early	  attempts	  using	  either	  low	  thrombin	  (<10Units/ml),	  fibrinogen	  (2	  mg/ml)	  or	  cell	  
seeding	   densities	   below	   150K	   cells/ml	   did	   not	   result	   in	   any	   intact	   constructs	   by	   day	   14	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(Table	   5.1).	   	   Success	   rates	   were	   improved	   to	   68%	   above	   these	   minimum	   thresholds,	  
particularly	  when	  seeding	  at	  a	  density	  of	  300K	  cells/ml	  (Table	  5.1)	  	  
In	  an	  attempt	  to	  increase	  the	  number	  of	  mature	  smooth	  muscle	  cells	  maintained	  within	  the	  
construct,	  and	  thereby	  increase	  the	  theoretical	  force	  that	  could	  be	  generated	  by	  the	  model	  
the	  cell	  density	  was	  increased	  further	  to	  400K	  cells/ml.	  However,	  this	  was	  associated	  with	  a	  
further	  reduction	  in	  the	  reliability	  of	  forming	  a	  mature,	  stable	  ring	  in	  culture	  by	  14	  days.	  
	  
Figure	  5.1.	  	  Human	  colonic	  smooth	  muscle	  model	  using	  a	  fibrin	  scaffold	  
Figure	  5.1.	  	  A:	  Human	  smooth	  muscle	  was	  isolated	  from	  colonic	  biopsies	  as	  previously	  described	  to	  generate	  
a	  single	  cell	  suspension	  (B).	  C:	  Standard	  35mm	  plastic	  dishes	  were	  prepared	  with	  a	  Sylgard®	  base	  and	  5mm	  
central	   pole,	   onto	   which	   a	   polymerised	   layer	   of	   fibrin	   was	   produced.	   	   The	   single	   cell	   suspension	   is	   then	  
seeded	  onto	  the	  fibrin	  at	  varying	  concentrations	  (Table	  6.1).	  	  D-­‐H:	  	  As	  the	  fibrin	  scaffold	  contracts	  it	  forms	  a	  
tighter	  ring	  embedded	  with	  smooth	  muscle	  cells	  around	  the	  central	  pole	  and	  this	  becomes	  the	  HCSMM.	  	  E-­‐H:	  
Represent	  a	  typical	  time	  course,	  E	  =	  0h	  after	  seeding,	  F	  =	  48h,	  G	  =	  5d,	  H	  =	  10d	  (white	  arrow	  highlighting	  the	  
forming	  HCSMM).	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Table	  5.1.	  	  List	  of	  conditions	  and	  outcomes	  for	  each	  fibrin-­‐based	  HCSMM	  
	   Thrombin	   Fibrinogen	   Seeding	  
Density	  
Patient	   Ring	  
formed	  
Outcome	  
1	   10	  Units/ml	   2	  mg/ml	   200K/ml	   H001	   48h	   Ring	  snapped	  at	  16d	  
2	   10	  Units/ml	   2	  mg/ml	   200K/ml	   H001	   -­‐	   Failed	  to	  form	  by	  14d	  
3	   10	  Units/ml	   2	  mg/ml	   200K/ml	   H001	   -­‐	   Failed	  to	  form	  by	  14d	  
	  
4	   10	  Units/ml	   4	  mg/ml	   200K/ml	   H001	   48h	   Electively	  sacrificed	  at	  30d	  
5	   10	  Units/ml	   4	  mg/ml	   200K/ml	   H001	   48h	   Electively	  sacrificed	  at	  70d	  
6	   10	  Units/ml	   4	  mg/ml	   200K/ml	   H001	   -­‐	   Failed	  to	  form	  by	  14d	  
7	   10	  Units/ml	   4	  mg/ml	   200K/ml	   H001	   72h	   Electively	  sacrificed	  at	  30d	  
	  
8	   10	  Units/ml	   4	  mg/ml	   150K/ml	   H001	   -­‐	   Failed	  to	  form	  
9	   10	  Units/ml	   4	  mg/ml	   150K/ml	   H001	   -­‐	   Failed	  to	  form	  
	  
10	   10	  Units/ml	   4	  mg/ml	   300K/ml	   H001	   72h	   Electively	  sacrificed	  at	  64d	  
11	   10	  Units/ml	   4	  mg/ml	   300K/ml	   H001	   72h	   Electively	  sacrificed	  at	  64d	  
	  
12	   5	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   48h	   Ring	  Snapped	  at	  5d	  
13	   5	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   48h	   Ring	  Snapped	  at	  6d	  
14	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   24h	   Electively	  sacrificed	  at	  30d	  
15	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   24h	   Electively	  sacrificed	  at	  30d	  
16	   15	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   24h	   Electively	  sacrificed	  at	  30d	  
17	   15	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   24h	   Ring	  snapped	  at	  8d	  
	  
18	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Electively	  sacrificed	  at	  30d	  
19	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Electively	  sacrificed	  at	  30d	  
20	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Ring	  snapped	  at	  8d	  
21	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Electively	  sacrificed	  at	  30d	  
22	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Electively	  sacrificed	  at	  30d	  
23	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Electively	  sacrificed	  at	  30d	  
24	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Ring	  snapped	  at	  7d	  
25	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Electively	  sacrificed	  at	  30d	  
26	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Ring	  snapped	  at	  7d	  
27	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   -­‐	   Failed	  to	  form	  by	  14d	  
28	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   24h	   Electively	  sacrificed	  at	  30d	  
29	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   24h	   Electively	  sacrificed	  at	  30d	  
30	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   24h	   Electively	  sacrificed	  at	  30d	  
31	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H002	   -­‐	   Failed	  to	  form	  by	  14d	  
32	   10	  Units/ml	   6	  mg/ml	   300K/ml	   H001	   24h	   Electively	  sacrificed	  at	  30d	  
33	   10	  Units/ml	   6	  mg/ml	   300K/ml	  	   H002	   24h	   Electively	  sacrificed	  at	  30d	  
34	   10	  Units/ml	   8	  mg/ml	   300K/ml	   H002	   48h	   Electively	  sacrificed	  at	  30d	  
35	   10	  Units/ml	   8	  mg/ml	   300K/ml	   H002	   24h	   Ring	  snapped	  at	  4d	  
	  
36	   10	  Units/ml	   6	  mg/ml	   400K/ml	   H002	   24h	   Ring	  snapped	  at	  6d	  
37	   10	  Units/ml	   6	  mg/ml	   400K/ml	   H001	   24h	   Transplanted	  at	  20d	  
38	   10	  Units/ml	   6	  mg/ml	   400K/ml	   H001	   48h	   Transplanted	  at	  20d	  
39	   10	  Units/ml	   6	  mg/ml	   400K/ml	   H001	   -­‐	   Failed	  to	  form	  by	  14d	  
40	   10	  Units/ml	   6	  mg/ml	   400K/ml	   H001	   24h	   Transplanted	  at	  20d	  
41	   10	  Units/ml	   6	  mg/ml	   400K/ml	   H002	   -­‐	   Failed	  to	  form	  by	  14	  d	  
	  
42	   10	  Units/ml	   8	  mg/ml	   400K/ml	   H005	   24h	   Rings	  snapped	  at	  8d	  
43	   10	  Units/ml	   8	  mg/ml	   400K/ml	   H005	   24h	   Failed	  to	  form	  by	  14d	  
44	   10	  Units/ml	   8	  mg/ml	   400K/ml	   H005	   24h	   Rings	  snapped	  at	  6d	  
Table	  5.1	  	  Highlighted	  cells	   indicate	  HCSMMs	  which	  failed	  to	  form	  or	  lost	  structural	  integrity	  within	  
10d.	   	  Rows	  detail	   the	  concentration	  of	   thrombin/fibrinogen	  and	   seeding	  density	  of	   smooth	  muscle	  
cells	   used	   for	   each	   HCSMM	   formed.	   	   Time	   taken	   to	   formation	   of	   a	   ring,	   length	   in	   culture	   and	  
outcome	  for	  each	  model	  is	  also	  given.	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5.2.2.	   Confirmation	  that	  fibrin-­‐based	  HCSMMs	  contain	  smooth	  muscle	  
Although	   there	   was	   limited	   success	   in	   developing	   a	   HCSMM	   of	   reliable	   and	   consistent	  
structural	   integrity,	   if	   a	   construct	   formed	   and	   remained	   intact	   by	   day	   10,	   it	   could	   be	  
maintained	   in	   culture	   for	   between	   1	   and	   2	   months,	   with	   all	   constructs	   being	   sacrificed	  
electively	  (Table	  5.1).	  	  Therefore	  it	  was	  of	  importance	  to	  ascertain	  whether	  each	  construct	  
contained	  differentiated	  smooth	  muscle	  cells.	  	  HCSMMs	  were	  fixed	  with	  PFA	  at	  day	  30	  and	  
either	   processed	   as	   paraffin	   sections	   for	   H&E	   or	   frozen	   sections	   to	   determine	   the	  
expression	  of	  smooth	  muscle	  markers	  (Figure	  5.2).	  
Mature	  (30d)	  HCSMMs	  were	  rarely	  uniform	  in	  their	  thickness	  (Figure	  6.2A).	  	  Cross-­‐sectional	  
analysis	  demonstrated	   the	  presence	  of	  bands	  of	   cells	   surrounded	  by	  a	   significant	   layer	  of	  
fibrin	   with	   little	   cellular	   infiltration	   (Figure	   6.2B).	   	   Subsequent	   immunostaining	   for	   the	  
expression	   of	   the	   smooth	   muscle	   markers	   desmin	   and	   smooth	   muscle	   actin	   (SMA)	  
demonstrated	  dual	  labelling	  in	  the	  majority	  of	  cells	  within	  these	  bands,	  with	  no	  reactivity	  in	  
the	  surrounding	  layers	  of	  fibrin	  (Figure	  6.2C).	  
	  







Figure	  5.2.	  	  Mature	  HCSMMs	  were	  fixed	  with	  4%	  PFA	  for	  10minutes	  after	  30d	  in	  culture	  (A).	  	  Each	  ring	  
was	  bisected	  with	  half	  the	  ring	  embedded	   in	  paraffin	  for	  subsequent	  H&E	  analysis	  with	  the	  remaining	  
half	   embedded	   for	   frozen	   sections.	   	   B:	   H&E	   staining	   demonstrates	   cells	   orientated	   in	   bands	   (white	  
arrow)	  along	  the	   inner	  surface	  of	  each	  construct	  with	  very	  few	  cells	   infiltrating	  the	  outer	  fibrin	  layers.	  	  
C:	   	   Standard	   immunofluorescence	   for	   the	   smooth	   human	  muscle	  markers	   smooth	  muscle	   actin	   (red)	  
and	   desmin	   (green)	   reveals	   that	   the	   majority	   of	   cells	   express	   both	   of	   these	   common	  markers.	   	   Cell	  
nuclei	  are	  stained	  with	  Dapi	  (blue).	  	  Scale	  bars	  =	  50µm.	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5.2.3.	   Transplanted	  ENSPC	  survive	  and	  migrate	  within	  fibrin-­‐based	  HCSMMs	  
Having	   found	   that	   formed	   HCSMMs	   contain	   cells	   expressing	   typical	   markers	   for	  
differentiated	  smooth	  muscle,	  the	  next	  question	  was	  to	  determine	  whether	  human	  ENSPC	  
would	  survive	  and	  migrate	  within	  this	  environment.	  
To	  achieve	   this	  human	  ENSPC	   isolated	   from	  patients	  with	  HSCR	  were	   labelled	  with	  green	  
fluorescent	   protein	   (GFP,	   see	   2.6)	   and	   allowed	   to	   form	   neurospheres	   before	   being	  
transplanted	  onto	  day	  20	  HCSMM	  (Figure	  5.3).	  	  Live	  cell	  imaging	  of	  the	  constructs	  over	  the	  
course	  of	  7	  days	  demonstrated	   that	   labelled	  ENSPC	  were	  still	  present	   in	   the	  HCSMM	  and	  
suggested	  that	  cells	  were	  migrating	  away	  (50-­‐100µm)	  from	  the	  transplantation	  site	  (Figure	  
5.3A-­‐E).	  
The	   transplanted	   constructs	   were	   fixed	   at	   10d	   and	   cross-­‐sectional	   immunofluorescence	  
imaging	  performed	  on	  frozen	  sections	  (Figure	  5.3F,G).	  	  This	  confirmed	  that	  cells	  expressing	  
GFP	   had	   both	   migrated	   into	   the	   constructs	   and	   also	   migrated	   away	   from	   the	  
transplantation	  site	  (Figure	  5.3F).	   	  On	  sections	  co-­‐stained	  with	  the	  smooth	  muscle	  marker	  
SMA,	  GFP+ve	   cells	  were	   identified	   in	  what	   appeared	   to	   be	   in	   a	   ‘chain-­‐like’	   arrangement,	  
which	  may	  represent	  early	  neurite	  formation	  (Figure	  5.3G).	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Figure	  5.3.	   	  Transplantation	  of	  GFP	   labelled	  human	  neurospheres	  onto	  HCSMMs
Figure	   5.3.	   	  A-­‐G:	   GFP	   labelled	   human	   neurospheres	   (green)	  
were	  transplanted	  onto	  well	  established	  (d20)	  HSCMMs	  using	  
a	   pipette.	   	   A:	   	   Three	   neurospheres	   were	   transplanted	   per	  
construct	   and	   live-­‐cell	   imaging	   performed	   daily	   to	   track	   the	  
progress	  of	  each	  transplanted	  neurosphere	  (B-­‐E).	  	  Constructs	  
were	   fixed	   at	   d10	   post	   transplant	   and	   7µm	   frozen	   sections	  
were	   taken.	   	   F:	   	   GFP	   labelled	   cells	   have	   migrated	   into	   the	  
construct	  and	  away	   from	  the	  site	  of	   transplantation	   (dotted	  
white	   arrow).	   	   G:	   	   Sections	   co-­‐stained	   with	   the	   marker	   of	  
differentiated	   human	   smooth	   muscle	   SMA	   (red)	  
demonstrating	  the	  formation	  of	  ‘chains’	  of	  transplanted	  cells	  
expressing	  GFP	  (solid	  white	  arrow).	  	  Scale	  bars	  =	  50µm.	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5.2.4.	   Development	  of	  a	  decellularised	  mouse	  colon-­‐based	  HCSMM	  
Although	   using	   the	   fibrin-­‐based	   model	   permitted	   demonstration	   of	   the	   ability	   to	   grow	  
human	   smooth	  muscle	  within	   the	   construct	   and	   confirmed	   that	   human	   ENSPC	   can	   grow	  
within	  this	  environment,	  it	  was	  decided	  to	  look	  at	  alternative	  scaffolds	  for	  the	  HSCMM	  for	  
two	  reasons:	  	  Firstly,	  the	  fibrin-­‐based	  model	  was	  unreliable	  in	  forming	  a	  stable	  construct	  in	  
culture	  and	  secondly,	  attempts	  to	  increase	  the	  number	  of	  smooth	  muscle	  cells	  seeded	  onto	  
the	  construct	  reduced	  the	  reliability	  further.	  	  Following	  a	  wider	  review	  of	  the	  literature	  on	  
the	   use	   of	   scaffolds	   in	   tissue	   engineering	   it	   was	   decided	   to	   follow	   the	   approach	   of	  
researchers	  who	  had	  used	  a	  decellularised	  trachea	  as	  a	  scaffold	  (Baiguera,	  et	  al.	  2010)	  and	  
adapt	   this	   technique	  using	  a	  decellularised	  mouse	  colon	  as	  a	   scaffold	  and	   seeding	   it	  with	  
human	  colonic	  smooth	  muscle.	  
To	  prepare	  the	  decellularised	  colonic	  scaffold	  colons	  were	  harvested	  from	  adult	  mice	  and	  
the	  mesentery	  +/-­‐	  any	  accompanying	  blood	  vessels	  stripped	  off	  before	  washing	  in	  distilled	  
water	   (dH2O).	   	   The	   scaffolds	   were	   then	   placed	   in	   a	   1%	   (v/v)	   povidone-­‐iodine	   solution	  
(Sigma-­‐Aldrich)	   for	  30minutes,	   remove	  any	  bacterial	  contamination,	   followed	  by	  a	   further	  
two	  washes	  with	  dH2O.	  	  The	  decellularisation	  process	  was	  optimised	  to	  produce	  as	  scaffold	  
that	   was	   microscopically	   free	   of	   cellular	   debris	   while	   maintaining	   its	   structural	   integrity	  
(Figure	   5.4).	   	   Each	   decellularisation	   cycle	   involved	   incubating	   the	   scaffolds	   in	   4%	   sodium	  
deoxycholate	  (SDC,	  Sigma-­‐Aldrich)	  diluted	  in	  dH2O	  for	  24h	  on	  a	  mechanical	  rocker	  (Thermo-­‐
Scientific)	   at	   room	   temperature.	   	   On	   the	   second	   day,	   two	   further	   dH2O	   washes	   were	  
performed	   following	   a	   further	   6h	   incubation	  with	   2000KU	  DNase-­‐I	   (Sigma-­‐Aldrich)	   in	   1M	  
NaCl	  under	  the	  same	  conditions.	  	  Two	  further	  complete	  cycles	  were	  performed	  to	  remove	  
all	  macroscopic	  traces	  of	  cellular	  material	  (see	  Figure	  5.4).	  	  Once	  complete,	  scaffolds	  were	  
stored	   in	   PBS	   containing	   2%	   penicillin-­‐streptomycin	   and	   1µg/ml	   amphotericin	   B	   (Both	  
Gibco)	  at	  4˚C	  until	  required.	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The	  decellularised	  scaffold	  was	  then	  placed	  into	  a	  custom	  made	  InBreath®	  Bioreactor	  with	  
a	   3mm	   internal	   spindle	   (Harvard	   Apparatus,	   Kent,	   UK).	   	   The	   scaffold	  was	   secured	   to	   the	  
spindle	   with	   ties	   before	   filling	   the	   bioreactor	   with	   FB	   media	   until	   the	   scaffold	   was	   fully	  
covered	  (Figure	  5.5).	  	  After	  a	  1	  h	  incubation	  period	  (37˚C,	  5%	  CO2)	  media	  was	  removed	  until	  
the	  scaffold	  was	  exposed.	  	  Cell	  were	  then	  seeded	  directly	  onto	  the	  superior	  surface	  of	  the	  
construct	  (see	  table	  5.2)	  and	  returned	  to	  the	  incubator	  for	  20	  minutes	  before	  rotating	  the	  
spindle	  90˚.	  	  This	  process	  was	  repeated	  until	  cells	  had	  been	  seeded	  onto	  all	  four	  aspects	  of	  
the	  scaffold.	  	  The	  construct	  was	  then	  returned	  to	  the	  incubator	  under	  the	  same	  conditions	  
for	  24h	  before	  adding	  fresh	  FB	  media	  to	  fully	  cover	  the	  construct	  and	  starting	  to	  rotate	  the	  
spindle	  at	  1.5	  rpm.	  	  A	  second	  round	  of	  seeding	  was	  performed	  at	  5	  days	  if	  indicated	  in	  table	  
5.2.	  
Figure	   5.4.	   	   7µm	   frozen	   sections	  of	  mouse	  colonic	   scaffolds	  stained	  with	  H&E	  to	   identify	   residual	  
cellular	  material.	   	   	  A:	   	   Freshly	   isolated	  mouse	   colon	   prior	   to	  decellularisation,	  demonstrating	   the	  
normal	  architecture	  of	  the	  colon,	  with	  the	  presence	  of	  distinct	  cells	  within	  the	  mucosa	  and	  muscle	  
layers	   (arrows).	   	  B:	   Colonic	   scaffold	   after	   1	   cycle	   of	   decellularisation,	   demonstrating	   loss	   of	   the	  
normal	   distinct	   architecture,	   but	   a	   significant	   amount	   of	   cellular/nuclear	   debris	   is	   still	   present	  
(arrow).	   	   C:	   	   Scaffold	   after	   3	   complete	   cycles.	   	   The	   scaffold	   remains	   intact	   with	  minimal	   visible	  
cellular	  debris	  remaining.	  	  Scale	  bar	  =	  50µm.	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Partial	  (50%)	  media	  changes	  are	  made	  every	  4	  days	  and	  as	  with	  the	  fibrin-­‐based	  model	  the	  
media	  was	  changed	  to	  HS	  medium	  after	  1	  week	  to	  stimulate	  the	  differentiation	  of	  mature	  
smooth	  muscle	  cells.	  	  
Each	   decellularised	   colon	   HCSMM	   formed	   is	   recorded	   in	   table	   5.2.	   	   The	   most	   striking	  
difference	  between	  the	  models	  is	  that	  all	  but	  one	  construct	  remained	  stable	  until	  the	  end	  
of	   the	   experiment	   and	   the	   only	   failure	   was	   due	   to	   infection	   rather	   than	   mechanical	  
instability.	  	  Constructs	  remained	  stable	  whether	  one	  or	  two	  seeding	  cycles	  were	  performed.	  	  	  
Figure	   5.5.	   	   Diagram	   depicting	   the	   setup	   of	   the	   InBreath®	   bioreactor.	   	   The	   decellularised	  
mouse	  colonic	   scaffold	   (A)	   is	   secured	   to	   the	  3mm	  central	   spindles	  and	   the	   tissue	  bath	   filled	  
with	  FB	  media	  to	  cover	  the	  scaffold.	  Following	  a	  1h	  incubation	  (at	  37˚C)	  media	  is	  removed	  to	  
expose	  the	  scaffold	  and	  smooth	  muscle	  cells	  gently	  pipetted	  onto	  the	  superior	  surface.	  	  After	  
20mins	   the	   scaffold	   is	   rotated	   90˚	   and	   cells	   pipetted	   to	   the	   newly	   exposed	   surface.	   	   This	  
process	   is	   repeated	   a	   further	   two	   times.	   	   The	   construct	   is	   then	   incubated	   for	   a	   further	   24h	  
under	  the	  same	  conditions	  before	  refilling	  with	  FB	  media	  to	  cover	  the	  scaffold	  and	  starting	  the	  
bioreactor	  motor	  to	  continuously	  rotate	  the	  spindle	  at	  1.5rpm.	  
A	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5.2.4.	   Decellularised	   colonic	   HCSMM	   contains	   physiologically	   active	   smooth	  
muscle	  
Although	   the	   decellularised	   colon-­‐based	   HCSMMs	   solved	   both	   the	   structural	   reliability	  
issues	  associated	  with	  the	  fibrin-­‐based	  models	  and	  allowed	  repeated	  cycles	  of	  cell	  seeding,	  
it	  was	  still	  to	  left	  to	  be	  determined	  whether	  the	  seeded	  aganglionic	  colonic	  smooth	  muscle	  
cells	  would	  survive	  and	  integrate	  with	  the	  scaffold	  itself.	  	  Hence,	  30d	  old	  constructs	  (45	  and	  
47,	  see	  table	  5.2)	  were	   fixed	  with	  4%	  PFA	  and	  frozen	  sections	  prepared	  to	  determine	  the	  
expression	  of	  markers	  of	  mature	  human	  smooth	  muscle.	  	  Figure	  5.6	  shows	  that	  after	  30d	  in	  
culture	  HCSMMs	  contain	  cells	  expressing	  the	  mature	  human	  smooth	  muscle	  marker	  SMA.	  








45	   1M/ml	   1	   Electively	  sacrificed	  at	  30d	  
46	   1M/ml	   1	   Electively	  sacrificed	  at	  60d	  
47	   1M/ml	   2	   Electively	  sacrificed	  at	  30d	  
48	   1M/ml	   2	   Electively	  sacrificed	  at	  60d	  
49	   2M/ml	   2	   Infected	  at	  28	  days	  
50	   1M/ml	   2	   Physiological	  testing	  at	  30d	  
51	   1M/ml	   2	   Physiological	  testing	  at	  30d	  
Table	  5.2.	  	  Highlighted	  cell	  indicates	  a	  construct	  lost	  prior	  to	  completion	  of	  the	  experiment	  due	  
to	   infection	   at	   28	   days.	   	   Rows	   detail	   the	   cell	   seeding	   density	   of	   human	   aganglionic	   colonic	  
smooth	  muscle	  cells	  used	  for	  each	  HCSMM	  formed.	  	  The	  number	  of	  seeding	  cycles,	  the	  length	  
of	  time	  in	  culture	  and	  outcome	  for	  each	  model	  is	  also	  given.	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Electrophysiological	   assessment	   of	   the	   same	   constructs	   was	   performed	   to	   determine	  
whether	   they	   had	   contractile	   properties	   consistent	   with	   colonic	   smooth	   muscle.	   	   Both	  
HCSMMs	  generated	  contractions	  with	   forces	  of	  up	   to	  150µN	   in	   response	   to	  both	  KCl	  and	  
carbachol	  (Figure	  5.7).	  	  Furthermore,	  the	  biphasic	  response	  seen	  following	  stimulation	  with	  
carbachol	  is	  similar	  that	  seen	  in	  other	  studies	  using	  colonic	  smooth	  muscle	  (McCarron,	  et	  al.	  
2002).	  
	   	  
Figure	   5.6.	   	   Aganglionic	   human	   colonic	   smooth	   muscle	   was	   seeded	   onto	   a	   decellularised	   mouse	   scaffold	   and	  
cultured	  for	  60d.	  	  The	  constructs	  were	  fixed	  with	  4%	  PFA	  and	  7µm	  frozen	  sections	  prepared	  for	  analysis.	  	  	  A:	  Cell	  
nuclei	   (stained	  with	  dapi	  –	  blue)	  can	  be	  seen	   lining	  the	  surface	  of	  the	  construct	  and	  are	  found	  to	  have	  migrated	  
several	  cells	  deep	   into	  the	  construct.	   	  B-­‐C:	   	  These	  cells	  were	  found	  to	  express	  typical	  markers	  of	  mature	  human	  
colonic	  smooth	  muscle:	  desmin	  (green)	  and	  smooth	  muscle	  actin	  (red).	  	  	  Scale	  bars	  =	  50µm.	  
A	   C	  B	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Figure	   5.7.	   Two	  30d	   old	  HCSMM	  were	  cut	   into	   1cm	  strips	   for	  electrophysiological	   analysis.	   	   Strips	  
were	  attached	  to	  a	  force	  transducer	  and	  buffered	  in	  physiological	  saline	  at	  37˚C	  before	  determining	  
their	  response	  to	  120mM	  KCl	  and	  120mM	  carbachol.	  	  Typical	  force/time	  traces	  are	  demonstrated	  in	  
A-­‐D.	   	   A-­‐B:	   	   Both	   constructs	   had	   a	   positive	   response	   to	   KCl	   infusion	   generating	   contractions	   with	  
forces	   of	   >100µN.	   	   	   C-­‐D:	   	   Similarly,	   infusion	   of	   carbachol	   resulted	   in	   a	   swift	   contraction	   and	   slow	  
relaxation	  phase.	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5.2.5.	   Cultured	  smooth	  muscle	  from	  aganglionic	  human	  bowel	  contains	  cells	  with	  
a	  neuronal	  phenotype	  
Human	  aganglionic	  smooth	  muscle	  was	  maintained	  in	  culture	  for	  periods	  of	  up	  to	  12	  weeks	  
prior	  to	  use	  in	  in	  the	  HCSMM.	  	  During	  routine	  passaging	  of	  these	  cell	  cultures	  it	  was	  noted	  
that	   they	   contained	   cells	   with	   a	   neuronal	   phenotype	   (figure	   5.8)	   and	  within	   one	   culture	  
flask	  appeared	   to	   form	  spheroid	  neurosphere-­‐like	  bodies.	   	   This	  unexpected	   finding	   led	   to	  
the	  further	  studies	  described	  in	  chapter	  6	  and	  meant	  that	  no	  further	  work	  was	  undertaken	  
on	  the	  HCSMM	  during	  my	  remaining	  time	  in	  the	  lab.	  
	  
Figure	   5.8.	   	   Cells	   with	   a	   neuronal	   phenotype	   can	   be	   identified	   in	   aganglionic	  








Figure	  5.8.	  14d	  old	  human	  aganglionic	  colonic	  smooth	  muscle	  cultures	  maintained	  under	  standard	  
conditions.	   	   A:	   Cells	   with	   a	   neuronal	   phenotype	   were	   identified	   within	   cultures	   derived	  
(highlighted	  in	  red).	  	  B:	  	  Higher	  power	  image	  of	  region	  of	  interest	  in	  A.	  	  White	  arrow	  demonstrates	  
the	  presence	  of	  a	  cell	  with	  a	  neuronal	  phenotype.	  	  Scale	  bars	  =	  50µm.	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5.3.	   Discussion	  
Previous	   work	   has	   highlighted	   the	   therapeutic	   potential	   of	   autologous	   ENSPC	  
transplantation	  for	  HSCR	  (Dong,	  et	  al	  2008,	  Lindley,	  et	  al	  2008,	  Hotta,	  et	  al	  2013).	  	  In	  order	  
to	  progress	  towards	  human	  clinical	  trials	  we	  need	  to	  be	  able	  to	  predict	  how	  these	  rapidly	  
proliferating	  cells	  will	  behave	  once	  transplanted	   into	  human	  colonic	  smooth	  muscle.	   	  This	  
chapter	   describes	   the	   development	   of	   a	   human	   colonic	   smooth	  muscle	  model	   (HCSMM)	  
that	   is	   derived	   from	   the	   aganglionic	   colon	   of	   patients	   with	   HSCR.	   	   It	   demonstrates	  
aganglionic	  human	  colonic	  smooth	  muscle	  can	  be	  maintained	   in	  culture	  on	  a	  scaffold	  and	  
more	   importantly	   that	   these	   cells	   retain	   both	   the	   typical	   expression	   profile	   and	  
electrophysiological	  responses	  of	  human	  colonic	  smooth	  muscle.	   	  Thereby	  suggesting	  that	  
models	   such	   as	   these	   have	   the	   potential	   advantage	   of	   allowing	   us	   to	   investigate	   the	  
behaviour	   of	   transplanted	   ENSPC	   in	   an	   environment	   that	   is	   closer	   to	   that	   of	   the	   human	  
colon.	  
	  
5.3.1	   Development	  of	  a	  fibrin	  based	  HCSMM	  
The	  original	  protocol,	  that	  the	  fibrin-­‐based	  HCSMM	  was	  based	  on,	  was	  developed	  with	  the	  
intention	  of	   developing	   an	   artificial	   internal	   sphincter	   (Hecker	   2005,	   Somara,	   et	   al	   2009).	  	  
This	  had	  the	  attraction	  of	  being	  a	  cheap	  and	  potentially	  simple	  scaffold	  on	  which	  to	  seed	  
aganglionic	   colonic	   smooth	   muscle	   that	   could	   be	   maintained	   in	   culture	   for	   a	   significant	  
length	  of	  time.	  	  The	  results	  within	  this	  chapter	  show	  that	  a	  fibrin-­‐based	  HCSMM	  can	  meet	  
two	  of	  the	  main	  aims	  of	  this	  chapter:	  	  Firstly,	  that	  the	  model	  could	  be	  maintained	  in	  culture	  
for	  at	  least	  2	  weeks	  (up	  to	  70	  days	  in	  some	  cases),	  and	  secondly	  that	  these	  cells	  organised	  
themselves	   into	   bands	   similar	   to	   and	   retaining	   the	   typical	   expression	   profiles	   of	   human	  
colonic	   smooth	   muscle.	   	   Furthermore,	   the	   important	   finding	   that	   human	   ENSPC	   can	   be	  
transplanted	   into	   the	   model	   and	   migrate	   within	   it	   forming	   ‘chains-­‐like’	   arrangements	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confirms,	   in	  principle	  the	  potential	  for	  a	  HCSMM	  to	  enable	  us	  to	  observe	  ENSPC	  and	  their	  
interactions	  with	  human	  colonic	  smooth	  muscle.	  
However,	  significant	  issues	  lie	  with	  the	  remaining	  two	  aims,	  which	  are	  both	  linked	  together:	  
the	   ability	   to	   allow	   physiological	   testing	   pre	   and	   post	   ENSPC	   transplantation	   and	   the	  
reproducibility	  (at	  best	  68%).	  	  The	  original	  reports	  of	  the	  forces	  generated	  by	  this	  model	  in	  
the	   literature	  are	  only	   in	  the	  range	  of	  10-­‐20µN	  (Somara,	  et	  al	  2009),	  which	  although	  they	  
confirm	   the	   presence	   of	   physiologically	   active	   smooth	   muscle	   within	   these	   models	   the	  
forces	  are	  of	  such	  low	  levels	  that	  it	  would	  be	  difficult	  if	  not	  impossible	  to	  reliably	  determine	  
the	  effect	  of	  ENSPC	  transplantation.	  	  Attempts	  were	  made	  to	  increase	  the	  seeding	  density	  
of	   smooth	  muscle	   cells	   with	   the	   aim	   of	   increasing	   the	   forces	   generated,	   however	   under	  
these	   conditions	   the	   failure	   rate	   rose	   to	   66%	  with	   the	   rings	   typically	   breaking	  within	   the	  
first	  week	  of	  seeding.	  
Because	  the	  majority	  of	  failures	  of	  the	  fibrin-­‐based	  HCSMM	  were	  due	  to	  problems	  with	  the	  
fibrin	  scaffold	  failing	  to	  form	  or	  ‘snapping’	  there	  was	  a	  need	  to	  look	  for	  alternative	  scaffolds.	  	  
For	   its	  originally	   intended	  purpose	  using	  a	  fibrin-­‐based	  scaffold	  had	  the	  major	  advantages	  
that	   it	   would	   not	   stimulate	   an	   immune	   response	   when	   transplanted,	   it	   would	   be	  
biodegradable	   and	   that	   it	   is	   a	   simple	   and	   cheap	   solution.	   	   However,	   these	  were	   not	   key	  
factors	  in	  the	  development	  of	  a	  HCSMM	  as	  there	  was	  no	  intention	  to	  transplant	  the	  model	  
into	  an	  in-­‐vivo	  environment.	  	  Therefore,	  alternative	  scaffolds	  were	  sought	  that	  might	  meet	  
all	  of	  the	  required	  aims.	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5.3.2.	   Development	  of	  a	  decellularised	  mouse	  colon	  based	  HCSMM	  
As	  previously	  stated	  the	  difficulty	  with	  observing	  the	  behaviour	  of	  ENSPC	  transplanted	  into	  
colonic	  explants	  is	  maintaining	  the	  explant	  in	  culture	  long	  enough	  to	  observe	  the	  effects	  of	  
the	   ENSPC	   on	   the	   host	   environment.	   	   As	   this	   is	   predominantly	   an	   issue	   of	   diffusion	   of	  
oxygen	  and	  nutrients	  (Griffith,	  et	  al	  2005),	  which	  in	  itself	   is	  related	  to	  the	  thickness	  of	  the	  
explant,	   initial	   attempts	  were	  made	   to	   simply	   shave	   a	   thin	   layer	   of	   smooth	  muscle	   from	  
colonic	  biopsies	  and	  maintain	  this	   in	  culture.	   	  However,	   it	  was	  not	  was	  not	  possible	  to	  do	  
this.	  	  There	  was	  inconsistency	  in	  the	  thickness	  of	  samples,	  leading	  to	  some	  dying	  within	  24h	  
in	  cultures	  while	  the	  thinner	  sections	  would	  fail	  to	  maintain	  their	  structure.	  	  This	  prompted	  
the	  search	  for	  a	  more	  robust	  scaffold	  on	  which	  smooth	  muscle	  cells	  could	  be	  seeded	  upon.	  	  	  
The	   majority	   of	   current	   work	   on	   in-­‐vitro	   smooth	   muscle	   engineering	   has	   the	   aim	   of	  
developing	   a	   graft	   or	   vessel	   replacement	   for	   vascular	   surgery,	   although	   there	   are	   groups	  
looking	  to	  develop	  a	  tissue	  engineered	  colon	  replacement	  (Denost,	  et	  al.	  2013,	  Y.	  Tan,	  et	  al.	  
2014,	   Walthers,	   et	   al.	   2014).	   	   However,	   the	   majority	   of	   these	   methods	   are	   based	   on	  
implanting	   a	   scaffold	   into	   the	   colon	   and	   allowing	   cells	   to	  migrate	   onto	   and	   colonise	   the	  
graft	  using	  both	  artificial	  and	  biological	  scaffolds	  (Henne-­‐Bruns,	  et	  al.	  1990,	  Oh,	  et	  al.	  2002,	  
Hoeppner,	  et	  al.	  2009,	  Nocca,	  et	  al.	  2009).	   	  Because	  aim	  of	  this	  chapter	  was	  to	  develop	  a	  
model	   that	   could	   be	   maintained	   in-­‐vitro	   these	   methods	   were	   not	   applicable,	   instead	   a	  
technique	  used	  to	  transplant	  a	  cadaveric	  trachea	  implanted	  with	  autologous	  stem	  cells	  was	  
taken	   as	   starting	   point	   (Macchiarini,	   et	   al.	   2008,	   Baiguera,	   et	   al	   2010).	   	   The	   decision	   to	  
utilise	   mouse	   colon	   rather	   than	   tracheal	   cartilage	   as	   a	   scaffold	   was	   taken	   to	   allow	   the	  
model	  to	  contract	  and	  also	  to	  reduce	  the	  size	  of	  the	  construct	  making	  it	  easier	  to	  maintain	  
in	  culture.	  
Because	   there	   was	   no	   intention	   to	   transplant	   the	   resulting	   HCSMM,	   there	   was	   no	  
requirement	  for	  the	  scaffold	  to	  lack	  any	  immunogenicity.	  	  Therefore,	  after	  optimisation	  the	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decellularisation	  process	  was	   found	   to	  be	  much	  shorter	   than	   that	   required	   for	   trachea	  as	  
the	  aim	  was	  limited	  to	  produce	  a	  microscopically	  decellularised	  scaffold	  for	  ex-­‐vivo	  analysis.	  
The	  	  decellularised	  mouse	  scaffold	  we	  developed	  maintained	  cells	  expressing	  typical	  colonic	  
smooth	  muscle	  markers	   in	   long-­‐term	   culture,	   was	   reproducible	   and	   importantly	   had	   the	  
characteristic	   electrophysiological	   response	   of	   colonic	   smooth	   muscle	   (McCarron,	   et	   al	  
2002).	   	   Furthermore,	   the	   forces	  generated	  by	   the	  decellularised	   colon-­‐based	  HCSMM	  are	  
up	  to	  15x	  greater	  than	  those	  published	  using	  the	  fibrin	  based	  model	  (Somara,	  et	  al	  2009).	  	  
This	   would	   potentially	   make	   it	   easier	   to	   identify	   changes	   in	   contractility	   following	  
transplantation	   of	   ENSPC.	   	   Taken	   together,	   these	   results	   suggest	   that	   the	   decellularised	  
HCSMM	   has	   the	   potential	   to	   be	   a	   useful	   tool	   with	   which	   to	   observe	   the	   behaviour	   of	  
transplanted	   ENSPC	   in	   the	   microenvironment	   of	   mature	   human	   colonic	   smooth	   muscle.	  	  
This	   may	   enable	   us	   to	   more	   accurately	   predict	   how	   these	   cells	   might	   behave	   post	  
transplantation,	   and	   in	   particular	   demonstrate	   if	   they	   continue	   to	   proliferate	   or	  
alternatively	   return	   to	  an	  essentially	  quiescent	   state	  as	   they	  were	  prior	   to	   isolation.	   	   The	  
model	  does	  not	  provide	  a	  perfect	  replica	  of	  the	  colonic	  microenvironment,	  but	  at	  present	  it	  
is	  not	  possible	  to	  replicate	  this	  within	  the	  lab,	  however	  it	  does	  help	  provide	  an	  environment	  
that	  can	  act	  as	  a	  stepping-­‐stone	  between	  animal	  studies	  and	  human	  clinical	  trials.	  
The	  major	  practical	  limitation	  of	  this	  model	  is	  the	  requirement	  for	  the	  bioreactor,	  meaning	  
that	  with	  only	   one	   available	   in	   the	   lab	  new	   constructs	   can	  only	   be	  made	   in	   series	   rather	  
than	  parallel.	   	  The	  implication	  of	  this	   is	  that	  it	   limits	  the	  speed	  at	  which	  the	  production	  of	  
the	  HCSMM	  can	  be	  optimised.	  	  The	  results	  in	  the	  chapter,	  although	  encouraging	  still	  leave	  a	  
number	  of	  steps	  that	  need	  to	  be	  completed	  before	  the	  model	  could	  be	  used	  reliably.	  	  Cell	  
seeding	   density	   and	   time	   in	   culture	   need	   to	   be	   optimised	   according	   to	   the	  
electrophysiological	   response	   that	   they	   generate.	   	   The	   inter-­‐construct	   reliability	   needs	   to	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be	   determined,	   for	   example,	   does	   the	   electrophysiological	   response	   between	   smooth	  
muscle	  cells	  derived	  from	  different	  patients?	  
Although	   much	   work	   still	   remains	   to	   be	   done,	   these	   preliminary	   results	   suggest	   that	   a	  
HCSMM,	   based	   on	   a	   decellularised	   mouse	   colonic	   scaffold	   has	   the	   potential	   to	   provide	  
valuable	  information	  on	  ENSPC	  behaviour	  prior	  to	  progressing	  towards	  human	  clinical	  trials.	  	  
	  
	  
5.3.3.	   Cultured	  smooth	  muscle	  contains	  cells	  with	  a	  neuronal	  phenotype	  
The	   observation	   that	   cells	   with	   a	   neuronal	   phenotype	   are	   present	   within	   aganglionic	  
smooth	  muscle	   cultures	  was	   surprising.	   	   Initially	   it	  was	   thought	   that	   the	   colonic	   biopsies	  
must	   have	   been	   taken	   in	   the	   transitional	   zone	   of	   the	   colon	   and	   the	   cells	   seen	   were	   a	  
contaminant	  from	  the	  more	  proximal	  ganglionic	  bowel.	  	  However,	  this	  is	  improbable	  as	  the	  
neuron-­‐like	  cells	  were	   found	   in	  cultures	  derived	   from	  nine	  patients	  all	  of	  which	  had	  been	  
determined	   by	   paediatric	   histopathologists	   	   to	   be	   well	   below	   the	   transitional	   zones.	   	   By	  
definition	   the	   aganglionic	   bowel	   should	   not	   contain	   neuronal	   cells,	   because	   although	  
abnormally	   thickened	   extrinsic	   nerve	   fibres	   are	   found	   in	   the	   aganglionic	   colon	   their	   cell	  
bodies	  are	  found	  in	  the	  pelvic	  ganglia	  (Tam,	  et	  al.	  1990).	  
This	   finding	   raises	   a	   number	   of	   questions,	   such	   as:	  Where	   are	   these	   cells	   coming	   from?	  
What	   are	   they?	   Are	   they	   functional	   and	   do	   they	   have	   any	   therapeutic	   potential	   for	   the	  
treatment	  of	  HSCR?	  	  These	  questions	  formed	  the	  basis	  of	  the	  work	  described	  in	  chapter	  6.	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5.4.	   Conclusions	  
The	   results	   in	   this	   chapter	   have	   shown	   that	   it	   is	   possible	   to	   culture	   aganglionic	   human	  
colonic	   smooth	  muscle	   on	   biological	   scaffolds.	   	   Furthermore,	   the	   resulting	   HCSMMs	   can	  
reliably	   be	  maintained	   in	   culture	   for	  more	   than	   2	   weeks,	   and	   can	   undergo	   physiological	  
testing,	  enabling	  a	  comparison	  to	  be	  made	  both	  pre	  and	  post	  transplantation	  with	  human	  
ENSPC.	   	   This	   would	   allow	   further	   study	   of	   ENSPC	   behaviour,	   helping	   develop	   our	  
understanding	  of	  their	  control	  mechanisms	  and	  helping	  us	  to	  more	  accurately	  predict	  how	  
they	  might	  behave	  once	  transplanted	  into	  the	  human	  colon.	  
However,	   perhaps	   of	   greater	   significance	   is	   the	   incidental	   observation	   that	   cells	   with	   a	  
neuronal	  phenotype	  are	  present	  within	  human	  aganglionic	   smooth	  muscle	   cultures.	   	   This	  
raises	   several	   important	  questions	   such	  as:	  as	   to	  are	   these	  cells	   indeed	  neuronal,	  what	   is	  
their	  origin,	  are	   they	   functional	  and	  do	   they	  have	   the	  potential	   to	  be	  used	  as	  part	  of	  any	  
future	  therapy.	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Chapter	   6:	   Neurospheres	   from	   Aganglionic	  
Hirschsprung	  Bowel	  
	  
6.1.	   Introduction	  
6.1.1.	   Background	  
The	  presence	  of	   ENSPC	  within	  normal	   ganglionic	  bowel	   is	  widely	   reported	   (Almond,	   et	   al	  
2007,	   Lindley,	   et	   al	   2008,	   Metzger,	   et	   al	   2009),	   but	   despite	   on-­‐going	   study	   into	   their	  
therapeutic	   potential	   for	   conditions	   such	   as	   HSCR	   the	   location	   of	   these	   progenitor	   cells	  
within	   the	   ganglionic	   bowel	   has	   yet	   to	   be	   determined.	   	   Recent	   studies	   have	   sought	   to	  
identify	   the	   source	   of	   neural	   progenitors	   within	   the	   bowel	   have	   suggested	   a	   glial	   origin,	  
supported	   by	   the	   expression	   of	   glial	   markers	   (GFAP,	   Sox10,	   S100)	   and	   lineage	   tracing	  
studies	  (Joseph,	  et	  al	  2011,	  Laranjeira,	  et	  al	  2011).	  	  However,	  the	  lack	  of	  a	  definitive	  marker	  
for	  ENS	  neural	  progenitors	  has	  hampered	  the	  study	  of	  their	  location	  and	  behaviour	  in-­‐vivo.	  	  
There	  has	  been	  a	  presumption	  that	  these	  progenitors	  arise	  from	  cells	  populating	  the	  bowel	  
during	  the	  initial	  craniocaudal	  migration	  of	  enteric	  NCCs	  during	  development,	  with	  studies	  
suggesting	  that	  they	  are	  located	  in	  the	  region	  of	  the	  myenteric	  plexus	  within	  enteric	  ganglia	  
(Kruger,	  et	  al	  2002),	  thereby	  explaining	  their	  absence	  from	  distal	  aganglionic	  bowel	  seen	  in	  
HSCR.	  
	  
The	  incidental	  observation	  that	  cells	  with	  a	  neuronal	  phenotype	  are	  present	  within	  in-­‐vitro	  
cultures	  of	   human	  aganglionic	   smooth	  muscle	   (see	   chapter	   5)	   raises	   significant	  questions	  
regarding	  these	  existing	  presumptions.	  	  There	  has	  been	  limited	  study	  into	  the	  properties	  of	  
aganglionic	   bowel,	   and	   what	   work	   has	   been	   carried	   out	   has	   been	   largely	   limited	   to	  
descriptive	   studies.	   	   It	   is	  well	   documented	   that	   the	   aganglionic	   regions	  of	   colon	   found	   in	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HSCR	   do	   not	   contain	   components	   of	   the	   intrinsic	   nervous	   supply	   to	   the	   bowel	   but	   do	  
contain	   abnormally	   thickened	   nerve	   trunks	   traversing	   through	   them	   in	   a	   largely	  
disorganised	  arrangement	   (Baumgarten,	  et	  al.	  1973,	  Tam,	  et	  al	  1990).	   	  No	  previous	  study	  
has	  looked	  for	  the	  presence	  of	  ENSPC	  within	  the	  aganglionic	  bowel.	  
	  
6.1.2.	   Aims	  
The	   identification	   of	   cells	   with	   a	   neuronal	   phenotype	   present	   within	   aganglionic	   smooth	  
muscle	   cultures	   raises	   significant	   questions	   regarding	   our	   current	   understanding	   of	   the	  
source	   of	   neural	   progenitors	   within	   the	   bowel.	   	   Therefore,	   the	   aim	   of	   the	   work	   in	   this	  
chapter	  was	   to:	   	   Firstly,	   determine	  whether	   these	   cells	   previously	   identified	  were	   indeed	  
neural	   progenitors;	   Secondly,	   to	   make	   a	   comparison	   between	   progenitors	   derived	   from	  
both	  the	  normal	  ganglionic	  and	  the	  aganglionic	  bowel	  from	  patients	  with	  HSCR;	  and	  finally	  
to	  make	   an	   assessment	   of	   the	   functional	   potential	   of	   these	   cells,	   i.e.	   did	   they	   have	   any	  
therapeutic	  potential	  for	  the	  treatment	  of	  HSCR?	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6.2.	   Results	  
6.2.1.	   Cells	   from	  human	  aganglionic	  colonic	  biopsies	  have	  the	  potential	   to	   form	  
neurospheres	  in-­‐vitro.	  	  
The	   presence	   or	   absence	   of	   enteric	   ganglia	   was	   confirmed	   both	   as	   part	   of	   the	   routine	  
histopathological	   diagnosis	   by	   clinical	   pathologists	   and	   within	   the	   lab	   (Figure	   6.1).	  	  
Thickened	  extrinsic	  nerve	  fibres	  were	  also	  identified	  in	  both	  the	  submucosal	  and	  myenteric	  
plexi	  of	  aganglionic	  biopsies.	  	  Of	  note,	  a	  striking	  difference	  in	  the	  localisation	  of	  expression	  
for	   the	  neural	   crest	  marker	   P75	  between	  human	  aganglionic	   and	   ganglionic	   biopsies	  was	  
seen	   in	   the	   submucosal	   plexus.	   	   Consistent	  with	   previous	   observations	   (Kobayashi,	   et	   al.	  
1994),	  nerve	  fibres	  within	  aganglionic	  colon	  were	  found	  to	  express	  P75	  throughout	  with	  a	  
predominantly	   peripheral	   pattern	   of	   localisation	   around	   the	   epineurium.	   	   However,	   the	  
weaker	  staining	  seen	  within	  the	  endoneurium	  is	  similar	   in	  both	  ganglionic	  and	  aganglionic	  
fibres,	  consistent	  with	  the	  expected	  distribution	  of	  Schwann	  cells	  	  (Figure	  6.1	  E-­‐H).	  
To	   assess	   the	   potential	   of	   cells	   derived	   from	   human	   aganglionic	   biopsies	   to	   develop	   a	  
neuronal	   phenotype,	   primary	   aganglionic	   smooth	   muscle	   cells	   were	   cultured	   in	   media	  
supplemented	  with	  horse	  serum	  in	  order	  to	  promote	  differentiation	  (Figure	  6.1	  G-­‐I).	  	  After	  
48	  hours,	  cell	  bodies	  became	  compact	  rather	  than	  spread	  on	  the	  substrate,	  cells	  started	  to	  
develop	   multiple	   projections	   before	   beginning	   to	   form	   aggregates.	   	   After	   seven	   days	   in	  
culture	  these	  aggregates	  had	  formed	  neurosphere-­‐like	  bodies,	  which	  were	  identical	  to	  the	  
macroscopic	  appearance	  of	  neurospheres	  derived	  from	  human	  ganglionic	  colonic	  biopsies	  
and	  grown	  under	  standard	  conditions.	  
Human	  aganglionic	  cultures	  maintained	  under	  conditions	  to	  promote	  growth	  (see	  2.3.2.2)	  
were	  found	  to	  contain	  a	  high	  proportion	  of	  cells	  expressing	  the	  smooth	  muscle	  marker	  SMA	  
(Figure	  6.2B),	  with	  fewer	  cells	  expressing	  the	  neural	  crest	  marker	  P75	  (Figure	  6.2A).	  	  	  There	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was	  no	  apparent	  expression	  of	  either	  the	  glial	  marker	  GFAP	  or	  the	  mature	  neuronal	  marker	  
PGP9.5	   (Figure	  6.2C-­‐D).	   	   In	   contrast,	  analysis	  of	  neurosphere-­‐like	  bodies	   formed	   from	  the	  
same	  patient	  under	  conditions	  promoting	  differentiation	  identified	  an	  increased	  number	  of	  
cells	  expressing	  P75	  (Figure	  6.2E).	  	  Alongside	  this	  there	  was	  a	  reduction	  in	  the	  proportion	  of	  
cells	   expressing	   smooth	   muscle	   markers	   (Figure	   6.2F)	   and	   the	   appearance	   of	   cells	  
expressing	  both	  glial	  and	  neuronal	  markers	  (Figure	  6.2	  G-­‐H).	  
The	  next	  step	  was	  to	  determine	  whether	  these	  aganglionic-­‐derived	  neurosphere-­‐like	  bodies	  
are	   inherently	   different	   to	   those	   derived	   using	   established	   techniques	   from	   ganglionic	  
human	   colon	   (Almond,	   et	   al	   2007,	   Lindley,	   et	   al	   2008).	   	   Therefore,	   neurospheres	   were	  
generated	   from	   the	   ganglionic	   colon	   from	   the	   same	   patient	   and	   comparison	   of	   the	  
expression	  of	  typical	  neural	  crest,	  glial	  and	  neuronal	  markers	  was	  made.	  	  Importantly,	  there	  
was	  no	  apparent	  difference	  in	  either	  the	  pattern	  of	  expression	  or	  cell	  phenotype	  between	  
cells	  derived	  from	  the	  aganglionic-­‐	  or	  ganglionic-­‐derived	  neurospheres	  (Figure	  6.2	  I-­‐L).	  	  This	  
prompted	   a	  more	   detailed	   analysis	   of	   the	   development	   of	   the	   expression	   of	   typical	   ENS	  
markers.	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Figure	  6.1.	  	  Aganglionic	  HSCR	  colon	  contains	  cells	  that	  can	  form	  neurosphere-­‐like	  
bodies	   	   Figure	   6.1.	   	   A-­‐D:	   4µm	   paraffin	  sections	   taken	   from	   ganglionic	  
and	   aganglionic	   colonic	   biopsies	  
taken	   from	  the	  same	  patient.	  A-­‐
B:	  The	  absence	  of	  enteric	  ganglia	  
(black	   arrow)	  was	   confirmed	   on	  
H&E	   analysis.	   	   C-­‐D:	   Calretinin	  
expression	   (brown)	   is	   seen	   in	  
ganglionic	   sections	   but	   not	  
aganglionic.	   	   E-­‐F:	   7µm	   frozen	  
sections	  confirm	  the	  presence	  of	  
calretinin	   expression	   (red)	   in	  
ganglionic	   sections	   (E)	   and	  
absence	   in	   aganglionic	   sections	  
(F).	   	   G-­‐H:	   Labelling	   with	   the	  
neural	   crest	  marker	   P75	   (green)	  
revealed	   a	  marked	   difference	   in	  
the	   localisation	   of	   P75	  
aganglionic	   sections	   (G-­‐H),	   with	  
prominent	   expression	   of	   P75	   in	  
the	   perineurium	   of	   extrinsic	  
nerve	   fibres	   (H).	   	   Nuclei	   are	  
counterstained	  with	  dapi	  (blue).	  
I-­‐K:	   Phase	   contrast	   microscopy	  
of	   aganglionic	   smooth	   muscle	  
cultures.	   	   I:	   Smooth	   muscle	  
cultured	   under	   standard	  
conditions.	  	  J:	  48h	  after	  addition	  
of	   HS	   media	   to	   promote	  
differentiation	   cells	   aggregate	  
together,	  demonstrating	  a	  more	  
elongated,	   neuronal	   phenotype	  
with	   multiple	   projections.	   	   Cells	  
continued	   to	   aggregate	   over	  
time	   and	   by	   7days	   (K)	  
neurosphere-­‐like	   bodies	   were	  
seen.	   	   	   Scale	   bars	   =100µm	  A-­‐H,	  
and	  50µm	  I-­‐K.	  
24h	   48h	   7d	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6.2.2.	   HSCR	  aganglionic-­‐derived	  neurospheres	  possess	   increasing	  proportions	  of	  
cells	  expressing	  neural	  crest	  markers	  
Unsurprisingly,	  when	  isolated	  from	  fresh	  human	  colonic	  tissues	  the	  majority	  of	  cells	  in	  the	  
initial	  isolate	  expressed	  the	  smooth	  muscle	  marker	  smooth	  muscle	  actin	  (SMA,	  Figure	  6.3).	  	  
After	  10	  days	  in	  culture	  the	  proportion	  of	  cells	  expressing	  SMA	  dropped	  significantly	  in	  the	  
first	  generation	  of	  neurospheres	  formed,	  and	  remained	  low	  over	  subsequent	  generations.	  	  
No	  significant	  difference	  was	  seen	  between	  neurospheres	  derived	  from	  human	  aganglionic	  
or	   ganglionic	   colonic	   biopsies.	   	   In	   contrast	   the	   proportion	   of	   cells	   expressing	   the	   neural	  
crest	  marker	  P75	  was	  low	  in	  both	  the	  initial	  human	  aganglionic	  and	  ganglionic	  cell	  isolates	  
but	   rose	   quickly	   with	   approximately	   one	   third	   of	   cells	   expressing	   P75	   in	   first	   generation	  
neurospheres	   (Figure	   6.3).	   	   Over	   the	   following	   20	   days	   this	   trend	   continued	   with	   the	  
majority	  of	  cells	  derived	  from	  tertiary	  neurospheres	  expressing	  the	  neural	  crest	  marker	  at	  
30	  days.	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Figure	  6.2.	   	  HSCR	  aganglionic-­‐derived	  neurospheres	  contain	  cells	  similar	  to	  those	  
derived	  from	  ganglionic	  colon	  
	   	  
Figure	   6.2.	   	   Both	   primary	   cultures	   of	   human	   aganglionic	   smooth	  muscle	   (A-­‐D)	   and	   14d	   old	  
neurospheres	   (E-­‐L)	   were	   dissociated	   and	   seeded	   onto	   fibronectin	   coated	   chamber	   slides	  
before	  fixing	  and	  labelling	  at	  24h.	  	  All	  samples	  were	  taken	  from	  the	  same	  patient.	  	  Cells	  were	  
stained	  for	  expression	  of	  the	  neural	  crest	  marker	  P75	  (red),	  smooth	  muscle	  actin	  (SMA,	  green),	  
the	  glial	  marker	  GFAP	  (red)	  and	  the	  mature	  pan-­‐neuronal	  marker	  PGP9.5	  (green).	  	  Dapi	  (blue)	  
was	  used	  to	  counterstain	  cell	  nuclei.	   	  A-­‐D:	  The	  majority	  of	  cells	  from	  smooth	  muscle	  cultures	  
typically	  express	  SMA	  (B),	  a	  smaller	  number	  of	  cells	  express	  P75	  (A)	  and	  there	  is	  no	  significant	  
expression	   of	   glial	   and	   neuronal	   markers	   (C-­‐D).	   	   In	   contrast,	   cells	   from	   human	   aganglionic-­‐
derived	   neurospheres	   (E-­‐H)	   and	   ganglionic-­‐derived	   neurospheres	   (I-­‐L)	   are	   shown	   to	   express	  
both	   glial	   and	   neuronal	   markers	   (G-­‐H,	   K,L).	   	   Furthermore,	   an	   increased	   proportion	   of	   cells	  
were	  	  found	  to	  express	  P75	  alongside	  a	  corresponding	  fall	  in	  the	  number	  of	  SMA	  positive	  cells	  
(E-­‐F,	  I-­‐J).	  Scale	  bars	  =	  50µm.	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Figure	   6.3.	   Expression	   of	   smooth	  muscle	   and	   neural	   crest	  markers	   over	   time	   in	  
human	  HSCR	  aganglionic-­‐	  and	  ganglionic-­‐derived	  neurospheres	   	  
Figure	  6.3.	  	  Expression	  of	  the	  smooth	  muscle	  marker	  smooth	  muscle	  actin(red)	  and	  neural	  crest	  marker	  
P75	  (green)	   in	  cells	  derived	  from	  both	  ganglionic	  and	  aganglionic	  human	  colon	  over	  time.	   	  Dapi	   (blue)	  
was	  used	  to	  counterstain	  cell	  nuclei.	  	  Cells	  were	  analysed	  at	  isolation	  and	  follow	  routine	  passaging	  at	  10d	  
intervals.	  The	  proportion	  of	  cells	  expressing	  smooth	  muscle	  markers	  (A)	  drops	  significantly	  after	  isolation	  
(0d)	   and	   remains	   low	   in	   subsequent	   neurosphere	   generations.	   	   Expression	   of	   P75	   (A)	   is	   low	   in	   initial	  
isolates	  (0d)	  but	  increases	  over	  time	  until	  the	  majority	  of	  cells	  are	  P75	  positive	  at	  30	  days.	  	  No	  significant	  
differences	  were	   identified	  between	  cells	  derived	  from	  ganglionic	  and	  aganglionic	  sources	  (A-­‐E).	   	  Scale	  
bars	  =	  50µm,	  Error	  bars	  represent	  standard	  error	  of	  the	  mean	  (SEM)	  from	  5	  experiments.	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6.2.3.	   HSCR	  aganglionic-­‐derived	  neurospheres	  possess	   increasing	  proportions	  of	  
the	  immature	  glial	  marker	  GFAP	  over	  time.	  
As	  seen	  with	  the	  neuronal	  markers,	  the	  proportion	  of	  cells	  expressing	  of	  the	  immature	  glial	  
marker	  glial	  fibrillary	  acidic	  protein	  (GFAP)	  increased	  significantly	  during	  the	  maturation	  of	  
neurospheres	  with	  nearly	  50%	  of	  cells	  expressing	  GFAP	  in	  tertiary	  neurospheres	  at	  30	  days	  
(Figure	   6.4)	   .	   However,	   this	  was	   not	   seen	   in	   the	  mature	   glial/Schwann	   cell	  marker	   S100;	  
expression	  of	  S100	  in	  the	  initial	  single	  cell	  isolates	  was	  more	  than	  ten	  times	  higher	  than	  that	  
seen	  for	  the	  immature	  marker	  GFAP.	  	  The	  proportion	  of	  cells	  expressing	  S100	  increased	  in	  
1st	  generation	  neurospheres	  and	  subsequently	  gradually	  decreased,	  however	   this	  was	  not	  
statistically	  significant.	  	  No	  significant	  difference	  was	  identified	  between	  human	  aganglionic	  
and	  ganglionic	  derived	  cells.	  
	  
6.2.4.	   HSCR	  aganglionic-­‐derived	  neurospheres	  possess	   increasing	  proportions	  of	  
cells	  expressing	  neuronal	  markers	  over	  time	  
At	  the	  start	  of	  culture,	  expression	  of	  the	  pan-­‐neuronal	  marker	  PGP9.5	  was	  limited	  to	  a	  small	  
minority	   of	   cells	   (Figure	   6.5).	   	   This	   proportion	   increased	   significantly	  with	   time	   in	   culture	  
with	  more	  than	  40%	  of	  cells	  expressing	  the	  neuronal	  marker	  in	  mature	  (30	  day	  old)	  tertiary	  
neurospheres.	   	   Dual	   labelling	  with	   the	   ENS	   specific	  marker	   calretinin	  was	   absent	   in	   cells	  
isolated	   from	   aganglionic	   colon,	   but	   importantly	   after	   10	   days	   in	   culture	   approximately	  
10	  %	  of	  cells	  were	  identified	  as	  calretinin	  positive	  in	  both	  aganglionic	  and	  ganglionic	  derived	  
neurospheres.	   	  The	  proportion	  of	  positive	  cells	  continued	  to	  increase	  with	  time	  in	  culture,	  
however	   this	   increase	   was	   significantly	   smaller	   in	   the	   aganglionic-­‐derived	   neurospheres.	  	  
18%	  cells	  in	  tertiary	  aganglionic-­‐derived	  neurospheres	  expressed	  calretinin	  vs.	  30%	  of	  cells	  
in	  tertiary	  ganglionic-­‐derived	  neurospheres	  at	  day	  30.	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Figure	  6.4.	  	  Expression	  of	  glial	  markers	  over	  time	  in	  human	  HSCR	  aganglionic-­‐	  and	  
ganglionic-­‐derived	  neurospheres	   	  
Figure	   6.4.	   	   Expression	   of	   the	   GFAP	   (green)	   and	   S100	   (red)	   glial	   markers	   in	   cells	   derived	   from	   both	  
ganglionic	   and	   aganglionic	   human	   colon	   over	   time.	   	   Dapi	   (blue)	  was	   used	   to	   counterstain	   cell	   nuclei.	  	  
Cells	  were	  analysed	  at	  isolation	  and	  follow	  routine	  passaging	  at	  10d	  intervals.	  	  In	  the	  initial	  isolate	  there	  
are	  minimal	   cells	   expressing	  GFAP,	   however	   this	  proportion	   increases	   steadily	   over	   time	   (A).	   	   S100	   is	  
expressed	   in	   freshly	   isolated	   cells,	   however	   after	   an	   initial	   rise	   it	   gradually	   falls	   over	   time	   (A).	   	   No	  
significant	   differences	   (P>0.05)	  were	   identified	   between	   cells	   derived	   from	   ganglionic	   and	   aganglionic	  
sources	   (A-­‐E).	   	   Scale	   bars	   =	   50µm,	   Error	   bars	   represent	   standard	   error	   of	   the	   mean	   (SEM)	   from	   5	  
experiments.	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Figure	  6.5.	  	  Expression	  of	  neuronal	  markers	  over	  time	  in	  human	  HSCR	  aganglionic-­‐	  
and	  ganglionic-­‐derived	  neurospheres	   	  
Figure	   6.5.	   	   Expression	   of	   the	   pan-­‐neuronal	   marker	   PGP9.5	   (green)	   and	   the	   ENS	   specific	   marker	  
calretinin	  (red)	   in	   cells	  derived	  from	  both	  ganglionic	  and	  aganglionic	  human	  colon	  over	  time.	   	  Dapi	  
(blue)	   was	   used	   to	   counterstain	   cell	   nuclei.	   	   Cells	   were	   analysed	   at	   isolation	   and	   follow	   routine	  
passaging	   at	   10d	   intervals	   Expression	   of	   the	   pan-­‐neuronal	   marker	   PGP9.5	   increases	   steadily	   over	  
time	  with	  no	   significant	  difference	   seen	  between	  ganglionic	  and	  aganglionic	   samples	   (A,	  D,	   E).	  No	  
expression	  of	  calretinin	  was	  detected	   in	  initial	  aganglionic	   isolates,	  by	  10d	  cells	  expressing	  this	  ENS	  
specific	  marker	  can	  be	  identified	  and	  by	  30d	  more	  than	  10%	  of	  cells	  in	  mature	  (3º)	  neurospheres	  are	  
positive	  (A,	  B,C).	   	  However,	  the	  proportion	  of	  calretinin+	  cells	  remains	  significantly	  lower	  (P<0.001)	  
than	  that	  seen	  in	  human	  ganglionic	  derived	  neurospheres.	  	  Scale	  bars	  =	  50µm,	  Error	  bars	  represent	  
standard	  error	  of	  the	  mean	  (SEM)	  from	  5	  experiments.	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6.2.5.	   HSCR	   aganglionic-­‐derived	   neurospheres	   contain	   cells	   capable	   of	  
differentiating	  into	  mature	  neuronal	  phenotypes	  
To	  determine	  whether	  human	  aganglionic-­‐derived	  neurospheres	  contain	  cells	  with	  the	  potential	   to	  
differentiate	   into	   mature	   neuronal	   phenotypes	   typically	   seen	   within	   the	   ENS	   neurospheres	   were	  
plated	   out	   on	   poly-­‐D-­‐lysine/laminin	   coated	   dishes.	   	   At	   day	   7	   cells	   with	   a	   distinct	   neuronal	  
morphology	  were	  seen	  that	  expressed	  the	  mature	  neuronal	  markers	  nNOS	  and	  VIP.	  	  In	  addition	  cells	  
were	  also	  identified	  expressing	  both	  the	  immature	  neuronal	  marker	  Tuj	  and	  calretinin,	  which	  is	  only	  
found	  within	  ENS	  neurons	  and	  not	  those	  of	  an	  extrinsic	  origin.	  
Figure	   6.6.	   	   Aganglionic-­‐derived	   neurospheres	   can	   differentiate	   into	   cells	  
expressing	  mature	  neuronal	  phenotypes	  
	   	  
Figure	   6.6.	   Neurons	   migrating	   away	   from	   human	   aganglionic-­‐derived	   neurospheres	   express	  
increasingly	  mature	  neuronal	  markers	  over	   time.	   	   (A)	  Cells	  migrating	  away	  from	  mature,	   tertiary	  
human	   aganglionic	   derived	   neurospheres	   are	   labelled	   for	   the	   immature	   neuronal	   marker	   Tuj	  
(green,	   β-­‐tubulin	   III).	   By	   day	   7	   cells	   continued	   to	   express	   Tuj	   but	   cells	   were	   also	   identified	  
expressing	  the	  mature	  ENS	  neuronal	  markers	   vasoactive	   intestinal	  peptide	   (VIP,	  B)	  and	  neuronal	  
nitric	   oxide	   synthase	   (nNOS,	   B).	   	   Dual	   labelling	   of	   cells	   with	   Tuj	   and	   the	   ENS	   specific	   marker	  
calretinin	  (red)	  was	  also	  noted	  (D).	  	  Scale	  bars	  =	  50µm.	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6.2.6.	   Cell	  proliferation	  does	  not	  differ	  between	  HSCR	  aganglionic-­‐	  or	  ganglionic-­‐
derived	  neurospheres	  
Having	  identified	  similarities	  in	  the	  expression	  profile	  of	  neurospheres	  derived	  from	  control	  
patients	   and	   from	   ganglionic	   and	   aganglionic	   samples	   the	   next	   step	   was	   to	   look	   at	   cell	  
behaviour.	   	   Following	   a	   24h	   incubation	   period	   approximately	   3%	   of	   cells	   within	  
neurospheres	   were	   found	   to	   have	   incorporated	   EdU.	   	   No	   significant	   difference	   could	   be	  
identified	  between	  neurospheres	  derived	  from	  control,	  ganglionic	  or	  aganglionic	  sources.	  
Figure	  6.7.	   	  Rates	  of	  proliferation	  are	  not	   significantly	  different	  between	  human	  
aganglionic-­‐	  and	  ganglionic-­‐derived	  neurospheres	  
Figure	  6.7.	  	  	  Primary	  neurospheres	  were	  isolated	  from	  3-­‐month	  old	  human	  controls,	  aganglionic	  
colon	  and	  ganglionic	  HSCR	  colon.	   	  Primary	  neurospheres	  were	  cultured	   in	   the	  presence	  of	  EdU	  
for	  24h	  then	   immediately	  dissociated	  and	  spun	  down	  onto	  slides	  for	  fixation	  and	  analysis	  (B-­‐D).	  	  
No	   significant	   difference	   in	   incorporation	   of	   EdU	   was	   identified	   between	   human	   controls,	  
aganglionic-­‐	  or	  ganglionic-­‐derived	  neurospheres	  (A,	  P>0.05).	  	  Error	  bars	  represent	  standard	  error	  
of	  the	  mean	  (SEM)	  from	  3	  experiments.	  	  	  Scale	  bars	  =	  50µm,	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6.2.7.	   Transplanted	   HSCR	   aganglionic-­‐derived	   neurospheres	   give	   rise	   to	   cells	  
expressing	  immature	  neuronal	  markers	  
To	   test	   the	   functional	   potential	   of	   HSCR	   aganglionic-­‐derived	   neural	   progenitors,	  
neurospheres	   were	   transplanted	   into	   the	   ex-­‐vivo	   aganglionic	   embryonic	   mouse	   model	  
previously	  developed	  within	  the	  lab	  (Lindley,	  et	  al	  2008).	  	  After	  8	  days	  in	  culture	  cells	  that	  
had	  migrated	  away	  from	  the	  transplanted	  neurosphere	  and	  into	  the	  aganglionic	  embryonic	  
colon	  were	  found	  to	  express	  the	  human	  specific	  marker	  HRNP.	  	  In	  addition,	  cells	  expressing	  
the	   immature	   neuronal	   marker	   Tuj	   could	   also	   be	   identified	   in	   similar	   patterns	   to	   those	  
found	   in	   ganglionic	   colonic	   explants	   (Figure	   6.8).	   No	   neuronal	   cells	   were	   identified	   in	  
control	  colonic	  explants	  that	  had	  not	  received	  neurosphere	  transplants.	  
Figure	  6.8.	  	  Transplanted	  HSCR	  aganglionic-­‐derived	  neurospheres	  give	  rise	  to	  cells	  
expressing	  immature	  neuronal	  markers	  
	  
	  
	   	  
Figure	   6.8.	   Cells	   from	   human	  
HSCR	   aganglionic-­‐derived	  
neurospheres	  migrate	   into	  an	  
embryonic	  aganglionic	  mouse	  
colon.	   	   (A	   to	   C)	  
Immunofluorescent	   labelling	  
for	   human-­‐specific	  
ribonucleoprotein	   (green,	  
HRNP)	   antibody	   after	   8	   days	  
in	   culture	   were	   seen	   in	   the	  
transplanted	   explants	   (C)	   but	  
not	   in	   non-­‐transplanted	  
controls	   (A,B).	   (E	   to	   G)	   	   The	  
immature	   neuronal	   marker	  
Tuj	   was	   detected	   in	   both	  
ganglionic	   controls	   (D)	   and	  
the	   transplanted	   explants	   (E)	  
but	   not	   in	   aganglionic	  
controls	   (F).	   	   Scale	   bars	   =	  
50µm	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6.2.8.	   Transplanted	  HSCR	  aganglionic-­‐derived	  neurospheres	  can	  restore	  a	  normal	  
pattern	  of	  contraction	  to	  an	  embryonic,	  aganglionic	  mouse	  model	  
Contractions	   were	   identified	   in	   all	   mouse	   colonic	   explants	   after	   3-­‐4days	   in	   culture,	   the	  
pattern	  of	  which	  was	  determined	  using	  established	  motion	  capture	  techniques	  (Lindley,	  et	  
al	  2008).	  	  Contractions	  in	  control	  aganglionic	  explants	  were	  found	  to	  be	  short,	  irregular	  and	  
would	   propagated	   only	   over	   short	   distances.	   	   In	   contrast	   contractions	   in	   both	   ganglionic	  
controls	   (explants	   with	   the	   caecum	   intact	   allowing	   normal	   ENSPC	   migration)	   and	  
aganglionic	  HSCR	  neurosphere	  transplants	  were	  regular,	  more	  sustained	  slower	  and	  could	  
be	  seen	  to	  propagate	  over	  greater	  distances.	  Representative	  examples	  taken	  at	  day	  8	  are	  
shown	  in	  Figure	  6.9.	  
The	   frequency	   of	   contractions	   measured	   at	   the	   same	   time	   point	   was	   found	   to	   be	  
significantly	   lower	   in	   human	   aganglionic-­‐derived	   neurosphere	   transplanted	   explants	  
compared	   to	   aganglionic	   controls.	   	   No	   significant	   difference	   was	   found	   between	   human	  
aganglionic-­‐derived	   transplants	   and	   ganglionic-­‐derived	   controls	   (Figure	   6.9).	   	   Taken	  
together	   these	   results	   demonstrate	   that	   transplantation	   of	   human	   aganglionic-­‐derived	  
derived	  neurospheres	  can	  restore	  a	  normal	  pattern	  of	  contractility	  in	  the	  aganglionic	  model.	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Figure	  6.9.	  	  HSCR	  aganglionic-­‐derived	  neurospheres	  can	  restore	  a	  normal	  pattern	  









	   	  
Figure	  6.9.	  Cells	  from	  transplanted	  
human	   aganglionic-­‐derived	  
neurospheres	   have	   the	   potential	  
to	   restore	   a	   normal	   pattern	   of	  
contraction	   to	   an	   embryonic,	  
aganglionic	   mouse	   model.	  	  
Explants	   were	   harvested	   at	  
embryonic	   day	   11.5	   and	   analysed	  
after	   8	   days	   in	   culture.	   	   The	  
pattern	   of	   contraction	   was	  
determined	   using	   image	   analysis	  
software	   (Diamtrak,	   Prof	   Nield,	  
Flinders	  University,	  Australia).	   	   (A)	  
After	   8	   days	   in	   culture	   waves	   of	  
contraction	   were	   identified	   in	   all	  
distal	   ganglionic	   colonic	   explants.	  	  
In	  aganglionic	  explants	  (no	  caecum	  
/	   proximal	   colon)	   short	   (mean	  
3.1s),	   irregular	   contractions	  
propagating	   over	   short	   distances	  
were	   seen	   (B).	   	   Strikingly,	   at	   the	  
same	   time-­‐point	   in	   explants	  
transplanted	   with	   aganglionic-­‐
derived	  neurospheres	  contractions	  
appeared	  to	  be	  more	  co-­‐ordinated	  
with	   contractions	   found	   to	   be	  
more	   regular,	   slower	   (mean	   6.1s)	  
and	   propagating	   over	   longer	  
distances.	   	   These	   were	   similar	   to	  
those	   seen	   in	   ganglionic	   controls	  
(A	  and	  C).	  	  When	  the	  frequency	  of	  
contraction	   was	   analysed	   no	  
significant	   (P>0.05)	   difference	  
could	   be	   found	   between	  
ganglionic	   controls	   and	   human	  
aganglionic-­‐derived	   transplants	  
(D).	   	   In	   contrast	   both	   of	   these	  
conditions	  were	   associated	  with	  a	  
significant	   (p<0.001)	   reduction	   in	  
frequency	   when	   compared	   to	  
aganglionic	  controls.	  	  n=5	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6.3.	   Discussion	  
The	  most	  commonly	  accepted	  model	  for	  the	  development	  of	  HSCR	  is	  that	  there	  is	  a	  failure	  
of	   vagal	  neural	   crest	   ENS	  progenitor	   cell	  migration	   (Yntema,	   et	  al	   1954,	   Le	  Douarin,	   et	  al	  
1973,	  Young,	  et	  al	  1998),	  resulting	  in	  the	  aganglionosis	  of	  the	  distal	  bowel.	  	  Surprisingly,	  the	  
results	   in	   this	   chapter	  demonstrate	   that	  ENSPC-­‐like	  cells	   can	  be	   isolated	   from	  aganglionic	  
HSCR	   gut.	   	   These	   aganglionic	   progenitors	   express	   the	   same	   markers	   as	   their	   ganglionic	  
counterparts	  and	  have	  the	  ability	  to	  differentiate	  into	  mature	  neuronal	  phenotypes.	  	  More	  
importantly,	   when	   transplanted	   into	   an	   embryonic,	   aganglionic	  mouse	  model	   these	   cells	  
can	   restore	   a	   normal	   pattern	   of	   contractility	   to	   the	   bowel.	   	   These	   observations	   have	  
implications	  both	  for	  our	  understanding	  of	  the	  ENS	  developmental	  mechanisms	  involved	  in	  
the	  pathogenesis	  of	  HSCR	  and	  also	  for	  development	  of	  novel	  therapies.	  
	  
6.4.1.	   Aganglionic	  HSCR	  bowel	  contains	  neuronal	  progenitors	  
In	  this	  study	  we	  have	  been	  able	  to	  consistently	  isolate	  ENSPC-­‐like	  cells	  from	  human	  smooth	  
muscle	  biopsies	   taken	   from	   the	   aganglionic	   bowel	   of	   patients	  with	  HSCR,	   including	   those	  
with	   long-­‐segment	   disease.	   	   Importantly,	   the	   absence	   of	   enteric	   ganglia	   within	   these	  
original	  aganglionic	  biopsies	  was	  confirmed	  both	  on	  H&E	  and	  by	  the	  absence	  of	  calretinin	  
expression.	  	  Furthermore	  these	  findings	  have	  been	  corroborated	  by	  the	  clinical	  analysis	  of	  
resected	  specimens	  by	  paediatric	  histopathologists,	  confirming	  the	  absence	  of	  components	  
of	   the	   intrinsic	   nervous	   system	   in	   the	   regions	   where	   the	   biopsies	   were	   taken.	   	   When	  
cultured	  under	  conditions	  promoting	  neuronal	  differentiation	  cells	   taken	  from	  aganglionic	  
muscle	  biopsies	   form	  characteristic	  neurospheres	  that	  contain	  cells	  expressing	  markers	  of	  
neural	  crest,	  neuronal	  and	  glial	  lineages.	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These	  findings,	  coupled	  with	  the	  reproducibility	  of	  the	  findings	  in	  multiple	  patient	  samples	  
makes	   the	   possibility	   of	   these	   findings	   being	   due	   to	   contamination	   from	   transitional	   or	  
ganglionic	  bowel	  unlikely.	  
	  
6.4.2.	   Cells	   from	   human	   aganglionic-­‐	   and	   ganglionic-­‐derived	   neurospheres	  
differentiate	  to	  express	  neuronal	  markers	  characteristic	  of	  the	  ENS	  
We	  have	  shown	  that	  neurospheres	  derived	  from	  both	  the	  ganglionic	  and	  aganglionic	  HSCR	  
biopsies	   contain	   progressively	   increasing	   proportions	   of	   cells	   expressing	   the	   neural	   crest	  
marker	   P75	   over	   time	   in	   culture,	  with	   a	   corresponding	   dramatic	   fall	   in	   the	   proportion	   of	  
cells	  expressing	  smooth	  muscle	  markers	  after	  isolation.	  	  This	  suggests	  that	  cells	  within	  these	  
neurospheres	   continue	   to	   develop	   or	   mature	   over	   time,	   ultimately	   resulting	   in	  
neurospheres	  that	  predominantly	  contain	  cells	  expressing	  typical	  neural	  crest	  markers.	  
Perhaps	   most	   significantly	   of	   all	   the	   markers	   expressed	   by	   human	   aganglionic-­‐derived	  
neurospheres	   is	   the	   appearance	   of	   calretinin	   positivity.	   	   	   Calretinin	   is	   a	   calcium	   binding	  
protein	  normally	  expressed	  by	  a	  subset	  of	  enteric	  ganglion	  cells	  within	  both	  the	  submucosal	  
and	  myenteric	  plexi,	  and	  the	  absence	  of	   its	  expression	   is	  widely	  used	  a	  diagnostic	  test	  for	  
HSCR	  (Palczewska,	  et	  al.	  2005,	  Kapur,	  et	  al.	  2009).	  	  The	  absence	  of	  calretinin	  expression	  in	  
the	  initial	  aganglionic	  isolates	  was	  therefore	  expected,	  however	  its	  subsequent	  appearance	  
in	   1st	   generation	   neurospheres	   was	   surprising,	   albeit	   if	   it	   is	   slightly	   lower	   than	   the	  
proportion	  found	  in	  ganglionic-­‐derived	  neurospheres.	  	  Thus,	  the	  new	  neurons	  produced	  by	  
aganglionic-­‐derived	   neural	   progenitors	   have	   the	   defining	   characteristic	   used	   in	   clinical	  
diagnosis	  of	  HSCR	  ganglionic	  and	  aganglionic	  gut.	  	  Furthermore,	  the	  nNOS	  and	  VIP	  neuronal	  
phenotypes	   that	  developed	   from	   these	   cells	   are	   characteristic	  of	   ENS	  neurons	  expressing	  
the	  typical	  neuronal	  markers	  seen	  in	  the	  ENS	  and	  calretinin.	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6.4.3.	   ENSPC	  derived	  from	  aganglionic	  bowel	  can	  generate	  functional	  neurons	  
Previous	   work	   has	   shown	   that	   neurospheres	   derived	   from	   human	   ganglionic	   bowel	   are	  
capable	  of	   restoring	  a	  normal	  pattern	  of	   contractility	   to	  an	  embryonic	  aganglionic	  mouse	  
model	   (Lindley,	   et	   al	   2008).	   	  Utilising	   this	  model,	  HSCR	   aganglionic-­‐derived	  neurons	   have	  
been	   found	   to	   demonstrate	   the	   same	   properties	   as	   ganglionic-­‐derived	   controls.	   	   These	  
results	   show	   that	   HSCR	   aganglionic-­‐derived	   neurons	   have	   the	   ability	   to	   migrate	   into	   an	  
embryonic	   aganglionic	   mouse	   model	   and	   more	   importantly,	   just	   like	   HSCR	   ganglionic-­‐
derived	   neurons,	   they	   can	   restore	   a	   normal	   pattern	   of	   contractility	   (Lindley,	   et	   al	   2008).	  	  
Thus,	   providing	   further	   support	   for	   a	   common	   source	   of	   neural	   progenitors	   in	   ganglionic	  
and	  aganglionic	  bowel.	  
These	  observations	  bring	  in	  to	  question	  our	  current	  understanding	  of	  the	  precise	  aetiology	  
of	  HSCR.	  	  It	  is	  a	  commonly	  held	  assumption	  that	  the	  lack	  of	  enteric	  neurons	  in	  the	  affected,	  
distal	  aganglionic	  bowel	  is	  due	  to	  a	  failure	  of	  the	  enteric	  NC	  progenitors	  to	  migrate	  during	  
development.	   	   This	   itself	   is	   supported	   by	   the	   studies	   of	   Simpson	   and	   Landman,	   et	   al.	  
demonstrating	  that	  migration	  is	   largely	  driven	  by	  the	  ‘population	  pressure’	  of	  NCCs	  at	  the	  
rapidly	  proliferating	  wave	  front.	  	  Furthermore	  they	  suggest	  that	  the	  failure	  of	  colonisation	  
seen	   in	   HSCR	   is	   therefore	   either	   due	   to	   inadequate	   proliferation	   at	   the	   migratory	   wave	  
front	  or	  due	  to	  rapid	  bowel	  elongation	  (Simpson,	  et	  al.	  2006,	  Landman,	  et	  al	  2007,	  Simpson,	  
et	  al	  2007).	   	  However,	  the	  observations	   in	  this	  chapter	  suggest	  that	  there	  are	  progenitors	  
present	  within	  the	  aganglionic	  bowel	  of	  children	  with	  HSCR	  that	  are	  capable	  of	  producing	  
functioning	  components	  of	  the	  enteric	  nervous	  system.	  	  If	  these	  progenitors	  are	  present	  it	  
begs	  the	  question	  as	  to	  why	  did	  they	  not	  differentiate	  during	  development?	  	  Along	  with	  the	  
current	   theories	   regarding	   the	   cause	   of	   HSCR	   there	  may	   be	   a	   third	   factor	   -­‐	   an	   inherent	  
problem	   with	   the	   distal	   bowel	   preventing	   colonisation	   and	   differentiation	   of	   neural	  
progenitors.	  	  Further	  study	  into	  the	  microenvironment	  of	  the	  aganglionic	  bowel	  in	  HSCR	  is	  
warranted.	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6.4.4.	   Progenitors	  in	  the	  aganglionic	  colon	  may	  arise	  from	  extrinsic	  nerve	  fibres	  	  
In	  culture	  the	  proportion	  of	  cells	  derived	  from	  human	  HSCR	  aganglionic	  gut	  expressing	  the	  
more	   immature	   marker	   GFAP	   rose	   quickly.	   	   In	   contrast	   immediately	   after	   isolation	   the	  
proportion	   of	   cells	   expressing	   the	   more	   mature	   glial	   and	   Schwann	   cell	   marker	   S100	  
(Bramanti,	  et	  al.	  2010)	  was	  significantly	  higher	  than	  that	  of	  GFAP,	  and	  this	  ratio	  was	  quickly	  
reversed	   in	   1st	   generation	   neurospheres.	   	   The	   behaviour	   of	   glial	   markers	   in	   aganglionic	  
HSCR	   cultures	   –	   in	   particular	   the	   relatively	   high	   number	   of	   cells	   expressing	   the	   S100	  
Schwann	  cell	  marker	  in	  cell	  isolates	  –	  prompted	  further	  us	  to	  further	  investigate	  the	  glia	  of	  
aganglionic	  HSCR	  bowel.	  
Despite	   the	   absence	   of	   ENS	   neurons	   within	   the	   aganglionic	   regions	   of	   the	   bowel,	   one	  
striking	   observation	   was	   the	   localisation	   of	   the	   neural	   crest	   marker	   P75	   expression	  
associated	  with	   extrinsic	   nerve	   fibres.	   	   These	   abnormally	   thickened	   fibres	   arise	   from	   the	  
pelvic	  ganglia,	  which,	  in	  addition	  to	  the	  axons,	  contain	  p75-­‐expressing	  cells	  of	  neural	  crest	  
origin	   (Baumgarten,	   et	   al	   1973,	   Kobayashi,	   et	   al	   1994,	  Watanabe,	   et	   al.	   1998).	   	   The	   high	  
levels	   of	   P75	  expression	   identified	   in	   the	  outer	  perineural	   cells	   of	   these	  nerve	   trunks	   are	  
consistent	  with	  previous	  studies	  (Kobayashi,	  et	  al	  1994).	  	  In	  addition	  lower	  levels	  of	  P75,	  are	  
also	  expressed	  by	  the	  Schwann	  cells	  of	  the	  endoneurium	  characteristic	  of	  the	  Schwann	  cells	  
of	   normal	   peripheral	   nerves	   (Kobayashi,	   et	   al	   1994).	   	   Schwann	   cells	   have	   been	   well	  
documented	   to	   show	   a	   high	   degree	   of	   plasticity	   in	   response	   injury	   or	   after	   experimental	  
dissociation	   from	   peripheral	   nerves	   and	   culture.	   	   In	   particular,	   such	   treatments	   result	   in	  
their	  proliferation,	  during	  or	  after	  which	  they	  have	  been	  shown	  to	  possess	  the	  capability	  of	  
dedifferentiating	  to	  a	  multi-­‐potent	  state	  and	  importantly	  have	  been	  shown	  to	  be	  capable	  of	  
giving	  rise	  to	  new	  neurons	  in-­‐vitro	  (Mirsky,	  et	  al	  2008,	  Widera,	  et	  al.	  2011).	  
The	   ability	   to	   isolate	   neural	   progenitors	   that	   possess	   properties	   similar	   to	   those	   derived	  
from	  ganglionic	  colon	  is	  consistent	  with	  previous	  studies	  suggesting	  that	  ENSPC	  do	  not	  arise	  
from	  within	  the	  enteric	  ganglia	  but	  instead	  from	  a	  separate	  extra-­‐ganglionic	  niche	  (Liu,	  et	  al	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2009).	   	  Although	   it	  has	  been	  often	  assumed	  that	  such	  progenitors	  would	  be	  derived	  from	  
ENS	  ganglia	   (Kruger,	   et	  al	  2002),	  a	  pulse-­‐chase	  DNA	   labelling	   study	  provided	  evidence	   for	  
the	  existence	  of	  a	  small	  population	  of	  proliferating	  extra-­‐ganglionic	  cells	  that	  subsequently	  
migrate	   into	   the	   ganglia	   of	   the	   postnatal	   gut	   in-­‐vivo	   (Liu,	   et	   al	   2009),	   although	   in	   the	  
absence	   of	   suitable	   markers	   the	   identity	   of	   these	   cells	   and	   their	   progeny	   could	   not	   be	  
established.	   	   Rather,	   these	   results	   are	   consistent	   with	   the	   progenitors	   originating	   from	  
mature	   Schwann	   cells	   de-­‐differentiating	   in	   response	   to	   the	   insult	   of	   dissociation.	   	   This	  
would	  explain	  shift	   from	  the	  relatively	  higher	  expression	  of	   the	  mature	  glial/Schwann	  cell	  
marker	   S100	   in	   the	   fresh	   isolate	   to	   the	   high	   levels	   of	   GFAP	   expression	   within	   mature	  
neurospheres.	   	   Interestingly,	   two	   recent	   studies	   looking	   at	   neurogenesis	   in	   the	   normal	  
ganglionic	   postnatal	   ENS	   have	   shown	   that	   injury	   either	   by	   dissociation	   or	   application	   of	  
benzalkonium	  chloride	  may	   stimulate	  neurogenesis	   in	   cells	   that	  express	   Sox10,	  GFAP	  and	  
S100	  –	  all	  of	  which	  may	  also	  be	  expressed	  by	  Schwann	  cells	  (Mirsky,	  et	  al	  2008,	  Joseph,	  et	  al	  
2011,	   Laranjeira,	   et	   al	   2011).	   	   This	   raises	   the	   possibility	   that	   Schwann	   cells	   may	   be	   the	  
common	  ENS	  progenitor	  found	  in	  both	  ganglionic	  and	  aganglionic	  bowel.	  
	  
These	  results	  support	  the	  hypothesis	  that	  the	  P75-­‐positive	  cells	  of	  the	  extrinsic	  nerve	  trunks	  
of	  aganglionic	  HSCR	  gut	  are	  the	  source	  of	  the	  progenitors	  identified	  arising	  from	  aganglionic	  
biopsies.	  	  It	  should	  be	  noted	  that	  we	  have	  been	  unable	  to	  isolate	  such	  cells	  from	  the	  total	  
aganglionic	  gut	  we	  were	  able	  to	  obtain	  from	  two	  very	  rare	  HSCR	  patients	  (Table	  2.1).	  	  The	  
total	   aganglionic	   gut	   has	   been	   reported	   to	   lack	   thickened	  extrinsic	   nerve	   trunks,	   and	  our	  
inability	  to	  isolate	  ENSPC	  from	  it	  is	  consistent	  with	  a	  nerve	  trunk	  origin	  of	  the	  cells	  in	  short	  
and	  long	  segment	  HSCR.	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6.4.	   Conclusions	  
We	  have	   shown	   that	   neurospheres	   derived	   from	   both	   human	   ganglionic	   and	   aganglionic	  
HSCR	  biopsies	  contain	  an	  increasing	  proportion	  of	  cells	  expressing	  the	  both	  the	  neural	  crest	  
marker	  P75	  and	  the	   immature	  glial	  marker	  GFAP	  with	  time	   in	  culture.	   	  Furthermore,	  cells	  
within	   neurospheres	   derived	   from	   both	   ganglionic	   and	   aganglionic	   sources	   possess	   the	  
capacity	   to	  differentiate	   into	  mature	  neuronal	   phenotypes	  expressing	   typical	   ENS	   specific	  
markers	  and	  which	  can	  restore	  function	  to	  aganglionic	  embryonic	  gut	  ex-­‐vivo.	  	  Clearly,	  the	  
question	   remains	   as	   to	   whether	   these	   functional	   results	   can	   be	   translated	   to	   human	  
postnatal	  bowel.	   	  However,	   this	   finding	   raises	   several	   interesting	  possibilities.	   	  The	   first	   is	  
that	  it	  provides	  a	  source	  of	  progenitors	  for	  future	  autologous	  transplants	  in	  the	  treatment	  
of	  HSCR.	   	   Secondly,	   if	   these	   progenitors	   are	   present	   throughout	   the	   aganglionic	   bowel	   it	  
raises	   the	   question	   as	   to	   what	   is	   it	   in	   the	   local	   environment	   that	   prevents	   them	   from	  
generating	   ENS	  neurons	   in-­‐vivo	   and	   restoring	   a	   normal	   phenotype?	   	   Furthermore,	   it	   also	  
opens	   up	   the	   possibility	   of	   developing	   future	   therapeutic	   modalities	   that	   stimulate	  
neurogenesis	   in-­‐vivo,	   which	   may	   reduce	   the	   need	   for	   surgery	   and	   ultimately	   improve	  
outcomes	  for	  children	  with	  HSCR.	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Chapter	  7:	  Final	  conclusions	  
	  
Human	   ENSPC,	   isolated	   from	   patients	   with	   HSCR,	   have	   previously	   been	   shown	   to	   be	  
capable	  of	   restoring	  a	  normal	  pattern	  of	   contractility	   to	  an	  embryonic	  aganglionic	  mouse	  
model	  (Lindley,	  et	  al	  2008).	  	  This	  study,	  and	  more	  recent	  in-­‐vivo	  transplantation	  studies	  in	  
mice	  (Hotta,	  et	  al	  2013)	  support	  the	  possibility	  of	  using	  these	  cells	  to	  restore	  function	  and	  
thereby	  improve	  the	  current	  long-­‐term	  morbidity	  encountered	  by	  patients	  with	  HSCR.	  	  The	  
original	   aim	   of	   this	   thesis,	   building	   on	   previous	   work	   within	   the	   lab	   was	   to	   better	  
understand	  the	  behaviour	  of	  ENPSC	  both	  in	  the	  environment	  of	  the	  neurosphere	  and	  in	  the	  
microenvironment	  of	  human	  postnatal	   colonic	   smooth	  muscle,	   and	   subsequently	   to	  elicit	  
the	   mechanisms	   controlling	   this	   behaviour.	   	   This	   knowledge	   would	   better	   enable	   us	   to	  
predict	  how	  these	  cells	  might	  behave	  when	   transplanted	   into	  post-­‐natal	  human	  bowel	   to	  
both	   ensure	   the	   safety	   of	   any	   future	   cell-­‐based	   therapy	   and	   allow	   us	   to	   maximise	   its	  
effectiveness.	   	   Furthermore,	   this	   thesis	   reports	   the	   novel	   finding,	   arising	   from	   work	  
pursuing	  the	  original	  aims,	  that	  ENSPC	  can	  be	  isolated	  from	  aganglionic	  bowel.	  	  This	  finding	  
both	  questions	  our	  current	  understanding	  regarding	  the	  aetiology	  of	  HSCR	  and	  raises	  new	  
therapeutic	  possibilities.	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7.1.	  	  Embryonic	  ENSPC	  behaviour	  is	  not	  comparable	  to	  that	  of	  similar	  
cells	  derived	  from	  the	  postnatal	  gut	  
The	   work	   within	   this	   thesis	   (chapter	   3)	   supports	   previous	   studies	   which	   found	   little	  
difference	   in	   the	  expression	  profiles	  of	   common	  ENS	  markers	  between	  embryonic	  mouse	  
and	  postnatal	   human	   ENSPC	   in	   neurospheres	   (Almond,	   et	   al	   2007).	   	   However,	   there	  was	  
found	  to	  be	  a	  significant	  difference	  in	  the	  rate	  of	  proliferation	  seen	  in	  neurospheres	  derived	  
from	  both	  sources.	  	  This	  difference	  appears	  to	  be	  due	  to	  the	  developmental	  maturation	  of	  
the	   source	   tissue	   rather	   than	   the	   species,	   as	   not	   difference	   could	   be	   identified	   between	  
mature	  postnatal	  mouse	  and	  human	  bowel.	  	  These	  results	  suggest	  that	  where	  human	  tissue	  
is	  not	  available,	  or	  appropriate	  for	  experimental	  work	  that	  ENSPC	  derived	  from	  adult	  mouse	  
(postnatal	  day	  28)	  may	  be	  a	  more	  appropriate	  replacement	  than	  embryonic	  mouse	  ENSPC.	  
	  
7.2.	  	  Notch	  signalling	  is	  involved	  in	  the	  regulation	  of	  both	  proliferation	  
and	  differentiation	  of	  ENSPC	  
The	   work	   in	   this	   thesis	   demonstrates	   that	   ENSPC	   behave	   differently	   according	   to	   their	  
position	   within	   neurospheres,	   e.g.	   proliferating	   cells	   are	   predominantly	   found	   at	   the	  
periphery.	   	   These	   findings	   prompted	   further	   study	   into	   the	   mechanisms	   regulating	   this	  
behaviour.	   	   Following	   work	   focusing	   on	   the	   control	   of	   normal	   ENS	   development	   in	   the	  
mouse	  (Okamura,	  et	  al	  2008,	  Ngan,	  et	  al	  2011),	  we	  have	  now	  demonstrated	  that	  the	  Notch	  
signalling	   pathway	   is	   implicated	   in	   the	   regulation	   of	  mature	   human	   ENSPC.	   	   Thus,	   Notch	  
signalling	   is	   necessary	   to	  maintain	   a	   proliferative	   and	   undifferentiated	   state	   of	   ENSPC	   in	  
tissue	   culture.	   	   These	   findings	   are	   of	   importance	   in	   terms	   of	   predicting	   and	   potentially	  
regulating	  future	  transplanted	  ENSPC	  behaviour.	  	  When	  ENSPC	  are	  isolated	  from	  the	  colon	  
there	  is	  a	  dramatic	  change	  in	  behaviour	  moving	  from	  an	  apparent	  quiescent	  state	  in-­‐vivo	  to	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that	  of	  rapid	  proliferation	  in	  culture.	  	  Before	  studies	  move	  towards	  human	  clinical	  trials	  we	  
need	  to	  be	  able	  to	  know	  whether	  these	  cells	  will	  come	  back	  under	  of	  the	  host	  environment	  
or	  whether	   they	  will	  progress	   towards	  unregulated	  proliferation	  and	   thereby	  develop	   the	  
potential	  risk	  of	  tumour	  formation.	  	  Therefore,	  it	  is	  important	  to	  investigate	  the	  behaviour	  
of	  transplanted	  human	  ENSPC	  in	  a	  controlled	  and	  safe	  environment.	  
	  
7.3.	  	  Transplanted	  ENSPC	  behaviour	  can	  be	  investigated	  in	  a	  post-­‐natal	  
human	  aganglionic	  colonic	  smooth	  muscle	  model	  
Recent	  studies	  have	  reported	  that	   it	   is	  possible	  to	  transplant	  murine	  ENSPC	   into	  recipient	  
mice	  and	  for	  these	  progenitors	  to	  migrate,	  interact	  with	  the	  host	  ENS	  and	  differentiate	  into	  
electrically	  active	  neurons	  (Hotta,	  et	  al	  2013).	  	  However,	  it	  remains	  important	  to	  determine	  
how	   transplanted	   human	   ENSPC	   might	   behave	   in	   the	   microenvironment	   of	   post-­‐natal	  
human	   aganglionic	   smooth	   muscle.	   	   The	   work	   within	   this	   thesis	   (chapter	   5)	   details	   the	  
development	  of	  an	  ex-­‐vivo	  model	  using	  human	  aganglionic	  smooth	  muscle	  seeded	  onto	  a	  
decellularised	  mouse	   bowel	   scaffold.	   	   The	   ex-­‐vivo	  model	  was	   found	   to	   contain	   cells	   that	  
both	   expressed	   typical	   smooth	   markers	   and	   produced	   characteristic	   electrophysiological	  
responses	   to	   administration	   of	   KCl	   and	   carbachol.	   	   Furthermore,	   the	   constructs	   could	   be	  
reliably	  maintained	   in	   long-­‐term	  culture	  and	  the	  behaviour	  of	   transplanted	  human	  ENSPC	  
could	  be	  observed	  within	  them.	  
Although	   showing	   promise	   as	   a	   useful	  model	   in	  which	   to	   investigate	   both	   the	   behaviour	  
and	  functional	  response	  of	  transplanted	  ENSPC	  further	  work	  is	  still	  required	  to	  validate	  the	  
reliability	  of	  the	  model.	  The	  unexpected	  observation	  that,	  in	  in-­‐vitro	  cultures,	  cells	  with	  an	  
apparent	   neuronal	   phenotype	   were	   present	   within	   aganglionic	   samples	   meant	   that	   the	  
optimisation	  of	  this	  model	  could	  not	  be	  completed	  within	  the	  timeframe	  of	  this	  thesis.	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7.4.	  	  ENSPC	  can	  be	  isolated	  from	  HSCR	  aganglionic	  bowel	  
Human	  aganglionic	  bowel	  has	  been	  shown	  to	  contain	  progenitor	  cells	   that	  are	  capable	  of	  
differentiating	   into	   functional	   mature	   ENS-­‐specific	   neurons	   (chapter	   6).	   	   These	   novel	  
findings	  question	  our	  current	  understanding	  of	  the	  aetiology	  behind	  HSCR	  such	  as	  the	  distal	  
bowel	   is	   aganglionic	   because	   of	   a	   failure	   of	   craniocaudal	   migration	   of	   NCC	   progenitors	  
during	  development.	   	   If	   this	   is	   true	  why	  are	  progenitors	  present	   in	   the	  aganglionic	  bowel	  
that	  are	  capable	  of	  differentiating	  into	  ENS	  neurons?	  	  Why	  have	  these	  progenitors	  failed	  to	  
differentiate	   in-­‐vivo?	   	   These	   results	   suggest	   that	   there	  may	   be	   an	   intrinsic	   defect	   in	   the	  
aganglionic	  bowel	   that	   is	  preventing	  existing	  progenitors	  developing	   into	   function	  enteric	  
neurons.	  	  	  
The	   results	   also	   raise	   the	  possibility	  of	  utilising	   these	  progenitors	   for	   therapeutic	  benefit.	  	  
Progenitors	   isolated	   from	   the	   aganglionic	   bowel	   could	   be	   used	   as	   part	   of	   an	   autologous	  
transplantation	  therapy	  into	  the	  internal	  anal	  sphincter	  after	  surgery.	  	  The	  aim	  is	  analogous	  
to	   that	   of	   delivering	   dopaminergic	   neurons	   in	   Parkinson’s	   disease	   (Fan,	   et	   al.	   2013)	  
delivering	  neurons	  and	  thereby	  the	  missing	  neurotransmitter	  to	  this	  aganglionic	  region	  that	  
cannot	  be	  resected.	   	  But	  perhaps	  more	   interestingly,	   it	   raises	   the	  potential	   to	  manipulate	  
the	  microenvironment	   in-­‐vivo	  to	  stimulate	  progenitor	  cell	  differentiation	   into	  mature	  ENS	  
neurons	  in-­‐situ	  and	  in-­‐vivo.	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7.5.	  	  Final	  conclusion	  
The	  work	  in	  this	  thesis	  furthers	  our	  understanding	  of	  the	  control	  and	  behaviour	  of	  human	  
ENPSC,	  specifically	  within	  the	  ex-­‐vivo	  environment	  of	  the	  neurosphere.	   	  But	  perhaps	  most	  
significantly,	   this	   thesis	  describes	   the	  discovery	  of	  previously	  unknown	  ENS	  progenitors	   in	  
the	  aganglionic	  bowel	  of	  children	  with	  HSCR.	   	  This	  raises	  questions	  about	  the	  aetiology	  of	  
HSCR,	   the	  source	  of	  ENSPC	   in	  the	  ganglionic	  bowel	  and	   the	  potential	   to	  use	  these	  cells	   in	  
future	  cell-­‐based	  therapies.	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7.6.	  	  Future	  work	  
The	  findings	  within	  this	  thesis	  remain	  consistent	  with	  a	  potential	  therapeutic	  role	  for	  ENPSC	  
in	  treating	  conditions	  such	  as	  HSCR.	  	  However,	  significant	  work	  still	  remains	  to	  be	  done	  to	  
ensure	   the	   safety	   and	  optimise	   the	  effectiveness	  of	   any	   future	   cell-­‐based	   transplantation	  
therapy.	  
	  
7.6.1.	  	  Role	  of	  Notch	  signalling	  post-­‐transplantation	  
The	  work	  in	  chapter	  4	  details	  the	  significant	  role	  of	  Notch	  signalling	  in	  the	  control	  of	  ENSPC	  
behaviour	  in	  the	  neurosphere.	  	  This	  chapter	  also	  demonstrates	  the	  ability	  to	  determine	  its	  
activation	   state	   using	   the	   intracellular	   expression	   of	   NICD	   (Figures	   4.12/13).	   	   Using	   this	  
technique	  and	  others	  such	  as	  expression	  of	  downstream	  proteins,	  e.g.	  HES	  (Theocharatos,	  
et	  al	  2013),	  or	  live	  imaging	  with	  a	  luciferase	  based	  promoter	  (Ilagan,	  et	  al	  2011)	  would	  allow	  
assessment	   of	   the	   state	   of	   Notch	   signalling	   in	   ENSPC	   both	   pre	   and	   post	   transplantation.	  	  
Using	   the	  ex-­‐vivo	  human	  colonic	   smooth	  muscle	  model	  described	   in	  chapter	  5,	   it	  may	  be	  
possible	   to	   determine	   whether	   Notch	   signalling	   is	   switched	   off	   after	   transplantation	  
thereby	  limiting	  proliferation	  and	  driving	  cells	  towards	  a	  neuronal	  lineage.	  	  Furthermore,	  if	  
the	   rate	   of	   proliferation	   remains	   high	   in	   transplanted	   ENSPC,	   it	   may	   be	   possible	   to	  
manipulate	  the	  Notch	  pathway	  to	  inhibit	  this	  proliferative	  behaviour	  and	  minimise	  the	  risk	  
of	  tumour	  formation.	  
	  
7.6.2.	  	  Development	  of	  the	  human	  colonic	  smooth	  muscle	  model	  
Due	   to	   the	   unexpected	   findings	   detailed	   in	   chapters	   5	   and	   6	   it	   was	   not	   possible	   to	   fully	  
optimise	   the	   human	   colonic	   smooth	   muscle	   model	   (HCSMM).	   	   The	   provisional	   data	  
contained	  in	  chapter	  5	  does	  suggest	  that	  there	  is	  a	  role	  for	  this	  model	   in	  bridging	  the	  gap	  
between	  animal	  model	  studies	  and	  in-­‐vivo	  human	  clinical	  trials.	  	  Further	  work	  is	  required	  to	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optimise	   the	   seeding	   density	   and	   time	   in	   culture	   to	   produce	   a	  model	   that	   generates	   the	  
maximum	   resting	   force	   possible	   while	   remaining	   stable	   in	   culture.	   	   This	   will	   allow	   the	  
functional	  effect	  of	  ENPSC	  transplantation	  to	  be	  more	  easily	  identified.	  	  It	  is	  also	  important	  
to	   determine	   the	   reproducibility	   of	   this	  model,	   i.e.	   does	   a	  model	   seeded	  with	   the	   same	  
density	   of	   cells	   as	   another	   possess	   the	   same	   electrophysiological	   properties	   as	   another.	  	  
Determining	   this	   degree	   of	   variability	   is	   required	   again	   so	   that	   we	   can	   be	   certain	   that	   a	  
difference	  in	  physiological	  response	  is	  due	  to	  the	  transplanted	  cells	  and	  not	  to	  intermodal	  
variability.	  	  Once	  these	  factors	  are	  optimised	  it	  should	  then	  be	  possible	  to	  transplant	  ENSPC,	  
track	   their	   integration	   and	   determine	   their	   functional	   potential	   in	   a	   safe,	   reproducible	  
environment	  that	  is	  closer	  to	  that	  of	  the	  human	  colon.	  
	  
7.6.3.	  	  The	  optimum	  method	  of	  ENSPC	  transplantation	  
ENSPC	  have	  previously	  been	  transplanted	  in-­‐vivo	  either	  directly	  into	  the	  peritoneum	  or	  by	  
direct	   placement	   into	   the	  muscular	  wall	   of	   the	   colon	   (Micci,	   et	   al	   2005,	   Tsai,	   et	   al	   2010,	  
Hotta,	  et	  al	  2013).	  	  The	  most	  promising	  results	  are	  seen	  with	  the	  direct	  placement	  of	  ENSPC,	  
but	   alternative	   methods	   such	   as	   microinjection	   directly	   into	   the	   internal	   anal	   sphincter	  
under	  endoscopic	  or	  ultrasound	  control,	  need	  to	  be	  evaluated	  for	  their	  effectiveness	  prior	  
to	  clinical	  trials.	  	  
	  
7.6.4.	  	  Origin	  of	  ENSPC	  in	  the	  aganglionic	  bowel	  
The	   results	   in	   chapter	   6	   suggest	   that	   the	   progenitors	   identified	   in	   the	   aganglionic	   bowel	  
may	  be	   related	   to	   the	  abnormally	   thickened	  nerve	   trunks	  seen	   in	   these	   regions,	  however	  
these	  results	  require	  further	  confirmation.	  	  Given	  that	  expression	  of	  the	  neural	  crest	  marker	  
P75	  is	  limited	  to	  these	  fibres	  it	  should	  be	  possible	  to	  use	  flow	  cytometry	  assisted	  cell	  sorting	  
to	   isolate	  P75+ve	  cells	   from	  the	   initial	  cell	   isolate	  produced	  when	  human	  colonic	  biopsies	  
are	   processed.	   	   If	   these	   cells	   can	   then	   be	   shown	   to	   go	   on	   to	   differentiate	   into	   the	   same	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mature	  neurons	  as	  seen	  in	  chapter	  6	  it	  would	  confirm	  the	  relationship	  of	  these	  progenitors	  
to	   the	  abnormal	  nerve	   fibres.	   	  However,	   although	   the	   relationship	  would	  be	  confirmed	   it	  
would	  still	  not	  explain	  their	  origin.	  
	  
7.6.5.	  	  Stimulating	  ENSPC	  differentiation	  in	  aganglionic	  bowel	  
Groups	   have	   already	   started	   to	   investigate	   the	   possibility	   of	   manipulating	   the	   local	  
microenvironment	  to	  stimulate	  proliferation	  and	  neuronal	  migration	  into	  aganglionic	  areas	  
from	   the	   neighbouring	   ganglionic	   bowel	   (Matsuyoshi,	   et	   al	   2010,	   Laranjeira,	   et	   al	   2011).	  	  
However,	  now	  having	  identified	  the	  presence	  of	  progenitors	  in	  the	  aganglionic	  HSCR	  bowel	  
the	   question	   remains	   why	   did	   these	   cells	   not	   differentiate	   into	   mature	   neurons	   during	  
development	   and	   therefore,	   can	   they	   now	   be	   stimulated	   to	   differentiate	   in-­‐vivo?	  	  
Experiments	  are	  needed	   in	  mouse	  models	  of	  HSCR,	   firstly	  to	  confirm	  the	  presence	  of	  ENS	  
progenitors	  in	  the	  aganglionic	  bowel	  of	  these	  mice	  and	  subsequently	  to	  determine	  whether	  
the	   addition	   of	   agents	   known	   to	   affect	   ENSPC	   behaviour	   such	   a	   5HT4,	   GDNF,	   ET3	   can	  
influence	  neuronal	  differentiation	  in	  aganglionic	  bowel.	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7.7.	  	  Publications	  arising	  from	  this	  thesis	  
Publications	  arising	  from	  this	  thesis	  are	  included	  in	  the	  appendix	  at	  the	  end	  of	  the	  thesis.	  	  A	  
manuscript	  reporting	  the	  results	  of	  chapter	  6	  is	  currently	  being	  prepared.	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Regulation of Progenitor Cell Proliferation and Neuronal
Differentiation in Enteric Nervous System Neurospheres
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Abstract
Enteric nervous system (ENS) progenitor cells isolated from mouse and human bowel can be cultured in vitro as
neurospheres which are aggregates of the proliferating progenitor cells, together with neurons and glial cells derived from
them. To investigate the factors regulating progenitor cell proliferation and differentiation, we first characterised cell
proliferation in mouse ENS neurospheres by pulse chase experiments using thymidine analogs. We demonstrate rapid and
continuous cell proliferation near the neurosphere periphery, after which postmitotic cells move away from the periphery to
become distributed throughout the neurosphere. While many proliferating cells expressed glial markers, expression of the
neuronal markers b-tubulin III (Tuj1) and nitric oxide synthase was detected in increasing numbers of post-mitotic cells after
a delay of several days. Treatment of both mouse and human neurospheres with the c-secretase inhibitor N-[N-(3,5-
Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) reduced expression of the transcription factors Hes1 and
Hes5, demonstrating inhibition of Notch signaling. DAPT treatment also inhibited progenitor cell proliferation and increased
the numbers of differentiating neurons expressing Tuj1 and nitric oxide synthase. To confirm that the cellular effects of
DAPT treatment were due to inhibition of Notch signaling, siRNA knockdown of RBPjk, a key component of the canonical
Notch signaling pathway, was demonstrated both to reduce proliferation and to increase neuronal differentiation in
neurosphere cells. These observations indicate that Notch signaling promotes progenitor cell proliferation and inhibits
neuronal differentiation in ENS neurospheres.
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Introduction
During vertebrate embryonic development, enteric nervous
system (ENS) progenitor cells arising primarily from the vagal
region of the neural crest migrate rostrocaudally along the gut,
proliferating and differentiating to form the ganglia of the ENS
[1,2,3]. Failure of this migration in humans results in Hirsch-
sprung’s disease (HSCR), characterised by intestinal aganglionosis,
which typically extends to a variable extent rostrally to include the
internal anal sphincter, rectum and distal colon [4]. The absence
of the ENS in the distal bowel causes a smooth muscle constriction
that in turn gives rise to the megacolon seen in neonatal HSCR
patients. Current treatment involves surgical resection of the
aganglionic gut, but a high proportion of patients continue to
experience postoperative morbidity [5], which may result from the
small region of residual aganglionic distal bowel that always
remains after surgery [4]. In recent years several groups have
begun to assess the feasibility of using ENS progenitor cells for
future use to provide a source of neurons to improve the function
of this residual aganglionic gut [6].
We and others have isolated ENS progenitor cells from human
and mouse gut and begun to characterise their properties both
in vitro and after transplantation [7,8,9,10]. Typically, the cells are
grown in culture as aggregates known as neurospheres, by analogy
with the neurosphere cultures previously described for stem cells
derived from the central nervous system (CNS) [11,12]. Both CNS
and ENS neurospheres contain multipotent self-renewing neural
progenitor cells and their neuronal and glial progeny [7,11].
Significantly, ENS neurosphere transplantation into ex vivo
explants of aganglionic embryonic gut restored a normal pattern
of contractility [13].
It is essential to understand the mechanisms controlling
progenitor cell proliferation, self-renewal and differentiation in
neurospheres before the cells can be used safely for transplantation
therapy, as continuing proliferation after transplantation could
result in tumor formation. Clearly the niche provided by
neurospheres in culture differs from that of ENS ganglia in vivo,
and this difference is likely to be the reason for the proliferative
behavior of the cells in neurospheres. It has been well documented
that the proliferation and differentiation of a variety of neural
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e54809
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